data_1pih_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1pih _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo . . . . . 0 N--CA 1.454 -0.84 0 N-CA-C 110.515 -0.61 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 43.9 mtt-85 -58.19 126.33 27.02 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.814 1.245 . . . . 0.0 110.243 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.36 142.95 46.7 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.117 1.367 . . . . 0.0 112.489 -172.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -76.61 143.27 40.31 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.422 1.089 . . . . 0.0 108.294 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -62.03 117.01 5.41 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 165.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.8 16.59 67.59 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 118.263 -1.298 . . . . 0.0 113.652 -174.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -45.58 -58.29 3.52 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 119.818 1.809 . . . . 0.0 112.051 173.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.97 162.18 40.39 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 45.33 47.36 10.51 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.15 1.38 . . . . 0.0 113.199 172.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.85 25.81 10.84 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.69 0.796 . . . . 0.0 111.845 173.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -62.07 142.67 57.42 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 117.928 0.331 . . . . 0.0 111.194 -175.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.9 146.1 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 172.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -73.17 -26.99 61.39 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 124.402 1.081 . . . . 0.0 112.235 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -115.99 116.59 28.19 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 171.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -42.62 -48.97 5.54 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.343 1.057 . . . . 0.0 110.99 175.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.63 -38.16 31.01 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.839 0.856 . . . . 0.0 113.018 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -49.11 -39.53 28.71 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 119.181 0.9 . . . . 0.0 111.477 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.66 9.04 1.2 Allowed 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 118.301 -0.857 . . . . 0.0 113.119 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 62.6 m -49.77 -31.02 10.59 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 120.47 1.486 . . . . 0.0 114.226 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.44 -24.45 76.86 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.64 1.114 . . . . 0.0 112.927 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -79.99 120.13 78.84 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.562 1.145 . . . . 0.0 110.426 -171.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -46.48 -49.28 12.11 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.145 2.563 . . . . 0.0 113.924 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -15.76 60.79 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 117.563 -1.208 . . . . 0.0 113.418 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -73.91 145.82 44.48 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 120.878 1.672 . . . . 0.0 111.529 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -133.38 150.04 51.83 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 127.973 2.509 . . . . 0.0 104.377 165.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -66.69 165.02 15.72 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 124.064 0.852 . . . . 0.0 111.512 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.72 -26.26 3.21 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.077 1.322 . . . . 0.0 112.009 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -69.96 112.1 6.13 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 117.534 0.667 . . . . 0.0 109.333 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.1 mp -123.36 148.96 45.51 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.5 m -42.03 -46.71 4.28 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.437 1.095 . . . . 0.0 110.939 172.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -56.34 -26.8 53.82 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -109.2 23.61 14.27 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.711 1.204 . . . . 0.0 112.001 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 45.7 t -86.48 139.0 31.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.711 1.204 . . . . 0.0 108.942 174.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.52 -25.3 66.0 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 121.319 -0.863 . . . . 0.0 111.813 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -91.29 8.35 36.43 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.479 -0.772 . . . . 0.0 112.047 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 66.3 t-105 -56.73 138.18 53.31 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 120.188 1.358 . . . . 0.0 109.99 174.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.78 -85.18 1.03 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 171.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -163.91 159.1 20.57 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.27 136.41 39.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 90.2 t -106.74 -48.53 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.652 1.181 . . . . 0.0 108.383 -172.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -151.43 -138.98 0.09 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.93 0.492 . . . . 0.0 112.24 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -69.19 66.83 0.17 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.919 2.488 . . . . 0.0 113.013 -163.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.52 33.34 61.13 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 -175.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -131.65 143.5 50.35 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 125.893 1.677 . . . . 0.0 108.684 173.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -153.14 178.01 30.44 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 124.183 0.897 . . . . 0.0 111.489 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 32.4 mtp85 -88.31 159.13 18.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.308 0.643 . . . . 0.0 111.998 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.5 t . . . . . 0 CA--C 1.531 0.226 0 C-N-CA 125.837 1.655 . . . . 0.0 108.038 179.259 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.7 t70 . . . . . 0 CA--C 1.536 0.409 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -35.87 -45.44 0.4 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.98 1.312 . . . . 0.0 112.075 166.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 m -116.5 150.63 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 123.831 0.852 . . . . 0.0 108.987 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.4 tp -82.64 121.39 26.77 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.3 m -88.44 144.25 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 118.923 0.783 . . . . 0.0 109.161 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.3 tttm -67.01 136.97 56.11 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 174.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.62 -40.9 66.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 119.313 -0.375 . . . . 0.0 111.488 174.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -85.05 7.95 19.62 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 174.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.73 -177.27 23.46 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -160.07 155.58 25.48 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 172.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.0 p -143.27 167.17 22.78 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.097 0.959 . . . . 0.0 110.766 173.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.3 p -73.5 -21.7 60.34 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.33 1.0 OUTLIER -71.13 -5.37 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 119.433 1.015 . . . . 0.0 112.448 171.022 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -45.72 132.16 8.77 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 119.058 0.844 . . . . 0.0 111.652 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.32 139.47 35.74 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 166.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.25 151.14 54.28 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.058 1.838 . . . . 0.0 110.657 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.351 0 C-N-CA 123.894 0.878 . . . . 0.0 110.289 178.206 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 N--CA 1.455 -0.791 0 N-CA-C 111.079 -0.393 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 42.5 mtt-85 -63.95 125.31 24.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.557 1.143 . . . . 0.0 110.212 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.22 142.75 54.02 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.796 1.238 . . . . 0.0 112.171 -173.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -76.17 145.7 39.7 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.497 1.119 . . . . 0.0 108.731 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -62.37 121.21 12.65 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 164.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.87 20.85 75.53 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 118.267 -1.296 . . . . 0.0 113.448 -172.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -40.97 -56.8 2.17 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 119.488 1.644 . . . . 0.0 111.46 169.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.2 172.74 10.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.658 1.583 . . . . 0.0 106.96 174.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 44.28 47.56 7.84 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 124.412 1.085 . . . . 0.0 112.76 171.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 57.53 21.29 6.92 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 122.799 0.44 . . . . 0.0 111.498 172.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -62.53 140.7 58.63 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.521 0.601 . . . . 0.0 111.259 -172.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.2 m -126.88 143.56 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 173.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -71.33 -26.89 63.02 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.882 0.873 . . . . 0.0 111.684 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -112.08 111.42 22.31 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 169.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -45.13 -44.32 10.52 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.909 1.284 . . . . 0.0 110.957 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.55 -35.54 63.36 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.125 -0.94 . . . . 0.0 112.627 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -48.18 -43.75 32.02 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-O 122.278 1.037 . . . . 0.0 110.84 174.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.35 6.23 5.92 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.458 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -55.08 -28.54 53.19 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 120.258 1.39 . . . . 0.0 112.368 171.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.44 -14.15 59.47 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.518 1.056 . . . . 0.0 113.769 174.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -99.89 108.19 50.33 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 125.891 1.677 . . . . 0.0 111.502 -171.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -54.51 117.55 4.08 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 N-CA-C 108.258 -1.478 . . . . 0.0 108.258 162.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.7 tpt85 127.18 -41.32 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 129.023 2.929 . . . . 0.0 108.517 -169.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -66.81 153.79 42.49 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 169.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -152.75 136.26 15.97 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.198 168.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.5 mp0 -60.3 115.35 3.46 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.521 1.928 . . . . 0.0 110.112 -169.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.4 -30.76 5.29 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -176.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -66.93 115.66 6.91 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 mp -131.04 149.85 52.42 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 127.004 2.122 . . . . 0.0 105.405 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.2 m -43.58 -47.37 7.42 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.953 1.301 . . . . 0.0 111.43 173.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.44 -22.02 52.99 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -109.77 26.13 11.0 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.307 1.043 . . . . 0.0 112.344 175.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.7 t -97.06 136.78 37.12 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.568 1.547 . . . . 0.0 109.263 175.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.46 -20.86 65.93 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 120.929 -1.107 . . . . 0.0 113.002 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -80.4 -8.58 59.58 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.437 0.562 . . . . 0.0 112.113 175.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 74.9 t-105 -58.29 141.12 51.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.705 0.684 . . . . 0.0 111.501 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.61 -69.0 1.27 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 173.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -174.5 157.35 2.62 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -168.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.32 130.97 35.22 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 166.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.4 t -97.05 -49.31 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -175.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -152.07 -128.59 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -171.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -74.77 63.93 1.21 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.379 1.872 . . . . 0.0 112.623 -162.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.6 28.19 67.9 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.258 0.933 . . . . 0.0 110.944 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -126.79 145.17 50.73 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.823 1.649 . . . . 0.0 109.168 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -153.77 178.7 30.56 Favored Glycine 0 N--CA 1.436 -1.352 0 CA-C-O 122.208 0.893 . . . . 0.0 112.302 177.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -89.58 145.87 24.97 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.22 -0.99 . . . . 0.0 108.437 -172.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 175.241 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.471 0.578 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.0 pm0 -61.75 -16.82 52.68 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -175.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.2 m -132.01 158.36 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 119.556 1.071 . . . . 0.0 110.499 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.1 tp -91.85 123.2 35.04 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 175.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.0 m -94.85 148.97 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -67.65 137.22 55.42 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.14 -42.23 65.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.936 173.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -81.32 6.1 15.3 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 175.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.62 -177.32 34.76 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 119.539 1.063 . . . . 0.0 110.654 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 43.8 t90 -163.15 154.72 17.49 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 170.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 7.9 p -139.92 161.54 37.35 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.748 1.619 . . . . 0.0 110.034 173.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 89.9 p -70.65 -10.05 58.46 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.327 -0.858 . . . . 0.0 112.921 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.7 t -64.76 -35.26 74.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.268 1.027 . . . . 0.0 109.256 168.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -27.06 113.01 0.06 Allowed 'General case' 0 C--N 1.347 0.46 0 C-N-CA 126.43 1.892 . . . . 0.0 114.285 -170.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -113.24 133.18 22.14 Favored Pre-proline 0 N--CA 1.455 -0.22 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 167.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.11 150.55 66.26 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.704 1.602 . . . . 0.0 110.929 -177.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.331 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.342 177.003 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo . . . . . 0 N--CA 1.458 -0.603 0 N-CA-C 111.239 -0.331 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.9 mtt-85 -62.41 133.25 54.78 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.491 1.116 . . . . 0.0 110.895 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.98 145.49 55.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.986 1.315 . . . . 0.0 112.25 -174.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -75.45 142.89 42.88 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 124.82 1.248 . . . . 0.0 108.183 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -62.38 120.33 10.83 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 164.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.94 26.41 66.88 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 118.116 -1.38 . . . . 0.0 113.37 -172.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -42.73 -55.8 3.46 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 119.765 1.782 . . . . 0.0 110.767 167.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -165.48 169.99 14.93 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.715 1.206 . . . . 0.0 108.315 174.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.0 m-70 46.71 40.73 9.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.561 1.544 . . . . 0.0 113.335 172.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 57.16 30.65 18.68 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.621 1.168 . . . . 0.0 111.771 177.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -62.92 139.74 58.77 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 122.159 -0.338 . . . . 0.0 111.048 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 m -124.74 141.35 45.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 125.028 1.331 . . . . 0.0 107.841 172.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -68.54 -24.43 64.63 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 123.899 0.88 . . . . 0.0 112.196 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -117.7 122.8 44.46 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.138 1.375 . . . . 0.0 108.031 170.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.6 -49.05 62.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.667 0.787 . . . . 0.0 111.35 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.61 -23.06 66.13 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 117.768 -1.111 . . . . 0.0 112.793 -174.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -44.42 -44.08 8.15 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.831 1.196 . . . . 0.0 110.493 167.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.58 10.09 4.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.651 -175.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.9 t -69.45 -1.03 7.42 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 120.107 1.321 . . . . 0.0 114.43 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.96 -15.19 56.7 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.384 0.992 . . . . 0.0 111.81 169.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -81.28 114.41 48.97 Favored Pre-proline 0 N--CA 1.452 -0.346 0 C-N-CA 124.414 1.086 . . . . 0.0 109.671 -172.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -62.05 118.38 5.26 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 N-CA-C 107.114 -1.918 . . . . 0.0 107.114 165.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.7 tpt85 124.96 -37.62 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 129.204 3.002 . . . . 0.0 108.776 -168.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -64.83 148.3 51.59 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 168.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.7 tm0? -154.83 131.89 10.93 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -62.04 125.01 22.38 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 126.694 1.998 . . . . 0.0 112.532 -168.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.68 -25.18 23.61 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-O 118.822 -0.988 . . . . 0.0 111.345 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -60.08 119.5 7.93 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.096 1.448 . . . . 0.0 108.28 173.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 mp -131.41 153.26 49.88 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 127.048 2.139 . . . . 0.0 107.044 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 55.6 m -48.5 -49.45 35.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.619 0.768 . . . . 0.0 111.269 173.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.252 4.6 tt0 -76.92 31.35 0.13 Allowed 'General case' 0 CA--C 1.547 0.832 0 O-C-N 119.881 -1.762 . . . . 0.0 113.615 175.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -143.11 30.31 1.43 Allowed 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.573 -1.329 . . . . 0.0 110.629 155.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 47.9 t -102.69 138.41 39.63 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.056 1.742 . . . . 0.0 110.48 -175.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.59 -19.02 64.44 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 120.929 -1.107 . . . . 0.0 112.256 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -85.09 -0.21 53.74 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.853 0.861 . . . . 0.0 111.672 172.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 33.5 t-105 -66.05 148.72 51.38 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 119.384 0.993 . . . . 0.0 110.897 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.01 -99.25 1.45 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 107.42 -2.272 . . . . 0.0 107.42 165.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -148.36 159.91 43.53 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.788 1.635 . . . . 0.0 107.061 175.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.91 146.61 41.61 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.266 0.555 . . . . 0.0 110.694 166.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.6 t -118.83 -52.75 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 125.575 1.55 . . . . 0.0 108.568 -177.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -147.67 -152.85 0.46 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.672 0.789 . . . . 0.0 111.21 -175.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -56.54 68.45 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 130.031 3.332 . . . . 0.0 114.353 -163.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.05 30.71 67.37 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.648 1.118 . . . . 0.0 110.569 -174.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -129.19 146.35 51.13 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.359 1.464 . . . . 0.0 108.902 174.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -155.95 173.52 33.93 Favored Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.8 mtp-105 -78.13 130.22 36.11 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.097 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 39.8 t . . . . . 0 CA--C 1.536 0.422 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 150.574 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 121.178 0.513 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -48.64 -46.63 40.12 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 127.16 2.184 . . . . 0.0 113.102 -176.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.1 m -111.71 153.68 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.88 1.272 . . . . 0.0 109.781 -169.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.2 tp -84.53 127.97 34.33 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.2 t -98.62 141.84 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -170.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -68.07 133.85 49.65 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.56 -35.17 71.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 119.264 -0.398 . . . . 0.0 111.856 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.53 3.86 34.62 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 173.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.65 -176.48 16.1 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 119.499 1.045 . . . . 0.0 111.257 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 72.9 t90 -158.7 156.59 30.19 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 171.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 10.3 p -142.24 171.38 14.13 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.779 0.831 . . . . 0.0 110.718 169.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.0 p -71.41 -29.66 65.18 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -174.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.5 m -67.74 -70.35 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 58.2 t80 58.72 -85.34 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.203 1.801 . . . . 0.0 112.241 177.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 62.68 124.95 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.258 1.823 . . . . 0.0 111.299 -162.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -71.26 146.75 51.86 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.096 1.864 . . . . 0.0 111.196 -177.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 121.733 0.778 . . . . 0.0 109.423 175.626 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo . . . . . 0 N--CA 1.454 -0.819 0 N-CA-C 110.821 -0.492 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 34.9 mtt-85 -61.78 129.58 41.66 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.683 1.193 . . . . 0.0 111.137 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.97 143.35 56.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.241 1.417 . . . . 0.0 112.442 -172.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -78.03 144.7 36.42 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.48 1.112 . . . . 0.0 108.595 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -63.46 122.08 15.4 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 165.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.66 22.98 73.98 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.174 -1.348 . . . . 0.0 113.085 -172.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -39.96 -56.77 1.76 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 119.431 1.615 . . . . 0.0 111.253 167.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -168.32 175.85 6.2 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.612 1.565 . . . . 0.0 107.275 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 37.11 50.07 0.9 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.053 1.741 . . . . 0.0 112.865 175.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 57.37 23.53 9.04 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.57 0.748 . . . . 0.0 112.054 172.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -63.4 136.97 57.98 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 118.111 0.414 . . . . 0.0 110.911 -174.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.7 m -124.04 141.61 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 173.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 -69.32 -23.91 63.85 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 123.851 0.86 . . . . 0.0 111.764 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -115.55 115.13 25.93 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.675 1.19 . . . . 0.0 107.931 171.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -43.39 -48.33 7.02 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.807 1.243 . . . . 0.0 110.983 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.5 -35.18 52.44 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.45 -0.786 . . . . 0.0 112.962 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -51.42 -40.52 59.5 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.617 1.098 . . . . 0.0 110.809 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.72 6.6 5.75 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.343 -0.837 . . . . 0.0 112.785 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.9 t -52.2 -32.66 37.46 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.917 1.235 . . . . 0.0 112.507 173.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.37 -21.67 76.04 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 114.659 -1.155 . . . . 0.0 113.8 176.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -80.32 114.93 51.22 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 119.079 1.44 . . . . 0.0 111.355 -168.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.29 107.65 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 N-CA-C 107.229 -1.873 . . . . 0.0 107.229 165.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 143.16 -35.81 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 1 C-N-CA 132.074 4.15 . . . . 0.0 108.652 -174.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -77.12 151.27 35.45 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.284 1.034 . . . . 0.0 110.946 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -137.6 146.49 44.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.675 2.39 . . . . 0.0 105.638 166.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -63.28 158.97 18.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.077 0.951 . . . . 0.0 111.155 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.38 -26.71 4.95 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.28 0.943 . . . . 0.0 111.792 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -67.18 112.25 4.37 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.2 mp -124.61 148.26 48.0 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 177.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.8 m -42.18 -45.66 4.14 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.482 1.113 . . . . 0.0 111.919 172.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -56.08 -26.43 49.42 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.729 -1.232 . . . . 0.0 113.972 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -108.91 27.24 9.69 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.131 1.372 . . . . 0.0 112.055 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 50.1 t -94.95 139.9 30.7 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.108 1.363 . . . . 0.0 109.331 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.73 -24.82 67.05 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.333 -0.855 . . . . 0.0 112.569 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -82.19 -2.8 53.45 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.37 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -61.98 140.51 58.33 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 119.256 0.935 . . . . 0.0 111.726 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.64 -71.78 1.25 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.277 1.418 . . . . 0.0 109.78 173.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -174.7 157.38 2.51 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.197 1.399 . . . . 0.0 107.39 -167.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.73 133.47 34.37 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 169.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.98 -49.08 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 124.568 1.147 . . . . 0.0 109.887 -174.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -146.41 -161.25 1.28 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.26 1.024 . . . . 0.0 110.108 -172.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -56.4 71.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 129.361 3.064 . . . . 0.0 114.293 -161.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.74 34.35 77.78 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -172.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -129.58 146.15 51.41 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 125.259 1.424 . . . . 0.0 109.222 173.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.28 -172.6 28.84 Favored Glycine 0 N--CA 1.432 -1.621 0 CA-C-O 121.99 0.772 . . . . 0.0 112.097 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -93.11 139.68 30.31 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -171.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.1 t . . . . . 0 C--N 1.33 -0.26 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 173.202 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 p30 . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -51.05 -35.06 32.63 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.996 0.816 . . . . 0.0 112.881 169.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.1 m -128.43 163.56 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 125.325 1.45 . . . . 0.0 109.736 -172.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.4 tp -86.93 129.57 34.82 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.4 t -98.58 135.34 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 124.069 0.948 . . . . 0.0 108.812 -168.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -65.25 131.12 45.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 176.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.02 -39.81 63.41 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.226 0.611 . . . . 0.0 111.626 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -83.87 2.33 38.95 Favored 'General case' 0 C--N 1.342 0.242 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.78 -177.06 23.24 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 119.412 1.005 . . . . 0.0 111.314 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 60.8 t90 -160.77 149.98 16.97 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 171.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 7.5 p -134.77 162.51 32.14 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.194 1.398 . . . . 0.0 109.838 174.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.8 p -71.93 -14.33 61.89 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 120.655 -1.278 . . . . 0.0 112.79 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.348 1.7 p -85.44 10.0 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 125.562 1.545 . . . . 0.0 111.723 166.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -52.84 126.16 19.28 Favored 'General case' 0 C--N 1.342 0.27 0 O-C-N 120.54 -1.35 . . . . 0.0 110.232 163.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.83 134.06 24.81 Favored Pre-proline 0 N--CA 1.454 -0.254 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 169.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.51 148.42 66.62 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 121.675 1.583 . . . . 0.0 110.821 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.356 0 C-N-CA 123.882 0.873 . . . . 0.0 110.213 177.913 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo . . . . . 0 N--CA 1.452 -0.952 0 N-CA-C 110.353 -0.672 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 -71.59 125.61 27.52 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -174.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -54.39 145.25 18.57 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.513 1.525 . . . . 0.0 113.1 -166.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -76.2 142.66 41.43 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.227 1.011 . . . . 0.0 108.459 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -63.36 116.33 5.42 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 164.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.74 25.23 60.82 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.327 -1.263 . . . . 0.0 113.222 -172.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -41.74 -53.69 3.56 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 119.399 1.599 . . . . 0.0 110.743 166.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.06 178.57 6.29 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.298 1.439 . . . . 0.0 107.415 169.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.1 m170 39.97 48.13 2.05 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 125.977 1.711 . . . . 0.0 112.414 165.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.41 20.86 7.79 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.046 1.338 . . . . 0.0 112.545 170.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -63.12 133.97 55.28 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 118.397 0.544 . . . . 0.0 110.036 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.56 144.15 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 168.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -60.38 -38.1 82.83 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.346 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.12 136.11 44.35 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 168.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.62 -28.29 69.26 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.583 0.753 . . . . 0.0 110.884 171.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.68 -52.71 29.1 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.383 0.538 . . . . 0.0 111.792 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -55.71 -30.95 62.01 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.961 1.305 . . . . 0.0 111.729 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.4 -8.77 49.55 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.941 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.7 t -51.53 -31.6 24.67 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 119.672 1.124 . . . . 0.0 113.253 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.01 -24.55 67.06 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-N 115.02 -0.991 . . . . 0.0 113.158 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -88.51 107.56 17.58 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 124.779 1.232 . . . . 0.0 110.841 -171.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -58.67 120.57 8.53 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 N-CA-C 107.006 -1.959 . . . . 0.0 107.006 161.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 52.6 tpt85 127.58 -38.6 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 129.103 2.961 . . . . 0.0 108.876 -167.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -70.39 160.07 33.01 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.765 0.793 . . . . 0.0 109.715 169.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -155.18 131.36 10.25 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 113.87 -1.513 . . . . 0.0 109.242 169.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.0 mp0 -56.1 113.0 1.35 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 127.198 2.199 . . . . 0.0 109.998 -175.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 126.43 -33.79 3.36 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -67.42 118.79 11.24 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.377 1.088 . . . . 0.0 108.335 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.7 mp -131.94 152.85 50.83 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.452 1.901 . . . . 0.0 106.875 176.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.3 m -49.29 -47.58 46.74 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.661 0.784 . . . . 0.0 111.148 175.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.257 6.3 tt0 -75.1 23.96 0.1 Allowed 'General case' 0 CA--C 1.55 0.961 0 O-C-N 120.261 -1.524 . . . . 0.0 113.838 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -139.04 28.19 2.33 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.54 -1.35 . . . . 0.0 110.998 157.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 50.4 t -96.34 135.78 37.72 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.857 1.663 . . . . 0.0 108.291 175.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.42 -22.27 64.86 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.322 -0.861 . . . . 0.0 112.232 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -88.74 2.99 52.46 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 118.821 -0.609 . . . . 0.0 112.481 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 60.7 t-105 -59.51 139.39 57.17 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 119.065 0.848 . . . . 0.0 110.9 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.38 -105.87 0.6 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.163 -1.975 . . . . 0.0 108.163 167.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -146.26 156.31 43.29 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.959 1.304 . . . . 0.0 107.876 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.12 146.16 54.68 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 123.867 0.729 . . . . 0.0 110.577 171.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.5 t -118.99 -54.99 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.897 1.279 . . . . 0.0 109.214 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -154.1 155.63 35.76 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 124.515 1.126 . . . . 0.0 109.454 -176.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.9 t0 48.91 31.8 3.43 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 148.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.17 33.4 44.92 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 120.908 -1.12 . . . . 0.0 112.921 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 64.7 m95 -134.55 160.39 38.2 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 127.376 2.27 . . . . 0.0 108.739 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.56 175.69 38.95 Favored Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.3 mtp-105 -78.97 142.03 37.0 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.154 -0.523 . . . . 0.0 110.437 174.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.6 t . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 168.15 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.4 t70 . . . . . 0 N--CA 1.466 0.356 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -42.9 -42.21 3.6 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.4 1.08 . . . . 0.0 112.89 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.7 m -117.04 156.75 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 124.727 1.211 . . . . 0.0 109.569 -173.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.8 tp -81.66 132.4 35.3 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 69.0 t -104.58 131.14 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 123.763 0.825 . . . . 0.0 109.166 -167.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -62.02 132.1 51.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.02 -34.98 78.73 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.068 -177.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -81.34 -1.19 44.42 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 118.077 -0.963 . . . . 0.0 113.568 172.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.62 -174.55 16.63 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 119.751 1.16 . . . . 0.0 111.159 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 17.8 t90 -165.53 153.09 10.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 7.7 p -135.62 161.72 34.73 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.575 1.15 . . . . 0.0 109.259 174.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.2 p -71.64 -14.63 62.11 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.091 -1.006 . . . . 0.0 112.713 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.35 0.9 OUTLIER -75.32 -6.85 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 119.327 0.967 . . . . 0.0 112.478 170.007 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -40.39 125.45 2.12 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 124.642 1.177 . . . . 0.0 112.441 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.18 134.44 23.37 Favored Pre-proline 0 C--N 1.331 -0.197 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 168.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.19 149.27 63.91 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 121.607 1.538 . . . . 0.0 110.917 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.336 0 C-N-CA 123.801 0.841 . . . . 0.0 110.508 178.417 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 N--CA 1.452 -0.945 0 N-CA-C 110.687 -0.543 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 26.0 mtp180 -81.71 126.93 32.38 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -170.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -53.84 140.14 31.25 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.339 1.456 . . . . 0.0 113.544 -165.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.7 145.31 48.92 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.348 1.459 . . . . 0.0 108.348 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -50.29 122.15 6.54 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 157.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 65.79 27.75 73.01 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.027 -1.43 . . . . 0.0 114.188 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -42.94 -56.37 3.32 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 119.839 1.819 . . . . 0.0 111.816 171.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.88 165.56 35.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 173.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 44.57 48.52 8.54 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.815 1.246 . . . . 0.0 113.22 170.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.24 20.23 10.82 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.995 0.518 . . . . 0.0 111.882 170.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -62.19 144.33 55.61 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.605 0.639 . . . . 0.0 112.676 -171.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.1 m -127.86 144.39 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 124.764 1.226 . . . . 0.0 108.594 173.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -70.49 -26.51 63.64 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.395 0.678 . . . . 0.0 112.372 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -117.69 116.31 26.8 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 173.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -46.5 -44.75 17.93 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.245 1.018 . . . . 0.0 111.065 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.47 -37.89 58.13 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.464 -0.779 . . . . 0.0 112.619 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -48.07 -43.08 30.23 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-O 122.237 1.018 . . . . 0.0 110.83 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.35 3.21 11.48 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 118.05 -0.976 . . . . 0.0 112.762 -174.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.4 t -58.73 -24.37 61.44 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 120.615 1.552 . . . . 0.0 112.463 173.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.59 -25.8 70.48 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.134 0.873 . . . . 0.0 113.117 171.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -81.5 111.06 22.23 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 124.477 1.111 . . . . 0.0 110.954 -172.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -61.39 111.44 1.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 N-CA-C 107.172 -1.895 . . . . 0.0 107.172 163.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 141.1 -44.19 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.785 1 C-N-CA 131.991 4.116 . . . . 0.0 105.762 -170.093 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -64.28 153.75 37.25 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.991 0.901 . . . . 0.0 110.89 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -144.57 138.51 27.52 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 128.168 2.587 . . . . 0.0 106.526 170.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -58.48 149.49 25.05 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 127.223 2.209 . . . . 0.0 110.19 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.24 -16.96 35.76 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.657 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -75.32 96.96 3.47 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.046 1.423 . . . . 0.0 109.242 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.7 mp -101.56 147.44 26.4 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.905 1.682 . . . . 0.0 107.408 165.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 m -44.64 -43.19 8.06 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.396 1.479 . . . . 0.0 111.425 175.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -61.97 -16.85 54.42 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.436 -1.415 . . . . 0.0 113.933 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -94.84 2.8 55.49 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.128 1.371 . . . . 0.0 111.84 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 38.3 t -81.28 131.92 35.31 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.537 1.135 . . . . 0.0 109.129 -173.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.73 -19.11 47.93 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.198 -0.939 . . . . 0.0 112.165 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.6 m-30 -87.39 -9.65 54.18 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.171 0.988 . . . . 0.0 112.328 177.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -55.38 142.41 32.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.189 0.596 . . . . 0.0 111.154 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.62 -97.79 1.4 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 171.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -141.89 158.83 43.31 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.254 1.422 . . . . 0.0 107.834 178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.04 151.08 43.4 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 123.822 0.701 . . . . 0.0 109.972 172.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.1 t -123.82 -50.72 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.208 1.403 . . . . 0.0 109.99 -172.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -140.73 -138.64 0.12 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.538 0.735 . . . . 0.0 112.206 -176.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -68.51 64.18 0.11 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 127.943 2.497 . . . . 0.0 113.583 -167.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.04 56.14 25.66 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 108.206 -1.957 . . . . 0.0 108.206 -168.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -133.75 154.51 50.92 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 165.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -164.97 174.82 40.94 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-O 122.489 1.05 . . . . 0.0 112.468 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -73.68 145.43 45.26 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 126.473 1.909 . . . . 0.0 111.452 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 29.0 t . . . . . 0 CA--C 1.549 0.924 0 C-N-CA 127.986 2.515 . . . . 0.0 110.148 -176.0 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.6 t70 . . . . . 0 CA--C 1.535 0.374 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.94 -55.5 10.76 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 171.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.3 m -78.01 165.94 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 169.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 22.5 tp -102.87 131.3 49.86 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.624 1.17 . . . . 0.0 108.508 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.0 m -97.21 143.29 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 119.393 0.997 . . . . 0.0 110.368 -175.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.12 137.02 57.3 Favored 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 172.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.08 -42.13 72.43 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.909 0.884 . . . . 0.0 110.214 171.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -80.95 7.1 11.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.91 -175.38 32.0 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 76.8 t90 -159.37 154.16 24.62 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 169.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 6.8 p -138.21 165.97 25.35 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 124.0 0.812 . . . . 0.0 110.755 170.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.0 p -64.48 -31.99 73.43 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.698 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.284 1.3 m -72.97 -3.23 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 118.353 -0.832 . . . . 0.0 113.095 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -44.84 127.15 6.21 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.35 0.977 . . . . 0.0 110.859 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.2 132.81 24.27 Favored Pre-proline 0 N--CA 1.454 -0.259 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 168.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.44 151.2 65.03 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.823 1.682 . . . . 0.0 110.971 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.348 0 C-N-CA 123.808 0.843 . . . . 0.0 110.429 176.388 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo . . . . . 0 N--CA 1.451 -1.018 0 N-CA-C 110.009 -0.804 . . . . 0.0 110.009 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 34.0 mtt-85 -58.59 126.25 26.83 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.849 1.26 . . . . 0.0 110.476 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.33 143.58 39.23 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.474 1.51 . . . . 0.0 111.253 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.64 149.38 22.83 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.496 0.665 . . . . 0.0 111.113 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.85 121.02 11.86 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.94 15.78 69.21 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 117.913 -1.493 . . . . 0.0 113.124 -173.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -38.84 -58.44 1.08 Allowed 'General case' 0 C--N 1.346 0.448 0 CA-C-N 119.603 1.701 . . . . 0.0 111.994 172.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -169.03 172.01 7.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.548 1.539 . . . . 0.0 107.221 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 39.02 50.52 1.78 Allowed 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.709 1.604 . . . . 0.0 112.476 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 55.41 25.71 7.98 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.272 1.029 . . . . 0.0 112.553 174.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -63.65 137.58 58.15 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.386 0.539 . . . . 0.0 111.125 -175.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.4 m -124.22 144.29 34.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 172.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -71.89 -27.43 62.84 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.25 1.02 . . . . 0.0 111.852 176.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -113.98 114.21 25.85 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 171.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -40.63 -49.33 3.0 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.352 1.461 . . . . 0.0 111.054 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.54 -34.69 59.13 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.589 0.756 . . . . 0.0 112.982 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -50.04 -41.2 47.09 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.532 1.06 . . . . 0.0 110.935 174.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.74 9.78 2.61 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 118.428 -0.796 . . . . 0.0 112.805 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.3 t -52.66 -31.76 38.76 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 120.115 1.325 . . . . 0.0 112.691 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.82 -21.77 78.11 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.696 1.141 . . . . 0.0 113.823 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -79.72 115.45 53.78 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 118.752 1.276 . . . . 0.0 111.362 -168.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.02 72.87 3.22 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.961 2.441 . . . . 0.0 111.21 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 52.8 mmt-85 -178.06 -36.27 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 131.623 3.969 . . . . 0.0 107.953 173.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -58.91 151.63 21.31 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.58 0.705 . . . . 0.0 110.399 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -136.75 146.04 45.31 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 166.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -59.38 148.43 32.58 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.462 0.649 . . . . 0.0 110.167 176.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.43 -23.16 16.7 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.348 0.975 . . . . 0.0 112.569 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -72.63 105.09 4.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 118.342 1.071 . . . . 0.0 108.765 177.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.7 mp -117.29 149.0 41.18 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 14.8 m -42.19 -46.19 4.32 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.248 1.419 . . . . 0.0 111.33 172.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -56.91 -26.82 59.98 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.789 -1.194 . . . . 0.0 114.152 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -107.16 19.15 20.79 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.11 0.964 . . . . 0.0 112.562 176.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.5 t -82.88 134.56 35.08 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.612 1.165 . . . . 0.0 108.525 173.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.87 -19.26 59.88 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.056 -1.027 . . . . 0.0 112.108 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -87.63 -5.21 58.83 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.451 -0.785 . . . . 0.0 111.425 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -53.86 142.71 23.32 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.543 1.065 . . . . 0.0 111.465 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.87 -85.95 1.17 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 173.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -166.31 158.95 14.43 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.08 137.01 38.68 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 123.603 0.564 . . . . 0.0 110.029 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 90.1 t -108.99 -49.93 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 125.417 1.487 . . . . 0.0 109.255 -175.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -151.71 -155.44 0.62 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.339 1.056 . . . . 0.0 110.886 -175.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -56.96 70.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 129.394 3.077 . . . . 0.0 114.416 -160.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.58 36.65 88.53 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -172.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -130.81 143.44 50.74 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 125.444 1.497 . . . . 0.0 109.065 173.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -156.77 -176.56 28.99 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-O 121.755 0.642 . . . . 0.0 112.189 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 48.4 mmm-85 -90.87 154.89 19.16 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.34 1.056 . . . . 0.0 109.963 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.455 -0.183 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -179.097 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.2 t70 . . . . . 0 CA--C 1.536 0.433 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -24.34 -53.74 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.469 2.308 . . . . 0.0 112.897 160.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.6 m -126.7 159.05 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.853 1.661 . . . . 0.0 108.064 -170.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.3 tp -79.16 123.41 27.36 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.2 t -92.32 129.24 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -171.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -63.38 131.28 47.74 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.14 -41.99 49.85 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.484 0.714 . . . . 0.0 111.512 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -84.84 5.45 28.7 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.35 -176.01 27.43 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 119.414 1.006 . . . . 0.0 111.148 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 83.1 t90 -159.19 153.72 24.25 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 170.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 2.0 p -142.06 163.63 32.35 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.861 1.264 . . . . 0.0 110.578 175.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.1 p -78.14 -5.95 53.22 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.284 1.5 m -83.61 0.3 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 119.598 1.09 . . . . 0.0 112.169 164.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -47.14 137.98 7.33 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 119.073 0.852 . . . . 0.0 111.708 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -134.57 138.7 30.59 Favored Pre-proline 0 N--CA 1.454 -0.259 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 167.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.11 149.85 52.97 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.033 1.822 . . . . 0.0 111.147 -176.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.321 0 C-N-CA 123.932 0.893 . . . . 0.0 110.071 176.463 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo . . . . . 0 N--CA 1.455 -0.743 0 N-CA-C 110.813 -0.495 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -57.89 125.69 24.16 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.065 1.346 . . . . 0.0 110.604 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.15 150.14 30.69 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.189 1.396 . . . . 0.0 112.75 -173.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -83.34 144.57 29.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.913 1.285 . . . . 0.0 108.623 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.1 121.98 14.4 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 166.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.79 22.91 76.28 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.175 -1.347 . . . . 0.0 113.271 -173.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -42.04 -55.09 3.31 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 119.557 1.678 . . . . 0.0 111.182 168.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -165.94 173.89 10.03 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.066 1.347 . . . . 0.0 108.06 173.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 38.33 50.69 1.5 Allowed 'General case' 0 C--N 1.341 0.23 0 C-N-CA 126.025 1.73 . . . . 0.0 112.986 172.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.2 20.5 8.56 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.384 0.674 . . . . 0.0 111.905 171.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -63.22 136.02 57.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.862 0.755 . . . . 0.0 110.543 -175.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.9 m -122.62 142.19 40.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -62.74 -36.66 83.74 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.921 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -109.01 123.3 48.93 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 123.401 0.68 . . . . 0.0 109.362 170.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.56 -36.44 10.56 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.25 1.42 . . . . 0.0 110.919 171.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.24 -40.99 64.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -56.38 -37.63 70.34 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 122.024 0.916 . . . . 0.0 110.604 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.51 0.69 13.96 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 117.831 -1.081 . . . . 0.0 112.245 -175.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.2 t -52.29 -30.39 27.88 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 120.36 1.436 . . . . 0.0 112.861 172.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.25 -27.2 72.13 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.49 1.043 . . . . 0.0 113.679 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -81.49 114.86 52.91 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 118.375 1.087 . . . . 0.0 111.494 -169.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.05 108.7 0.8 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 N-CA-C 107.614 -1.726 . . . . 0.0 107.614 165.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 139.34 -35.41 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 131.487 3.915 . . . . 0.0 108.748 -173.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -71.9 156.55 39.15 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.492 0.663 . . . . 0.0 109.765 175.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -155.16 138.94 16.17 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.384 165.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -54.71 115.61 2.25 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 128.114 2.565 . . . . 0.0 109.53 -175.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.37 -21.19 11.96 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -72.92 109.27 6.35 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 167.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.2 mp -122.89 148.64 45.2 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.355 2.262 . . . . 0.0 106.137 172.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 6.5 m -45.07 -44.49 10.35 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.498 1.519 . . . . 0.0 111.711 175.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -59.12 -18.81 39.0 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 120.657 -1.277 . . . . 0.0 113.903 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -96.8 3.98 51.99 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.217 1.407 . . . . 0.0 112.043 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.2 t -90.79 139.99 30.21 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.849 1.26 . . . . 0.0 110.396 -169.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.84 -11.3 58.31 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.007 -1.058 . . . . 0.0 112.857 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -88.96 -3.92 58.59 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.604 171.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -59.52 132.28 53.52 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.07 0.85 . . . . 0.0 110.321 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.88 -81.03 1.13 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 171.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.6 165.68 12.18 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.612 0.765 . . . . 0.0 110.165 163.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.74 146.64 36.03 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.313 1.045 . . . . 0.0 111.034 170.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.2 t -125.23 -48.47 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 124.925 1.29 . . . . 0.0 109.211 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -149.17 -159.15 0.99 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.016 0.926 . . . . 0.0 110.192 -174.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -59.32 70.3 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 129.648 3.179 . . . . 0.0 113.799 -162.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.0 30.08 57.96 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -131.55 143.02 50.06 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 124.949 1.299 . . . . 0.0 108.845 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -152.89 172.91 31.91 Favored Glycine 0 N--CA 1.433 -1.508 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -72.03 127.76 33.56 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.105 170.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 52.0 t . . . . . 0 C--O 1.242 0.7 0 N-CA-C 104.778 -2.305 . . . . 0.0 104.778 141.062 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 t0 . . . . . 0 CA--C 1.532 0.279 0 CA-C-O 120.974 0.416 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -52.13 -41.43 62.5 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.456 1.903 . . . . 0.0 112.37 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.6 m -114.94 153.66 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 125.476 1.51 . . . . 0.0 109.424 -173.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.6 tp -85.28 136.27 33.57 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.6 t -104.97 134.8 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 123.608 0.763 . . . . 0.0 109.089 -167.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -64.01 129.64 40.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.17 -40.11 67.2 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.167 0.587 . . . . 0.0 111.632 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -82.7 1.26 39.5 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 175.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.57 -174.0 19.23 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 120.055 1.298 . . . . 0.0 111.832 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 75.2 t90 -163.87 150.64 11.81 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 174.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.6 p -135.76 162.99 31.21 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.142 1.377 . . . . 0.0 110.462 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.4 p -68.08 -21.76 64.96 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 118.454 -0.784 . . . . 0.0 112.521 -176.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.292 1.1 m -76.29 -4.64 6.39 Favored 'Isoleucine or valine' 0 C--N 1.344 0.36 0 CA-C-N 119.249 0.931 . . . . 0.0 112.705 175.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -42.69 126.47 3.67 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 118.777 0.717 . . . . 0.0 111.784 178.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.92 134.39 26.05 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 165.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.9 150.15 66.95 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 121.586 1.524 . . . . 0.0 111.027 -175.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.367 0 CA-C-O 121.574 0.702 . . . . 0.0 109.807 172.568 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo . . . . . 0 N--CA 1.458 -0.6 0 N-CA-C 110.752 -0.519 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.3 mtt180 -55.1 125.68 21.52 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.476 1.111 . . . . 0.0 110.868 172.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.58 152.5 34.8 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.64 1.176 . . . . 0.0 113.542 -172.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -84.8 143.4 29.13 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.452 1.501 . . . . 0.0 108.774 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -63.59 118.78 8.69 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 167.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.0 20.81 72.4 Favored Glycine 0 CA--C 1.531 1.094 0 CA-C-O 118.377 -1.235 . . . . 0.0 113.112 -173.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -43.89 -56.87 3.61 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 119.453 1.627 . . . . 0.0 111.477 169.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.09 172.96 10.79 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.146 1.378 . . . . 0.0 108.015 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 36.84 48.45 0.67 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.37 1.868 . . . . 0.0 113.246 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 55.77 23.85 6.75 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.853 0.861 . . . . 0.0 112.127 173.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -63.14 135.09 56.97 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.172 0.442 . . . . 0.0 110.096 -175.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.7 m -123.23 141.46 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 170.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.3 m-20 -62.61 -36.13 81.76 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 118.949 -0.548 . . . . 0.0 111.1 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.87 130.34 55.01 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 123.516 0.727 . . . . 0.0 109.334 168.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.49 -34.55 36.33 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.358 1.063 . . . . 0.0 110.654 170.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.05 -45.25 64.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.238 0.215 . . . . 0.0 111.434 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.52 -20.72 65.85 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.577 0.751 . . . . 0.0 111.933 -176.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.27 -6.53 55.26 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.544 -0.723 . . . . 0.0 111.968 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.2 m -62.73 91.88 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 119.162 0.892 . . . . 0.0 111.22 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.37 -36.0 1.03 Allowed Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.263 1.411 . . . . 0.0 110.764 -172.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -62.12 116.8 24.25 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.278 -0.868 . . . . 0.0 109.28 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.91 116.52 3.61 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 N-CA-C 107.455 -1.786 . . . . 0.0 107.455 170.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.5 tpt85 123.2 -35.54 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 129.438 3.095 . . . . 0.0 109.278 -170.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -62.7 149.73 42.96 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.52 0.676 . . . . 0.0 109.454 168.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -157.19 137.07 12.45 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.128 1.771 . . . . 0.0 106.368 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -58.33 123.47 16.21 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.522 2.329 . . . . 0.0 110.998 -172.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.94 -20.68 37.93 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-O 119.181 -0.788 . . . . 0.0 111.607 176.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -67.66 111.41 4.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 118.829 1.314 . . . . 0.0 107.909 173.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.6 mp -124.96 149.64 47.45 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 172.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.4 m -42.91 -45.54 5.01 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.042 1.337 . . . . 0.0 111.89 173.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -56.86 -26.08 57.83 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -109.26 25.72 11.47 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.178 0.991 . . . . 0.0 112.357 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 45.1 t -86.42 138.8 31.49 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.584 1.153 . . . . 0.0 108.838 172.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.09 -26.27 64.52 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.443 -0.785 . . . . 0.0 112.079 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -78.14 -10.92 59.85 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 117.719 -1.134 . . . . 0.0 112.559 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -49.56 127.77 16.22 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.988 1.267 . . . . 0.0 111.898 -172.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.18 -84.65 0.59 Allowed Glycine 0 C--N 1.335 0.485 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.81 171.17 11.64 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 155.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.28 145.76 46.3 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.55 1.14 . . . . 0.0 110.996 169.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.3 t -123.62 -47.45 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 125.746 1.619 . . . . 0.0 109.24 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -148.46 -162.73 1.62 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.987 0.915 . . . . 0.0 110.186 -174.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -58.05 71.23 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 129.675 3.19 . . . . 0.0 113.934 -163.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.95 26.82 57.61 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.985 1.278 . . . . 0.0 110.913 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -129.67 144.47 51.3 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 124.978 1.311 . . . . 0.0 109.644 176.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -154.04 -178.36 28.39 Favored Glycine 0 N--CA 1.437 -1.247 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.0 mtp85 -94.66 154.6 17.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 118.926 -0.559 . . . . 0.0 109.909 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.454 -0.239 0 C-N-CA 123.49 0.716 . . . . 0.0 109.093 159.972 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 . . . . . 0 N--CA 1.466 0.35 0 CA-C-O 122.253 1.025 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.3 pm0 -51.92 -34.08 40.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.085 1.354 . . . . 0.0 111.549 166.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 m -127.39 149.62 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 125.285 1.434 . . . . 0.0 108.598 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.4 tp -91.55 142.66 27.41 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.371 1.468 . . . . 0.0 108.963 -171.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.2 t -102.06 124.7 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 124.927 1.291 . . . . 0.0 108.457 -162.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.3 tttm -61.6 126.81 28.69 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 171.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.65 -38.0 30.62 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.069 0.948 . . . . 0.0 111.676 175.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -83.54 -4.34 58.46 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.41 -173.32 29.73 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 119.034 0.834 . . . . 0.0 111.991 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 86.0 t90 -161.75 148.88 14.31 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 5.6 p -135.11 163.83 29.02 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.186 1.394 . . . . 0.0 109.341 172.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.7 p -73.07 -18.1 61.35 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.969 -1.082 . . . . 0.0 112.672 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.373 1.5 p -77.87 7.13 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 124.866 1.266 . . . . 0.0 111.785 164.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -52.5 130.36 31.48 Favored 'General case' 0 C--N 1.345 0.394 0 O-C-N 120.206 -1.559 . . . . 0.0 110.28 162.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.95 134.63 26.53 Favored Pre-proline 0 N--CA 1.453 -0.291 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 171.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -73.28 148.37 43.62 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 121.788 1.659 . . . . 0.0 110.658 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.389 0 CA-C-O 121.746 0.784 . . . . 0.0 109.523 178.843 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 N--CA 1.454 -0.804 0 N-CA-C 109.881 -0.853 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -80.32 122.61 27.12 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -172.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.53 135.54 33.86 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.974 1.31 . . . . 0.0 112.804 -166.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -68.41 147.93 51.37 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.681 1.192 . . . . 0.0 109.464 177.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.27 87.75 0.12 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.744 0.818 . . . . 0.0 109.55 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.16 37.55 5.63 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.917 -173.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -39.65 -54.19 2.06 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 123.91 0.884 . . . . 0.0 109.943 164.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -165.76 175.21 8.94 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.494 1.518 . . . . 0.0 106.986 170.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 55.21 30.02 13.81 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.966 1.307 . . . . 0.0 113.603 169.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 57.08 34.58 25.1 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.603 1.161 . . . . 0.0 111.938 175.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -54.12 -64.48 0.81 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -171.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.284 23.6 m 55.52 134.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 127.206 2.202 . . . . 0.0 114.077 -169.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -66.69 -28.9 68.81 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 120.77 -1.206 . . . . 0.0 112.405 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -113.11 118.95 36.16 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 171.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.91 -43.59 29.01 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.48 1.112 . . . . 0.0 109.818 175.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.97 -40.24 13.99 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.75 0.82 . . . . 0.0 112.889 175.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -52.44 -34.85 50.61 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.507 1.049 . . . . 0.0 111.445 178.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.29 5.11 3.07 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 116.895 -1.526 . . . . 0.0 113.811 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.8 m -13.68 99.99 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 128.13 2.572 . . . . 0.0 113.942 170.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.15 21.66 64.19 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.312 0.958 . . . . 0.0 115.052 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -48.09 127.47 11.99 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 119.31 1.555 . . . . 0.0 107.783 162.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -61.01 110.26 0.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.708 0 CA-C-N 121.252 1.483 . . . . 0.0 108.299 175.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.5 tpt85 123.66 -40.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 129.578 3.151 . . . . 0.0 110.161 -171.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -70.82 143.39 51.14 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.795 0.725 . . . . 0.0 110.557 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -132.95 123.2 25.49 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 162.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.0 mp0 -54.15 119.05 4.58 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 128.407 2.683 . . . . 0.0 109.181 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.99 -34.55 3.38 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -174.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -63.94 118.4 8.38 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 171.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.87 147.27 50.8 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 126.086 1.754 . . . . 0.0 107.154 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.5 m -44.04 -48.8 8.88 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.15 0.98 . . . . 0.0 111.444 174.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -61.34 -20.45 62.99 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 120.431 -1.418 . . . . 0.0 113.983 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -107.21 24.12 13.34 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.811 1.244 . . . . 0.0 111.845 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.4 t -95.3 134.52 37.98 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.391 1.476 . . . . 0.0 109.595 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.0 -20.21 56.55 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.433 -0.792 . . . . 0.0 112.726 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -97.52 6.64 47.83 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.138 0.575 . . . . 0.0 112.192 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 -59.66 145.74 43.67 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.594 0.633 . . . . 0.0 110.392 171.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.18 -69.78 1.28 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 172.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -176.46 160.4 2.06 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 -169.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.37 140.38 31.61 Favored 'General case' 0 N--CA 1.457 -0.083 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 169.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.5 t -107.53 -51.37 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.401 1.48 . . . . 0.0 109.279 -173.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -149.55 -136.88 0.08 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.421 0.689 . . . . 0.0 111.728 -170.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -71.43 65.71 0.45 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.054 2.142 . . . . 0.0 112.988 -163.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.0 42.38 77.82 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -173.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -133.45 156.12 48.29 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 125.514 1.526 . . . . 0.0 108.232 170.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -157.47 -174.08 26.71 Favored Glycine 0 N--CA 1.434 -1.476 0 O-C-N 124.496 1.122 . . . . 0.0 110.507 177.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -98.23 153.64 18.35 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.402 1.081 . . . . 0.0 108.882 -176.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 9.2 t . . . . . 0 CA--C 1.528 0.132 0 C-N-CA 125.463 1.505 . . . . 0.0 107.867 177.036 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.4 p-10 . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -44.91 -42.56 8.19 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.939 1.296 . . . . 0.0 114.311 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.3 m -130.4 156.4 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.07 0.948 . . . . 0.0 111.951 -160.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.1 tp -78.81 126.76 31.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 173.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.0 m -98.13 134.93 34.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 118.815 0.734 . . . . 0.0 109.546 -178.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -61.16 134.91 57.52 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.1 -40.56 73.87 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.66 0.384 . . . . 0.0 111.223 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -76.8 -2.34 32.72 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 175.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.11 -178.52 8.62 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 70.5 t90 -148.71 -179.48 7.02 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 170.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 5.7 p -162.66 164.85 26.37 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 119.038 0.835 . . . . 0.0 110.357 159.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.5 p -63.0 -30.99 72.03 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 118.939 -0.553 . . . . 0.0 111.781 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.301 1.1 m -72.42 -5.34 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 118.885 0.766 . . . . 0.0 112.478 177.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -46.03 137.0 6.19 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.884 0.874 . . . . 0.0 112.031 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.43 140.59 39.12 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 165.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.04 147.76 38.96 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.282 1.988 . . . . 0.0 111.248 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 121.611 0.72 . . . . 0.0 109.424 177.016 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 N--CA 1.458 -0.577 0 N-CA-C 110.795 -0.502 . . . . 0.0 110.795 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -79.23 123.13 27.12 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -54.61 142.7 27.12 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.82 1.248 . . . . 0.0 112.68 -170.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.58 145.61 38.85 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.006 1.322 . . . . 0.0 108.417 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -64.86 121.57 14.92 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 167.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.97 25.73 74.12 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 118.275 -1.292 . . . . 0.0 112.855 -170.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -41.95 -57.87 2.26 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 119.388 1.594 . . . . 0.0 110.7 168.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.19 174.06 4.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.746 1.619 . . . . 0.0 107.351 173.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 54.46 31.97 15.78 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.802 1.241 . . . . 0.0 113.137 172.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 55.1 29.99 13.54 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.256 1.023 . . . . 0.0 111.596 -176.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -64.35 134.68 55.11 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.972 -0.455 . . . . 0.0 110.043 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.0 m -122.9 142.04 40.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 170.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -63.27 -34.92 78.73 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 118.993 -0.527 . . . . 0.0 111.534 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.69 127.27 54.47 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 123.634 0.774 . . . . 0.0 109.733 169.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.16 -38.47 11.86 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.732 1.213 . . . . 0.0 110.58 168.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.15 -41.76 60.33 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -59.7 -30.61 68.91 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.131 0.491 . . . . 0.0 111.373 -176.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.01 -0.31 30.67 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 118.85 -0.595 . . . . 0.0 112.448 -176.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.3 m -61.79 91.56 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 119.248 0.931 . . . . 0.0 111.377 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.06 -32.43 1.41 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.087 1.327 . . . . 0.0 111.431 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -60.26 125.12 80.79 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 118.067 0.933 . . . . 0.0 109.567 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.21 102.3 0.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 N-CA-C 107.258 -1.862 . . . . 0.0 107.258 169.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 139.9 -29.44 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 130.9 3.68 . . . . 0.0 110.235 -173.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -75.71 79.86 2.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.432 0.635 . . . . 0.0 109.769 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -64.75 137.62 57.9 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 161.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -59.46 118.55 6.16 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 128.085 2.554 . . . . 0.0 112.193 -172.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.67 -1.18 63.57 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-O 119.381 -0.677 . . . . 0.0 111.909 174.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -60.87 121.87 13.42 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.388 1.094 . . . . 0.0 108.372 166.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.7 mp -128.94 145.1 51.32 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.661 1.984 . . . . 0.0 107.723 173.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 6.8 m -45.54 -45.17 13.28 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 124.829 1.252 . . . . 0.0 112.75 177.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -64.84 -13.97 57.82 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 119.863 -1.773 . . . . 0.0 114.01 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -93.09 -1.16 56.76 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.318 1.047 . . . . 0.0 111.416 173.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.6 t -80.12 131.41 35.73 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.417 1.087 . . . . 0.0 109.138 -175.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.67 -6.29 19.89 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.969 -1.082 . . . . 0.0 112.472 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -93.57 -2.28 54.41 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.936 0.789 . . . . 0.0 111.755 171.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -59.56 149.37 30.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 118.518 0.599 . . . . 0.0 111.194 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.86 -74.82 1.27 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.287 1.422 . . . . 0.0 109.593 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -173.21 154.11 2.63 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.284 1.433 . . . . 0.0 107.152 -168.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.61 137.24 37.05 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 171.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.9 t -107.69 -48.62 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 125.244 1.418 . . . . 0.0 108.972 -173.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -149.37 -140.8 0.1 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.728 0.411 . . . . 0.0 111.866 -168.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -72.12 65.05 0.56 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.257 2.223 . . . . 0.0 112.561 -167.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.42 31.08 47.38 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -132.2 152.39 51.33 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 125.301 1.441 . . . . 0.0 109.224 173.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -154.84 -179.93 30.42 Favored Glycine 0 N--CA 1.431 -1.64 0 O-C-N 124.669 1.231 . . . . 0.0 110.832 178.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -86.05 145.77 26.92 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.142 0 C-N-CA 126.589 1.956 . . . . 0.0 105.751 174.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 . . . . . 0 N--CA 1.471 0.578 0 CA-C-O 121.482 0.658 . . . . 0.0 111.98 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -65.86 -17.24 64.51 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.701 1.6 . . . . 0.0 115.28 -174.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.27 149.02 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 120.192 1.36 . . . . 0.0 111.239 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.3 tp -77.78 130.41 36.67 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 174.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.4 t -106.04 129.67 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -174.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.5 tttm -61.87 129.79 42.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 174.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.9 -36.69 67.94 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.565 0.746 . . . . 0.0 111.483 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -80.83 -7.03 59.32 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.57 -0.729 . . . . 0.0 112.455 178.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.38 -173.07 20.8 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 118.906 0.775 . . . . 0.0 111.915 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -161.19 150.68 16.8 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.8 p -139.82 172.44 12.78 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.235 1.014 . . . . 0.0 111.223 170.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 81.0 p -72.06 -35.53 69.31 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 m -64.84 -23.85 34.31 Favored 'Isoleucine or valine' 0 C--N 1.347 0.467 0 CA-C-N 118.568 0.622 . . . . 0.0 111.632 -175.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -20.45 105.39 0.02 OUTLIER 'General case' 0 C--O 1.237 0.403 0 C-N-CA 128.033 2.533 . . . . 0.0 113.486 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.57 120.57 57.26 Favored Pre-proline 0 N--CA 1.454 -0.234 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 165.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -66.1 134.41 36.67 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.253 1.302 . . . . 0.0 112.81 -173.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.235 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 142.48 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.453 -0.876 0 N-CA-C 111.312 -0.303 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.1 mtt180 -62.46 127.37 31.01 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.783 1.233 . . . . 0.0 109.987 171.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.41 145.53 43.31 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.584 1.553 . . . . 0.0 111.514 -175.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.3 146.15 24.91 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.375 0.607 . . . . 0.0 110.94 175.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.92 120.33 9.43 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 172.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.75 18.7 65.12 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 117.997 -1.446 . . . . 0.0 113.742 -174.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -36.01 -55.3 0.76 Allowed 'General case' 0 C--N 1.347 0.467 0 CA-C-N 119.637 1.718 . . . . 0.0 111.602 168.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -164.77 -179.47 5.87 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 164.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.4 m170 46.22 45.95 13.1 Favored 'General case' 0 CA--C 1.527 0.071 0 O-C-N 124.213 0.945 . . . . 0.0 111.865 160.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 56.23 24.59 8.28 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.955 1.302 . . . . 0.0 112.219 172.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -62.49 136.69 58.02 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 118.152 0.433 . . . . 0.0 111.415 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.1 m -125.46 142.26 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 174.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -70.65 -24.87 62.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.2 1.0 . . . . 0.0 112.053 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -115.31 120.57 40.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.12 1.368 . . . . 0.0 107.919 168.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.04 -49.62 40.38 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.189 0.996 . . . . 0.0 111.665 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.7 -20.03 64.4 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 118.201 -0.904 . . . . 0.0 112.785 -173.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -44.57 -43.84 8.37 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.805 1.184 . . . . 0.0 110.466 165.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.03 7.9 12.07 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -175.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.6 p -33.14 -59.16 0.37 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 127.344 2.257 . . . . 0.0 113.19 174.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.93 -29.82 35.64 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 112.239 -2.255 . . . . 0.0 113.805 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -70.04 117.51 54.73 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 118.687 1.243 . . . . 0.0 110.908 -171.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -60.68 105.74 0.33 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 N-CA-C 107.439 -1.793 . . . . 0.0 107.439 163.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 141.41 -40.0 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 130.983 3.713 . . . . 0.0 108.662 -172.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -68.78 150.4 47.89 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 173.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -150.3 132.14 15.09 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.272 1.1 pm0 -56.94 107.26 0.38 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.31 1.444 . . . . 0.0 112.076 -173.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.39 -1.87 27.98 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 119.139 -0.811 . . . . 0.0 111.983 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -73.07 110.81 7.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.74 1.77 . . . . 0.0 107.044 164.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.5 mp -121.57 150.27 41.9 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.925 2.09 . . . . 0.0 106.346 170.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.8 m -47.7 -45.72 28.79 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.326 1.05 . . . . 0.0 111.946 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -62.89 -13.65 36.79 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 120.209 -1.557 . . . . 0.0 113.588 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -95.68 2.52 54.07 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 120.82 -1.175 . . . . 0.0 111.874 175.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 24.6 t -86.83 137.06 32.72 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.754 1.222 . . . . 0.0 109.448 -171.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.02 -20.66 65.52 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.188 -0.945 . . . . 0.0 111.867 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -87.29 2.07 51.31 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.566 -0.731 . . . . 0.0 112.528 173.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 48.2 t-105 -59.09 142.93 50.14 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.749 1.158 . . . . 0.0 111.071 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.43 -109.47 0.93 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 165.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -139.43 157.26 46.16 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.274 1.43 . . . . 0.0 107.782 175.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.27 141.44 58.02 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 123.929 0.768 . . . . 0.0 109.444 165.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.7 t -113.5 -54.05 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 124.5 1.12 . . . . 0.0 109.257 -174.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -157.87 153.97 27.19 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.364 1.066 . . . . 0.0 109.46 -177.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.4 t0 50.09 35.99 11.18 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 155.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.3 31.89 80.38 Favored Glycine 0 CA--C 1.535 1.331 0 O-C-N 120.615 -1.303 . . . . 0.0 112.992 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -123.37 152.73 41.22 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 127.935 2.494 . . . . 0.0 108.394 170.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -159.29 176.85 36.03 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-O 122.002 0.779 . . . . 0.0 111.363 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.62 145.06 30.79 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 114.647 -0.776 . . . . 0.0 111.814 176.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 21.7 t . . . . . 0 N--CA 1.445 -0.723 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 160.429 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 111.212 0.078 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -70.46 0.32 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -175.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -69.84 165.98 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.712 0.805 . . . . 0.0 111.755 -171.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.3 tp -91.62 118.5 30.68 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 170.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.2 m -91.88 148.45 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -66.59 138.78 57.71 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.96 -36.93 80.68 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.178 0.445 . . . . 0.0 111.09 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -82.26 3.2 28.47 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 171.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.08 -176.91 28.24 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 73.5 t90 -163.64 153.93 15.5 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.1 p -135.69 160.26 39.06 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.774 1.23 . . . . 0.0 110.329 172.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.8 p -71.35 -15.9 62.41 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.325 -0.859 . . . . 0.0 112.654 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.322 0.9 OUTLIER -76.48 -4.44 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 119.342 0.974 . . . . 0.0 112.323 172.132 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -42.91 130.92 4.26 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 124.183 0.993 . . . . 0.0 112.261 177.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.58 135.21 26.31 Favored Pre-proline 0 N--CA 1.455 -0.217 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 165.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -69.5 149.84 69.05 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 121.735 1.623 . . . . 0.0 110.798 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 121.667 0.746 . . . . 0.0 110.007 174.01 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 N--CA 1.458 -0.574 0 CA-C-O 121.025 0.344 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 31.9 mtt-85 -61.25 131.43 50.37 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.482 1.513 . . . . 0.0 111.158 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.32 142.96 54.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.012 1.325 . . . . 0.0 112.057 -178.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -84.95 155.23 21.72 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 122.042 0.925 . . . . 0.0 112.197 174.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -67.34 96.23 0.48 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.616 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.48 24.99 10.42 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.56 1.076 . . . . 0.0 111.667 -176.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -34.21 -55.52 0.51 Allowed 'General case' 0 C--N 1.345 0.372 0 C-N-CA 125.238 1.415 . . . . 0.0 111.896 170.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.37 169.66 22.64 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 169.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 43.77 46.45 6.46 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.933 1.293 . . . . 0.0 113.419 170.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 58.83 27.0 15.5 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.184 0.594 . . . . 0.0 112.298 169.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -46.99 -60.3 2.54 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -165.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.254 34.7 m 56.85 132.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 126.757 2.023 . . . . 0.0 113.893 -171.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -68.78 -27.68 66.1 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 120.574 -1.329 . . . . 0.0 112.746 -177.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -110.43 115.29 29.4 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 170.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -42.36 -46.64 4.7 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.07 1.348 . . . . 0.0 110.656 173.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.99 -37.31 44.16 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.915 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -51.63 -35.45 42.0 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.411 1.005 . . . . 0.0 111.643 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.88 2.83 13.5 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -177.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 64.8 m -61.62 93.0 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 119.598 1.09 . . . . 0.0 111.306 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.5 -34.51 1.06 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.52 1.533 . . . . 0.0 110.49 -174.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -62.74 115.71 18.86 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 117.871 -1.062 . . . . 0.0 109.335 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -62.73 120.34 7.82 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 N-CA-C 107.587 -1.736 . . . . 0.0 107.587 171.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 118.91 -39.22 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 129.185 2.994 . . . . 0.0 108.902 -168.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -64.05 142.11 58.53 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 166.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -144.84 147.82 33.28 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 174.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.1 mp0 -55.73 117.46 3.66 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.434 1.493 . . . . 0.0 110.776 -170.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.13 7.41 70.18 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 119.705 -0.497 . . . . 0.0 112.373 175.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -72.63 91.14 1.41 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 119.037 1.419 . . . . 0.0 108.509 167.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.5 mp -95.48 150.0 20.79 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.949 1.3 . . . . 0.0 109.003 169.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 2.1 m -46.21 -44.98 16.64 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.936 1.295 . . . . 0.0 110.653 172.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -63.06 -12.68 28.31 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 120.714 -1.241 . . . . 0.0 114.123 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -97.99 2.63 49.15 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.867 1.267 . . . . 0.0 111.938 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 35.2 t -84.04 135.59 34.37 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.784 1.234 . . . . 0.0 109.779 -171.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.17 -16.17 59.23 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.601 -0.687 . . . . 0.0 112.446 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -94.65 0.03 54.77 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.387 174.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -55.58 140.11 42.03 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.525 1.057 . . . . 0.0 110.807 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.41 -100.14 1.05 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 172.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -145.65 155.55 43.08 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.743 1.617 . . . . 0.0 107.388 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.38 145.75 49.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 123.749 0.655 . . . . 0.0 109.562 170.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.0 t -123.1 -45.21 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 125.316 1.446 . . . . 0.0 109.504 -174.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -147.78 -165.06 2.16 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.151 0.98 . . . . 0.0 109.821 -175.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -51.74 71.36 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 129.815 3.246 . . . . 0.0 114.847 -164.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.2 42.47 94.26 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -173.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -133.39 142.83 48.56 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.43 1.492 . . . . 0.0 108.9 172.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -156.46 173.34 34.27 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-O 122.25 0.917 . . . . 0.0 112.965 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -74.76 153.55 38.75 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 125.982 1.713 . . . . 0.0 112.317 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.53 0.208 0 C-N-CA 125.109 1.364 . . . . 0.0 108.188 179.937 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.8 t0 . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.51 -55.56 4.23 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 167.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.3 m -76.3 176.73 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.497 169.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 22.3 tp -109.92 130.82 55.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.76 1.624 . . . . 0.0 107.763 171.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.6 m -93.85 140.66 16.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 118.703 0.683 . . . . 0.0 109.912 -174.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 tttm -62.96 135.45 57.31 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.02 -41.72 64.97 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 123.168 0.587 . . . . 0.0 111.018 173.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -83.42 6.3 20.6 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 175.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.66 -169.48 14.04 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 171.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 60.7 t90 -158.29 -179.7 8.35 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 174.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 5.2 p -163.03 161.15 25.29 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.531 1.06 . . . . 0.0 110.217 161.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.9 p -72.28 -9.84 59.01 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.227 -0.92 . . . . 0.0 113.084 -174.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.1 m -74.94 -17.56 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 119.427 1.012 . . . . 0.0 111.423 168.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -38.57 132.79 1.11 Allowed 'General case' 0 C--N 1.348 0.502 0 C-N-CA 125.31 1.444 . . . . 0.0 113.117 -174.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.84 135.02 26.85 Favored Pre-proline 0 N--CA 1.452 -0.343 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 165.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -72.4 147.29 46.52 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.998 1.799 . . . . 0.0 111.169 -175.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.462 0 CA-C-O 121.765 0.793 . . . . 0.0 109.306 176.011 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 N--CA 1.456 -0.687 0 N-CA-C 111.274 -0.318 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 36.6 mtt-85 -55.14 127.83 30.99 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.467 1.507 . . . . 0.0 111.956 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.11 147.51 52.05 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.441 1.096 . . . . 0.0 112.491 -175.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.4 pm0 -92.26 152.67 19.7 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 125.815 1.646 . . . . 0.0 112.324 -177.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.28 96.4 0.65 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.604 -175.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.01 28.71 14.48 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.426 -175.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -36.87 -53.11 0.94 Allowed 'General case' 0 C--N 1.344 0.344 0 C-N-CA 124.608 1.163 . . . . 0.0 111.001 166.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.55 -178.63 5.94 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 169.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 31.86 50.7 0.16 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.88 2.472 . . . . 0.0 113.269 173.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 55.49 30.34 14.95 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.676 0.79 . . . . 0.0 112.228 169.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -50.91 -64.95 0.65 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -168.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.288 19.1 m 54.18 130.12 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 126.897 2.079 . . . . 0.0 114.212 -171.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -66.1 -25.52 67.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 120.646 -1.284 . . . . 0.0 112.881 -172.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -110.32 117.12 32.78 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 171.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -45.47 -43.62 11.69 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.686 1.194 . . . . 0.0 110.793 172.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.3 -38.13 57.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.461 -0.78 . . . . 0.0 112.913 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -52.49 -39.64 61.46 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.199 0.909 . . . . 0.0 110.61 175.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.59 2.18 8.54 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 118.91 -0.567 . . . . 0.0 112.501 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.5 t -66.86 -2.95 5.77 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 120.055 1.298 . . . . 0.0 114.411 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.62 -9.87 71.19 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.27 0.938 . . . . 0.0 112.337 169.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -95.04 112.11 57.14 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 124.917 1.287 . . . . 0.0 110.449 -169.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -59.31 120.86 8.95 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 N-CA-C 107.424 -1.798 . . . . 0.0 107.424 163.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.5 tpt85 122.76 -40.33 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 129.175 2.99 . . . . 0.0 108.452 -168.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -65.39 146.32 55.04 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 166.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? -143.04 135.35 27.29 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -50.33 111.45 0.53 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.716 2.007 . . . . 0.0 111.736 -174.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.6 -10.31 45.59 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-O 118.98 -0.9 . . . . 0.0 111.623 174.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -64.75 118.58 9.16 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 119.109 1.455 . . . . 0.0 107.534 171.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 mp -130.04 149.06 51.92 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 125.989 1.716 . . . . 0.0 106.486 176.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.4 m -45.73 -46.91 15.31 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.065 0.946 . . . . 0.0 111.943 174.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -62.45 -15.84 51.85 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.428 -1.42 . . . . 0.0 114.167 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -110.74 23.38 14.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.625 1.17 . . . . 0.0 112.21 172.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.8 t -90.82 135.63 33.6 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.372 1.469 . . . . 0.0 108.236 172.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.79 -23.49 63.34 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 121.268 -0.895 . . . . 0.0 112.645 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -74.98 -13.49 60.52 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 118.337 -0.84 . . . . 0.0 112.53 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -52.33 136.33 31.22 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.52 1.055 . . . . 0.0 112.821 -171.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.83 -66.38 1.28 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 125.831 1.681 . . . . 0.0 110.352 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -178.24 154.02 0.81 Allowed 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -161.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.47 134.82 34.09 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 166.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.1 t -113.7 -39.73 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.891 1.676 . . . . 0.0 110.153 -172.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -147.27 -172.67 4.06 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.303 1.041 . . . . 0.0 110.192 -169.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -52.81 72.08 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 130.196 3.398 . . . . 0.0 113.69 -172.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.77 37.24 83.99 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -172.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -129.76 148.39 51.63 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 125.663 1.585 . . . . 0.0 108.852 172.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -165.07 -176.12 36.42 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.5 mtp-105 -96.65 152.69 18.41 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 119.008 -0.52 . . . . 0.0 110.313 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 156.593 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 t70 . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -49.4 -44.96 45.58 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.738 1.615 . . . . 0.0 111.568 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.2 m -111.91 149.88 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.697 1.599 . . . . 0.0 108.653 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.6 tp -77.95 132.43 37.87 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.0 t -90.31 122.47 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 125.912 1.685 . . . . 0.0 107.856 -169.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -60.78 130.55 47.03 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 121.023 -1.048 . . . . 0.0 108.455 171.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.02 -40.17 66.8 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.071 0.548 . . . . 0.0 111.657 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -83.51 3.04 34.04 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 175.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.24 -172.52 8.59 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 172.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -154.91 178.0 10.67 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 172.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.6 p -161.08 159.15 28.84 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.489 1.041 . . . . 0.0 109.013 163.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.7 p -73.77 -1.79 20.72 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.021 -1.049 . . . . 0.0 112.99 -175.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.329 0.9 OUTLIER -83.31 -8.77 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 119.35 0.977 . . . . 0.0 112.286 164.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -38.86 123.7 1.31 Allowed 'General case' 0 C--N 1.344 0.368 0 C-N-CA 125.3 1.44 . . . . 0.0 112.914 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.33 134.84 23.06 Favored Pre-proline 0 N--CA 1.455 -0.213 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 169.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -70.82 150.32 61.57 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.08 1.853 . . . . 0.0 110.957 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.341 0 C-N-CA 123.979 0.911 . . . . 0.0 110.227 176.759 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo . . . . . 0 N--CA 1.456 -0.726 0 N-CA-C 110.673 -0.549 . . . . 0.0 110.673 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -72.33 125.87 28.43 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -174.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -54.85 141.85 31.6 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.716 1.606 . . . . 0.0 112.817 -168.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -77.29 144.38 38.16 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.293 1.037 . . . . 0.0 108.592 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.09 120.16 10.91 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 165.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.86 25.19 72.37 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.219 -1.323 . . . . 0.0 112.93 -172.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -40.42 -54.84 2.38 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 119.595 1.698 . . . . 0.0 110.771 166.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -167.67 177.78 5.66 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.388 1.475 . . . . 0.0 107.579 172.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 33.38 52.04 0.35 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 127.057 2.143 . . . . 0.0 113.099 172.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 60.06 18.85 8.05 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.071 0.948 . . . . 0.0 112.675 169.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -62.69 137.42 58.26 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 118.554 0.615 . . . . 0.0 110.029 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.2 m -126.84 143.68 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 168.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -59.97 -34.59 73.49 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 119.12 -0.467 . . . . 0.0 111.284 -174.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.96 128.67 54.53 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 123.433 0.693 . . . . 0.0 110.285 169.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.11 -31.86 20.68 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.52 1.128 . . . . 0.0 110.63 165.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.18 -45.45 75.78 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.425 0.557 . . . . 0.0 111.406 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -29.75 70.09 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.216 0.532 . . . . 0.0 110.606 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.23 -6.05 36.71 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 118.324 -0.846 . . . . 0.0 112.599 -177.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 67.0 m -50.0 -32.41 15.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.22 -24.57 73.45 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.664 1.126 . . . . 0.0 113.164 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -79.03 117.72 68.42 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 118.404 1.102 . . . . 0.0 111.082 -169.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -63.94 108.45 0.93 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 N-CA-C 107.266 -1.859 . . . . 0.0 107.266 164.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 135.69 -31.79 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 131.166 3.787 . . . . 0.0 109.881 -173.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -68.5 149.12 49.63 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 171.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? -143.46 136.7 27.97 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -50.58 110.48 0.42 Allowed 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.954 2.101 . . . . 0.0 111.753 -174.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.14 -9.82 43.11 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-O 119.093 -0.837 . . . . 0.0 111.561 174.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -64.82 120.03 11.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.06 1.43 . . . . 0.0 107.824 172.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 mp -131.77 153.06 50.49 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.218 1.807 . . . . 0.0 107.206 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 33.6 m -48.96 -47.12 44.19 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.873 0.76 . . . . 0.0 110.993 174.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.257 6.2 tt0 -75.72 26.13 0.11 Allowed 'General case' 0 CA--C 1.549 0.915 0 O-C-N 120.32 -1.488 . . . . 0.0 113.671 176.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -142.25 29.77 1.61 Allowed 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.596 -1.315 . . . . 0.0 110.793 156.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 50.6 t -96.72 139.24 33.07 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.886 1.674 . . . . 0.0 109.208 177.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.89 -21.12 64.45 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.569 -0.707 . . . . 0.0 112.572 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -96.4 15.28 21.75 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 119.001 -0.523 . . . . 0.0 111.951 175.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -66.85 149.74 50.16 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.424 1.011 . . . . 0.0 110.997 175.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.53 -101.23 1.97 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.372 -1.891 . . . . 0.0 108.372 169.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -149.95 153.92 37.41 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.76 1.624 . . . . 0.0 107.648 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.13 141.54 58.72 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 123.69 0.619 . . . . 0.0 110.612 168.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.5 t -114.13 -49.19 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 126.28 1.832 . . . . 0.0 109.23 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -148.02 -150.58 0.35 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.408 0.683 . . . . 0.0 111.214 -171.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -67.55 68.16 0.09 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 128.338 2.655 . . . . 0.0 113.21 -161.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.01 29.33 46.92 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.548 1.07 . . . . 0.0 110.501 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -132.19 148.21 52.45 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.192 1.397 . . . . 0.0 109.462 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.64 178.8 36.49 Favored Glycine 0 N--CA 1.433 -1.564 0 O-C-N 124.395 1.059 . . . . 0.0 110.691 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -82.0 132.69 35.26 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.852 -0.674 . . . . 0.0 110.67 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 43.2 t . . . . . 0 CA--C 1.535 0.378 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 155.036 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.9 t0 . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -45.71 -39.73 8.41 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.119 0.968 . . . . 0.0 113.257 176.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.5 m -117.04 160.39 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 125.071 1.348 . . . . 0.0 109.872 -172.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 22.5 tp -83.64 131.18 34.97 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.8 t -104.63 133.71 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 123.674 0.79 . . . . 0.0 108.909 -167.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -62.98 126.72 28.28 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 175.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.56 -31.78 68.3 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.343 0.657 . . . . 0.0 110.841 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -81.21 -8.19 59.71 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.796 1.238 . . . . 0.0 112.443 176.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.76 -172.42 35.87 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 72.3 t90 -165.84 150.58 8.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.7 p -134.22 162.36 32.36 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.965 1.306 . . . . 0.0 110.001 175.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.4 p -69.91 -20.42 63.36 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.0 -1.062 . . . . 0.0 112.672 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.364 0.8 OUTLIER -71.94 -3.75 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 119.553 1.069 . . . . 0.0 112.595 170.596 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -45.14 128.83 7.63 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.809 0.732 . . . . 0.0 111.012 171.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.73 137.67 31.45 Favored Pre-proline 0 N--CA 1.452 -0.334 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 165.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.8 148.95 59.47 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.028 1.819 . . . . 0.0 110.794 -177.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.308 0 C-N-CA 123.492 0.717 . . . . 0.0 109.953 179.536 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.384 0 CA-C-O 117.674 -1.155 . . . . 0.0 108.859 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.73 71.47 1.45 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 162.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -52.0 151.57 6.48 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 123.17 0.588 . . . . 0.0 110.465 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -62.6 142.06 88.38 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.468 2.112 . . . . 0.0 110.515 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 43.9 mtt-85 -58.19 126.33 27.02 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.814 1.245 . . . . 0.0 110.243 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.36 142.95 46.7 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.117 1.367 . . . . 0.0 112.489 -172.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -76.61 143.27 40.31 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.422 1.089 . . . . 0.0 108.294 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -62.03 117.01 5.41 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 165.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.8 16.59 67.59 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 118.263 -1.298 . . . . 0.0 113.652 -174.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -45.58 -58.29 3.52 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 119.818 1.809 . . . . 0.0 112.051 173.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.97 162.18 40.39 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.434 ' NE2' ' OD2' ' A' ' 54' ' ' ASP . 24.7 m-70 45.33 47.36 10.51 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.15 1.38 . . . . 0.0 113.199 172.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.85 25.81 10.84 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.69 0.796 . . . . 0.0 111.845 173.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -62.07 142.67 57.42 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 117.928 0.331 . . . . 0.0 111.194 -175.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.9 146.1 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 172.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -73.17 -26.99 61.39 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 124.402 1.081 . . . . 0.0 112.235 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -115.99 116.59 28.19 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 171.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -42.62 -48.97 5.54 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.343 1.057 . . . . 0.0 110.99 175.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.63 -38.16 31.01 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.839 0.856 . . . . 0.0 113.018 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -49.11 -39.53 28.71 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 119.181 0.9 . . . . 0.0 111.477 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.66 9.04 1.2 Allowed 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 118.301 -0.857 . . . . 0.0 113.119 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 62.6 m -49.77 -31.02 10.59 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 120.47 1.486 . . . . 0.0 114.226 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.44 -24.45 76.86 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.64 1.114 . . . . 0.0 112.927 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -79.99 120.13 78.84 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.562 1.145 . . . . 0.0 110.426 -171.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -46.48 -49.28 12.11 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.145 2.563 . . . . 0.0 113.924 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -15.76 60.79 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 117.563 -1.208 . . . . 0.0 113.418 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -73.91 145.82 44.48 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 120.878 1.672 . . . . 0.0 111.529 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -133.38 150.04 51.83 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 127.973 2.509 . . . . 0.0 104.377 165.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -66.69 165.02 15.72 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 124.064 0.852 . . . . 0.0 111.512 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.72 -26.26 3.21 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.077 1.322 . . . . 0.0 112.009 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -69.96 112.1 6.13 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 117.534 0.667 . . . . 0.0 109.333 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.1 mp -123.36 148.96 45.51 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.5 m -42.03 -46.71 4.28 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.437 1.095 . . . . 0.0 110.939 172.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -56.34 -26.8 53.82 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -109.2 23.61 14.27 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.711 1.204 . . . . 0.0 112.001 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 45.7 t -86.48 139.0 31.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.711 1.204 . . . . 0.0 108.942 174.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.52 -25.3 66.0 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 121.319 -0.863 . . . . 0.0 111.813 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -91.29 8.35 36.43 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.479 -0.772 . . . . 0.0 112.047 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 66.3 t-105 -56.73 138.18 53.31 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 120.188 1.358 . . . . 0.0 109.99 174.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.78 -85.18 1.03 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 171.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -163.91 159.1 20.57 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.27 136.41 39.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 90.2 t -106.74 -48.53 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.652 1.181 . . . . 0.0 108.383 -172.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -151.43 -138.98 0.09 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.93 0.492 . . . . 0.0 112.24 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -69.19 66.83 0.17 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.919 2.488 . . . . 0.0 113.013 -163.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.52 33.34 61.13 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 -175.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -131.65 143.5 50.35 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 125.893 1.677 . . . . 0.0 108.684 173.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -153.14 178.01 30.44 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 124.183 0.897 . . . . 0.0 111.489 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 32.4 mtp85 -88.31 159.13 18.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.308 0.643 . . . . 0.0 111.998 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.5 t -133.39 120.86 21.49 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.837 1.655 . . . . 0.0 108.038 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.1 p -74.89 68.62 1.79 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.926 1.291 . . . . 0.0 110.921 -173.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -146.43 131.77 9.16 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 167.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -59.2 -43.97 37.58 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 121.839 1.693 . . . . 0.0 109.519 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.434 ' OD2' ' NE2' ' A' ' 12' ' ' HIS . 11.2 p-10 -70.1 47.14 0.08 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.701 2.401 . . . . 0.0 111.603 169.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -172.71 -55.4 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.097 1.359 . . . . 0.0 110.468 177.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -55.47 -27.93 51.32 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.74 1.216 . . . . 0.0 113.513 -172.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -35.87 -45.44 0.4 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.98 1.312 . . . . 0.0 112.075 166.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 m -116.5 150.63 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 123.831 0.852 . . . . 0.0 108.987 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.4 tp -82.64 121.39 26.77 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.3 m -88.44 144.25 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 118.923 0.783 . . . . 0.0 109.161 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.3 tttm -67.01 136.97 56.11 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 174.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.62 -40.9 66.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 119.313 -0.375 . . . . 0.0 111.488 174.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -85.05 7.95 19.62 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 174.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.73 -177.27 23.46 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -160.07 155.58 25.48 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 172.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.0 p -143.27 167.17 22.78 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.097 0.959 . . . . 0.0 110.766 173.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.3 p -73.5 -21.7 60.34 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.33 1.0 OUTLIER -71.13 -5.37 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 119.433 1.015 . . . . 0.0 112.448 171.022 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -45.72 132.16 8.77 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 119.058 0.844 . . . . 0.0 111.652 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.32 139.47 35.74 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 166.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.25 151.14 54.28 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.058 1.838 . . . . 0.0 110.657 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.4 34.84 1.72 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.894 0.878 . . . . 0.0 110.289 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.3 m . . . . . 0 C--O 1.255 1.346 0 C-N-CA 128.674 2.79 . . . . 0.0 105.367 178.852 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 1.112 ' CB ' ' OE1' ' A' ' 3' ' ' GLU . . . . . . . . 0 CA--C 1.513 -0.445 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.2 m -134.3 31.83 3.45 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 123.598 0.561 . . . . 0.0 110.846 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 1.112 ' OE1' ' CB ' ' A' ' 1' ' ' ALA . 3.4 mp0 -64.72 132.39 95.42 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 174.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.13 130.04 19.38 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.39 2.06 . . . . 0.0 111.079 -171.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 42.5 mtt-85 -63.95 125.31 24.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.557 1.143 . . . . 0.0 110.212 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.22 142.75 54.02 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.796 1.238 . . . . 0.0 112.171 -173.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -76.17 145.7 39.7 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.497 1.119 . . . . 0.0 108.731 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -62.37 121.21 12.65 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 164.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.87 20.85 75.53 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 118.267 -1.296 . . . . 0.0 113.448 -172.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -40.97 -56.8 2.17 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 119.488 1.644 . . . . 0.0 111.46 169.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.2 172.74 10.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.658 1.583 . . . . 0.0 106.96 174.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 44.28 47.56 7.84 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 124.412 1.085 . . . . 0.0 112.76 171.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 57.53 21.29 6.92 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 122.799 0.44 . . . . 0.0 111.498 172.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -62.53 140.7 58.63 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.521 0.601 . . . . 0.0 111.259 -172.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.2 m -126.88 143.56 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 173.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -71.33 -26.89 63.02 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.882 0.873 . . . . 0.0 111.684 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -112.08 111.42 22.31 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 169.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -45.13 -44.32 10.52 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.909 1.284 . . . . 0.0 110.957 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.55 -35.54 63.36 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.125 -0.94 . . . . 0.0 112.627 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -48.18 -43.75 32.02 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-O 122.278 1.037 . . . . 0.0 110.84 174.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.35 6.23 5.92 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.458 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -55.08 -28.54 53.19 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 120.258 1.39 . . . . 0.0 112.368 171.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.44 -14.15 59.47 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.518 1.056 . . . . 0.0 113.769 174.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -99.89 108.19 50.33 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 125.891 1.677 . . . . 0.0 111.502 -171.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -54.51 117.55 4.08 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 N-CA-C 108.258 -1.478 . . . . 0.0 108.258 162.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.7 tpt85 127.18 -41.32 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 129.023 2.929 . . . . 0.0 108.517 -169.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -66.81 153.79 42.49 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 169.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -152.75 136.26 15.97 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.198 168.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.5 mp0 -60.3 115.35 3.46 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.521 1.928 . . . . 0.0 110.112 -169.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.4 -30.76 5.29 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -176.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -66.93 115.66 6.91 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 mp -131.04 149.85 52.42 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 127.004 2.122 . . . . 0.0 105.405 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.2 m -43.58 -47.37 7.42 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.953 1.301 . . . . 0.0 111.43 173.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.44 -22.02 52.99 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -109.77 26.13 11.0 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.307 1.043 . . . . 0.0 112.344 175.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.7 t -97.06 136.78 37.12 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.568 1.547 . . . . 0.0 109.263 175.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.46 -20.86 65.93 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 120.929 -1.107 . . . . 0.0 113.002 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -80.4 -8.58 59.58 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.437 0.562 . . . . 0.0 112.113 175.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 74.9 t-105 -58.29 141.12 51.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.705 0.684 . . . . 0.0 111.501 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.61 -69.0 1.27 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 173.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -174.5 157.35 2.62 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -168.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.32 130.97 35.22 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 166.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.4 t -97.05 -49.31 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -175.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -152.07 -128.59 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -171.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -74.77 63.93 1.21 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.379 1.872 . . . . 0.0 112.623 -162.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.6 28.19 67.9 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.258 0.933 . . . . 0.0 110.944 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -126.79 145.17 50.73 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.823 1.649 . . . . 0.0 109.168 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -153.77 178.7 30.56 Favored Glycine 0 N--CA 1.436 -1.352 0 CA-C-O 122.208 0.893 . . . . 0.0 112.302 177.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -89.58 145.87 24.97 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.22 -0.99 . . . . 0.0 108.437 -172.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 2.3 t -134.85 128.64 33.08 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 73.7 p -91.71 158.02 16.61 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.108 0.563 . . . . 0.0 111.331 -167.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 95.72 136.8 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 130.617 3.567 . . . . 0.0 110.227 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -59.51 139.74 90.75 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.715 2.277 . . . . 0.0 110.045 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.393 0.2 OUTLIER 98.28 -13.49 0.06 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 128.022 2.529 . . . . 0.0 111.133 -168.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -127.24 -41.11 1.78 Allowed 'General case' 0 C--N 1.346 0.443 0 CA-C-O 117.975 -1.012 . . . . 0.0 113.342 158.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -36.98 -45.69 0.59 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.435 1.494 . . . . 0.0 112.807 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.0 pm0 -61.75 -16.82 52.68 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -175.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.2 m -132.01 158.36 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 119.556 1.071 . . . . 0.0 110.499 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.1 tp -91.85 123.2 35.04 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 175.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.0 m -94.85 148.97 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -67.65 137.22 55.42 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.14 -42.23 65.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.936 173.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -81.32 6.1 15.3 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 175.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.62 -177.32 34.76 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 119.539 1.063 . . . . 0.0 110.654 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 43.8 t90 -163.15 154.72 17.49 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 170.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 7.9 p -139.92 161.54 37.35 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.748 1.619 . . . . 0.0 110.034 173.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 89.9 p -70.65 -10.05 58.46 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.327 -0.858 . . . . 0.0 112.921 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.7 t -64.76 -35.26 74.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.268 1.027 . . . . 0.0 109.256 168.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -27.06 113.01 0.06 Allowed 'General case' 0 C--N 1.347 0.46 0 C-N-CA 126.43 1.892 . . . . 0.0 114.285 -170.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -113.24 133.18 22.14 Favored Pre-proline 0 N--CA 1.455 -0.22 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 167.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.11 150.55 66.26 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.704 1.602 . . . . 0.0 110.929 -177.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.76 35.41 1.85 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.342 177.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.5 m . . . . . 0 C--O 1.253 1.253 0 C-N-CA 128.624 2.77 . . . . 0.0 105.462 177.615 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.993 ' CB ' ' OE1' ' A' ' 44' ' ' GLN . . . . . . . . 0 CA--C 1.516 -0.352 0 N-CA-C 107.022 -1.474 . . . . 0.0 107.022 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -158.48 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.127 164.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -45.53 154.34 0.53 Allowed Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 129.247 3.019 . . . . 0.0 114.773 -166.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -64.78 147.98 89.89 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.006 2.47 . . . . 0.0 111.239 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.9 mtt-85 -62.41 133.25 54.78 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.491 1.116 . . . . 0.0 110.895 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.98 145.49 55.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.986 1.315 . . . . 0.0 112.25 -174.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -75.45 142.89 42.88 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 124.82 1.248 . . . . 0.0 108.183 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -62.38 120.33 10.83 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 164.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.94 26.41 66.88 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 118.116 -1.38 . . . . 0.0 113.37 -172.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -42.73 -55.8 3.46 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 119.765 1.782 . . . . 0.0 110.767 167.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -165.48 169.99 14.93 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.715 1.206 . . . . 0.0 108.315 174.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.452 ' CD2' ' CE2' ' A' ' 55' ' ' PHE . 35.0 m-70 46.71 40.73 9.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.561 1.544 . . . . 0.0 113.335 172.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 57.16 30.65 18.68 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.621 1.168 . . . . 0.0 111.771 177.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -62.92 139.74 58.77 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 122.159 -0.338 . . . . 0.0 111.048 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 m -124.74 141.35 45.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 125.028 1.331 . . . . 0.0 107.841 172.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -68.54 -24.43 64.63 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 123.899 0.88 . . . . 0.0 112.196 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -117.7 122.8 44.46 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.138 1.375 . . . . 0.0 108.031 170.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.6 -49.05 62.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.667 0.787 . . . . 0.0 111.35 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.61 -23.06 66.13 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 117.768 -1.111 . . . . 0.0 112.793 -174.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -44.42 -44.08 8.15 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.831 1.196 . . . . 0.0 110.493 167.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.58 10.09 4.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.651 -175.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.9 t -69.45 -1.03 7.42 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 120.107 1.321 . . . . 0.0 114.43 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.96 -15.19 56.7 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.384 0.992 . . . . 0.0 111.81 169.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -81.28 114.41 48.97 Favored Pre-proline 0 N--CA 1.452 -0.346 0 C-N-CA 124.414 1.086 . . . . 0.0 109.671 -172.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -62.05 118.38 5.26 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 N-CA-C 107.114 -1.918 . . . . 0.0 107.114 165.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.7 tpt85 124.96 -37.62 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 129.204 3.002 . . . . 0.0 108.776 -168.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -64.83 148.3 51.59 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 168.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.7 tm0? -154.83 131.89 10.93 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -62.04 125.01 22.38 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 126.694 1.998 . . . . 0.0 112.532 -168.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.68 -25.18 23.61 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-O 118.822 -0.988 . . . . 0.0 111.345 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -60.08 119.5 7.93 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.096 1.448 . . . . 0.0 108.28 173.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 mp -131.41 153.26 49.88 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 127.048 2.139 . . . . 0.0 107.044 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 55.6 m -48.5 -49.45 35.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.619 0.768 . . . . 0.0 111.269 173.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.252 4.6 tt0 -76.92 31.35 0.13 Allowed 'General case' 0 CA--C 1.547 0.832 0 O-C-N 119.881 -1.762 . . . . 0.0 113.615 175.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -143.11 30.31 1.43 Allowed 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.573 -1.329 . . . . 0.0 110.629 155.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 47.9 t -102.69 138.41 39.63 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.056 1.742 . . . . 0.0 110.48 -175.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.59 -19.02 64.44 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 120.929 -1.107 . . . . 0.0 112.256 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -85.09 -0.21 53.74 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.853 0.861 . . . . 0.0 111.672 172.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 33.5 t-105 -66.05 148.72 51.38 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 119.384 0.993 . . . . 0.0 110.897 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.01 -99.25 1.45 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 107.42 -2.272 . . . . 0.0 107.42 165.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -148.36 159.91 43.53 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.788 1.635 . . . . 0.0 107.061 175.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.91 146.61 41.61 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.266 0.555 . . . . 0.0 110.694 166.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.6 t -118.83 -52.75 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 125.575 1.55 . . . . 0.0 108.568 -177.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.993 ' OE1' ' CB ' ' A' ' 1' ' ' ALA . 13.9 pt20 -147.67 -152.85 0.46 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.672 0.789 . . . . 0.0 111.21 -175.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -56.54 68.45 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 130.031 3.332 . . . . 0.0 114.353 -163.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.05 30.71 67.37 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.648 1.118 . . . . 0.0 110.569 -174.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -129.19 146.35 51.13 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.359 1.464 . . . . 0.0 108.902 174.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -155.95 173.52 33.93 Favored Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.8 mtp-105 -78.13 130.22 36.11 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.097 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 39.8 t -88.25 161.61 17.09 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 150.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.1 p -123.97 166.4 15.77 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.709 0.686 . . . . 0.0 110.926 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 61.1 m80 96.41 117.59 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 129.811 3.244 . . . . 0.0 108.68 174.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -44.57 129.79 9.13 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.881 3.054 . . . . 0.0 113.319 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.326 0.6 OUTLIER 100.08 -20.33 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 130.135 3.374 . . . . 0.0 110.639 -166.363 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.452 ' CE2' ' CD2' ' A' ' 12' ' ' HIS . 0.2 OUTLIER -131.08 13.85 5.18 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.278 2.231 . . . . 0.0 112.162 175.407 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.58 -35.33 6.05 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.305 0.957 . . . . 0.0 110.956 -175.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -48.64 -46.63 40.12 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 127.16 2.184 . . . . 0.0 113.102 -176.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.1 m -111.71 153.68 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.88 1.272 . . . . 0.0 109.781 -169.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.2 tp -84.53 127.97 34.33 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.2 t -98.62 141.84 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -170.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -68.07 133.85 49.65 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.56 -35.17 71.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 119.264 -0.398 . . . . 0.0 111.856 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.53 3.86 34.62 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 173.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.65 -176.48 16.1 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 119.499 1.045 . . . . 0.0 111.257 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 72.9 t90 -158.7 156.59 30.19 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 171.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 10.3 p -142.24 171.38 14.13 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.779 0.831 . . . . 0.0 110.718 169.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.0 p -71.41 -29.66 65.18 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -174.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.5 m -67.74 -70.35 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 58.2 t80 58.72 -85.34 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.203 1.801 . . . . 0.0 112.241 177.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 62.68 124.95 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.258 1.823 . . . . 0.0 111.299 -162.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -71.26 146.75 51.86 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.096 1.864 . . . . 0.0 111.196 -177.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -91.93 48.66 1.46 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.733 0.778 . . . . 0.0 109.423 175.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.5 p . . . . . 0 C--O 1.247 0.972 0 C-N-CA 125.563 1.545 . . . . 0.0 107.188 -174.469 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.416 ' N ' ' OE1' ' A' ' 3' ' ' GLU . . . . . . . . 0 C--O 1.236 0.374 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 p -94.13 38.11 1.09 Allowed 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 124.714 1.259 . . . . 0.0 109.626 169.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.416 ' OE1' ' N ' ' A' ' 1' ' ' ALA . 3.1 mp0 -60.06 129.29 88.22 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -70.52 128.75 15.76 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.419 2.08 . . . . 0.0 110.821 -169.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 34.9 mtt-85 -61.78 129.58 41.66 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.683 1.193 . . . . 0.0 111.137 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.97 143.35 56.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.241 1.417 . . . . 0.0 112.442 -172.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -78.03 144.7 36.42 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.48 1.112 . . . . 0.0 108.595 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -63.46 122.08 15.4 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 165.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.66 22.98 73.98 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.174 -1.348 . . . . 0.0 113.085 -172.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -39.96 -56.77 1.76 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 119.431 1.615 . . . . 0.0 111.253 167.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -168.32 175.85 6.2 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.612 1.565 . . . . 0.0 107.275 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 37.11 50.07 0.9 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.053 1.741 . . . . 0.0 112.865 175.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 57.37 23.53 9.04 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.57 0.748 . . . . 0.0 112.054 172.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -63.4 136.97 57.98 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 118.111 0.414 . . . . 0.0 110.911 -174.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.7 m -124.04 141.61 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 173.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 -69.32 -23.91 63.85 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 123.851 0.86 . . . . 0.0 111.764 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -115.55 115.13 25.93 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.675 1.19 . . . . 0.0 107.931 171.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -43.39 -48.33 7.02 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.807 1.243 . . . . 0.0 110.983 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.5 -35.18 52.44 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.45 -0.786 . . . . 0.0 112.962 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -51.42 -40.52 59.5 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.617 1.098 . . . . 0.0 110.809 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.72 6.6 5.75 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.343 -0.837 . . . . 0.0 112.785 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.9 t -52.2 -32.66 37.46 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.917 1.235 . . . . 0.0 112.507 173.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.37 -21.67 76.04 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 114.659 -1.155 . . . . 0.0 113.8 176.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -80.32 114.93 51.22 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 119.079 1.44 . . . . 0.0 111.355 -168.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.29 107.65 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 N-CA-C 107.229 -1.873 . . . . 0.0 107.229 165.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 143.16 -35.81 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 1 C-N-CA 132.074 4.15 . . . . 0.0 108.652 -174.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -77.12 151.27 35.45 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.284 1.034 . . . . 0.0 110.946 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -137.6 146.49 44.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.675 2.39 . . . . 0.0 105.638 166.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -63.28 158.97 18.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.077 0.951 . . . . 0.0 111.155 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.38 -26.71 4.95 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.28 0.943 . . . . 0.0 111.792 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -67.18 112.25 4.37 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.2 mp -124.61 148.26 48.0 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 177.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.8 m -42.18 -45.66 4.14 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.482 1.113 . . . . 0.0 111.919 172.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -56.08 -26.43 49.42 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.729 -1.232 . . . . 0.0 113.972 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -108.91 27.24 9.69 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.131 1.372 . . . . 0.0 112.055 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 50.1 t -94.95 139.9 30.7 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.108 1.363 . . . . 0.0 109.331 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.73 -24.82 67.05 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.333 -0.855 . . . . 0.0 112.569 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -82.19 -2.8 53.45 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.37 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -61.98 140.51 58.33 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 119.256 0.935 . . . . 0.0 111.726 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.64 -71.78 1.25 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.277 1.418 . . . . 0.0 109.78 173.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -174.7 157.38 2.51 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.197 1.399 . . . . 0.0 107.39 -167.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.73 133.47 34.37 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 169.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.98 -49.08 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 124.568 1.147 . . . . 0.0 109.887 -174.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -146.41 -161.25 1.28 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.26 1.024 . . . . 0.0 110.108 -172.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -56.4 71.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 129.361 3.064 . . . . 0.0 114.293 -161.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.74 34.35 77.78 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -172.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -129.58 146.15 51.41 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 125.259 1.424 . . . . 0.0 109.222 173.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.28 -172.6 28.84 Favored Glycine 0 N--CA 1.432 -1.621 0 CA-C-O 121.99 0.772 . . . . 0.0 112.097 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -93.11 139.68 30.31 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -171.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.1 t -118.44 98.9 6.5 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 173.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.4 p -76.8 71.69 3.37 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.646 0.778 . . . . 0.0 109.91 -171.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -161.67 123.45 1.67 Allowed Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 123.495 0.718 . . . . 0.0 110.092 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.13 132.88 25.32 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.945 1.763 . . . . 0.0 108.405 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 122.01 -40.19 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 129.228 3.011 . . . . 0.0 105.637 -155.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -124.05 -44.16 2.06 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.231 1.412 . . . . 0.0 113.18 -174.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -55.86 -18.51 8.96 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -173.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -51.05 -35.06 32.63 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.996 0.816 . . . . 0.0 112.881 169.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.1 m -128.43 163.56 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 125.325 1.45 . . . . 0.0 109.736 -172.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.4 tp -86.93 129.57 34.82 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.4 t -98.58 135.34 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 124.069 0.948 . . . . 0.0 108.812 -168.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -65.25 131.12 45.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 176.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.02 -39.81 63.41 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.226 0.611 . . . . 0.0 111.626 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -83.87 2.33 38.95 Favored 'General case' 0 C--N 1.342 0.242 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.78 -177.06 23.24 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 119.412 1.005 . . . . 0.0 111.314 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 60.8 t90 -160.77 149.98 16.97 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 171.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 7.5 p -134.77 162.51 32.14 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.194 1.398 . . . . 0.0 109.838 174.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.8 p -71.93 -14.33 61.89 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 120.655 -1.278 . . . . 0.0 112.79 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.348 1.7 p -85.44 10.0 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 125.562 1.545 . . . . 0.0 111.723 166.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -52.84 126.16 19.28 Favored 'General case' 0 C--N 1.342 0.27 0 O-C-N 120.54 -1.35 . . . . 0.0 110.232 163.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.83 134.06 24.81 Favored Pre-proline 0 N--CA 1.454 -0.254 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 169.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.51 148.42 66.62 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 121.675 1.583 . . . . 0.0 110.821 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.96 35.43 1.88 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.882 0.873 . . . . 0.0 110.213 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.9 m . . . . . 0 C--O 1.254 1.306 0 C-N-CA 128.706 2.803 . . . . 0.0 105.257 179.458 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.237 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.1 m -81.83 64.91 6.73 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 167.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.58 153.37 40.66 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 122.294 0.237 . . . . 0.0 111.198 -174.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -59.44 145.09 98.98 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.532 2.155 . . . . 0.0 110.353 177.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.2 mtp180 -71.59 125.61 27.52 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -174.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -54.39 145.25 18.57 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.513 1.525 . . . . 0.0 113.1 -166.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -76.2 142.66 41.43 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.227 1.011 . . . . 0.0 108.459 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -63.36 116.33 5.42 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 164.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.74 25.23 60.82 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.327 -1.263 . . . . 0.0 113.222 -172.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -41.74 -53.69 3.56 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 119.399 1.599 . . . . 0.0 110.743 166.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.06 178.57 6.29 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.298 1.439 . . . . 0.0 107.415 169.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.411 ' ND1' ' OD2' ' A' ' 54' ' ' ASP . 18.1 m170 39.97 48.13 2.05 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 125.977 1.711 . . . . 0.0 112.414 165.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.41 20.86 7.79 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.046 1.338 . . . . 0.0 112.545 170.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -63.12 133.97 55.28 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 118.397 0.544 . . . . 0.0 110.036 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.56 144.15 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 168.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -60.38 -38.1 82.83 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.346 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.12 136.11 44.35 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 168.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.62 -28.29 69.26 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.583 0.753 . . . . 0.0 110.884 171.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.68 -52.71 29.1 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.383 0.538 . . . . 0.0 111.792 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -55.71 -30.95 62.01 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.961 1.305 . . . . 0.0 111.729 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.4 -8.77 49.55 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.941 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.7 t -51.53 -31.6 24.67 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 119.672 1.124 . . . . 0.0 113.253 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.01 -24.55 67.06 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-N 115.02 -0.991 . . . . 0.0 113.158 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -88.51 107.56 17.58 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 124.779 1.232 . . . . 0.0 110.841 -171.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -58.67 120.57 8.53 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 N-CA-C 107.006 -1.959 . . . . 0.0 107.006 161.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 52.6 tpt85 127.58 -38.6 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 129.103 2.961 . . . . 0.0 108.876 -167.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -70.39 160.07 33.01 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.765 0.793 . . . . 0.0 109.715 169.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -155.18 131.36 10.25 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 113.87 -1.513 . . . . 0.0 109.242 169.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.0 mp0 -56.1 113.0 1.35 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 127.198 2.199 . . . . 0.0 109.998 -175.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 126.43 -33.79 3.36 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -67.42 118.79 11.24 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.377 1.088 . . . . 0.0 108.335 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.7 mp -131.94 152.85 50.83 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.452 1.901 . . . . 0.0 106.875 176.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.3 m -49.29 -47.58 46.74 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.661 0.784 . . . . 0.0 111.148 175.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.257 6.3 tt0 -75.1 23.96 0.1 Allowed 'General case' 0 CA--C 1.55 0.961 0 O-C-N 120.261 -1.524 . . . . 0.0 113.838 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -139.04 28.19 2.33 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.54 -1.35 . . . . 0.0 110.998 157.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 50.4 t -96.34 135.78 37.72 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.857 1.663 . . . . 0.0 108.291 175.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.42 -22.27 64.86 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.322 -0.861 . . . . 0.0 112.232 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -88.74 2.99 52.46 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 118.821 -0.609 . . . . 0.0 112.481 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 60.7 t-105 -59.51 139.39 57.17 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 119.065 0.848 . . . . 0.0 110.9 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.38 -105.87 0.6 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.163 -1.975 . . . . 0.0 108.163 167.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -146.26 156.31 43.29 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.959 1.304 . . . . 0.0 107.876 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.12 146.16 54.68 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 123.867 0.729 . . . . 0.0 110.577 171.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.5 t -118.99 -54.99 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.897 1.279 . . . . 0.0 109.214 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -154.1 155.63 35.76 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 124.515 1.126 . . . . 0.0 109.454 -176.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.9 t0 48.91 31.8 3.43 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 148.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.17 33.4 44.92 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 120.908 -1.12 . . . . 0.0 112.921 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 64.7 m95 -134.55 160.39 38.2 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 127.376 2.27 . . . . 0.0 108.739 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.56 175.69 38.95 Favored Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.3 mtp-105 -78.97 142.03 37.0 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.154 -0.523 . . . . 0.0 110.437 174.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.6 t -107.22 106.16 16.5 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 168.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -76.45 70.95 3.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.715 -0.616 . . . . 0.0 109.949 -174.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.401 ' ND1' ' OD1' ' A' ' 54' ' ' ASP . 63.9 t-80 -154.83 113.8 2.37 Favored Pre-proline 0 N--CA 1.451 -0.397 0 C-N-CA 123.757 0.823 . . . . 0.0 109.625 177.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -53.19 124.66 16.17 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.521 2.147 . . . . 0.0 110.206 170.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.411 ' OD2' ' ND1' ' A' ' 12' ' ' HIS . 5.1 p-10 120.8 -29.2 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 130.455 3.502 . . . . 0.0 108.877 -167.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -124.03 -42.12 2.17 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.529 1.532 . . . . 0.0 112.375 177.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -44.49 -38.03 3.86 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.737 1.615 . . . . 0.0 113.192 -175.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -42.9 -42.21 3.6 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.4 1.08 . . . . 0.0 112.89 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.7 m -117.04 156.75 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 124.727 1.211 . . . . 0.0 109.569 -173.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.8 tp -81.66 132.4 35.3 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 69.0 t -104.58 131.14 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 123.763 0.825 . . . . 0.0 109.166 -167.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -62.02 132.1 51.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.02 -34.98 78.73 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.068 -177.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -81.34 -1.19 44.42 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 118.077 -0.963 . . . . 0.0 113.568 172.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.62 -174.55 16.63 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 119.751 1.16 . . . . 0.0 111.159 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 17.8 t90 -165.53 153.09 10.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 7.7 p -135.62 161.72 34.73 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.575 1.15 . . . . 0.0 109.259 174.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.2 p -71.64 -14.63 62.11 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.091 -1.006 . . . . 0.0 112.713 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.35 0.9 OUTLIER -75.32 -6.85 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 119.327 0.967 . . . . 0.0 112.478 170.007 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -40.39 125.45 2.12 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 124.642 1.177 . . . . 0.0 112.441 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.18 134.44 23.37 Favored Pre-proline 0 C--N 1.331 -0.197 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 168.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.19 149.27 63.91 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 121.607 1.538 . . . . 0.0 110.917 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.33 33.59 2.4 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.801 0.841 . . . . 0.0 110.508 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.3 m . . . . . 0 C--O 1.249 1.046 0 C-N-CA 128.633 2.773 . . . . 0.0 105.598 177.929 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.766 ' CB ' ' OE2' ' A' ' 3' ' ' GLU . . . . . . . . 0 CA--C 1.534 0.348 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.3 m -153.75 47.49 0.64 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.434 1.015 . . . . 0.0 109.445 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.766 ' OE2' ' CB ' ' A' ' 1' ' ' ALA . 5.8 mp0 -79.87 151.55 73.69 Favored Pre-proline 0 N--CA 1.448 -0.542 0 C-N-CA 124.017 0.927 . . . . 0.0 108.503 -176.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -60.68 145.77 98.31 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.051 1.834 . . . . 0.0 110.687 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 26.0 mtp180 -81.71 126.93 32.38 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -170.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -53.84 140.14 31.25 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.339 1.456 . . . . 0.0 113.544 -165.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.7 145.31 48.92 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.348 1.459 . . . . 0.0 108.348 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -50.29 122.15 6.54 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 157.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 65.79 27.75 73.01 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.027 -1.43 . . . . 0.0 114.188 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -42.94 -56.37 3.32 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 119.839 1.819 . . . . 0.0 111.816 171.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.88 165.56 35.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 173.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.42 ' NE2' ' OD2' ' A' ' 54' ' ' ASP . 51.9 m-70 44.57 48.52 8.54 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.815 1.246 . . . . 0.0 113.22 170.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.24 20.23 10.82 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.995 0.518 . . . . 0.0 111.882 170.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -62.19 144.33 55.61 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.605 0.639 . . . . 0.0 112.676 -171.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.1 m -127.86 144.39 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 124.764 1.226 . . . . 0.0 108.594 173.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -70.49 -26.51 63.64 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.395 0.678 . . . . 0.0 112.372 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -117.69 116.31 26.8 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 173.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -46.5 -44.75 17.93 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.245 1.018 . . . . 0.0 111.065 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.47 -37.89 58.13 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.464 -0.779 . . . . 0.0 112.619 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -48.07 -43.08 30.23 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-O 122.237 1.018 . . . . 0.0 110.83 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.35 3.21 11.48 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 118.05 -0.976 . . . . 0.0 112.762 -174.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.4 t -58.73 -24.37 61.44 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 120.615 1.552 . . . . 0.0 112.463 173.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.59 -25.8 70.48 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.134 0.873 . . . . 0.0 113.117 171.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -81.5 111.06 22.23 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 124.477 1.111 . . . . 0.0 110.954 -172.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -61.39 111.44 1.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 N-CA-C 107.172 -1.895 . . . . 0.0 107.172 163.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 141.1 -44.19 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.785 1 C-N-CA 131.991 4.116 . . . . 0.0 105.762 -170.093 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -64.28 153.75 37.25 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.991 0.901 . . . . 0.0 110.89 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -144.57 138.51 27.52 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 128.168 2.587 . . . . 0.0 106.526 170.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -58.48 149.49 25.05 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 127.223 2.209 . . . . 0.0 110.19 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.24 -16.96 35.76 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.657 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -75.32 96.96 3.47 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.046 1.423 . . . . 0.0 109.242 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.7 mp -101.56 147.44 26.4 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.905 1.682 . . . . 0.0 107.408 165.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 m -44.64 -43.19 8.06 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.396 1.479 . . . . 0.0 111.425 175.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -61.97 -16.85 54.42 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.436 -1.415 . . . . 0.0 113.933 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -94.84 2.8 55.49 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.128 1.371 . . . . 0.0 111.84 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 38.3 t -81.28 131.92 35.31 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.537 1.135 . . . . 0.0 109.129 -173.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.73 -19.11 47.93 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.198 -0.939 . . . . 0.0 112.165 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.6 m-30 -87.39 -9.65 54.18 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.171 0.988 . . . . 0.0 112.328 177.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 77.1 t-105 -55.38 142.41 32.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.189 0.596 . . . . 0.0 111.154 179.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.62 -97.79 1.4 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 171.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -141.89 158.83 43.31 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.254 1.422 . . . . 0.0 107.834 178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.04 151.08 43.4 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 123.822 0.701 . . . . 0.0 109.972 172.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.1 t -123.82 -50.72 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.208 1.403 . . . . 0.0 109.99 -172.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -140.73 -138.64 0.12 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.538 0.735 . . . . 0.0 112.206 -176.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -68.51 64.18 0.11 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 127.943 2.497 . . . . 0.0 113.583 -167.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.04 56.14 25.66 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 108.206 -1.957 . . . . 0.0 108.206 -168.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 66.7 m95 -133.75 154.51 50.92 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 165.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -164.97 174.82 40.94 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-O 122.489 1.05 . . . . 0.0 112.468 175.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -73.68 145.43 45.26 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 126.473 1.909 . . . . 0.0 111.452 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 29.0 t -116.55 -9.67 11.35 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.986 2.515 . . . . 0.0 110.148 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.3 p 71.44 -29.44 0.19 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.279 2.232 . . . . 0.0 114.758 169.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -85.68 134.11 40.43 Favored Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 123.791 0.837 . . . . 0.0 109.522 -170.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -57.06 -51.03 9.66 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.355 2.703 . . . . 0.0 111.903 -166.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.42 ' OD2' ' NE2' ' A' ' 12' ' ' HIS . 12.9 p-10 -72.72 51.17 0.27 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.56 1.944 . . . . 0.0 110.736 173.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -179.46 -42.29 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.084 0.953 . . . . 0.0 112.955 -177.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -92.19 5.64 49.64 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.818 0.847 . . . . 0.0 112.668 -164.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.94 -55.5 10.76 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 171.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.3 m -78.01 165.94 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 169.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 22.5 tp -102.87 131.3 49.86 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.624 1.17 . . . . 0.0 108.508 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.0 m -97.21 143.29 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 119.393 0.997 . . . . 0.0 110.368 -175.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.12 137.02 57.3 Favored 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 172.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.08 -42.13 72.43 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.909 0.884 . . . . 0.0 110.214 171.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -80.95 7.1 11.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.91 -175.38 32.0 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 76.8 t90 -159.37 154.16 24.62 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 169.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 6.8 p -138.21 165.97 25.35 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 124.0 0.812 . . . . 0.0 110.755 170.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.0 p -64.48 -31.99 73.43 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.698 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.284 1.3 m -72.97 -3.23 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 118.353 -0.832 . . . . 0.0 113.095 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -44.84 127.15 6.21 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.35 0.977 . . . . 0.0 110.859 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.2 132.81 24.27 Favored Pre-proline 0 N--CA 1.454 -0.259 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 168.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.44 151.2 65.03 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.823 1.682 . . . . 0.0 110.971 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.73 33.07 1.92 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.808 0.843 . . . . 0.0 110.429 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.7 m . . . . . 0 C--O 1.254 1.3 0 C-N-CA 128.326 2.65 . . . . 0.0 105.748 177.418 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.836 ' CB ' ' OE2' ' A' ' 3' ' ' GLU . . . . . . . . 0 CA--C 1.53 0.175 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.5 m -162.09 55.92 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.147 1.779 . . . . 0.0 107.288 172.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.836 ' OE2' ' CB ' ' A' ' 1' ' ' ALA . 2.1 mp0 -59.63 150.95 64.32 Favored Pre-proline 0 N--CA 1.446 -0.629 0 C-N-CA 125.621 1.568 . . . . 0.0 108.463 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.74 131.28 28.76 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.557 1.504 . . . . 0.0 110.009 -174.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 34.0 mtt-85 -58.59 126.25 26.83 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.849 1.26 . . . . 0.0 110.476 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.33 143.58 39.23 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.474 1.51 . . . . 0.0 111.253 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.64 149.38 22.83 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.496 0.665 . . . . 0.0 111.113 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.85 121.02 11.86 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.94 15.78 69.21 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 117.913 -1.493 . . . . 0.0 113.124 -173.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -38.84 -58.44 1.08 Allowed 'General case' 0 C--N 1.346 0.448 0 CA-C-N 119.603 1.701 . . . . 0.0 111.994 172.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -169.03 172.01 7.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.548 1.539 . . . . 0.0 107.221 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 39.02 50.52 1.78 Allowed 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.709 1.604 . . . . 0.0 112.476 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 55.41 25.71 7.98 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.272 1.029 . . . . 0.0 112.553 174.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -63.65 137.58 58.15 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.386 0.539 . . . . 0.0 111.125 -175.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.4 m -124.22 144.29 34.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 172.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -71.89 -27.43 62.84 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.25 1.02 . . . . 0.0 111.852 176.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -113.98 114.21 25.85 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 171.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -40.63 -49.33 3.0 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.352 1.461 . . . . 0.0 111.054 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.54 -34.69 59.13 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.589 0.756 . . . . 0.0 112.982 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -50.04 -41.2 47.09 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.532 1.06 . . . . 0.0 110.935 174.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.74 9.78 2.61 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 118.428 -0.796 . . . . 0.0 112.805 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.3 t -52.66 -31.76 38.76 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 120.115 1.325 . . . . 0.0 112.691 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.82 -21.77 78.11 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.696 1.141 . . . . 0.0 113.823 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -79.72 115.45 53.78 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 118.752 1.276 . . . . 0.0 111.362 -168.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.02 72.87 3.22 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.961 2.441 . . . . 0.0 111.21 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 52.8 mmt-85 -178.06 -36.27 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 131.623 3.969 . . . . 0.0 107.953 173.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -58.91 151.63 21.31 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.58 0.705 . . . . 0.0 110.399 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -136.75 146.04 45.31 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 166.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -59.38 148.43 32.58 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.462 0.649 . . . . 0.0 110.167 176.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.43 -23.16 16.7 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.348 0.975 . . . . 0.0 112.569 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -72.63 105.09 4.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 118.342 1.071 . . . . 0.0 108.765 177.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.7 mp -117.29 149.0 41.18 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 14.8 m -42.19 -46.19 4.32 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.248 1.419 . . . . 0.0 111.33 172.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -56.91 -26.82 59.98 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.789 -1.194 . . . . 0.0 114.152 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -107.16 19.15 20.79 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.11 0.964 . . . . 0.0 112.562 176.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.5 t -82.88 134.56 35.08 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.612 1.165 . . . . 0.0 108.525 173.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.87 -19.26 59.88 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.056 -1.027 . . . . 0.0 112.108 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -87.63 -5.21 58.83 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.451 -0.785 . . . . 0.0 111.425 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -53.86 142.71 23.32 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.543 1.065 . . . . 0.0 111.465 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.87 -85.95 1.17 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 173.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -166.31 158.95 14.43 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.08 137.01 38.68 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 123.603 0.564 . . . . 0.0 110.029 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 90.1 t -108.99 -49.93 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 125.417 1.487 . . . . 0.0 109.255 -175.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -151.71 -155.44 0.62 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.339 1.056 . . . . 0.0 110.886 -175.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -56.96 70.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 129.394 3.077 . . . . 0.0 114.416 -160.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.58 36.65 88.53 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -172.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -130.81 143.44 50.74 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 125.444 1.497 . . . . 0.0 109.065 173.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -156.77 -176.56 28.99 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-O 121.755 0.642 . . . . 0.0 112.189 177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 48.4 mmm-85 -90.87 154.89 19.16 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.34 1.056 . . . . 0.0 109.963 -178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 t -139.04 130.12 26.59 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.0 p -96.64 -179.37 4.57 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.593 1.157 . . . . 0.0 110.432 -169.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 10.3 m80 82.52 163.26 0.12 Allowed Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 126.288 1.835 . . . . 0.0 108.4 -176.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.61 148.05 12.3 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.651 2.234 . . . . 0.0 113.435 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 63.43 -171.5 0.17 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.179 1.792 . . . . 0.0 109.865 -172.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 73.84 -62.66 0.46 Allowed 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.309 1.444 . . . . 0.0 113.794 166.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -54.68 -24.68 22.9 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.442 0.697 . . . . 0.0 112.283 -176.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -24.34 -53.74 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.469 2.308 . . . . 0.0 112.897 160.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.6 m -126.7 159.05 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.853 1.661 . . . . 0.0 108.064 -170.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 10.3 tp -79.16 123.41 27.36 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.2 t -92.32 129.24 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -171.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -63.38 131.28 47.74 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.14 -41.99 49.85 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.484 0.714 . . . . 0.0 111.512 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -84.84 5.45 28.7 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.35 -176.01 27.43 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 119.414 1.006 . . . . 0.0 111.148 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 83.1 t90 -159.19 153.72 24.25 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 170.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 2.0 p -142.06 163.63 32.35 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.861 1.264 . . . . 0.0 110.578 175.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.1 p -78.14 -5.95 53.22 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.284 1.5 m -83.61 0.3 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 119.598 1.09 . . . . 0.0 112.169 164.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -47.14 137.98 7.33 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 119.073 0.852 . . . . 0.0 111.708 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -134.57 138.7 30.59 Favored Pre-proline 0 N--CA 1.454 -0.259 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 167.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.11 149.85 52.97 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.033 1.822 . . . . 0.0 111.147 -176.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.22 37.82 1.3 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.932 0.893 . . . . 0.0 110.071 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 45.7 m . . . . . 0 C--O 1.253 1.284 0 C-N-CA 128.365 2.666 . . . . 0.0 105.527 178.832 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.263 0 CA-C-O 117.455 -1.26 . . . . 0.0 108.45 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m 50.91 35.08 11.59 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.821 1.248 . . . . 0.0 113.078 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 51.3 mp0 -61.59 150.77 80.26 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 123.316 0.646 . . . . 0.0 109.433 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.21 145.73 79.23 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.308 2.005 . . . . 0.0 110.813 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -57.89 125.69 24.16 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.065 1.346 . . . . 0.0 110.604 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.15 150.14 30.69 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.189 1.396 . . . . 0.0 112.75 -173.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -83.34 144.57 29.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.913 1.285 . . . . 0.0 108.623 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.1 121.98 14.4 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 166.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.79 22.91 76.28 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.175 -1.347 . . . . 0.0 113.271 -173.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -42.04 -55.09 3.31 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 119.557 1.678 . . . . 0.0 111.182 168.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -165.94 173.89 10.03 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.066 1.347 . . . . 0.0 108.06 173.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 38.33 50.69 1.5 Allowed 'General case' 0 C--N 1.341 0.23 0 C-N-CA 126.025 1.73 . . . . 0.0 112.986 172.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.2 20.5 8.56 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.384 0.674 . . . . 0.0 111.905 171.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -63.22 136.02 57.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.862 0.755 . . . . 0.0 110.543 -175.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.9 m -122.62 142.19 40.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -62.74 -36.66 83.74 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.921 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -109.01 123.3 48.93 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 123.401 0.68 . . . . 0.0 109.362 170.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.56 -36.44 10.56 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.25 1.42 . . . . 0.0 110.919 171.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.24 -40.99 64.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -56.38 -37.63 70.34 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 122.024 0.916 . . . . 0.0 110.604 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.51 0.69 13.96 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 117.831 -1.081 . . . . 0.0 112.245 -175.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.2 t -52.29 -30.39 27.88 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 120.36 1.436 . . . . 0.0 112.861 172.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.25 -27.2 72.13 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.49 1.043 . . . . 0.0 113.679 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -81.49 114.86 52.91 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 118.375 1.087 . . . . 0.0 111.494 -169.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -63.05 108.7 0.8 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 N-CA-C 107.614 -1.726 . . . . 0.0 107.614 165.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.0 mmm180 139.34 -35.41 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 131.487 3.915 . . . . 0.0 108.748 -173.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -71.9 156.55 39.15 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.492 0.663 . . . . 0.0 109.765 175.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -155.16 138.94 16.17 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.384 165.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -54.71 115.61 2.25 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 128.114 2.565 . . . . 0.0 109.53 -175.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.37 -21.19 11.96 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -72.92 109.27 6.35 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 167.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.2 mp -122.89 148.64 45.2 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.355 2.262 . . . . 0.0 106.137 172.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 6.5 m -45.07 -44.49 10.35 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.498 1.519 . . . . 0.0 111.711 175.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -59.12 -18.81 39.0 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 120.657 -1.277 . . . . 0.0 113.903 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -96.8 3.98 51.99 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.217 1.407 . . . . 0.0 112.043 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.2 t -90.79 139.99 30.21 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.849 1.26 . . . . 0.0 110.396 -169.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.84 -11.3 58.31 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.007 -1.058 . . . . 0.0 112.857 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -88.96 -3.92 58.59 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.604 171.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -59.52 132.28 53.52 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.07 0.85 . . . . 0.0 110.321 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.88 -81.03 1.13 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 171.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.6 165.68 12.18 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.612 0.765 . . . . 0.0 110.165 163.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.74 146.64 36.03 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.313 1.045 . . . . 0.0 111.034 170.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.2 t -125.23 -48.47 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 124.925 1.29 . . . . 0.0 109.211 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -149.17 -159.15 0.99 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.016 0.926 . . . . 0.0 110.192 -174.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -59.32 70.3 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 129.648 3.179 . . . . 0.0 113.799 -162.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.0 30.08 57.96 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -131.55 143.02 50.06 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 124.949 1.299 . . . . 0.0 108.845 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -152.89 172.91 31.91 Favored Glycine 0 N--CA 1.433 -1.508 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 176.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -72.03 127.76 33.56 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.105 170.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 52.0 t -84.64 167.74 15.95 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 104.778 -2.305 . . . . 0.0 104.778 141.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.4 p -127.45 165.8 19.13 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.933 0.893 . . . . 0.0 109.686 175.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 45.0 m80 93.95 120.09 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 129.276 3.03 . . . . 0.0 108.9 173.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -53.46 129.8 35.52 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.637 2.224 . . . . 0.0 111.295 -174.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 118.69 -46.14 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 130.984 3.714 . . . . 0.0 105.757 -160.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -133.51 52.44 2.07 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.386 1.474 . . . . 0.0 110.132 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -132.42 -40.68 0.99 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.792 0.837 . . . . 0.0 110.39 172.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -52.13 -41.43 62.5 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.456 1.903 . . . . 0.0 112.37 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.6 m -114.94 153.66 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 125.476 1.51 . . . . 0.0 109.424 -173.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.6 tp -85.28 136.27 33.57 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.6 t -104.97 134.8 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 123.608 0.763 . . . . 0.0 109.089 -167.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -64.01 129.64 40.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.17 -40.11 67.2 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.167 0.587 . . . . 0.0 111.632 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -82.7 1.26 39.5 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 175.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.57 -174.0 19.23 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 120.055 1.298 . . . . 0.0 111.832 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 75.2 t90 -163.87 150.64 11.81 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 174.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.6 p -135.76 162.99 31.21 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.142 1.377 . . . . 0.0 110.462 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.4 p -68.08 -21.76 64.96 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 118.454 -0.784 . . . . 0.0 112.521 -176.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.292 1.1 m -76.29 -4.64 6.39 Favored 'Isoleucine or valine' 0 C--N 1.344 0.36 0 CA-C-N 119.249 0.931 . . . . 0.0 112.705 175.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -42.69 126.47 3.67 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 118.777 0.717 . . . . 0.0 111.784 178.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.92 134.39 26.05 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 165.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.9 150.15 66.95 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 121.586 1.524 . . . . 0.0 111.027 -175.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.42 41.18 1.11 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.574 0.702 . . . . 0.0 109.807 172.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.6 m . . . . . 0 C--O 1.249 1.046 0 C-N-CA 127.977 2.511 . . . . 0.0 106.045 178.089 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 118.823 -0.608 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.4 m 61.92 51.86 3.6 Favored 'General case' 0 C--N 1.337 0.048 0 C-N-CA 124.846 1.258 . . . . 0.0 109.15 174.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -104.21 117.93 58.16 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.849 -148.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -65.3 154.8 71.91 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.546 2.164 . . . . 0.0 110.752 170.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.3 mtt180 -55.1 125.68 21.52 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.476 1.111 . . . . 0.0 110.868 172.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.58 152.5 34.8 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.64 1.176 . . . . 0.0 113.542 -172.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -84.8 143.4 29.13 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.452 1.501 . . . . 0.0 108.774 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -63.59 118.78 8.69 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 167.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.0 20.81 72.4 Favored Glycine 0 CA--C 1.531 1.094 0 CA-C-O 118.377 -1.235 . . . . 0.0 113.112 -173.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -43.89 -56.87 3.61 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 119.453 1.627 . . . . 0.0 111.477 169.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.09 172.96 10.79 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.146 1.378 . . . . 0.0 108.015 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 36.84 48.45 0.67 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.37 1.868 . . . . 0.0 113.246 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 55.77 23.85 6.75 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.853 0.861 . . . . 0.0 112.127 173.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -63.14 135.09 56.97 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.172 0.442 . . . . 0.0 110.096 -175.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.7 m -123.23 141.46 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 170.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.3 m-20 -62.61 -36.13 81.76 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 118.949 -0.548 . . . . 0.0 111.1 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.87 130.34 55.01 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 123.516 0.727 . . . . 0.0 109.334 168.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.49 -34.55 36.33 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.358 1.063 . . . . 0.0 110.654 170.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.05 -45.25 64.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.238 0.215 . . . . 0.0 111.434 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.52 -20.72 65.85 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.577 0.751 . . . . 0.0 111.933 -176.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.27 -6.53 55.26 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.544 -0.723 . . . . 0.0 111.968 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.2 m -62.73 91.88 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 119.162 0.892 . . . . 0.0 111.22 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.37 -36.0 1.03 Allowed Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.263 1.411 . . . . 0.0 110.764 -172.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -62.12 116.8 24.25 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.278 -0.868 . . . . 0.0 109.28 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.91 116.52 3.61 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 N-CA-C 107.455 -1.786 . . . . 0.0 107.455 170.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.5 tpt85 123.2 -35.54 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 129.438 3.095 . . . . 0.0 109.278 -170.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -62.7 149.73 42.96 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.52 0.676 . . . . 0.0 109.454 168.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -157.19 137.07 12.45 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.128 1.771 . . . . 0.0 106.368 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -58.33 123.47 16.21 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.522 2.329 . . . . 0.0 110.998 -172.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.94 -20.68 37.93 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-O 119.181 -0.788 . . . . 0.0 111.607 176.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -67.66 111.41 4.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 118.829 1.314 . . . . 0.0 107.909 173.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.6 mp -124.96 149.64 47.45 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 172.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.4 m -42.91 -45.54 5.01 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.042 1.337 . . . . 0.0 111.89 173.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -56.86 -26.08 57.83 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -109.26 25.72 11.47 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.178 0.991 . . . . 0.0 112.357 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 45.1 t -86.42 138.8 31.49 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.584 1.153 . . . . 0.0 108.838 172.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.09 -26.27 64.52 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.443 -0.785 . . . . 0.0 112.079 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -78.14 -10.92 59.85 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 117.719 -1.134 . . . . 0.0 112.559 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -49.56 127.77 16.22 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.988 1.267 . . . . 0.0 111.898 -172.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.18 -84.65 0.59 Allowed Glycine 0 C--N 1.335 0.485 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.81 171.17 11.64 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 155.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.28 145.76 46.3 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.55 1.14 . . . . 0.0 110.996 169.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.3 t -123.62 -47.45 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 125.746 1.619 . . . . 0.0 109.24 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -148.46 -162.73 1.62 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.987 0.915 . . . . 0.0 110.186 -174.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -58.05 71.23 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 129.675 3.19 . . . . 0.0 113.934 -163.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.95 26.82 57.61 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.985 1.278 . . . . 0.0 110.913 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -129.67 144.47 51.3 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 124.978 1.311 . . . . 0.0 109.644 176.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -154.04 -178.36 28.39 Favored Glycine 0 N--CA 1.437 -1.247 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.0 mtp85 -94.66 154.6 17.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 118.926 -0.559 . . . . 0.0 109.909 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.3 p -131.09 143.01 50.34 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.49 0.716 . . . . 0.0 109.093 159.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 34.4 p -82.26 61.14 5.33 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.62 1.168 . . . . 0.0 111.108 -160.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -153.81 114.58 2.59 Favored Pre-proline 0 N--CA 1.451 -0.397 0 CA-C-O 117.833 -1.08 . . . . 0.0 108.944 175.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -48.23 128.22 16.79 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 N-CA-C 107.917 -1.609 . . . . 0.0 107.917 159.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 124.03 -44.39 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 128.403 2.681 . . . . 0.0 105.953 -154.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -143.85 33.51 1.26 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.471 2.308 . . . . 0.0 110.024 -169.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -127.51 -41.89 1.68 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 122.253 1.025 . . . . 0.0 109.666 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.3 pm0 -51.92 -34.08 40.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.085 1.354 . . . . 0.0 111.549 166.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 m -127.39 149.62 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 125.285 1.434 . . . . 0.0 108.598 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.4 tp -91.55 142.66 27.41 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.371 1.468 . . . . 0.0 108.963 -171.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.2 t -102.06 124.7 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 124.927 1.291 . . . . 0.0 108.457 -162.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.3 tttm -61.6 126.81 28.69 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 171.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.65 -38.0 30.62 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.069 0.948 . . . . 0.0 111.676 175.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -83.54 -4.34 58.46 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.41 -173.32 29.73 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 119.034 0.834 . . . . 0.0 111.991 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 86.0 t90 -161.75 148.88 14.31 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 5.6 p -135.11 163.83 29.02 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.186 1.394 . . . . 0.0 109.341 172.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.7 p -73.07 -18.1 61.35 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.969 -1.082 . . . . 0.0 112.672 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.373 1.5 p -77.87 7.13 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 124.866 1.266 . . . . 0.0 111.785 164.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -52.5 130.36 31.48 Favored 'General case' 0 C--N 1.345 0.394 0 O-C-N 120.206 -1.559 . . . . 0.0 110.28 162.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.95 134.63 26.53 Favored Pre-proline 0 N--CA 1.453 -0.291 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 171.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -73.28 148.37 43.62 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 121.788 1.659 . . . . 0.0 110.658 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.26 46.27 1.2 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.746 0.784 . . . . 0.0 109.523 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.2 p . . . . . 0 C--O 1.249 1.076 0 C-N-CA 125.84 1.656 . . . . 0.0 106.79 -172.284 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.604 ' N ' ' OE1' ' A' ' 44' ' ' GLN . . . . . . . . 0 CA--C 1.513 -0.476 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.82 29.34 0.06 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -174.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -81.6 128.7 68.49 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -65.96 131.39 27.01 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.848 1.698 . . . . 0.0 109.881 -176.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -80.32 122.61 27.12 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -172.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.53 135.54 33.86 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.974 1.31 . . . . 0.0 112.804 -166.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -68.41 147.93 51.37 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.681 1.192 . . . . 0.0 109.464 177.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.27 87.75 0.12 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.744 0.818 . . . . 0.0 109.55 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.16 37.55 5.63 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.917 -173.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -39.65 -54.19 2.06 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 123.91 0.884 . . . . 0.0 109.943 164.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -165.76 175.21 8.94 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.494 1.518 . . . . 0.0 106.986 170.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.51 ' CD2' ' CE2' ' A' ' 55' ' ' PHE . 3.4 m-70 55.21 30.02 13.81 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.966 1.307 . . . . 0.0 113.603 169.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 57.08 34.58 25.1 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.603 1.161 . . . . 0.0 111.938 175.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -54.12 -64.48 0.81 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -171.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.284 23.6 m 55.52 134.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 127.206 2.202 . . . . 0.0 114.077 -169.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -66.69 -28.9 68.81 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 120.77 -1.206 . . . . 0.0 112.405 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -113.11 118.95 36.16 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 171.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.91 -43.59 29.01 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.48 1.112 . . . . 0.0 109.818 175.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.97 -40.24 13.99 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.75 0.82 . . . . 0.0 112.889 175.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -52.44 -34.85 50.61 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.507 1.049 . . . . 0.0 111.445 178.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.29 5.11 3.07 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 116.895 -1.526 . . . . 0.0 113.811 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.8 m -13.68 99.99 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 128.13 2.572 . . . . 0.0 113.942 170.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.15 21.66 64.19 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.312 0.958 . . . . 0.0 115.052 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -48.09 127.47 11.99 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 119.31 1.555 . . . . 0.0 107.783 162.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -61.01 110.26 0.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.708 0 CA-C-N 121.252 1.483 . . . . 0.0 108.299 175.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.5 tpt85 123.66 -40.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 129.578 3.151 . . . . 0.0 110.161 -171.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -70.82 143.39 51.14 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.795 0.725 . . . . 0.0 110.557 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -132.95 123.2 25.49 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 162.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.0 mp0 -54.15 119.05 4.58 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 128.407 2.683 . . . . 0.0 109.181 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.99 -34.55 3.38 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -174.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -63.94 118.4 8.38 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 171.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.87 147.27 50.8 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 126.086 1.754 . . . . 0.0 107.154 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.5 m -44.04 -48.8 8.88 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.15 0.98 . . . . 0.0 111.444 174.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -61.34 -20.45 62.99 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 120.431 -1.418 . . . . 0.0 113.983 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -107.21 24.12 13.34 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.811 1.244 . . . . 0.0 111.845 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.4 t -95.3 134.52 37.98 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.391 1.476 . . . . 0.0 109.595 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.0 -20.21 56.55 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.433 -0.792 . . . . 0.0 112.726 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -97.52 6.64 47.83 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.138 0.575 . . . . 0.0 112.192 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 -59.66 145.74 43.67 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.594 0.633 . . . . 0.0 110.392 171.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.18 -69.78 1.28 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 172.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -176.46 160.4 2.06 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 -169.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.37 140.38 31.61 Favored 'General case' 0 N--CA 1.457 -0.083 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 169.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 55.5 t -107.53 -51.37 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.401 1.48 . . . . 0.0 109.279 -173.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.604 ' OE1' ' N ' ' A' ' 1' ' ' ALA . 16.6 pt20 -149.55 -136.88 0.08 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.421 0.689 . . . . 0.0 111.728 -170.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -71.43 65.71 0.45 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.054 2.142 . . . . 0.0 112.988 -163.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.0 42.38 77.82 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -173.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 80.7 m95 -133.45 156.12 48.29 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 125.514 1.526 . . . . 0.0 108.232 170.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -157.47 -174.08 26.71 Favored Glycine 0 N--CA 1.434 -1.476 0 O-C-N 124.496 1.122 . . . . 0.0 110.507 177.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -98.23 153.64 18.35 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.402 1.081 . . . . 0.0 108.882 -176.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 9.2 t -134.25 134.66 42.21 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 125.463 1.505 . . . . 0.0 107.867 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 64.3 p -105.98 52.62 0.72 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.909 0.883 . . . . 0.0 111.271 -162.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.01 154.65 72.73 Favored Pre-proline 0 CA--C 1.53 0.207 0 C-N-CA 123.916 0.886 . . . . 0.0 109.012 177.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.54 144.32 72.43 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.757 2.304 . . . . 0.0 110.855 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.9 t0 60.55 46.66 9.28 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.579 1.152 . . . . 0.0 107.935 -173.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.51 ' CE2' ' CD2' ' A' ' 12' ' ' HIS . 1.1 m-85 -166.4 -53.37 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.861 1.664 . . . . 0.0 107.759 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.4 p-10 -23.49 -50.89 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.595 1.958 . . . . 0.0 113.327 153.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -44.91 -42.56 8.19 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.939 1.296 . . . . 0.0 114.311 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.3 m -130.4 156.4 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.07 0.948 . . . . 0.0 111.951 -160.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.1 tp -78.81 126.76 31.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 173.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.0 m -98.13 134.93 34.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 118.815 0.734 . . . . 0.0 109.546 -178.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -61.16 134.91 57.52 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.1 -40.56 73.87 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.66 0.384 . . . . 0.0 111.223 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -76.8 -2.34 32.72 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 175.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.11 -178.52 8.62 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 70.5 t90 -148.71 -179.48 7.02 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 170.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 5.7 p -162.66 164.85 26.37 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 119.038 0.835 . . . . 0.0 110.357 159.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.5 p -63.0 -30.99 72.03 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 118.939 -0.553 . . . . 0.0 111.781 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.301 1.1 m -72.42 -5.34 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 118.885 0.766 . . . . 0.0 112.478 177.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -46.03 137.0 6.19 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.884 0.874 . . . . 0.0 112.031 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.43 140.59 39.12 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 165.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.04 147.76 38.96 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.282 1.988 . . . . 0.0 111.248 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.3 46.75 1.27 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.611 0.72 . . . . 0.0 109.424 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.5 p . . . . . 0 C--O 1.248 1.018 0 C-N-CA 125.66 1.584 . . . . 0.0 107.122 -172.937 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 1.348 ' CB ' ' OE1' ' A' ' 3' ' ' GLU . . . . . . . . 0 CA--C 1.513 -0.453 0 CA-C-O 117.276 -1.345 . . . . 0.0 107.834 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 m -50.74 -32.45 19.7 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-O 122.621 1.201 . . . . 0.0 112.931 161.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 1.348 ' OE1' ' CB ' ' A' ' 1' ' ' ALA . 2.7 mp0 -77.29 127.51 82.94 Favored Pre-proline 0 C--N 1.318 -0.795 0 C-N-CA 126.78 2.032 . . . . 0.0 108.252 171.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.92 153.76 58.25 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.495 2.797 . . . . 0.0 110.795 174.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -79.23 123.13 27.12 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -54.61 142.7 27.12 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.82 1.248 . . . . 0.0 112.68 -170.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.58 145.61 38.85 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.006 1.322 . . . . 0.0 108.417 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -64.86 121.57 14.92 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 167.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.97 25.73 74.12 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 118.275 -1.292 . . . . 0.0 112.855 -170.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -41.95 -57.87 2.26 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 119.388 1.594 . . . . 0.0 110.7 168.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.19 174.06 4.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.746 1.619 . . . . 0.0 107.351 173.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . 0.455 ' CD2' ' CE2' ' A' ' 55' ' ' PHE . 10.4 m-70 54.46 31.97 15.78 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.802 1.241 . . . . 0.0 113.137 172.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 55.1 29.99 13.54 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.256 1.023 . . . . 0.0 111.596 -176.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -64.35 134.68 55.11 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.972 -0.455 . . . . 0.0 110.043 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.0 m -122.9 142.04 40.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 170.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -63.27 -34.92 78.73 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 118.993 -0.527 . . . . 0.0 111.534 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.69 127.27 54.47 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 123.634 0.774 . . . . 0.0 109.733 169.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.16 -38.47 11.86 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.732 1.213 . . . . 0.0 110.58 168.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.15 -41.76 60.33 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -59.7 -30.61 68.91 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.131 0.491 . . . . 0.0 111.373 -176.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.01 -0.31 30.67 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 118.85 -0.595 . . . . 0.0 112.448 -176.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.3 m -61.79 91.56 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 119.248 0.931 . . . . 0.0 111.377 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.06 -32.43 1.41 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.087 1.327 . . . . 0.0 111.431 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -60.26 125.12 80.79 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 118.067 0.933 . . . . 0.0 109.567 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -65.21 102.3 0.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 N-CA-C 107.258 -1.862 . . . . 0.0 107.258 169.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 139.9 -29.44 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 130.9 3.68 . . . . 0.0 110.235 -173.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -75.71 79.86 2.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.432 0.635 . . . . 0.0 109.769 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -64.75 137.62 57.9 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 161.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -59.46 118.55 6.16 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 128.085 2.554 . . . . 0.0 112.193 -172.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.67 -1.18 63.57 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-O 119.381 -0.677 . . . . 0.0 111.909 174.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -60.87 121.87 13.42 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.388 1.094 . . . . 0.0 108.372 166.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.7 mp -128.94 145.1 51.32 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.661 1.984 . . . . 0.0 107.723 173.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 6.8 m -45.54 -45.17 13.28 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 124.829 1.252 . . . . 0.0 112.75 177.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -64.84 -13.97 57.82 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 119.863 -1.773 . . . . 0.0 114.01 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -93.09 -1.16 56.76 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.318 1.047 . . . . 0.0 111.416 173.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.6 t -80.12 131.41 35.73 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.417 1.087 . . . . 0.0 109.138 -175.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.67 -6.29 19.89 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.969 -1.082 . . . . 0.0 112.472 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -93.57 -2.28 54.41 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.936 0.789 . . . . 0.0 111.755 171.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -59.56 149.37 30.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 118.518 0.599 . . . . 0.0 111.194 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.86 -74.82 1.27 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.287 1.422 . . . . 0.0 109.593 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -173.21 154.11 2.63 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.284 1.433 . . . . 0.0 107.152 -168.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.61 137.24 37.05 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 171.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 75.9 t -107.69 -48.62 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 125.244 1.418 . . . . 0.0 108.972 -173.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -149.37 -140.8 0.1 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.728 0.411 . . . . 0.0 111.866 -168.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -72.12 65.05 0.56 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.257 2.223 . . . . 0.0 112.561 -167.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.42 31.08 47.38 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -132.2 152.39 51.33 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 125.301 1.441 . . . . 0.0 109.224 173.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -154.84 -179.93 30.42 Favored Glycine 0 N--CA 1.431 -1.64 0 O-C-N 124.669 1.231 . . . . 0.0 110.832 178.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -86.05 145.77 26.92 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.62 133.2 34.08 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 126.589 1.956 . . . . 0.0 105.751 174.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.9 p -91.42 171.08 9.45 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 122.754 0.421 . . . . 0.0 111.321 -168.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 18.5 m80 100.23 141.19 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 130.231 3.412 . . . . 0.0 107.91 174.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -57.6 147.63 78.13 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.25 1.967 . . . . 0.0 111.554 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.2 t0 58.83 40.01 23.36 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.742 1.217 . . . . 0.0 109.94 -165.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.455 ' CE2' ' CD2' ' A' ' 12' ' ' HIS . 1.2 m-85 -163.22 -55.56 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.152 1.781 . . . . 0.0 109.483 172.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -37.37 -46.66 0.79 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.423 1.489 . . . . 0.0 111.98 173.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -65.86 -17.24 64.51 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.701 1.6 . . . . 0.0 115.28 -174.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.27 149.02 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 120.192 1.36 . . . . 0.0 111.239 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 7.3 tp -77.78 130.41 36.67 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 174.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.4 t -106.04 129.67 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -174.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.5 tttm -61.87 129.79 42.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 174.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.9 -36.69 67.94 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.565 0.746 . . . . 0.0 111.483 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -80.83 -7.03 59.32 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.57 -0.729 . . . . 0.0 112.455 178.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.38 -173.07 20.8 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 118.906 0.775 . . . . 0.0 111.915 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -161.19 150.68 16.8 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.8 p -139.82 172.44 12.78 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.235 1.014 . . . . 0.0 111.223 170.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 81.0 p -72.06 -35.53 69.31 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 m -64.84 -23.85 34.31 Favored 'Isoleucine or valine' 0 C--N 1.347 0.467 0 CA-C-N 118.568 0.622 . . . . 0.0 111.632 -175.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -20.45 105.39 0.02 OUTLIER 'General case' 0 C--O 1.237 0.403 0 C-N-CA 128.033 2.533 . . . . 0.0 113.486 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.57 120.57 57.26 Favored Pre-proline 0 N--CA 1.454 -0.234 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 165.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -66.1 134.41 36.67 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.253 1.302 . . . . 0.0 112.81 -173.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.56 -13.71 33.98 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 142.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.9 m . . . . . 0 C--O 1.25 1.108 1 C-N-CA 134.156 4.982 . . . . 0.0 103.518 174.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.432 ' O ' ' OE2' ' A' ' 3' ' ' GLU . . . . . . . . 0 CA--C 1.52 -0.194 0 CA-C-O 116.592 -1.67 . . . . 0.0 109.874 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.4 p -105.64 58.42 0.67 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 173.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.432 ' OE2' ' O ' ' A' ' 1' ' ' ALA . 1.8 pm0 -73.93 140.55 77.54 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -173.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.49 147.91 65.64 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.527 2.151 . . . . 0.0 111.312 -176.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.1 mtt180 -62.46 127.37 31.01 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.783 1.233 . . . . 0.0 109.987 171.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.41 145.53 43.31 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.584 1.553 . . . . 0.0 111.514 -175.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.3 146.15 24.91 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.375 0.607 . . . . 0.0 110.94 175.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.92 120.33 9.43 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 172.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.75 18.7 65.12 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 117.997 -1.446 . . . . 0.0 113.742 -174.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -36.01 -55.3 0.76 Allowed 'General case' 0 C--N 1.347 0.467 0 CA-C-N 119.637 1.718 . . . . 0.0 111.602 168.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -164.77 -179.47 5.87 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 164.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.4 m170 46.22 45.95 13.1 Favored 'General case' 0 CA--C 1.527 0.071 0 O-C-N 124.213 0.945 . . . . 0.0 111.865 160.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 56.23 24.59 8.28 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.955 1.302 . . . . 0.0 112.219 172.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -62.49 136.69 58.02 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 118.152 0.433 . . . . 0.0 111.415 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.1 m -125.46 142.26 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 174.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -70.65 -24.87 62.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.2 1.0 . . . . 0.0 112.053 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -115.31 120.57 40.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.12 1.368 . . . . 0.0 107.919 168.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.04 -49.62 40.38 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.189 0.996 . . . . 0.0 111.665 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.7 -20.03 64.4 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 118.201 -0.904 . . . . 0.0 112.785 -173.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -44.57 -43.84 8.37 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.805 1.184 . . . . 0.0 110.466 165.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.03 7.9 12.07 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -175.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.6 p -33.14 -59.16 0.37 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 127.344 2.257 . . . . 0.0 113.19 174.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.93 -29.82 35.64 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 112.239 -2.255 . . . . 0.0 113.805 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -70.04 117.51 54.73 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 118.687 1.243 . . . . 0.0 110.908 -171.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -60.68 105.74 0.33 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 N-CA-C 107.439 -1.793 . . . . 0.0 107.439 163.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 141.41 -40.0 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 130.983 3.713 . . . . 0.0 108.662 -172.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -68.78 150.4 47.89 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 173.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -150.3 132.14 15.09 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.272 1.1 pm0 -56.94 107.26 0.38 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.31 1.444 . . . . 0.0 112.076 -173.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.39 -1.87 27.98 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 119.139 -0.811 . . . . 0.0 111.983 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -73.07 110.81 7.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.74 1.77 . . . . 0.0 107.044 164.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.5 mp -121.57 150.27 41.9 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.925 2.09 . . . . 0.0 106.346 170.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.8 m -47.7 -45.72 28.79 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.326 1.05 . . . . 0.0 111.946 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -62.89 -13.65 36.79 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 120.209 -1.557 . . . . 0.0 113.588 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -95.68 2.52 54.07 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 120.82 -1.175 . . . . 0.0 111.874 175.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 24.6 t -86.83 137.06 32.72 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.754 1.222 . . . . 0.0 109.448 -171.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.02 -20.66 65.52 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.188 -0.945 . . . . 0.0 111.867 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -87.29 2.07 51.31 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.566 -0.731 . . . . 0.0 112.528 173.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 48.2 t-105 -59.09 142.93 50.14 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.749 1.158 . . . . 0.0 111.071 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.43 -109.47 0.93 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 165.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -139.43 157.26 46.16 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.274 1.43 . . . . 0.0 107.782 175.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.27 141.44 58.02 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 123.929 0.768 . . . . 0.0 109.444 165.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.7 t -113.5 -54.05 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 124.5 1.12 . . . . 0.0 109.257 -174.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -157.87 153.97 27.19 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.364 1.066 . . . . 0.0 109.46 -177.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.4 t0 50.09 35.99 11.18 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 155.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.3 31.89 80.38 Favored Glycine 0 CA--C 1.535 1.331 0 O-C-N 120.615 -1.303 . . . . 0.0 112.992 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -123.37 152.73 41.22 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 127.935 2.494 . . . . 0.0 108.394 170.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -159.29 176.85 36.03 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-O 122.002 0.779 . . . . 0.0 111.363 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.62 145.06 30.79 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 114.647 -0.776 . . . . 0.0 111.814 176.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 21.7 t -107.07 144.05 34.31 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 160.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.8 p -97.36 -15.72 20.59 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.479 0.711 . . . . 0.0 111.391 -174.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -63.22 118.74 46.29 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-O 117.805 -1.093 . . . . 0.0 110.391 -176.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.3 119.37 5.36 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 123.223 2.615 . . . . 0.0 111.497 172.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.372 0.8 OUTLIER 110.07 -16.06 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 130.755 3.622 . . . . 0.0 112.203 -170.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -128.23 14.22 6.69 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.982 1.713 . . . . 0.0 110.928 165.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -80.72 -31.22 36.17 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.292 1.437 . . . . 0.0 111.212 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -70.46 0.32 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -175.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -69.84 165.98 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.712 0.805 . . . . 0.0 111.755 -171.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.3 tp -91.62 118.5 30.68 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 170.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.2 m -91.88 148.45 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -66.59 138.78 57.71 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.96 -36.93 80.68 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.178 0.445 . . . . 0.0 111.09 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -82.26 3.2 28.47 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 171.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.08 -176.91 28.24 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 73.5 t90 -163.64 153.93 15.5 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.1 p -135.69 160.26 39.06 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.774 1.23 . . . . 0.0 110.329 172.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.8 p -71.35 -15.9 62.41 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.325 -0.859 . . . . 0.0 112.654 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.322 0.9 OUTLIER -76.48 -4.44 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 119.342 0.974 . . . . 0.0 112.323 172.132 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -42.91 130.92 4.26 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 124.183 0.993 . . . . 0.0 112.261 177.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.58 135.21 26.31 Favored Pre-proline 0 N--CA 1.455 -0.217 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 165.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -69.5 149.84 69.05 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 121.735 1.623 . . . . 0.0 110.798 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.7 39.54 1.16 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.667 0.746 . . . . 0.0 110.007 174.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 C--O 1.248 0.981 0 C-N-CA 128.388 2.675 . . . . 0.0 105.699 178.127 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.349 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.6 m 48.92 37.05 9.34 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.079 1.352 . . . . 0.0 114.412 174.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -80.75 148.87 66.37 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 122.684 0.394 . . . . 0.0 110.053 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.6 140.6 26.85 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.659 2.239 . . . . 0.0 111.73 -173.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 31.9 mtt-85 -61.25 131.43 50.37 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.482 1.513 . . . . 0.0 111.158 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.32 142.96 54.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.012 1.325 . . . . 0.0 112.057 -178.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -84.95 155.23 21.72 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 122.042 0.925 . . . . 0.0 112.197 174.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -67.34 96.23 0.48 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.616 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.48 24.99 10.42 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.56 1.076 . . . . 0.0 111.667 -176.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -34.21 -55.52 0.51 Allowed 'General case' 0 C--N 1.345 0.372 0 C-N-CA 125.238 1.415 . . . . 0.0 111.896 170.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.37 169.66 22.64 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 169.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 43.77 46.45 6.46 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.933 1.293 . . . . 0.0 113.419 170.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 58.83 27.0 15.5 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.184 0.594 . . . . 0.0 112.298 169.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -46.99 -60.3 2.54 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -165.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.254 34.7 m 56.85 132.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 126.757 2.023 . . . . 0.0 113.893 -171.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -68.78 -27.68 66.1 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 120.574 -1.329 . . . . 0.0 112.746 -177.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -110.43 115.29 29.4 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 170.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -42.36 -46.64 4.7 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.07 1.348 . . . . 0.0 110.656 173.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.99 -37.31 44.16 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.915 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -51.63 -35.45 42.0 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.411 1.005 . . . . 0.0 111.643 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.88 2.83 13.5 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -177.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 64.8 m -61.62 93.0 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 119.598 1.09 . . . . 0.0 111.306 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.5 -34.51 1.06 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.52 1.533 . . . . 0.0 110.49 -174.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -62.74 115.71 18.86 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 117.871 -1.062 . . . . 0.0 109.335 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -62.73 120.34 7.82 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 N-CA-C 107.587 -1.736 . . . . 0.0 107.587 171.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 118.91 -39.22 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 129.185 2.994 . . . . 0.0 108.902 -168.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -64.05 142.11 58.53 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 166.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -144.84 147.82 33.28 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 174.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.1 mp0 -55.73 117.46 3.66 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.434 1.493 . . . . 0.0 110.776 -170.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.13 7.41 70.18 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 119.705 -0.497 . . . . 0.0 112.373 175.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -72.63 91.14 1.41 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 119.037 1.419 . . . . 0.0 108.509 167.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.5 mp -95.48 150.0 20.79 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.949 1.3 . . . . 0.0 109.003 169.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 2.1 m -46.21 -44.98 16.64 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.936 1.295 . . . . 0.0 110.653 172.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -63.06 -12.68 28.31 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 120.714 -1.241 . . . . 0.0 114.123 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -97.99 2.63 49.15 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.867 1.267 . . . . 0.0 111.938 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 35.2 t -84.04 135.59 34.37 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.784 1.234 . . . . 0.0 109.779 -171.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.17 -16.17 59.23 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.601 -0.687 . . . . 0.0 112.446 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -94.65 0.03 54.77 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.387 174.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -55.58 140.11 42.03 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.525 1.057 . . . . 0.0 110.807 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.41 -100.14 1.05 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 172.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -145.65 155.55 43.08 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.743 1.617 . . . . 0.0 107.388 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.38 145.75 49.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 123.749 0.655 . . . . 0.0 109.562 170.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.0 t -123.1 -45.21 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 125.316 1.446 . . . . 0.0 109.504 -174.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -147.78 -165.06 2.16 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.151 0.98 . . . . 0.0 109.821 -175.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -51.74 71.36 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 129.815 3.246 . . . . 0.0 114.847 -164.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.2 42.47 94.26 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -173.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -133.39 142.83 48.56 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.43 1.492 . . . . 0.0 108.9 172.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -156.46 173.34 34.27 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-O 122.25 0.917 . . . . 0.0 112.965 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -74.76 153.55 38.75 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 125.982 1.713 . . . . 0.0 112.317 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.8 t -141.52 117.76 10.72 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.109 1.364 . . . . 0.0 108.188 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 62.8 p -77.57 64.3 2.86 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.448 1.099 . . . . 0.0 111.862 -164.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.64 127.31 9.13 Favored Pre-proline 0 C--O 1.223 -0.326 0 C-N-CA 125.128 1.371 . . . . 0.0 108.138 176.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -58.15 -41.77 63.9 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.102 1.868 . . . . 0.0 110.794 -177.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -69.03 38.59 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.773 2.429 . . . . 0.0 112.463 172.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -176.58 -36.74 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.839 0.856 . . . . 0.0 112.555 -172.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -90.41 20.94 4.15 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.193 0.997 . . . . 0.0 112.377 -169.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.51 -55.56 4.23 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 167.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.3 m -76.3 176.73 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.497 169.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 22.3 tp -109.92 130.82 55.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.76 1.624 . . . . 0.0 107.763 171.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.6 m -93.85 140.66 16.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 118.703 0.683 . . . . 0.0 109.912 -174.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 tttm -62.96 135.45 57.31 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.02 -41.72 64.97 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 123.168 0.587 . . . . 0.0 111.018 173.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -83.42 6.3 20.6 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 175.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.66 -169.48 14.04 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 171.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 60.7 t90 -158.29 -179.7 8.35 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 174.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 5.2 p -163.03 161.15 25.29 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.531 1.06 . . . . 0.0 110.217 161.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.9 p -72.28 -9.84 59.01 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.227 -0.92 . . . . 0.0 113.084 -174.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.1 m -74.94 -17.56 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 119.427 1.012 . . . . 0.0 111.423 168.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -38.57 132.79 1.11 Allowed 'General case' 0 C--N 1.348 0.502 0 C-N-CA 125.31 1.444 . . . . 0.0 113.117 -174.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.84 135.02 26.85 Favored Pre-proline 0 N--CA 1.452 -0.343 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 165.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -72.4 147.29 46.52 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.998 1.799 . . . . 0.0 111.169 -175.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.63 51.94 2.21 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.765 0.793 . . . . 0.0 109.306 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.4 p . . . . . 0 C--O 1.254 1.322 0 CA-C-O 115.282 -2.294 . . . . 0.0 107.886 -177.214 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.072 0 CA-C-O 118.366 -0.826 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.2 m 50.4 38.05 17.08 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.258 1.023 . . . . 0.0 113.288 -174.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -64.8 153.1 88.9 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 168.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.92 143.34 54.58 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.071 1.847 . . . . 0.0 111.274 -174.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 36.6 mtt-85 -55.14 127.83 30.99 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.467 1.507 . . . . 0.0 111.956 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.11 147.51 52.05 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.441 1.096 . . . . 0.0 112.491 -175.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.4 pm0 -92.26 152.67 19.7 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 125.815 1.646 . . . . 0.0 112.324 -177.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.28 96.4 0.65 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.604 -175.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.01 28.71 14.48 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.426 -175.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -36.87 -53.11 0.94 Allowed 'General case' 0 C--N 1.344 0.344 0 C-N-CA 124.608 1.163 . . . . 0.0 111.001 166.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.55 -178.63 5.94 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 169.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 31.86 50.7 0.16 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.88 2.472 . . . . 0.0 113.269 173.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 55.49 30.34 14.95 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.676 0.79 . . . . 0.0 112.228 169.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -50.91 -64.95 0.65 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -168.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.288 19.1 m 54.18 130.12 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 126.897 2.079 . . . . 0.0 114.212 -171.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -66.1 -25.52 67.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 120.646 -1.284 . . . . 0.0 112.881 -172.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -110.32 117.12 32.78 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 171.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -45.47 -43.62 11.69 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.686 1.194 . . . . 0.0 110.793 172.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.3 -38.13 57.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.461 -0.78 . . . . 0.0 112.913 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -52.49 -39.64 61.46 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.199 0.909 . . . . 0.0 110.61 175.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.59 2.18 8.54 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 118.91 -0.567 . . . . 0.0 112.501 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.5 t -66.86 -2.95 5.77 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 120.055 1.298 . . . . 0.0 114.411 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.62 -9.87 71.19 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.27 0.938 . . . . 0.0 112.337 169.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -95.04 112.11 57.14 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 124.917 1.287 . . . . 0.0 110.449 -169.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -59.31 120.86 8.95 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 N-CA-C 107.424 -1.798 . . . . 0.0 107.424 163.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.5 tpt85 122.76 -40.33 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 129.175 2.99 . . . . 0.0 108.452 -168.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -65.39 146.32 55.04 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 166.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? -143.04 135.35 27.29 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -50.33 111.45 0.53 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.716 2.007 . . . . 0.0 111.736 -174.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.6 -10.31 45.59 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-O 118.98 -0.9 . . . . 0.0 111.623 174.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -64.75 118.58 9.16 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 119.109 1.455 . . . . 0.0 107.534 171.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 mp -130.04 149.06 51.92 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 125.989 1.716 . . . . 0.0 106.486 176.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.4 m -45.73 -46.91 15.31 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.065 0.946 . . . . 0.0 111.943 174.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -62.45 -15.84 51.85 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.428 -1.42 . . . . 0.0 114.167 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -110.74 23.38 14.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.625 1.17 . . . . 0.0 112.21 172.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.8 t -90.82 135.63 33.6 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.372 1.469 . . . . 0.0 108.236 172.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.79 -23.49 63.34 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 121.268 -0.895 . . . . 0.0 112.645 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -74.98 -13.49 60.52 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 118.337 -0.84 . . . . 0.0 112.53 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -52.33 136.33 31.22 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.52 1.055 . . . . 0.0 112.821 -171.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.83 -66.38 1.28 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 125.831 1.681 . . . . 0.0 110.352 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -178.24 154.02 0.81 Allowed 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -161.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.47 134.82 34.09 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 166.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.1 t -113.7 -39.73 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.891 1.676 . . . . 0.0 110.153 -172.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -147.27 -172.67 4.06 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.303 1.041 . . . . 0.0 110.192 -169.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -52.81 72.08 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 130.196 3.398 . . . . 0.0 113.69 -172.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.77 37.24 83.99 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -172.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -129.76 148.39 51.63 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 125.663 1.585 . . . . 0.0 108.852 172.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -165.07 -176.12 36.42 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.5 mtp-105 -96.65 152.69 18.41 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 119.008 -0.52 . . . . 0.0 110.313 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 p -123.86 136.1 54.16 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 156.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.4 p -80.84 56.33 2.69 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.985 1.314 . . . . 0.0 110.66 -161.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -155.14 99.1 2.35 Favored Pre-proline 0 N--CA 1.448 -0.567 0 O-C-N 121.754 -0.591 . . . . 0.0 110.784 -170.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -45.97 131.32 13.75 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.827 3.018 . . . . 0.0 111.482 170.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 118.27 -47.53 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 129.894 3.278 . . . . 0.0 104.884 -153.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -137.61 31.69 2.54 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.313 1.845 . . . . 0.0 110.757 -172.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -113.44 -41.84 3.58 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.669 0.788 . . . . 0.0 109.737 175.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -49.4 -44.96 45.58 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.738 1.615 . . . . 0.0 111.568 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.2 m -111.91 149.88 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.697 1.599 . . . . 0.0 108.653 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.6 tp -77.95 132.43 37.87 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.0 t -90.31 122.47 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 125.912 1.685 . . . . 0.0 107.856 -169.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -60.78 130.55 47.03 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 121.023 -1.048 . . . . 0.0 108.455 171.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.02 -40.17 66.8 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.071 0.548 . . . . 0.0 111.657 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -83.51 3.04 34.04 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 175.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.24 -172.52 8.59 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 172.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -154.91 178.0 10.67 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 172.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.6 p -161.08 159.15 28.84 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.489 1.041 . . . . 0.0 109.013 163.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.7 p -73.77 -1.79 20.72 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.021 -1.049 . . . . 0.0 112.99 -175.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.329 0.9 OUTLIER -83.31 -8.77 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 119.35 0.977 . . . . 0.0 112.286 164.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -38.86 123.7 1.31 Allowed 'General case' 0 C--N 1.344 0.368 0 C-N-CA 125.3 1.44 . . . . 0.0 112.914 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.33 134.84 23.06 Favored Pre-proline 0 N--CA 1.455 -0.213 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 169.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -70.82 150.32 61.57 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.08 1.853 . . . . 0.0 110.957 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.7 37.21 1.64 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.979 0.911 . . . . 0.0 110.227 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--O 1.25 1.106 0 C-N-CA 128.966 2.906 . . . . 0.0 105.242 177.764 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 m -107.97 55.29 0.65 Allowed 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 158.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -60.5 140.05 92.3 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 123.031 0.532 . . . . 0.0 110.239 -175.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.64 151.88 83.34 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.634 2.223 . . . . 0.0 110.673 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 14.4 mtp180 -72.33 125.87 28.43 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -174.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -54.85 141.85 31.6 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.716 1.606 . . . . 0.0 112.817 -168.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -77.29 144.38 38.16 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.293 1.037 . . . . 0.0 108.592 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.09 120.16 10.91 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 165.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.86 25.19 72.37 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.219 -1.323 . . . . 0.0 112.93 -172.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -40.42 -54.84 2.38 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 119.595 1.698 . . . . 0.0 110.771 166.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -167.67 177.78 5.66 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.388 1.475 . . . . 0.0 107.579 172.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 33.38 52.04 0.35 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 127.057 2.143 . . . . 0.0 113.099 172.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 60.06 18.85 8.05 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.071 0.948 . . . . 0.0 112.675 169.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -62.69 137.42 58.26 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 118.554 0.615 . . . . 0.0 110.029 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.2 m -126.84 143.68 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 168.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -59.97 -34.59 73.49 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 119.12 -0.467 . . . . 0.0 111.284 -174.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.96 128.67 54.53 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 123.433 0.693 . . . . 0.0 110.285 169.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.11 -31.86 20.68 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.52 1.128 . . . . 0.0 110.63 165.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.18 -45.45 75.78 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.425 0.557 . . . . 0.0 111.406 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -29.75 70.09 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.216 0.532 . . . . 0.0 110.606 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.23 -6.05 36.71 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 118.324 -0.846 . . . . 0.0 112.599 -177.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 67.0 m -50.0 -32.41 15.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.22 -24.57 73.45 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.664 1.126 . . . . 0.0 113.164 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -79.03 117.72 68.42 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 118.404 1.102 . . . . 0.0 111.082 -169.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -63.94 108.45 0.93 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 N-CA-C 107.266 -1.859 . . . . 0.0 107.266 164.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 135.69 -31.79 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 131.166 3.787 . . . . 0.0 109.881 -173.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -68.5 149.12 49.63 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 171.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? -143.46 136.7 27.97 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -50.58 110.48 0.42 Allowed 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.954 2.101 . . . . 0.0 111.753 -174.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.14 -9.82 43.11 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-O 119.093 -0.837 . . . . 0.0 111.561 174.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -64.82 120.03 11.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.06 1.43 . . . . 0.0 107.824 172.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 mp -131.77 153.06 50.49 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.218 1.807 . . . . 0.0 107.206 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 33.6 m -48.96 -47.12 44.19 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.873 0.76 . . . . 0.0 110.993 174.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.257 6.2 tt0 -75.72 26.13 0.11 Allowed 'General case' 0 CA--C 1.549 0.915 0 O-C-N 120.32 -1.488 . . . . 0.0 113.671 176.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -142.25 29.77 1.61 Allowed 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.596 -1.315 . . . . 0.0 110.793 156.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 50.6 t -96.72 139.24 33.07 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.886 1.674 . . . . 0.0 109.208 177.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.89 -21.12 64.45 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.569 -0.707 . . . . 0.0 112.572 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -96.4 15.28 21.75 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 119.001 -0.523 . . . . 0.0 111.951 175.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -66.85 149.74 50.16 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.424 1.011 . . . . 0.0 110.997 175.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.53 -101.23 1.97 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.372 -1.891 . . . . 0.0 108.372 169.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -149.95 153.92 37.41 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.76 1.624 . . . . 0.0 107.648 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.13 141.54 58.72 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 123.69 0.619 . . . . 0.0 110.612 168.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.5 t -114.13 -49.19 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 126.28 1.832 . . . . 0.0 109.23 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -148.02 -150.58 0.35 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.408 0.683 . . . . 0.0 111.214 -171.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -67.55 68.16 0.09 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 128.338 2.655 . . . . 0.0 113.21 -161.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.01 29.33 46.92 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.548 1.07 . . . . 0.0 110.501 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -132.19 148.21 52.45 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.192 1.397 . . . . 0.0 109.462 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.64 178.8 36.49 Favored Glycine 0 N--CA 1.433 -1.564 0 O-C-N 124.395 1.059 . . . . 0.0 110.691 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -82.0 132.69 35.26 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.852 -0.674 . . . . 0.0 110.67 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 43.2 t -89.12 153.31 21.07 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 155.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.8 p -119.84 28.8 7.9 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.49 0.716 . . . . 0.0 111.468 -175.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -113.07 112.68 49.78 Favored Pre-proline 0 N--CA 1.455 -0.203 0 CA-C-O 117.721 -1.133 . . . . 0.0 108.19 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -46.59 124.11 7.78 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.852 1.701 . . . . 0.0 107.89 160.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 129.82 -43.52 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 128.887 2.875 . . . . 0.0 106.472 -157.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -131.48 -38.4 1.18 Allowed 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.361 2.264 . . . . 0.0 111.87 -171.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -42.12 -39.39 1.98 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.7 1.6 . . . . 0.0 112.921 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -45.71 -39.73 8.41 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.119 0.968 . . . . 0.0 113.257 176.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.5 m -117.04 160.39 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 125.071 1.348 . . . . 0.0 109.872 -172.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 22.5 tp -83.64 131.18 34.97 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.8 t -104.63 133.71 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 123.674 0.79 . . . . 0.0 108.909 -167.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -62.98 126.72 28.28 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 175.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.56 -31.78 68.3 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.343 0.657 . . . . 0.0 110.841 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -81.21 -8.19 59.71 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.796 1.238 . . . . 0.0 112.443 176.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.76 -172.42 35.87 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 72.3 t90 -165.84 150.58 8.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.7 p -134.22 162.36 32.36 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.965 1.306 . . . . 0.0 110.001 175.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.4 p -69.91 -20.42 63.36 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.0 -1.062 . . . . 0.0 112.672 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.364 0.8 OUTLIER -71.94 -3.75 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 119.553 1.069 . . . . 0.0 112.595 170.596 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -45.14 128.83 7.63 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.809 0.732 . . . . 0.0 111.012 171.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.73 137.67 31.45 Favored Pre-proline 0 N--CA 1.452 -0.334 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 165.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.8 148.95 59.47 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.028 1.819 . . . . 0.0 110.794 -177.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.13 42.83 1.09 Allowed 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.492 0.717 . . . . 0.0 109.953 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.1 p . . . . . 0 C--O 1.253 1.272 0 CA-C-O 114.889 -2.481 . . . . 0.0 106.759 -172.345 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo . . . . . 0 N--CA 1.454 -0.84 0 N-CA-C 110.515 -0.61 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 43.9 mtt-85 -58.19 126.33 27.02 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.814 1.245 . . . . 0.0 110.243 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.36 142.95 46.7 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.117 1.367 . . . . 0.0 112.489 -172.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -76.61 143.27 40.31 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.422 1.089 . . . . 0.0 108.294 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -62.03 117.01 5.41 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 165.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.8 16.59 67.59 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 118.263 -1.298 . . . . 0.0 113.652 -174.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -45.58 -58.29 3.52 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 119.818 1.809 . . . . 0.0 112.051 173.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.97 162.18 40.39 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 45.33 47.36 10.51 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.15 1.38 . . . . 0.0 113.199 172.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.85 25.81 10.84 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.69 0.796 . . . . 0.0 111.845 173.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -62.07 142.67 57.42 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 117.928 0.331 . . . . 0.0 111.194 -175.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.9 146.1 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 172.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -73.17 -26.99 61.39 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 124.402 1.081 . . . . 0.0 112.235 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -115.99 116.59 28.19 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 171.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -42.62 -48.97 5.54 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.343 1.057 . . . . 0.0 110.99 175.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.63 -38.16 31.01 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.839 0.856 . . . . 0.0 113.018 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -49.11 -39.53 28.71 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 119.181 0.9 . . . . 0.0 111.477 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.66 9.04 1.2 Allowed 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 118.301 -0.857 . . . . 0.0 113.119 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 62.6 m -49.77 -31.02 10.59 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 120.47 1.486 . . . . 0.0 114.226 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.44 -24.45 76.86 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.64 1.114 . . . . 0.0 112.927 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -79.99 120.13 78.84 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.562 1.145 . . . . 0.0 110.426 -171.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -46.48 -49.28 12.11 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.145 2.563 . . . . 0.0 113.924 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -15.76 60.79 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 117.563 -1.208 . . . . 0.0 113.418 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -73.91 145.82 44.48 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 120.878 1.672 . . . . 0.0 111.529 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -133.38 150.04 51.83 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 127.973 2.509 . . . . 0.0 104.377 165.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -66.69 165.02 15.72 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 124.064 0.852 . . . . 0.0 111.512 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.72 -26.26 3.21 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.077 1.322 . . . . 0.0 112.009 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -69.96 112.1 6.13 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 117.534 0.667 . . . . 0.0 109.333 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.1 mp -123.36 148.96 45.51 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.5 m -42.03 -46.71 4.28 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.437 1.095 . . . . 0.0 110.939 172.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -56.34 -26.8 53.82 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -109.2 23.61 14.27 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.711 1.204 . . . . 0.0 112.001 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 45.7 t -86.48 139.0 31.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.711 1.204 . . . . 0.0 108.942 174.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.52 -25.3 66.0 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 121.319 -0.863 . . . . 0.0 111.813 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -91.29 8.35 36.43 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.479 -0.772 . . . . 0.0 112.047 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 66.3 t-105 -56.73 138.18 53.31 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 120.188 1.358 . . . . 0.0 109.99 174.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.78 -85.18 1.03 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 171.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -163.91 159.1 20.57 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.27 136.41 39.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.581 HG23 ' HA2' ' A' ' 48' ' ' GLY . 90.2 t -106.74 -48.53 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.652 1.181 . . . . 0.0 108.383 -172.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -151.43 -138.98 0.09 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.93 0.492 . . . . 0.0 112.24 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -69.19 66.83 0.17 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.919 2.488 . . . . 0.0 113.013 -163.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.52 33.34 61.13 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 -175.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -131.65 143.5 50.35 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 125.893 1.677 . . . . 0.0 108.684 173.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.581 ' HA2' HG23 ' A' ' 43' ' ' VAL . . . -153.14 178.01 30.44 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 124.183 0.897 . . . . 0.0 111.489 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.417 ' HG3' ' CG2' ' A' ' 43' ' ' VAL . 32.4 mtp85 -88.31 159.13 18.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.308 0.643 . . . . 0.0 111.998 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.5 t . . . . . 0 CA--C 1.531 0.226 0 C-N-CA 125.837 1.655 . . . . 0.0 108.038 179.259 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.7 t70 . . . . . 0 CA--C 1.536 0.409 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -35.87 -45.44 0.4 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.98 1.312 . . . . 0.0 112.075 166.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 m -116.5 150.63 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 123.831 0.852 . . . . 0.0 108.987 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.517 HD11 HG21 ' A' ' 43' ' ' VAL . 12.4 tp -82.64 121.39 26.77 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.3 m -88.44 144.25 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 118.923 0.783 . . . . 0.0 109.161 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.3 tttm -67.01 136.97 56.11 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 174.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.62 -40.9 66.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 119.313 -0.375 . . . . 0.0 111.488 174.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -85.05 7.95 19.62 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 174.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.73 -177.27 23.46 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -160.07 155.58 25.48 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 172.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.0 p -143.27 167.17 22.78 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.097 0.959 . . . . 0.0 110.766 173.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.3 p -73.5 -21.7 60.34 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.33 1.0 OUTLIER -71.13 -5.37 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 119.433 1.015 . . . . 0.0 112.448 171.022 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -45.72 132.16 8.77 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 119.058 0.844 . . . . 0.0 111.652 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.32 139.47 35.74 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 166.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.25 151.14 54.28 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.058 1.838 . . . . 0.0 110.657 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.351 0 C-N-CA 123.894 0.878 . . . . 0.0 110.289 178.206 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 N--CA 1.455 -0.791 0 N-CA-C 111.079 -0.393 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 42.5 mtt-85 -63.95 125.31 24.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.557 1.143 . . . . 0.0 110.212 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.22 142.75 54.02 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.796 1.238 . . . . 0.0 112.171 -173.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -76.17 145.7 39.7 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.497 1.119 . . . . 0.0 108.731 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -62.37 121.21 12.65 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 164.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.87 20.85 75.53 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 118.267 -1.296 . . . . 0.0 113.448 -172.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -40.97 -56.8 2.17 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 119.488 1.644 . . . . 0.0 111.46 169.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.2 172.74 10.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.658 1.583 . . . . 0.0 106.96 174.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 44.28 47.56 7.84 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 124.412 1.085 . . . . 0.0 112.76 171.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 57.53 21.29 6.92 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 122.799 0.44 . . . . 0.0 111.498 172.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -62.53 140.7 58.63 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.521 0.601 . . . . 0.0 111.259 -172.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.2 m -126.88 143.56 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 173.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -71.33 -26.89 63.02 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.882 0.873 . . . . 0.0 111.684 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -112.08 111.42 22.31 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 169.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -45.13 -44.32 10.52 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.909 1.284 . . . . 0.0 110.957 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.55 -35.54 63.36 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.125 -0.94 . . . . 0.0 112.627 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -48.18 -43.75 32.02 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-O 122.278 1.037 . . . . 0.0 110.84 174.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.35 6.23 5.92 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.458 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -55.08 -28.54 53.19 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 120.258 1.39 . . . . 0.0 112.368 171.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.44 -14.15 59.47 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.518 1.056 . . . . 0.0 113.769 174.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -99.89 108.19 50.33 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 125.891 1.677 . . . . 0.0 111.502 -171.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -54.51 117.55 4.08 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 N-CA-C 108.258 -1.478 . . . . 0.0 108.258 162.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.7 tpt85 127.18 -41.32 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 129.023 2.929 . . . . 0.0 108.517 -169.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -66.81 153.79 42.49 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 169.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.75 136.26 15.97 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.198 168.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.5 mp0 -60.3 115.35 3.46 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.521 1.928 . . . . 0.0 110.112 -169.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.4 -30.76 5.29 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -176.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -66.93 115.66 6.91 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 mp -131.04 149.85 52.42 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 127.004 2.122 . . . . 0.0 105.405 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.2 m -43.58 -47.37 7.42 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.953 1.301 . . . . 0.0 111.43 173.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.44 -22.02 52.99 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -109.77 26.13 11.0 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.307 1.043 . . . . 0.0 112.344 175.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.7 t -97.06 136.78 37.12 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.568 1.547 . . . . 0.0 109.263 175.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.46 -20.86 65.93 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 120.929 -1.107 . . . . 0.0 113.002 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -80.4 -8.58 59.58 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.437 0.562 . . . . 0.0 112.113 175.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.402 ' CH2' ' HA3' ' A' ' 48' ' ' GLY . 74.9 t-105 -58.29 141.12 51.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.705 0.684 . . . . 0.0 111.501 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.61 -69.0 1.27 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 173.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -174.5 157.35 2.62 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -168.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.32 130.97 35.22 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 166.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.4 t -97.05 -49.31 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -175.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -152.07 -128.59 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -171.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -74.77 63.93 1.21 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.379 1.872 . . . . 0.0 112.623 -162.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.6 28.19 67.9 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.258 0.933 . . . . 0.0 110.944 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -126.79 145.17 50.73 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.823 1.649 . . . . 0.0 109.168 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.402 ' HA3' ' CH2' ' A' ' 39' ' ' TRP . . . -153.77 178.7 30.56 Favored Glycine 0 N--CA 1.436 -1.352 0 CA-C-O 122.208 0.893 . . . . 0.0 112.302 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -89.58 145.87 24.97 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.22 -0.99 . . . . 0.0 108.437 -172.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 175.241 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.471 0.578 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.0 pm0 -61.75 -16.82 52.68 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -175.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.2 m -132.01 158.36 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 119.556 1.071 . . . . 0.0 110.499 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.1 tp -91.85 123.2 35.04 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 175.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.0 m -94.85 148.97 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -67.65 137.22 55.42 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.14 -42.23 65.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.936 173.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -81.32 6.1 15.3 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 175.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.62 -177.32 34.76 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 119.539 1.063 . . . . 0.0 110.654 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 43.8 t90 -163.15 154.72 17.49 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 170.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.486 ' SG ' ' HB ' ' A' ' 68' ' ' VAL . 7.9 p -139.92 161.54 37.35 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.748 1.619 . . . . 0.0 110.034 173.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 89.9 p -70.65 -10.05 58.46 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.327 -0.858 . . . . 0.0 112.921 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.486 ' HB ' ' SG ' ' A' ' 66' ' ' CYS . 4.7 t -64.76 -35.26 74.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.268 1.027 . . . . 0.0 109.256 168.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -27.06 113.01 0.06 Allowed 'General case' 0 C--N 1.347 0.46 0 C-N-CA 126.43 1.892 . . . . 0.0 114.285 -170.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -113.24 133.18 22.14 Favored Pre-proline 0 N--CA 1.455 -0.22 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 167.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.11 150.55 66.26 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.704 1.602 . . . . 0.0 110.929 -177.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.331 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.342 177.003 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo . . . . . 0 N--CA 1.458 -0.603 0 N-CA-C 111.239 -0.331 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.9 mtt-85 -62.41 133.25 54.78 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.491 1.116 . . . . 0.0 110.895 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.98 145.49 55.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.986 1.315 . . . . 0.0 112.25 -174.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.441 ' CD ' ' HD1' ' A' ' 10' ' ' HIS . 1.7 mp0 -75.45 142.89 42.88 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 124.82 1.248 . . . . 0.0 108.183 178.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -62.38 120.33 10.83 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 164.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.94 26.41 66.88 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 118.116 -1.38 . . . . 0.0 113.37 -172.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.441 ' HD1' ' CD ' ' A' ' 7' ' ' GLU . 86.3 t60 -42.73 -55.8 3.46 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 119.765 1.782 . . . . 0.0 110.767 167.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -165.48 169.99 14.93 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.715 1.206 . . . . 0.0 108.315 174.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.0 m-70 46.71 40.73 9.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.561 1.544 . . . . 0.0 113.335 172.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 57.16 30.65 18.68 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.621 1.168 . . . . 0.0 111.771 177.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -62.92 139.74 58.77 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 122.159 -0.338 . . . . 0.0 111.048 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 m -124.74 141.35 45.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 125.028 1.331 . . . . 0.0 107.841 172.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -68.54 -24.43 64.63 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 123.899 0.88 . . . . 0.0 112.196 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -117.7 122.8 44.46 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.138 1.375 . . . . 0.0 108.031 170.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.6 -49.05 62.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.667 0.787 . . . . 0.0 111.35 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.61 -23.06 66.13 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 117.768 -1.111 . . . . 0.0 112.793 -174.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -44.42 -44.08 8.15 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.831 1.196 . . . . 0.0 110.493 167.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.58 10.09 4.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.651 -175.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.9 t -69.45 -1.03 7.42 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 120.107 1.321 . . . . 0.0 114.43 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.96 -15.19 56.7 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.384 0.992 . . . . 0.0 111.81 169.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -81.28 114.41 48.97 Favored Pre-proline 0 N--CA 1.452 -0.346 0 C-N-CA 124.414 1.086 . . . . 0.0 109.671 -172.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -62.05 118.38 5.26 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 N-CA-C 107.114 -1.918 . . . . 0.0 107.114 165.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.7 tpt85 124.96 -37.62 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 129.204 3.002 . . . . 0.0 108.776 -168.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -64.83 148.3 51.59 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 168.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.7 tm0? -154.83 131.89 10.93 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -62.04 125.01 22.38 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 126.694 1.998 . . . . 0.0 112.532 -168.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.68 -25.18 23.61 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-O 118.822 -0.988 . . . . 0.0 111.345 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -60.08 119.5 7.93 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.096 1.448 . . . . 0.0 108.28 173.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 mp -131.41 153.26 49.88 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 127.048 2.139 . . . . 0.0 107.044 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 55.6 m -48.5 -49.45 35.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.619 0.768 . . . . 0.0 111.269 173.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.252 4.6 tt0 -76.92 31.35 0.13 Allowed 'General case' 0 CA--C 1.547 0.832 0 O-C-N 119.881 -1.762 . . . . 0.0 113.615 175.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -143.11 30.31 1.43 Allowed 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.573 -1.329 . . . . 0.0 110.629 155.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' A' ' 69' ' ' TYR . 47.9 t -102.69 138.41 39.63 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.056 1.742 . . . . 0.0 110.48 -175.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.59 -19.02 64.44 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 120.929 -1.107 . . . . 0.0 112.256 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -85.09 -0.21 53.74 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.853 0.861 . . . . 0.0 111.672 172.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 33.5 t-105 -66.05 148.72 51.38 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 119.384 0.993 . . . . 0.0 110.897 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.01 -99.25 1.45 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 107.42 -2.272 . . . . 0.0 107.42 165.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -148.36 159.91 43.53 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.788 1.635 . . . . 0.0 107.061 175.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.91 146.61 41.61 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.266 0.555 . . . . 0.0 110.694 166.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.6 t -118.83 -52.75 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 125.575 1.55 . . . . 0.0 108.568 -177.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -147.67 -152.85 0.46 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.672 0.789 . . . . 0.0 111.21 -175.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -56.54 68.45 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 130.031 3.332 . . . . 0.0 114.353 -163.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.05 30.71 67.37 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.648 1.118 . . . . 0.0 110.569 -174.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -129.19 146.35 51.13 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.359 1.464 . . . . 0.0 108.902 174.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -155.95 173.52 33.93 Favored Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.8 mtp-105 -78.13 130.22 36.11 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.097 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 39.8 t . . . . . 0 CA--C 1.536 0.422 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 150.574 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 121.178 0.513 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.527 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 2.2 mp0 -48.64 -46.63 40.12 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 127.16 2.184 . . . . 0.0 113.102 -176.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.1 m -111.71 153.68 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.88 1.272 . . . . 0.0 109.781 -169.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.2 tp -84.53 127.97 34.33 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.2 t -98.62 141.84 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -170.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -68.07 133.85 49.65 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.56 -35.17 71.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 119.264 -0.398 . . . . 0.0 111.856 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.53 3.86 34.62 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 173.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.65 -176.48 16.1 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 119.499 1.045 . . . . 0.0 111.257 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 72.9 t90 -158.7 156.59 30.19 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 171.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 10.3 p -142.24 171.38 14.13 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.779 0.831 . . . . 0.0 110.718 169.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.0 p -71.41 -29.66 65.18 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -174.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.5 m -67.74 -70.35 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . 0.455 ' HA ' ' SG ' ' A' ' 36' ' ' CYS . 58.2 t80 58.72 -85.34 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.203 1.801 . . . . 0.0 112.241 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 62.68 124.95 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.258 1.823 . . . . 0.0 111.299 -162.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -71.26 146.75 51.86 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.096 1.864 . . . . 0.0 111.196 -177.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 121.733 0.778 . . . . 0.0 109.423 175.626 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo . . . . . 0 N--CA 1.454 -0.819 0 N-CA-C 110.821 -0.492 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 34.9 mtt-85 -61.78 129.58 41.66 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.683 1.193 . . . . 0.0 111.137 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.97 143.35 56.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.241 1.417 . . . . 0.0 112.442 -172.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -78.03 144.7 36.42 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.48 1.112 . . . . 0.0 108.595 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -63.46 122.08 15.4 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 165.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.66 22.98 73.98 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.174 -1.348 . . . . 0.0 113.085 -172.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -39.96 -56.77 1.76 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 119.431 1.615 . . . . 0.0 111.253 167.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -168.32 175.85 6.2 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.612 1.565 . . . . 0.0 107.275 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 37.11 50.07 0.9 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.053 1.741 . . . . 0.0 112.865 175.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 57.37 23.53 9.04 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.57 0.748 . . . . 0.0 112.054 172.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -63.4 136.97 57.98 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 118.111 0.414 . . . . 0.0 110.911 -174.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.7 m -124.04 141.61 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 173.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 -69.32 -23.91 63.85 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 123.851 0.86 . . . . 0.0 111.764 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -115.55 115.13 25.93 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.675 1.19 . . . . 0.0 107.931 171.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -43.39 -48.33 7.02 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.807 1.243 . . . . 0.0 110.983 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.5 -35.18 52.44 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.45 -0.786 . . . . 0.0 112.962 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -51.42 -40.52 59.5 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.617 1.098 . . . . 0.0 110.809 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.72 6.6 5.75 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.343 -0.837 . . . . 0.0 112.785 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.9 t -52.2 -32.66 37.46 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.917 1.235 . . . . 0.0 112.507 173.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.37 -21.67 76.04 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 114.659 -1.155 . . . . 0.0 113.8 176.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -80.32 114.93 51.22 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 119.079 1.44 . . . . 0.0 111.355 -168.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.29 107.65 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 N-CA-C 107.229 -1.873 . . . . 0.0 107.229 165.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 143.16 -35.81 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 1 C-N-CA 132.074 4.15 . . . . 0.0 108.652 -174.934 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -77.12 151.27 35.45 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.284 1.034 . . . . 0.0 110.946 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -137.6 146.49 44.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.675 2.39 . . . . 0.0 105.638 166.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -63.28 158.97 18.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.077 0.951 . . . . 0.0 111.155 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.38 -26.71 4.95 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.28 0.943 . . . . 0.0 111.792 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -67.18 112.25 4.37 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.2 mp -124.61 148.26 48.0 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 177.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.8 m -42.18 -45.66 4.14 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.482 1.113 . . . . 0.0 111.919 172.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -56.08 -26.43 49.42 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.729 -1.232 . . . . 0.0 113.972 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -108.91 27.24 9.69 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.131 1.372 . . . . 0.0 112.055 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 50.1 t -94.95 139.9 30.7 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.108 1.363 . . . . 0.0 109.331 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.73 -24.82 67.05 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.333 -0.855 . . . . 0.0 112.569 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -82.19 -2.8 53.45 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.37 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -61.98 140.51 58.33 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 119.256 0.935 . . . . 0.0 111.726 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.64 -71.78 1.25 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.277 1.418 . . . . 0.0 109.78 173.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -174.7 157.38 2.51 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.197 1.399 . . . . 0.0 107.39 -167.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.73 133.47 34.37 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 169.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.98 -49.08 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 124.568 1.147 . . . . 0.0 109.887 -174.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -146.41 -161.25 1.28 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.26 1.024 . . . . 0.0 110.108 -172.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -56.4 71.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 129.361 3.064 . . . . 0.0 114.293 -161.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.74 34.35 77.78 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -172.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -129.58 146.15 51.41 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 125.259 1.424 . . . . 0.0 109.222 173.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.28 -172.6 28.84 Favored Glycine 0 N--CA 1.432 -1.621 0 CA-C-O 121.99 0.772 . . . . 0.0 112.097 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -93.11 139.68 30.31 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -171.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.1 t . . . . . 0 C--N 1.33 -0.26 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 173.202 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 p30 . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -51.05 -35.06 32.63 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.996 0.816 . . . . 0.0 112.881 169.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.1 m -128.43 163.56 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 125.325 1.45 . . . . 0.0 109.736 -172.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.4 tp -86.93 129.57 34.82 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.4 t -98.58 135.34 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 124.069 0.948 . . . . 0.0 108.812 -168.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -65.25 131.12 45.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 176.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.02 -39.81 63.41 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.226 0.611 . . . . 0.0 111.626 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -83.87 2.33 38.95 Favored 'General case' 0 C--N 1.342 0.242 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.78 -177.06 23.24 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 119.412 1.005 . . . . 0.0 111.314 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 60.8 t90 -160.77 149.98 16.97 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 171.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.559 ' SG ' HG13 ' A' ' 68' ' ' VAL . 7.5 p -134.77 162.51 32.14 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.194 1.398 . . . . 0.0 109.838 174.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.8 p -71.93 -14.33 61.89 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 120.655 -1.278 . . . . 0.0 112.79 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.559 HG13 ' SG ' ' A' ' 66' ' ' CYS 0.348 1.7 p -85.44 10.0 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 125.562 1.545 . . . . 0.0 111.723 166.194 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -52.84 126.16 19.28 Favored 'General case' 0 C--N 1.342 0.27 0 O-C-N 120.54 -1.35 . . . . 0.0 110.232 163.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.83 134.06 24.81 Favored Pre-proline 0 N--CA 1.454 -0.254 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 169.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.51 148.42 66.62 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 121.675 1.583 . . . . 0.0 110.821 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.356 0 C-N-CA 123.882 0.873 . . . . 0.0 110.213 177.913 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo . . . . . 0 N--CA 1.452 -0.952 0 N-CA-C 110.353 -0.672 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.434 ' HB3' ' CH2' ' A' ' 47' ' ' TRP . 14.2 mtp180 -71.59 125.61 27.52 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -174.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -54.39 145.25 18.57 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.513 1.525 . . . . 0.0 113.1 -166.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.442 ' CD ' ' HD1' ' A' ' 10' ' ' HIS . 1.8 mp0 -76.2 142.66 41.43 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.227 1.011 . . . . 0.0 108.459 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -63.36 116.33 5.42 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 164.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.74 25.23 60.82 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.327 -1.263 . . . . 0.0 113.222 -172.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.442 ' HD1' ' CD ' ' A' ' 7' ' ' GLU . 84.7 t60 -41.74 -53.69 3.56 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 119.399 1.599 . . . . 0.0 110.743 166.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.06 178.57 6.29 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.298 1.439 . . . . 0.0 107.415 169.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.1 m170 39.97 48.13 2.05 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 125.977 1.711 . . . . 0.0 112.414 165.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.41 20.86 7.79 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.046 1.338 . . . . 0.0 112.545 170.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -63.12 133.97 55.28 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 118.397 0.544 . . . . 0.0 110.036 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.56 144.15 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 168.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -60.38 -38.1 82.83 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.346 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.12 136.11 44.35 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 168.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.62 -28.29 69.26 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.583 0.753 . . . . 0.0 110.884 171.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.68 -52.71 29.1 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.383 0.538 . . . . 0.0 111.792 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -55.71 -30.95 62.01 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.961 1.305 . . . . 0.0 111.729 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.4 -8.77 49.55 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.941 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.7 t -51.53 -31.6 24.67 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 119.672 1.124 . . . . 0.0 113.253 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.01 -24.55 67.06 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-N 115.02 -0.991 . . . . 0.0 113.158 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -88.51 107.56 17.58 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 124.779 1.232 . . . . 0.0 110.841 -171.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -58.67 120.57 8.53 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 N-CA-C 107.006 -1.959 . . . . 0.0 107.006 161.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 52.6 tpt85 127.58 -38.6 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 129.103 2.961 . . . . 0.0 108.876 -167.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -70.39 160.07 33.01 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.765 0.793 . . . . 0.0 109.715 169.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -155.18 131.36 10.25 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 113.87 -1.513 . . . . 0.0 109.242 169.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.0 mp0 -56.1 113.0 1.35 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 127.198 2.199 . . . . 0.0 109.998 -175.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 126.43 -33.79 3.36 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -67.42 118.79 11.24 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.377 1.088 . . . . 0.0 108.335 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.7 mp -131.94 152.85 50.83 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.452 1.901 . . . . 0.0 106.875 176.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.3 m -49.29 -47.58 46.74 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.661 0.784 . . . . 0.0 111.148 175.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.257 6.3 tt0 -75.1 23.96 0.1 Allowed 'General case' 0 CA--C 1.55 0.961 0 O-C-N 120.261 -1.524 . . . . 0.0 113.838 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -139.04 28.19 2.33 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.54 -1.35 . . . . 0.0 110.998 157.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 50.4 t -96.34 135.78 37.72 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.857 1.663 . . . . 0.0 108.291 175.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.42 -22.27 64.86 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.322 -0.861 . . . . 0.0 112.232 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -88.74 2.99 52.46 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 118.821 -0.609 . . . . 0.0 112.481 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 60.7 t-105 -59.51 139.39 57.17 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 119.065 0.848 . . . . 0.0 110.9 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.38 -105.87 0.6 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.163 -1.975 . . . . 0.0 108.163 167.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -146.26 156.31 43.29 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.959 1.304 . . . . 0.0 107.876 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.12 146.16 54.68 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 123.867 0.729 . . . . 0.0 110.577 171.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.5 t -118.99 -54.99 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.897 1.279 . . . . 0.0 109.214 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -154.1 155.63 35.76 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 124.515 1.126 . . . . 0.0 109.454 -176.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.9 t0 48.91 31.8 3.43 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 148.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.17 33.4 44.92 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 120.908 -1.12 . . . . 0.0 112.921 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.434 ' CH2' ' HB3' ' A' ' 5' ' ' ARG . 64.7 m95 -134.55 160.39 38.2 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 127.376 2.27 . . . . 0.0 108.739 175.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.56 175.69 38.95 Favored Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.3 mtp-105 -78.97 142.03 37.0 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.154 -0.523 . . . . 0.0 110.437 174.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.6 t . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 168.15 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.4 t70 . . . . . 0 N--CA 1.466 0.356 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -42.9 -42.21 3.6 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.4 1.08 . . . . 0.0 112.89 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.7 m -117.04 156.75 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 124.727 1.211 . . . . 0.0 109.569 -173.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.8 tp -81.66 132.4 35.3 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 69.0 t -104.58 131.14 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 123.763 0.825 . . . . 0.0 109.166 -167.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -62.02 132.1 51.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.02 -34.98 78.73 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.068 -177.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -81.34 -1.19 44.42 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 118.077 -0.963 . . . . 0.0 113.568 172.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.62 -174.55 16.63 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 119.751 1.16 . . . . 0.0 111.159 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 17.8 t90 -165.53 153.09 10.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.426 ' SG ' HG22 ' A' ' 68' ' ' VAL . 7.7 p -135.62 161.72 34.73 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.575 1.15 . . . . 0.0 109.259 174.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.2 p -71.64 -14.63 62.11 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.091 -1.006 . . . . 0.0 112.713 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.426 HG22 ' SG ' ' A' ' 66' ' ' CYS 0.35 0.9 OUTLIER -75.32 -6.85 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 119.327 0.967 . . . . 0.0 112.478 170.007 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -40.39 125.45 2.12 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 124.642 1.177 . . . . 0.0 112.441 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.18 134.44 23.37 Favored Pre-proline 0 C--N 1.331 -0.197 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 168.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.19 149.27 63.91 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 121.607 1.538 . . . . 0.0 110.917 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.336 0 C-N-CA 123.801 0.841 . . . . 0.0 110.508 178.417 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 N--CA 1.452 -0.945 0 N-CA-C 110.687 -0.543 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.44 ' HB3' ' CH2' ' A' ' 47' ' ' TRP . 26.0 mtp180 -81.71 126.93 32.38 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -170.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -53.84 140.14 31.25 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.339 1.456 . . . . 0.0 113.544 -165.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.7 145.31 48.92 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.348 1.459 . . . . 0.0 108.348 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -50.29 122.15 6.54 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 157.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 65.79 27.75 73.01 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.027 -1.43 . . . . 0.0 114.188 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -42.94 -56.37 3.32 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 119.839 1.819 . . . . 0.0 111.816 171.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.88 165.56 35.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 173.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 44.57 48.52 8.54 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.815 1.246 . . . . 0.0 113.22 170.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.24 20.23 10.82 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.995 0.518 . . . . 0.0 111.882 170.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -62.19 144.33 55.61 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.605 0.639 . . . . 0.0 112.676 -171.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.1 m -127.86 144.39 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 124.764 1.226 . . . . 0.0 108.594 173.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -70.49 -26.51 63.64 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.395 0.678 . . . . 0.0 112.372 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -117.69 116.31 26.8 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 173.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -46.5 -44.75 17.93 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.245 1.018 . . . . 0.0 111.065 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.47 -37.89 58.13 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.464 -0.779 . . . . 0.0 112.619 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -48.07 -43.08 30.23 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-O 122.237 1.018 . . . . 0.0 110.83 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.35 3.21 11.48 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 118.05 -0.976 . . . . 0.0 112.762 -174.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.4 t -58.73 -24.37 61.44 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 120.615 1.552 . . . . 0.0 112.463 173.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.59 -25.8 70.48 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.134 0.873 . . . . 0.0 113.117 171.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -81.5 111.06 22.23 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 124.477 1.111 . . . . 0.0 110.954 -172.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 58.3 Cg_endo -61.39 111.44 1.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 N-CA-C 107.172 -1.895 . . . . 0.0 107.172 163.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER 141.1 -44.19 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.785 1 C-N-CA 131.991 4.116 . . . . 0.0 105.762 -170.093 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -64.28 153.75 37.25 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.991 0.901 . . . . 0.0 110.89 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -144.57 138.51 27.52 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 128.168 2.587 . . . . 0.0 106.526 170.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -58.48 149.49 25.05 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 127.223 2.209 . . . . 0.0 110.19 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.24 -16.96 35.76 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.657 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -75.32 96.96 3.47 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.046 1.423 . . . . 0.0 109.242 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.7 mp -101.56 147.44 26.4 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.905 1.682 . . . . 0.0 107.408 165.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 m -44.64 -43.19 8.06 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.396 1.479 . . . . 0.0 111.425 175.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -61.97 -16.85 54.42 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.436 -1.415 . . . . 0.0 113.933 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -94.84 2.8 55.49 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.128 1.371 . . . . 0.0 111.84 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 38.3 t -81.28 131.92 35.31 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.537 1.135 . . . . 0.0 109.129 -173.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.73 -19.11 47.93 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.198 -0.939 . . . . 0.0 112.165 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.6 m-30 -87.39 -9.65 54.18 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.171 0.988 . . . . 0.0 112.328 177.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.415 ' CH2' ' HA3' ' A' ' 48' ' ' GLY . 77.1 t-105 -55.38 142.41 32.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.189 0.596 . . . . 0.0 111.154 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.62 -97.79 1.4 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 171.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -141.89 158.83 43.31 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.254 1.422 . . . . 0.0 107.834 178.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.04 151.08 43.4 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 123.822 0.701 . . . . 0.0 109.972 172.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.1 t -123.82 -50.72 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.208 1.403 . . . . 0.0 109.99 -172.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -140.73 -138.64 0.12 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.538 0.735 . . . . 0.0 112.206 -176.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -68.51 64.18 0.11 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 127.943 2.497 . . . . 0.0 113.583 -167.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.04 56.14 25.66 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 108.206 -1.957 . . . . 0.0 108.206 -168.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.44 ' CH2' ' HB3' ' A' ' 5' ' ' ARG . 66.7 m95 -133.75 154.51 50.92 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 165.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.415 ' HA3' ' CH2' ' A' ' 39' ' ' TRP . . . -164.97 174.82 40.94 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-O 122.489 1.05 . . . . 0.0 112.468 175.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -73.68 145.43 45.26 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 126.473 1.909 . . . . 0.0 111.452 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 29.0 t . . . . . 0 CA--C 1.549 0.924 0 C-N-CA 127.986 2.515 . . . . 0.0 110.148 -176.0 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.6 t70 . . . . . 0 CA--C 1.535 0.374 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.94 -55.5 10.76 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 171.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.3 m -78.01 165.94 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 169.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 22.5 tp -102.87 131.3 49.86 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.624 1.17 . . . . 0.0 108.508 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.0 m -97.21 143.29 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 119.393 0.997 . . . . 0.0 110.368 -175.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.439 ' HE2' ' NE1' ' A' ' 47' ' ' TRP . 0.0 OUTLIER -58.12 137.02 57.3 Favored 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 172.587 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.08 -42.13 72.43 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.909 0.884 . . . . 0.0 110.214 171.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -80.95 7.1 11.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.91 -175.38 32.0 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 76.8 t90 -159.37 154.16 24.62 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 169.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 6.8 p -138.21 165.97 25.35 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 124.0 0.812 . . . . 0.0 110.755 170.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.0 p -64.48 -31.99 73.43 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.698 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.284 1.3 m -72.97 -3.23 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 118.353 -0.832 . . . . 0.0 113.095 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -44.84 127.15 6.21 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.35 0.977 . . . . 0.0 110.859 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.2 132.81 24.27 Favored Pre-proline 0 N--CA 1.454 -0.259 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 168.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.44 151.2 65.03 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.823 1.682 . . . . 0.0 110.971 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.348 0 C-N-CA 123.808 0.843 . . . . 0.0 110.429 176.388 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo . . . . . 0 N--CA 1.451 -1.018 0 N-CA-C 110.009 -0.804 . . . . 0.0 110.009 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 34.0 mtt-85 -58.59 126.25 26.83 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.849 1.26 . . . . 0.0 110.476 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.33 143.58 39.23 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.474 1.51 . . . . 0.0 111.253 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.64 149.38 22.83 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.496 0.665 . . . . 0.0 111.113 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.85 121.02 11.86 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.94 15.78 69.21 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 117.913 -1.493 . . . . 0.0 113.124 -173.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.444 ' HE2' ' CD ' ' A' ' 57' ' ' GLU . 83.9 t60 -38.84 -58.44 1.08 Allowed 'General case' 0 C--N 1.346 0.448 0 CA-C-N 119.603 1.701 . . . . 0.0 111.994 172.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -169.03 172.01 7.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.548 1.539 . . . . 0.0 107.221 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 39.02 50.52 1.78 Allowed 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.709 1.604 . . . . 0.0 112.476 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 55.41 25.71 7.98 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.272 1.029 . . . . 0.0 112.553 174.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -63.65 137.58 58.15 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.386 0.539 . . . . 0.0 111.125 -175.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.4 m -124.22 144.29 34.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 172.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -71.89 -27.43 62.84 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.25 1.02 . . . . 0.0 111.852 176.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -113.98 114.21 25.85 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 171.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -40.63 -49.33 3.0 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.352 1.461 . . . . 0.0 111.054 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.54 -34.69 59.13 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.589 0.756 . . . . 0.0 112.982 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -50.04 -41.2 47.09 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.532 1.06 . . . . 0.0 110.935 174.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.74 9.78 2.61 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 118.428 -0.796 . . . . 0.0 112.805 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.3 t -52.66 -31.76 38.76 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 120.115 1.325 . . . . 0.0 112.691 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.82 -21.77 78.11 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.696 1.141 . . . . 0.0 113.823 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -79.72 115.45 53.78 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 118.752 1.276 . . . . 0.0 111.362 -168.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.02 72.87 3.22 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.961 2.441 . . . . 0.0 111.21 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 52.8 mmt-85 -178.06 -36.27 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 131.623 3.969 . . . . 0.0 107.953 173.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -58.91 151.63 21.31 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.58 0.705 . . . . 0.0 110.399 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -136.75 146.04 45.31 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 166.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -59.38 148.43 32.58 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.462 0.649 . . . . 0.0 110.167 176.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.43 -23.16 16.7 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.348 0.975 . . . . 0.0 112.569 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -72.63 105.09 4.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 118.342 1.071 . . . . 0.0 108.765 177.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.7 mp -117.29 149.0 41.18 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 14.8 m -42.19 -46.19 4.32 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.248 1.419 . . . . 0.0 111.33 172.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -56.91 -26.82 59.98 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.789 -1.194 . . . . 0.0 114.152 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -107.16 19.15 20.79 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.11 0.964 . . . . 0.0 112.562 176.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.5 t -82.88 134.56 35.08 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.612 1.165 . . . . 0.0 108.525 173.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.87 -19.26 59.88 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.056 -1.027 . . . . 0.0 112.108 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -87.63 -5.21 58.83 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.451 -0.785 . . . . 0.0 111.425 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -53.86 142.71 23.32 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.543 1.065 . . . . 0.0 111.465 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.87 -85.95 1.17 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 173.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -166.31 158.95 14.43 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.08 137.01 38.68 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 123.603 0.564 . . . . 0.0 110.029 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.513 HG21 HD11 ' A' ' 59' ' ' LEU . 90.1 t -108.99 -49.93 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 125.417 1.487 . . . . 0.0 109.255 -175.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -151.71 -155.44 0.62 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.339 1.056 . . . . 0.0 110.886 -175.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -56.96 70.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 129.394 3.077 . . . . 0.0 114.416 -160.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.58 36.65 88.53 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -172.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -130.81 143.44 50.74 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 125.444 1.497 . . . . 0.0 109.065 173.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.419 ' HA2' HG23 ' A' ' 43' ' ' VAL . . . -156.77 -176.56 28.99 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-O 121.755 0.642 . . . . 0.0 112.189 177.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.481 ' HD2' HD12 ' A' ' 59' ' ' LEU . 48.4 mmm-85 -90.87 154.89 19.16 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.34 1.056 . . . . 0.0 109.963 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.455 -0.183 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -179.097 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.2 t70 . . . . . 0 CA--C 1.536 0.433 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.444 ' CD ' ' HE2' ' A' ' 10' ' ' HIS . 31.2 mt-10 -24.34 -53.74 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.469 2.308 . . . . 0.0 112.897 160.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.6 m -126.7 159.05 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.853 1.661 . . . . 0.0 108.064 -170.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.513 HD11 HG21 ' A' ' 43' ' ' VAL . 10.3 tp -79.16 123.41 27.36 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.2 t -92.32 129.24 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -171.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -63.38 131.28 47.74 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.14 -41.99 49.85 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.484 0.714 . . . . 0.0 111.512 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -84.84 5.45 28.7 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.35 -176.01 27.43 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 119.414 1.006 . . . . 0.0 111.148 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 83.1 t90 -159.19 153.72 24.25 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 170.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.411 ' SG ' HG22 ' A' ' 68' ' ' VAL . 2.0 p -142.06 163.63 32.35 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.861 1.264 . . . . 0.0 110.578 175.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.1 p -78.14 -5.95 53.22 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.411 HG22 ' SG ' ' A' ' 66' ' ' CYS 0.284 1.5 m -83.61 0.3 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 119.598 1.09 . . . . 0.0 112.169 164.574 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -47.14 137.98 7.33 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 119.073 0.852 . . . . 0.0 111.708 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -134.57 138.7 30.59 Favored Pre-proline 0 N--CA 1.454 -0.259 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 167.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.11 149.85 52.97 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.033 1.822 . . . . 0.0 111.147 -176.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.321 0 C-N-CA 123.932 0.893 . . . . 0.0 110.071 176.463 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo . . . . . 0 N--CA 1.455 -0.743 0 N-CA-C 110.813 -0.495 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -57.89 125.69 24.16 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.065 1.346 . . . . 0.0 110.604 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.15 150.14 30.69 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.189 1.396 . . . . 0.0 112.75 -173.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.426 ' CD ' ' HD1' ' A' ' 10' ' ' HIS . 1.8 mp0 -83.34 144.57 29.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.913 1.285 . . . . 0.0 108.623 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.1 121.98 14.4 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 166.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.79 22.91 76.28 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.175 -1.347 . . . . 0.0 113.271 -173.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.426 ' HD1' ' CD ' ' A' ' 7' ' ' GLU . 80.6 t60 -42.04 -55.09 3.31 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 119.557 1.678 . . . . 0.0 111.182 168.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -165.94 173.89 10.03 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.066 1.347 . . . . 0.0 108.06 173.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 38.33 50.69 1.5 Allowed 'General case' 0 C--N 1.341 0.23 0 C-N-CA 126.025 1.73 . . . . 0.0 112.986 172.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.2 20.5 8.56 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.384 0.674 . . . . 0.0 111.905 171.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -63.22 136.02 57.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.862 0.755 . . . . 0.0 110.543 -175.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.9 m -122.62 142.19 40.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -62.74 -36.66 83.74 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.921 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -109.01 123.3 48.93 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 123.401 0.68 . . . . 0.0 109.362 170.65 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.56 -36.44 10.56 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.25 1.42 . . . . 0.0 110.919 171.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.24 -40.99 64.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -56.38 -37.63 70.34 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 122.024 0.916 . . . . 0.0 110.604 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.51 0.69 13.96 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 117.831 -1.081 . . . . 0.0 112.245 -175.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.2 t -52.29 -30.39 27.88 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 120.36 1.436 . . . . 0.0 112.861 172.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.25 -27.2 72.13 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.49 1.043 . . . . 0.0 113.679 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -81.49 114.86 52.91 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 118.375 1.087 . . . . 0.0 111.494 -169.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.403 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 59.0 Cg_endo -63.05 108.7 0.8 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 N-CA-C 107.614 -1.726 . . . . 0.0 107.614 165.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 25' ' ' PRO . 2.0 mmm180 139.34 -35.41 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 131.487 3.915 . . . . 0.0 108.748 -173.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -71.9 156.55 39.15 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.492 0.663 . . . . 0.0 109.765 175.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -155.16 138.94 16.17 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.384 165.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -54.71 115.61 2.25 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 128.114 2.565 . . . . 0.0 109.53 -175.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.37 -21.19 11.96 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -72.92 109.27 6.35 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 167.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.2 mp -122.89 148.64 45.2 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.355 2.262 . . . . 0.0 106.137 172.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 6.5 m -45.07 -44.49 10.35 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.498 1.519 . . . . 0.0 111.711 175.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -59.12 -18.81 39.0 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 120.657 -1.277 . . . . 0.0 113.903 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -96.8 3.98 51.99 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.217 1.407 . . . . 0.0 112.043 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.2 t -90.79 139.99 30.21 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.849 1.26 . . . . 0.0 110.396 -169.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.84 -11.3 58.31 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.007 -1.058 . . . . 0.0 112.857 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -88.96 -3.92 58.59 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.604 171.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -59.52 132.28 53.52 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.07 0.85 . . . . 0.0 110.321 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.88 -81.03 1.13 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 171.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.6 165.68 12.18 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.612 0.765 . . . . 0.0 110.165 163.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.406 ' HA ' ' HA3' ' A' ' 48' ' ' GLY . . . -58.74 146.64 36.03 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.313 1.045 . . . . 0.0 111.034 170.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.2 t -125.23 -48.47 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 124.925 1.29 . . . . 0.0 109.211 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -149.17 -159.15 0.99 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.016 0.926 . . . . 0.0 110.192 -174.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -59.32 70.3 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 129.648 3.179 . . . . 0.0 113.799 -162.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.0 30.08 57.96 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -131.55 143.02 50.06 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 124.949 1.299 . . . . 0.0 108.845 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 42' ' ' ALA . . . -152.89 172.91 31.91 Favored Glycine 0 N--CA 1.433 -1.508 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -72.03 127.76 33.56 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.105 170.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 52.0 t . . . . . 0 C--O 1.242 0.7 0 N-CA-C 104.778 -2.305 . . . . 0.0 104.778 141.062 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 t0 . . . . . 0 CA--C 1.532 0.279 0 CA-C-O 120.974 0.416 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -52.13 -41.43 62.5 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.456 1.903 . . . . 0.0 112.37 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.6 m -114.94 153.66 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 125.476 1.51 . . . . 0.0 109.424 -173.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.6 tp -85.28 136.27 33.57 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.6 t -104.97 134.8 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 123.608 0.763 . . . . 0.0 109.089 -167.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -64.01 129.64 40.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.17 -40.11 67.2 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.167 0.587 . . . . 0.0 111.632 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -82.7 1.26 39.5 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 175.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.57 -174.0 19.23 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 120.055 1.298 . . . . 0.0 111.832 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 75.2 t90 -163.87 150.64 11.81 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 174.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.6 p -135.76 162.99 31.21 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.142 1.377 . . . . 0.0 110.462 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.4 p -68.08 -21.76 64.96 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 118.454 -0.784 . . . . 0.0 112.521 -176.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.292 1.1 m -76.29 -4.64 6.39 Favored 'Isoleucine or valine' 0 C--N 1.344 0.36 0 CA-C-N 119.249 0.931 . . . . 0.0 112.705 175.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -42.69 126.47 3.67 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 118.777 0.717 . . . . 0.0 111.784 178.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.92 134.39 26.05 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 165.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.9 150.15 66.95 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 121.586 1.524 . . . . 0.0 111.027 -175.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.367 0 CA-C-O 121.574 0.702 . . . . 0.0 109.807 172.568 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo . . . . . 0 N--CA 1.458 -0.6 0 N-CA-C 110.752 -0.519 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.3 mtt180 -55.1 125.68 21.52 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.476 1.111 . . . . 0.0 110.868 172.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.58 152.5 34.8 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.64 1.176 . . . . 0.0 113.542 -172.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -84.8 143.4 29.13 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.452 1.501 . . . . 0.0 108.774 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -63.59 118.78 8.69 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 167.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.0 20.81 72.4 Favored Glycine 0 CA--C 1.531 1.094 0 CA-C-O 118.377 -1.235 . . . . 0.0 113.112 -173.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -43.89 -56.87 3.61 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 119.453 1.627 . . . . 0.0 111.477 169.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.09 172.96 10.79 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.146 1.378 . . . . 0.0 108.015 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 36.84 48.45 0.67 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.37 1.868 . . . . 0.0 113.246 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 55.77 23.85 6.75 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.853 0.861 . . . . 0.0 112.127 173.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -63.14 135.09 56.97 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.172 0.442 . . . . 0.0 110.096 -175.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.7 m -123.23 141.46 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 170.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.3 m-20 -62.61 -36.13 81.76 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 118.949 -0.548 . . . . 0.0 111.1 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.87 130.34 55.01 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 123.516 0.727 . . . . 0.0 109.334 168.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.49 -34.55 36.33 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.358 1.063 . . . . 0.0 110.654 170.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.05 -45.25 64.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.238 0.215 . . . . 0.0 111.434 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.52 -20.72 65.85 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.577 0.751 . . . . 0.0 111.933 -176.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.27 -6.53 55.26 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.544 -0.723 . . . . 0.0 111.968 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.2 m -62.73 91.88 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 119.162 0.892 . . . . 0.0 111.22 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.37 -36.0 1.03 Allowed Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.263 1.411 . . . . 0.0 110.764 -172.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -62.12 116.8 24.25 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.278 -0.868 . . . . 0.0 109.28 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.91 116.52 3.61 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 N-CA-C 107.455 -1.786 . . . . 0.0 107.455 170.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.5 tpt85 123.2 -35.54 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 129.438 3.095 . . . . 0.0 109.278 -170.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -62.7 149.73 42.96 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.52 0.676 . . . . 0.0 109.454 168.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -157.19 137.07 12.45 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.128 1.771 . . . . 0.0 106.368 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -58.33 123.47 16.21 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.522 2.329 . . . . 0.0 110.998 -172.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.94 -20.68 37.93 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-O 119.181 -0.788 . . . . 0.0 111.607 176.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -67.66 111.41 4.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 118.829 1.314 . . . . 0.0 107.909 173.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.6 mp -124.96 149.64 47.45 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 172.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.4 m -42.91 -45.54 5.01 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.042 1.337 . . . . 0.0 111.89 173.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -56.86 -26.08 57.83 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -109.26 25.72 11.47 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.178 0.991 . . . . 0.0 112.357 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 45.1 t -86.42 138.8 31.49 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.584 1.153 . . . . 0.0 108.838 172.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.09 -26.27 64.52 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.443 -0.785 . . . . 0.0 112.079 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -78.14 -10.92 59.85 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 117.719 -1.134 . . . . 0.0 112.559 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -49.56 127.77 16.22 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.988 1.267 . . . . 0.0 111.898 -172.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.18 -84.65 0.59 Allowed Glycine 0 C--N 1.335 0.485 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.81 171.17 11.64 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 155.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.28 145.76 46.3 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.55 1.14 . . . . 0.0 110.996 169.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.3 t -123.62 -47.45 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 125.746 1.619 . . . . 0.0 109.24 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -148.46 -162.73 1.62 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.987 0.915 . . . . 0.0 110.186 -174.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -58.05 71.23 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 129.675 3.19 . . . . 0.0 113.934 -163.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.95 26.82 57.61 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.985 1.278 . . . . 0.0 110.913 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -129.67 144.47 51.3 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 124.978 1.311 . . . . 0.0 109.644 176.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -154.04 -178.36 28.39 Favored Glycine 0 N--CA 1.437 -1.247 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.0 mtp85 -94.66 154.6 17.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 118.926 -0.559 . . . . 0.0 109.909 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.454 -0.239 0 C-N-CA 123.49 0.716 . . . . 0.0 109.093 159.972 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 . . . . . 0 N--CA 1.466 0.35 0 CA-C-O 122.253 1.025 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.3 pm0 -51.92 -34.08 40.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.085 1.354 . . . . 0.0 111.549 166.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 m -127.39 149.62 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 125.285 1.434 . . . . 0.0 108.598 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.4 tp -91.55 142.66 27.41 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.371 1.468 . . . . 0.0 108.963 -171.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.2 t -102.06 124.7 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 124.927 1.291 . . . . 0.0 108.457 -162.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.3 tttm -61.6 126.81 28.69 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 171.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.65 -38.0 30.62 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.069 0.948 . . . . 0.0 111.676 175.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -83.54 -4.34 58.46 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.41 -173.32 29.73 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 119.034 0.834 . . . . 0.0 111.991 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 86.0 t90 -161.75 148.88 14.31 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.614 ' SG ' HG13 ' A' ' 68' ' ' VAL . 5.6 p -135.11 163.83 29.02 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.186 1.394 . . . . 0.0 109.341 172.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.7 p -73.07 -18.1 61.35 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.969 -1.082 . . . . 0.0 112.672 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.614 HG13 ' SG ' ' A' ' 66' ' ' CYS 0.373 1.5 p -77.87 7.13 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 124.866 1.266 . . . . 0.0 111.785 164.867 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -52.5 130.36 31.48 Favored 'General case' 0 C--N 1.345 0.394 0 O-C-N 120.206 -1.559 . . . . 0.0 110.28 162.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.95 134.63 26.53 Favored Pre-proline 0 N--CA 1.453 -0.291 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 171.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -73.28 148.37 43.62 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 121.788 1.659 . . . . 0.0 110.658 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.389 0 CA-C-O 121.746 0.784 . . . . 0.0 109.523 178.843 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 N--CA 1.454 -0.804 0 N-CA-C 109.881 -0.853 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.433 ' HB3' ' CH2' ' A' ' 47' ' ' TRP . 18.2 mtp180 -80.32 122.61 27.12 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -172.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.53 135.54 33.86 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.974 1.31 . . . . 0.0 112.804 -166.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.465 ' CD ' ' HD1' ' A' ' 10' ' ' HIS . 1.9 mp0 -68.41 147.93 51.37 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.681 1.192 . . . . 0.0 109.464 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.27 87.75 0.12 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.744 0.818 . . . . 0.0 109.55 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.16 37.55 5.63 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.917 -173.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.465 ' HD1' ' CD ' ' A' ' 7' ' ' GLU . 79.9 t60 -39.65 -54.19 2.06 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 123.91 0.884 . . . . 0.0 109.943 164.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -165.76 175.21 8.94 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.494 1.518 . . . . 0.0 106.986 170.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 5.2 m80 55.21 30.02 13.81 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.966 1.307 . . . . 0.0 113.603 169.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 57.08 34.58 25.1 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.603 1.161 . . . . 0.0 111.938 175.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -54.12 -64.48 0.81 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -171.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.284 23.6 m 55.52 134.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 127.206 2.202 . . . . 0.0 114.077 -169.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -66.69 -28.9 68.81 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 120.77 -1.206 . . . . 0.0 112.405 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -113.11 118.95 36.16 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 171.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.91 -43.59 29.01 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.48 1.112 . . . . 0.0 109.818 175.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.97 -40.24 13.99 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.75 0.82 . . . . 0.0 112.889 175.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -52.44 -34.85 50.61 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.507 1.049 . . . . 0.0 111.445 178.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.29 5.11 3.07 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 116.895 -1.526 . . . . 0.0 113.811 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.8 m -13.68 99.99 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 128.13 2.572 . . . . 0.0 113.942 170.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.15 21.66 64.19 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.312 0.958 . . . . 0.0 115.052 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -48.09 127.47 11.99 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 119.31 1.555 . . . . 0.0 107.783 162.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -61.01 110.26 0.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.708 0 CA-C-N 121.252 1.483 . . . . 0.0 108.299 175.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.5 tpt85 123.66 -40.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 129.578 3.151 . . . . 0.0 110.161 -171.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -70.82 143.39 51.14 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.795 0.725 . . . . 0.0 110.557 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . 0.512 ' H ' ' NE2' ' A' ' 31' ' ' GLN . 23.0 mp0 -132.95 123.2 25.49 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 162.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.0 mp0 -54.15 119.05 4.58 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 128.407 2.683 . . . . 0.0 109.181 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.99 -34.55 3.38 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -174.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.512 ' NE2' ' H ' ' A' ' 28' ' ' GLN . 25.7 mt-30 -63.94 118.4 8.38 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 171.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.87 147.27 50.8 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 126.086 1.754 . . . . 0.0 107.154 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.5 m -44.04 -48.8 8.88 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.15 0.98 . . . . 0.0 111.444 174.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -61.34 -20.45 62.99 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 120.431 -1.418 . . . . 0.0 113.983 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -107.21 24.12 13.34 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.811 1.244 . . . . 0.0 111.845 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.4 t -95.3 134.52 37.98 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.391 1.476 . . . . 0.0 109.595 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.0 -20.21 56.55 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.433 -0.792 . . . . 0.0 112.726 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -97.52 6.64 47.83 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.138 0.575 . . . . 0.0 112.192 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 -59.66 145.74 43.67 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.594 0.633 . . . . 0.0 110.392 171.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.18 -69.78 1.28 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 172.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -176.46 160.4 2.06 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 -169.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.37 140.38 31.61 Favored 'General case' 0 N--CA 1.457 -0.083 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 169.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.727 HG23 ' HA2' ' A' ' 48' ' ' GLY . 55.5 t -107.53 -51.37 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.401 1.48 . . . . 0.0 109.279 -173.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -149.55 -136.88 0.08 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.421 0.689 . . . . 0.0 111.728 -170.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -71.43 65.71 0.45 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.054 2.142 . . . . 0.0 112.988 -163.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.0 42.38 77.82 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -173.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.433 ' CH2' ' HB3' ' A' ' 5' ' ' ARG . 80.7 m95 -133.45 156.12 48.29 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 125.514 1.526 . . . . 0.0 108.232 170.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.727 ' HA2' HG23 ' A' ' 43' ' ' VAL . . . -157.47 -174.08 26.71 Favored Glycine 0 N--CA 1.434 -1.476 0 O-C-N 124.496 1.122 . . . . 0.0 110.507 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -98.23 153.64 18.35 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.402 1.081 . . . . 0.0 108.882 -176.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.519 ' HB2' HG21 ' A' ' 60' ' ' VAL . 9.2 t . . . . . 0 CA--C 1.528 0.132 0 C-N-CA 125.463 1.505 . . . . 0.0 107.867 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.4 p-10 . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -44.91 -42.56 8.19 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.939 1.296 . . . . 0.0 114.311 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.3 m -130.4 156.4 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.07 0.948 . . . . 0.0 111.951 -160.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.725 HD11 HG21 ' A' ' 43' ' ' VAL . 9.1 tp -78.81 126.76 31.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 173.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.519 HG21 ' HB2' ' A' ' 50' ' ' CYS . 11.0 m -98.13 134.93 34.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 118.815 0.734 . . . . 0.0 109.546 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -61.16 134.91 57.52 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.1 -40.56 73.87 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.66 0.384 . . . . 0.0 111.223 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -76.8 -2.34 32.72 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 175.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.11 -178.52 8.62 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 70.5 t90 -148.71 -179.48 7.02 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 170.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.432 ' SG ' HG22 ' A' ' 68' ' ' VAL . 5.7 p -162.66 164.85 26.37 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 119.038 0.835 . . . . 0.0 110.357 159.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.5 p -63.0 -30.99 72.03 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 118.939 -0.553 . . . . 0.0 111.781 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.432 HG22 ' SG ' ' A' ' 66' ' ' CYS 0.301 1.1 m -72.42 -5.34 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 118.885 0.766 . . . . 0.0 112.478 177.432 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -46.03 137.0 6.19 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.884 0.874 . . . . 0.0 112.031 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.43 140.59 39.12 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 165.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.04 147.76 38.96 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.282 1.988 . . . . 0.0 111.248 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 121.611 0.72 . . . . 0.0 109.424 177.016 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 N--CA 1.458 -0.577 0 N-CA-C 110.795 -0.502 . . . . 0.0 110.795 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.437 ' HB3' ' CH2' ' A' ' 47' ' ' TRP . 16.1 mtp180 -79.23 123.13 27.12 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -54.61 142.7 27.12 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.82 1.248 . . . . 0.0 112.68 -170.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.459 ' CD ' ' HD1' ' A' ' 10' ' ' HIS . 1.6 mp0 -76.58 145.61 38.85 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.006 1.322 . . . . 0.0 108.417 -178.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -64.86 121.57 14.92 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 167.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.97 25.73 74.12 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 118.275 -1.292 . . . . 0.0 112.855 -170.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.459 ' HD1' ' CD ' ' A' ' 7' ' ' GLU . 78.9 t60 -41.95 -57.87 2.26 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 119.388 1.594 . . . . 0.0 110.7 168.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.19 174.06 4.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.746 1.619 . . . . 0.0 107.351 173.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 54.46 31.97 15.78 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.802 1.241 . . . . 0.0 113.137 172.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 55.1 29.99 13.54 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.256 1.023 . . . . 0.0 111.596 -176.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -64.35 134.68 55.11 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.972 -0.455 . . . . 0.0 110.043 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.0 m -122.9 142.04 40.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 170.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -63.27 -34.92 78.73 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 118.993 -0.527 . . . . 0.0 111.534 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.69 127.27 54.47 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 123.634 0.774 . . . . 0.0 109.733 169.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.16 -38.47 11.86 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.732 1.213 . . . . 0.0 110.58 168.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.15 -41.76 60.33 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -59.7 -30.61 68.91 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.131 0.491 . . . . 0.0 111.373 -176.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.01 -0.31 30.67 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 118.85 -0.595 . . . . 0.0 112.448 -176.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.3 m -61.79 91.56 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 119.248 0.931 . . . . 0.0 111.377 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.06 -32.43 1.41 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.087 1.327 . . . . 0.0 111.431 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -60.26 125.12 80.79 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 118.067 0.933 . . . . 0.0 109.567 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 59.5 Cg_endo -65.21 102.3 0.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 N-CA-C 107.258 -1.862 . . . . 0.0 107.258 169.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER 139.9 -29.44 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 130.9 3.68 . . . . 0.0 110.235 -173.585 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -75.71 79.86 2.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.432 0.635 . . . . 0.0 109.769 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -64.75 137.62 57.9 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 161.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -59.46 118.55 6.16 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 128.085 2.554 . . . . 0.0 112.193 -172.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.67 -1.18 63.57 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-O 119.381 -0.677 . . . . 0.0 111.909 174.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -60.87 121.87 13.42 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.388 1.094 . . . . 0.0 108.372 166.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.7 mp -128.94 145.1 51.32 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.661 1.984 . . . . 0.0 107.723 173.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 6.8 m -45.54 -45.17 13.28 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 124.829 1.252 . . . . 0.0 112.75 177.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -64.84 -13.97 57.82 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 119.863 -1.773 . . . . 0.0 114.01 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -93.09 -1.16 56.76 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.318 1.047 . . . . 0.0 111.416 173.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.6 t -80.12 131.41 35.73 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.417 1.087 . . . . 0.0 109.138 -175.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.67 -6.29 19.89 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.969 -1.082 . . . . 0.0 112.472 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -93.57 -2.28 54.41 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.936 0.789 . . . . 0.0 111.755 171.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -59.56 149.37 30.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 118.518 0.599 . . . . 0.0 111.194 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.86 -74.82 1.27 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.287 1.422 . . . . 0.0 109.593 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -173.21 154.11 2.63 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.284 1.433 . . . . 0.0 107.152 -168.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.61 137.24 37.05 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 171.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.615 HG23 ' HA2' ' A' ' 48' ' ' GLY . 75.9 t -107.69 -48.62 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 125.244 1.418 . . . . 0.0 108.972 -173.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -149.37 -140.8 0.1 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.728 0.411 . . . . 0.0 111.866 -168.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -72.12 65.05 0.56 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.257 2.223 . . . . 0.0 112.561 -167.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.42 31.08 47.38 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.437 ' CH2' ' HB3' ' A' ' 5' ' ' ARG . 74.7 m95 -132.2 152.39 51.33 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 125.301 1.441 . . . . 0.0 109.224 173.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.615 ' HA2' HG23 ' A' ' 43' ' ' VAL . . . -154.84 -179.93 30.42 Favored Glycine 0 N--CA 1.431 -1.64 0 O-C-N 124.669 1.231 . . . . 0.0 110.832 178.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -86.05 145.77 26.92 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.142 0 C-N-CA 126.589 1.956 . . . . 0.0 105.751 174.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 . . . . . 0 N--CA 1.471 0.578 0 CA-C-O 121.482 0.658 . . . . 0.0 111.98 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -65.86 -17.24 64.51 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.701 1.6 . . . . 0.0 115.28 -174.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.27 149.02 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 120.192 1.36 . . . . 0.0 111.239 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.598 HD11 HG21 ' A' ' 43' ' ' VAL . 7.3 tp -77.78 130.41 36.67 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 174.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.4 t -106.04 129.67 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -174.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.419 ' HD2' ' CZ2' ' A' ' 47' ' ' TRP . 32.5 tttm -61.87 129.79 42.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 174.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.9 -36.69 67.94 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.565 0.746 . . . . 0.0 111.483 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -80.83 -7.03 59.32 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.57 -0.729 . . . . 0.0 112.455 178.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.38 -173.07 20.8 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 118.906 0.775 . . . . 0.0 111.915 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -161.19 150.68 16.8 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.41 ' SG ' HG22 ' A' ' 68' ' ' VAL . 1.8 p -139.82 172.44 12.78 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.235 1.014 . . . . 0.0 111.223 170.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 81.0 p -72.06 -35.53 69.31 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.41 HG22 ' SG ' ' A' ' 66' ' ' CYS . 2.4 m -64.84 -23.85 34.31 Favored 'Isoleucine or valine' 0 C--N 1.347 0.467 0 CA-C-N 118.568 0.622 . . . . 0.0 111.632 -175.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -20.45 105.39 0.02 OUTLIER 'General case' 0 C--O 1.237 0.403 0 C-N-CA 128.033 2.533 . . . . 0.0 113.486 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.57 120.57 57.26 Favored Pre-proline 0 N--CA 1.454 -0.234 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 165.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -66.1 134.41 36.67 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.253 1.302 . . . . 0.0 112.81 -173.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.235 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 142.48 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.453 -0.876 0 N-CA-C 111.312 -0.303 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.1 mtt180 -62.46 127.37 31.01 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.783 1.233 . . . . 0.0 109.987 171.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.41 145.53 43.31 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.584 1.553 . . . . 0.0 111.514 -175.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.3 146.15 24.91 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.375 0.607 . . . . 0.0 110.94 175.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.92 120.33 9.43 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 172.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.75 18.7 65.12 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 117.997 -1.446 . . . . 0.0 113.742 -174.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -36.01 -55.3 0.76 Allowed 'General case' 0 C--N 1.347 0.467 0 CA-C-N 119.637 1.718 . . . . 0.0 111.602 168.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -164.77 -179.47 5.87 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 164.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.4 m170 46.22 45.95 13.1 Favored 'General case' 0 CA--C 1.527 0.071 0 O-C-N 124.213 0.945 . . . . 0.0 111.865 160.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 56.23 24.59 8.28 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.955 1.302 . . . . 0.0 112.219 172.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -62.49 136.69 58.02 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 118.152 0.433 . . . . 0.0 111.415 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.1 m -125.46 142.26 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 174.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -70.65 -24.87 62.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.2 1.0 . . . . 0.0 112.053 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -115.31 120.57 40.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.12 1.368 . . . . 0.0 107.919 168.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.04 -49.62 40.38 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.189 0.996 . . . . 0.0 111.665 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.7 -20.03 64.4 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 118.201 -0.904 . . . . 0.0 112.785 -173.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -44.57 -43.84 8.37 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.805 1.184 . . . . 0.0 110.466 165.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.03 7.9 12.07 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -175.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.6 p -33.14 -59.16 0.37 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 127.344 2.257 . . . . 0.0 113.19 174.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.93 -29.82 35.64 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 112.239 -2.255 . . . . 0.0 113.805 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -70.04 117.51 54.73 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 118.687 1.243 . . . . 0.0 110.908 -171.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -60.68 105.74 0.33 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 N-CA-C 107.439 -1.793 . . . . 0.0 107.439 163.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 141.41 -40.0 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 130.983 3.713 . . . . 0.0 108.662 -172.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -68.78 150.4 47.89 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 173.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -150.3 132.14 15.09 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.272 1.1 pm0 -56.94 107.26 0.38 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.31 1.444 . . . . 0.0 112.076 -173.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.39 -1.87 27.98 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 119.139 -0.811 . . . . 0.0 111.983 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -73.07 110.81 7.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.74 1.77 . . . . 0.0 107.044 164.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.5 mp -121.57 150.27 41.9 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.925 2.09 . . . . 0.0 106.346 170.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.8 m -47.7 -45.72 28.79 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.326 1.05 . . . . 0.0 111.946 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -62.89 -13.65 36.79 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 120.209 -1.557 . . . . 0.0 113.588 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -95.68 2.52 54.07 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 120.82 -1.175 . . . . 0.0 111.874 175.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 24.6 t -86.83 137.06 32.72 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.754 1.222 . . . . 0.0 109.448 -171.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.02 -20.66 65.52 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.188 -0.945 . . . . 0.0 111.867 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -87.29 2.07 51.31 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.566 -0.731 . . . . 0.0 112.528 173.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 48.2 t-105 -59.09 142.93 50.14 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.749 1.158 . . . . 0.0 111.071 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.43 -109.47 0.93 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 165.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -139.43 157.26 46.16 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.274 1.43 . . . . 0.0 107.782 175.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.27 141.44 58.02 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 123.929 0.768 . . . . 0.0 109.444 165.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.7 t -113.5 -54.05 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 124.5 1.12 . . . . 0.0 109.257 -174.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -157.87 153.97 27.19 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.364 1.066 . . . . 0.0 109.46 -177.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.4 t0 50.09 35.99 11.18 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 155.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.3 31.89 80.38 Favored Glycine 0 CA--C 1.535 1.331 0 O-C-N 120.615 -1.303 . . . . 0.0 112.992 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -123.37 152.73 41.22 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 127.935 2.494 . . . . 0.0 108.394 170.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -159.29 176.85 36.03 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-O 122.002 0.779 . . . . 0.0 111.363 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.62 145.06 30.79 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 114.647 -0.776 . . . . 0.0 111.814 176.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 21.7 t . . . . . 0 N--CA 1.445 -0.723 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 160.429 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 111.212 0.078 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -70.46 0.32 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -175.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -69.84 165.98 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.712 0.805 . . . . 0.0 111.755 -171.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.3 tp -91.62 118.5 30.68 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 170.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.2 m -91.88 148.45 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -66.59 138.78 57.71 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.96 -36.93 80.68 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.178 0.445 . . . . 0.0 111.09 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -82.26 3.2 28.47 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 171.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.08 -176.91 28.24 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 73.5 t90 -163.64 153.93 15.5 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.408 ' SG ' HG22 ' A' ' 68' ' ' VAL . 3.1 p -135.69 160.26 39.06 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.774 1.23 . . . . 0.0 110.329 172.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.8 p -71.35 -15.9 62.41 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.325 -0.859 . . . . 0.0 112.654 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.408 HG22 ' SG ' ' A' ' 66' ' ' CYS 0.322 0.9 OUTLIER -76.48 -4.44 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 119.342 0.974 . . . . 0.0 112.323 172.132 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -42.91 130.92 4.26 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 124.183 0.993 . . . . 0.0 112.261 177.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.58 135.21 26.31 Favored Pre-proline 0 N--CA 1.455 -0.217 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 165.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -69.5 149.84 69.05 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 121.735 1.623 . . . . 0.0 110.798 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 121.667 0.746 . . . . 0.0 110.007 174.01 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 N--CA 1.458 -0.574 0 CA-C-O 121.025 0.344 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 31.9 mtt-85 -61.25 131.43 50.37 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.482 1.513 . . . . 0.0 111.158 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.32 142.96 54.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.012 1.325 . . . . 0.0 112.057 -178.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -84.95 155.23 21.72 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 122.042 0.925 . . . . 0.0 112.197 174.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -67.34 96.23 0.48 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.616 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.48 24.99 10.42 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.56 1.076 . . . . 0.0 111.667 -176.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -34.21 -55.52 0.51 Allowed 'General case' 0 C--N 1.345 0.372 0 C-N-CA 125.238 1.415 . . . . 0.0 111.896 170.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.37 169.66 22.64 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 169.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 43.77 46.45 6.46 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.933 1.293 . . . . 0.0 113.419 170.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 58.83 27.0 15.5 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.184 0.594 . . . . 0.0 112.298 169.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -46.99 -60.3 2.54 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -165.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.254 34.7 m 56.85 132.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 126.757 2.023 . . . . 0.0 113.893 -171.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -68.78 -27.68 66.1 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 120.574 -1.329 . . . . 0.0 112.746 -177.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -110.43 115.29 29.4 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 170.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -42.36 -46.64 4.7 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.07 1.348 . . . . 0.0 110.656 173.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.99 -37.31 44.16 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.915 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -51.63 -35.45 42.0 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.411 1.005 . . . . 0.0 111.643 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.88 2.83 13.5 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -177.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 64.8 m -61.62 93.0 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 119.598 1.09 . . . . 0.0 111.306 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.5 -34.51 1.06 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.52 1.533 . . . . 0.0 110.49 -174.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -62.74 115.71 18.86 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 117.871 -1.062 . . . . 0.0 109.335 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -62.73 120.34 7.82 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 N-CA-C 107.587 -1.736 . . . . 0.0 107.587 171.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 118.91 -39.22 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 129.185 2.994 . . . . 0.0 108.902 -168.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -64.05 142.11 58.53 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 166.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -144.84 147.82 33.28 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 174.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.1 mp0 -55.73 117.46 3.66 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.434 1.493 . . . . 0.0 110.776 -170.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.13 7.41 70.18 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 119.705 -0.497 . . . . 0.0 112.373 175.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -72.63 91.14 1.41 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 119.037 1.419 . . . . 0.0 108.509 167.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.5 mp -95.48 150.0 20.79 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.949 1.3 . . . . 0.0 109.003 169.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 2.1 m -46.21 -44.98 16.64 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.936 1.295 . . . . 0.0 110.653 172.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -63.06 -12.68 28.31 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 120.714 -1.241 . . . . 0.0 114.123 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -97.99 2.63 49.15 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.867 1.267 . . . . 0.0 111.938 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 35.2 t -84.04 135.59 34.37 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.784 1.234 . . . . 0.0 109.779 -171.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.17 -16.17 59.23 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.601 -0.687 . . . . 0.0 112.446 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -94.65 0.03 54.77 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.387 174.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -55.58 140.11 42.03 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.525 1.057 . . . . 0.0 110.807 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.41 -100.14 1.05 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 172.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -145.65 155.55 43.08 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.743 1.617 . . . . 0.0 107.388 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.38 145.75 49.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 123.749 0.655 . . . . 0.0 109.562 170.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.0 t -123.1 -45.21 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 125.316 1.446 . . . . 0.0 109.504 -174.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -147.78 -165.06 2.16 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.151 0.98 . . . . 0.0 109.821 -175.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -51.74 71.36 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 129.815 3.246 . . . . 0.0 114.847 -164.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.2 42.47 94.26 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -173.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -133.39 142.83 48.56 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.43 1.492 . . . . 0.0 108.9 172.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -156.46 173.34 34.27 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-O 122.25 0.917 . . . . 0.0 112.965 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -74.76 153.55 38.75 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 125.982 1.713 . . . . 0.0 112.317 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.53 0.208 0 C-N-CA 125.109 1.364 . . . . 0.0 108.188 179.937 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.8 t0 . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.51 -55.56 4.23 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 167.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.3 m -76.3 176.73 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.497 169.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 22.3 tp -109.92 130.82 55.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.76 1.624 . . . . 0.0 107.763 171.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.6 m -93.85 140.66 16.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 118.703 0.683 . . . . 0.0 109.912 -174.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 tttm -62.96 135.45 57.31 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.02 -41.72 64.97 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 123.168 0.587 . . . . 0.0 111.018 173.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -83.42 6.3 20.6 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 175.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.66 -169.48 14.04 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 171.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 60.7 t90 -158.29 -179.7 8.35 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 174.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.838 ' SG ' HG22 ' A' ' 68' ' ' VAL . 5.2 p -163.03 161.15 25.29 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.531 1.06 . . . . 0.0 110.217 161.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.9 p -72.28 -9.84 59.01 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.227 -0.92 . . . . 0.0 113.084 -174.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.838 HG22 ' SG ' ' A' ' 66' ' ' CYS . 3.1 m -74.94 -17.56 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 119.427 1.012 . . . . 0.0 111.423 168.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -38.57 132.79 1.11 Allowed 'General case' 0 C--N 1.348 0.502 0 C-N-CA 125.31 1.444 . . . . 0.0 113.117 -174.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.84 135.02 26.85 Favored Pre-proline 0 N--CA 1.452 -0.343 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 165.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -72.4 147.29 46.52 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.998 1.799 . . . . 0.0 111.169 -175.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.462 0 CA-C-O 121.765 0.793 . . . . 0.0 109.306 176.011 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 N--CA 1.456 -0.687 0 N-CA-C 111.274 -0.318 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 36.6 mtt-85 -55.14 127.83 30.99 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.467 1.507 . . . . 0.0 111.956 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.11 147.51 52.05 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.441 1.096 . . . . 0.0 112.491 -175.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.4 pm0 -92.26 152.67 19.7 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 125.815 1.646 . . . . 0.0 112.324 -177.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.28 96.4 0.65 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.604 -175.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.01 28.71 14.48 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.426 -175.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -36.87 -53.11 0.94 Allowed 'General case' 0 C--N 1.344 0.344 0 C-N-CA 124.608 1.163 . . . . 0.0 111.001 166.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.55 -178.63 5.94 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 169.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 31.86 50.7 0.16 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.88 2.472 . . . . 0.0 113.269 173.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 55.49 30.34 14.95 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.676 0.79 . . . . 0.0 112.228 169.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -50.91 -64.95 0.65 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -168.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.288 19.1 m 54.18 130.12 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 126.897 2.079 . . . . 0.0 114.212 -171.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -66.1 -25.52 67.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 120.646 -1.284 . . . . 0.0 112.881 -172.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -110.32 117.12 32.78 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 171.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -45.47 -43.62 11.69 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.686 1.194 . . . . 0.0 110.793 172.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.3 -38.13 57.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.461 -0.78 . . . . 0.0 112.913 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -52.49 -39.64 61.46 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.199 0.909 . . . . 0.0 110.61 175.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.59 2.18 8.54 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 118.91 -0.567 . . . . 0.0 112.501 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.5 t -66.86 -2.95 5.77 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 120.055 1.298 . . . . 0.0 114.411 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.62 -9.87 71.19 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.27 0.938 . . . . 0.0 112.337 169.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -95.04 112.11 57.14 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 124.917 1.287 . . . . 0.0 110.449 -169.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -59.31 120.86 8.95 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 N-CA-C 107.424 -1.798 . . . . 0.0 107.424 163.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.5 tpt85 122.76 -40.33 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 129.175 2.99 . . . . 0.0 108.452 -168.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -65.39 146.32 55.04 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 166.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? -143.04 135.35 27.29 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -50.33 111.45 0.53 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.716 2.007 . . . . 0.0 111.736 -174.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.6 -10.31 45.59 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-O 118.98 -0.9 . . . . 0.0 111.623 174.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -64.75 118.58 9.16 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 119.109 1.455 . . . . 0.0 107.534 171.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 mp -130.04 149.06 51.92 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 125.989 1.716 . . . . 0.0 106.486 176.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.4 m -45.73 -46.91 15.31 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.065 0.946 . . . . 0.0 111.943 174.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -62.45 -15.84 51.85 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.428 -1.42 . . . . 0.0 114.167 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -110.74 23.38 14.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.625 1.17 . . . . 0.0 112.21 172.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.8 t -90.82 135.63 33.6 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.372 1.469 . . . . 0.0 108.236 172.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.79 -23.49 63.34 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 121.268 -0.895 . . . . 0.0 112.645 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -74.98 -13.49 60.52 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 118.337 -0.84 . . . . 0.0 112.53 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -52.33 136.33 31.22 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.52 1.055 . . . . 0.0 112.821 -171.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.83 -66.38 1.28 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 125.831 1.681 . . . . 0.0 110.352 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -178.24 154.02 0.81 Allowed 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -161.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.47 134.82 34.09 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 166.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.1 t -113.7 -39.73 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.891 1.676 . . . . 0.0 110.153 -172.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -147.27 -172.67 4.06 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.303 1.041 . . . . 0.0 110.192 -169.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -52.81 72.08 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 130.196 3.398 . . . . 0.0 113.69 -172.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.77 37.24 83.99 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -172.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -129.76 148.39 51.63 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 125.663 1.585 . . . . 0.0 108.852 172.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -165.07 -176.12 36.42 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.5 mtp-105 -96.65 152.69 18.41 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 119.008 -0.52 . . . . 0.0 110.313 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 156.593 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 t70 . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.437 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 1.2 mp0 -49.4 -44.96 45.58 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.738 1.615 . . . . 0.0 111.568 177.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.2 m -111.91 149.88 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.697 1.599 . . . . 0.0 108.653 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.6 tp -77.95 132.43 37.87 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.0 t -90.31 122.47 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 125.912 1.685 . . . . 0.0 107.856 -169.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -60.78 130.55 47.03 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 121.023 -1.048 . . . . 0.0 108.455 171.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.02 -40.17 66.8 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.071 0.548 . . . . 0.0 111.657 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -83.51 3.04 34.04 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 175.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.24 -172.52 8.59 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 172.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -154.91 178.0 10.67 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 172.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.46 ' SG ' HG22 ' A' ' 68' ' ' VAL . 3.6 p -161.08 159.15 28.84 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.489 1.041 . . . . 0.0 109.013 163.098 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.7 p -73.77 -1.79 20.72 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.021 -1.049 . . . . 0.0 112.99 -175.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.46 HG22 ' SG ' ' A' ' 66' ' ' CYS 0.329 0.9 OUTLIER -83.31 -8.77 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 119.35 0.977 . . . . 0.0 112.286 164.957 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -38.86 123.7 1.31 Allowed 'General case' 0 C--N 1.344 0.368 0 C-N-CA 125.3 1.44 . . . . 0.0 112.914 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.33 134.84 23.06 Favored Pre-proline 0 N--CA 1.455 -0.213 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 169.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -70.82 150.32 61.57 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.08 1.853 . . . . 0.0 110.957 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.341 0 C-N-CA 123.979 0.911 . . . . 0.0 110.227 176.759 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo . . . . . 0 N--CA 1.456 -0.726 0 N-CA-C 110.673 -0.549 . . . . 0.0 110.673 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.441 ' HB3' ' CH2' ' A' ' 47' ' ' TRP . 14.4 mtp180 -72.33 125.87 28.43 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -174.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -54.85 141.85 31.6 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.716 1.606 . . . . 0.0 112.817 -168.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -77.29 144.38 38.16 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.293 1.037 . . . . 0.0 108.592 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.09 120.16 10.91 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 165.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.86 25.19 72.37 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.219 -1.323 . . . . 0.0 112.93 -172.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -40.42 -54.84 2.38 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 119.595 1.698 . . . . 0.0 110.771 166.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -167.67 177.78 5.66 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.388 1.475 . . . . 0.0 107.579 172.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 33.38 52.04 0.35 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 127.057 2.143 . . . . 0.0 113.099 172.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 60.06 18.85 8.05 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.071 0.948 . . . . 0.0 112.675 169.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -62.69 137.42 58.26 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 118.554 0.615 . . . . 0.0 110.029 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.2 m -126.84 143.68 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 168.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -59.97 -34.59 73.49 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 119.12 -0.467 . . . . 0.0 111.284 -174.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.96 128.67 54.53 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 123.433 0.693 . . . . 0.0 110.285 169.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.11 -31.86 20.68 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.52 1.128 . . . . 0.0 110.63 165.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.18 -45.45 75.78 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.425 0.557 . . . . 0.0 111.406 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -29.75 70.09 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.216 0.532 . . . . 0.0 110.606 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.23 -6.05 36.71 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 118.324 -0.846 . . . . 0.0 112.599 -177.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 67.0 m -50.0 -32.41 15.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.22 -24.57 73.45 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.664 1.126 . . . . 0.0 113.164 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -79.03 117.72 68.42 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 118.404 1.102 . . . . 0.0 111.082 -169.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -63.94 108.45 0.93 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 N-CA-C 107.266 -1.859 . . . . 0.0 107.266 164.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 135.69 -31.79 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 131.166 3.787 . . . . 0.0 109.881 -173.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -68.5 149.12 49.63 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 171.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? -143.46 136.7 27.97 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -50.58 110.48 0.42 Allowed 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.954 2.101 . . . . 0.0 111.753 -174.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.14 -9.82 43.11 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-O 119.093 -0.837 . . . . 0.0 111.561 174.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -64.82 120.03 11.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.06 1.43 . . . . 0.0 107.824 172.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 mp -131.77 153.06 50.49 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.218 1.807 . . . . 0.0 107.206 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 33.6 m -48.96 -47.12 44.19 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.873 0.76 . . . . 0.0 110.993 174.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.257 6.2 tt0 -75.72 26.13 0.11 Allowed 'General case' 0 CA--C 1.549 0.915 0 O-C-N 120.32 -1.488 . . . . 0.0 113.671 176.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -142.25 29.77 1.61 Allowed 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.596 -1.315 . . . . 0.0 110.793 156.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 50.6 t -96.72 139.24 33.07 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.886 1.674 . . . . 0.0 109.208 177.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.89 -21.12 64.45 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.569 -0.707 . . . . 0.0 112.572 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -96.4 15.28 21.75 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 119.001 -0.523 . . . . 0.0 111.951 175.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -66.85 149.74 50.16 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.424 1.011 . . . . 0.0 110.997 175.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.53 -101.23 1.97 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.372 -1.891 . . . . 0.0 108.372 169.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -149.95 153.92 37.41 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.76 1.624 . . . . 0.0 107.648 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.13 141.54 58.72 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 123.69 0.619 . . . . 0.0 110.612 168.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.5 t -114.13 -49.19 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 126.28 1.832 . . . . 0.0 109.23 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -148.02 -150.58 0.35 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.408 0.683 . . . . 0.0 111.214 -171.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -67.55 68.16 0.09 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 128.338 2.655 . . . . 0.0 113.21 -161.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.01 29.33 46.92 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.548 1.07 . . . . 0.0 110.501 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TRP . . . . . 0.441 ' CH2' ' HB3' ' A' ' 5' ' ' ARG . 84.6 m95 -132.19 148.21 52.45 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.192 1.397 . . . . 0.0 109.462 177.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.64 178.8 36.49 Favored Glycine 0 N--CA 1.433 -1.564 0 O-C-N 124.395 1.059 . . . . 0.0 110.691 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -82.0 132.69 35.26 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.852 -0.674 . . . . 0.0 110.67 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 43.2 t . . . . . 0 CA--C 1.535 0.378 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 155.036 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.9 t0 . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.431 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 2.5 mp0 -45.71 -39.73 8.41 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.119 0.968 . . . . 0.0 113.257 176.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.5 m -117.04 160.39 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 125.071 1.348 . . . . 0.0 109.872 -172.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 22.5 tp -83.64 131.18 34.97 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.8 t -104.63 133.71 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 123.674 0.79 . . . . 0.0 108.909 -167.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.413 ' HD2' ' CZ2' ' A' ' 47' ' ' TRP . 30.1 tttm -62.98 126.72 28.28 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 175.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.56 -31.78 68.3 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.343 0.657 . . . . 0.0 110.841 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -81.21 -8.19 59.71 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.796 1.238 . . . . 0.0 112.443 176.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.76 -172.42 35.87 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 72.3 t90 -165.84 150.58 8.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.7 p -134.22 162.36 32.36 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.965 1.306 . . . . 0.0 110.001 175.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.4 p -69.91 -20.42 63.36 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.0 -1.062 . . . . 0.0 112.672 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.364 0.8 OUTLIER -71.94 -3.75 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 119.553 1.069 . . . . 0.0 112.595 170.596 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -45.14 128.83 7.63 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.809 0.732 . . . . 0.0 111.012 171.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.73 137.67 31.45 Favored Pre-proline 0 N--CA 1.452 -0.334 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 165.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.8 148.95 59.47 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.028 1.819 . . . . 0.0 110.794 -177.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.308 0 C-N-CA 123.492 0.717 . . . . 0.0 109.953 179.536 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.384 0 CA-C-O 117.674 -1.155 . . . . 0.0 108.859 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.73 71.47 1.45 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 162.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -52.0 151.57 6.48 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 123.17 0.588 . . . . 0.0 110.465 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -62.6 142.06 88.38 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.468 2.112 . . . . 0.0 110.515 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 43.9 mtt-85 -58.19 126.33 27.02 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.814 1.245 . . . . 0.0 110.243 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.36 142.95 46.7 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.117 1.367 . . . . 0.0 112.489 -172.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -76.61 143.27 40.31 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.422 1.089 . . . . 0.0 108.294 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -62.03 117.01 5.41 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 165.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.8 16.59 67.59 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 118.263 -1.298 . . . . 0.0 113.652 -174.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -45.58 -58.29 3.52 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 119.818 1.809 . . . . 0.0 112.051 173.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.97 162.18 40.39 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.422 ' NE2' ' OD2' ' A' ' 54' ' ' ASP . 24.7 m-70 45.33 47.36 10.51 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.15 1.38 . . . . 0.0 113.199 172.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.85 25.81 10.84 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.69 0.796 . . . . 0.0 111.845 173.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -62.07 142.67 57.42 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 117.928 0.331 . . . . 0.0 111.194 -175.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.9 146.1 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 172.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -73.17 -26.99 61.39 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 124.402 1.081 . . . . 0.0 112.235 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -115.99 116.59 28.19 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 171.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -42.62 -48.97 5.54 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.343 1.057 . . . . 0.0 110.99 175.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.63 -38.16 31.01 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.839 0.856 . . . . 0.0 113.018 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -49.11 -39.53 28.71 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 119.181 0.9 . . . . 0.0 111.477 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.66 9.04 1.2 Allowed 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 118.301 -0.857 . . . . 0.0 113.119 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 62.6 m -49.77 -31.02 10.59 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 120.47 1.486 . . . . 0.0 114.226 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.44 -24.45 76.86 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.64 1.114 . . . . 0.0 112.927 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -79.99 120.13 78.84 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.562 1.145 . . . . 0.0 110.426 -171.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -46.48 -49.28 12.11 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.145 2.563 . . . . 0.0 113.924 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -15.76 60.79 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 117.563 -1.208 . . . . 0.0 113.418 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -73.91 145.82 44.48 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 120.878 1.672 . . . . 0.0 111.529 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -133.38 150.04 51.83 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 127.973 2.509 . . . . 0.0 104.377 165.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -66.69 165.02 15.72 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 124.064 0.852 . . . . 0.0 111.512 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.72 -26.26 3.21 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.077 1.322 . . . . 0.0 112.009 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -69.96 112.1 6.13 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 117.534 0.667 . . . . 0.0 109.333 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.1 mp -123.36 148.96 45.51 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.5 m -42.03 -46.71 4.28 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.437 1.095 . . . . 0.0 110.939 172.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -56.34 -26.8 53.82 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -109.2 23.61 14.27 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.711 1.204 . . . . 0.0 112.001 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 45.7 t -86.48 139.0 31.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.711 1.204 . . . . 0.0 108.942 174.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.52 -25.3 66.0 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 121.319 -0.863 . . . . 0.0 111.813 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -91.29 8.35 36.43 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.479 -0.772 . . . . 0.0 112.047 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 66.3 t-105 -56.73 138.18 53.31 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 120.188 1.358 . . . . 0.0 109.99 174.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.78 -85.18 1.03 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 171.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -163.91 159.1 20.57 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.27 136.41 39.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.581 HG23 ' HA2' ' A' ' 48' ' ' GLY . 90.2 t -106.74 -48.53 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.652 1.181 . . . . 0.0 108.383 -172.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -151.43 -138.98 0.09 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.93 0.492 . . . . 0.0 112.24 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -69.19 66.83 0.17 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.919 2.488 . . . . 0.0 113.013 -163.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.52 33.34 61.13 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 -175.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -131.65 143.5 50.35 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 125.893 1.677 . . . . 0.0 108.684 173.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.581 ' HA2' HG23 ' A' ' 43' ' ' VAL . . . -153.14 178.01 30.44 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 124.183 0.897 . . . . 0.0 111.489 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.417 ' HG3' ' CG2' ' A' ' 43' ' ' VAL . 32.4 mtp85 -88.31 159.13 18.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.308 0.643 . . . . 0.0 111.998 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.5 t -133.39 120.86 21.49 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.837 1.655 . . . . 0.0 108.038 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.1 p -74.89 68.62 1.79 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.926 1.291 . . . . 0.0 110.921 -173.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -146.43 131.77 9.16 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 167.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -59.2 -43.97 37.58 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 121.839 1.693 . . . . 0.0 109.519 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.422 ' OD2' ' NE2' ' A' ' 12' ' ' HIS . 11.2 p-10 -70.1 47.14 0.08 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.701 2.401 . . . . 0.0 111.603 169.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -172.71 -55.4 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.097 1.359 . . . . 0.0 110.468 177.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -55.47 -27.93 51.32 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.74 1.216 . . . . 0.0 113.513 -172.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -35.87 -45.44 0.4 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.98 1.312 . . . . 0.0 112.075 166.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 m -116.5 150.63 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 123.831 0.852 . . . . 0.0 108.987 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.517 HD11 HG21 ' A' ' 43' ' ' VAL . 12.4 tp -82.64 121.39 26.77 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.3 m -88.44 144.25 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 118.923 0.783 . . . . 0.0 109.161 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.3 tttm -67.01 136.97 56.11 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 174.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.62 -40.9 66.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 119.313 -0.375 . . . . 0.0 111.488 174.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -85.05 7.95 19.62 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 174.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.73 -177.27 23.46 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -160.07 155.58 25.48 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 172.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.0 p -143.27 167.17 22.78 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.097 0.959 . . . . 0.0 110.766 173.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.3 p -73.5 -21.7 60.34 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.33 1.0 OUTLIER -71.13 -5.37 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 119.433 1.015 . . . . 0.0 112.448 171.022 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -45.72 132.16 8.77 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 119.058 0.844 . . . . 0.0 111.652 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.32 139.47 35.74 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 166.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.25 151.14 54.28 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.058 1.838 . . . . 0.0 110.657 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.4 34.84 1.72 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.894 0.878 . . . . 0.0 110.289 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.3 m . . . . . 0 C--O 1.255 1.346 0 C-N-CA 128.674 2.79 . . . . 0.0 105.367 178.852 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 1.112 ' CB ' ' OE1' ' A' ' 3' ' ' GLU . . . . . . . . 0 CA--C 1.513 -0.445 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.2 m -134.3 31.83 3.45 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 123.598 0.561 . . . . 0.0 110.846 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 1.112 ' OE1' ' CB ' ' A' ' 1' ' ' ALA . 3.4 mp0 -64.72 132.39 95.42 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 174.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.13 130.04 19.38 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.39 2.06 . . . . 0.0 111.079 -171.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 42.5 mtt-85 -63.95 125.31 24.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.557 1.143 . . . . 0.0 110.212 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.22 142.75 54.02 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.796 1.238 . . . . 0.0 112.171 -173.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -76.17 145.7 39.7 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.497 1.119 . . . . 0.0 108.731 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -62.37 121.21 12.65 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 164.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.87 20.85 75.53 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 118.267 -1.296 . . . . 0.0 113.448 -172.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -40.97 -56.8 2.17 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 119.488 1.644 . . . . 0.0 111.46 169.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.2 172.74 10.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.658 1.583 . . . . 0.0 106.96 174.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 44.28 47.56 7.84 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 124.412 1.085 . . . . 0.0 112.76 171.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 57.53 21.29 6.92 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 122.799 0.44 . . . . 0.0 111.498 172.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -62.53 140.7 58.63 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.521 0.601 . . . . 0.0 111.259 -172.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.2 m -126.88 143.56 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 173.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -71.33 -26.89 63.02 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.882 0.873 . . . . 0.0 111.684 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -112.08 111.42 22.31 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 169.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -45.13 -44.32 10.52 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.909 1.284 . . . . 0.0 110.957 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.55 -35.54 63.36 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.125 -0.94 . . . . 0.0 112.627 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -48.18 -43.75 32.02 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-O 122.278 1.037 . . . . 0.0 110.84 174.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.35 6.23 5.92 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.458 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -55.08 -28.54 53.19 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 120.258 1.39 . . . . 0.0 112.368 171.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.44 -14.15 59.47 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.518 1.056 . . . . 0.0 113.769 174.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -99.89 108.19 50.33 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 125.891 1.677 . . . . 0.0 111.502 -171.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -54.51 117.55 4.08 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 N-CA-C 108.258 -1.478 . . . . 0.0 108.258 162.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.7 tpt85 127.18 -41.32 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 129.023 2.929 . . . . 0.0 108.517 -169.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -66.81 153.79 42.49 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 169.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.75 136.26 15.97 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.198 168.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.5 mp0 -60.3 115.35 3.46 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.521 1.928 . . . . 0.0 110.112 -169.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.4 -30.76 5.29 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -176.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -66.93 115.66 6.91 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 mp -131.04 149.85 52.42 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 127.004 2.122 . . . . 0.0 105.405 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.2 m -43.58 -47.37 7.42 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.953 1.301 . . . . 0.0 111.43 173.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.44 -22.02 52.99 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -109.77 26.13 11.0 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.307 1.043 . . . . 0.0 112.344 175.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.7 t -97.06 136.78 37.12 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.568 1.547 . . . . 0.0 109.263 175.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.46 -20.86 65.93 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 120.929 -1.107 . . . . 0.0 113.002 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -80.4 -8.58 59.58 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.437 0.562 . . . . 0.0 112.113 175.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.402 ' CH2' ' HA3' ' A' ' 48' ' ' GLY . 74.9 t-105 -58.29 141.12 51.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.705 0.684 . . . . 0.0 111.501 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.61 -69.0 1.27 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 173.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -174.5 157.35 2.62 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -168.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.32 130.97 35.22 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 166.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.4 t -97.05 -49.31 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -175.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -152.07 -128.59 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -171.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -74.77 63.93 1.21 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.379 1.872 . . . . 0.0 112.623 -162.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.6 28.19 67.9 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.258 0.933 . . . . 0.0 110.944 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -126.79 145.17 50.73 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.823 1.649 . . . . 0.0 109.168 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.402 ' HA3' ' CH2' ' A' ' 39' ' ' TRP . . . -153.77 178.7 30.56 Favored Glycine 0 N--CA 1.436 -1.352 0 CA-C-O 122.208 0.893 . . . . 0.0 112.302 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -89.58 145.87 24.97 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.22 -0.99 . . . . 0.0 108.437 -172.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 2.3 t -134.85 128.64 33.08 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 73.7 p -91.71 158.02 16.61 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.108 0.563 . . . . 0.0 111.331 -167.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 95.72 136.8 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 130.617 3.567 . . . . 0.0 110.227 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -59.51 139.74 90.75 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.715 2.277 . . . . 0.0 110.045 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.393 0.2 OUTLIER 98.28 -13.49 0.06 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 128.022 2.529 . . . . 0.0 111.133 -168.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -127.24 -41.11 1.78 Allowed 'General case' 0 C--N 1.346 0.443 0 CA-C-O 117.975 -1.012 . . . . 0.0 113.342 158.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -36.98 -45.69 0.59 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.435 1.494 . . . . 0.0 112.807 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.0 pm0 -61.75 -16.82 52.68 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -175.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.2 m -132.01 158.36 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 119.556 1.071 . . . . 0.0 110.499 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.1 tp -91.85 123.2 35.04 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 175.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.0 m -94.85 148.97 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -67.65 137.22 55.42 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.14 -42.23 65.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.936 173.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -81.32 6.1 15.3 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 175.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.62 -177.32 34.76 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 119.539 1.063 . . . . 0.0 110.654 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 43.8 t90 -163.15 154.72 17.49 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 170.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.486 ' SG ' ' HB ' ' A' ' 68' ' ' VAL . 7.9 p -139.92 161.54 37.35 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.748 1.619 . . . . 0.0 110.034 173.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 89.9 p -70.65 -10.05 58.46 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.327 -0.858 . . . . 0.0 112.921 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.486 ' HB ' ' SG ' ' A' ' 66' ' ' CYS . 4.7 t -64.76 -35.26 74.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.268 1.027 . . . . 0.0 109.256 168.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -27.06 113.01 0.06 Allowed 'General case' 0 C--N 1.347 0.46 0 C-N-CA 126.43 1.892 . . . . 0.0 114.285 -170.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -113.24 133.18 22.14 Favored Pre-proline 0 N--CA 1.455 -0.22 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 167.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.11 150.55 66.26 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.704 1.602 . . . . 0.0 110.929 -177.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.76 35.41 1.85 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.342 177.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.5 m . . . . . 0 C--O 1.253 1.253 0 C-N-CA 128.624 2.77 . . . . 0.0 105.462 177.615 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.993 ' CB ' ' OE1' ' A' ' 44' ' ' GLN . . . . . . . . 0 CA--C 1.516 -0.352 0 N-CA-C 107.022 -1.474 . . . . 0.0 107.022 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -158.48 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.127 164.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -45.53 154.34 0.53 Allowed Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 129.247 3.019 . . . . 0.0 114.773 -166.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -64.78 147.98 89.89 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.006 2.47 . . . . 0.0 111.239 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.9 mtt-85 -62.41 133.25 54.78 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.491 1.116 . . . . 0.0 110.895 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.98 145.49 55.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.986 1.315 . . . . 0.0 112.25 -174.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.441 ' CD ' ' HD1' ' A' ' 10' ' ' HIS . 1.7 mp0 -75.45 142.89 42.88 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 124.82 1.248 . . . . 0.0 108.183 178.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -62.38 120.33 10.83 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 164.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.94 26.41 66.88 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 118.116 -1.38 . . . . 0.0 113.37 -172.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.441 ' HD1' ' CD ' ' A' ' 7' ' ' GLU . 86.3 t60 -42.73 -55.8 3.46 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 119.765 1.782 . . . . 0.0 110.767 167.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -165.48 169.99 14.93 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.715 1.206 . . . . 0.0 108.315 174.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.452 ' CD2' ' CE2' ' A' ' 55' ' ' PHE . 35.0 m-70 46.71 40.73 9.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.561 1.544 . . . . 0.0 113.335 172.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 57.16 30.65 18.68 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.621 1.168 . . . . 0.0 111.771 177.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -62.92 139.74 58.77 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 122.159 -0.338 . . . . 0.0 111.048 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 m -124.74 141.35 45.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 125.028 1.331 . . . . 0.0 107.841 172.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -68.54 -24.43 64.63 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 123.899 0.88 . . . . 0.0 112.196 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -117.7 122.8 44.46 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.138 1.375 . . . . 0.0 108.031 170.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.6 -49.05 62.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.667 0.787 . . . . 0.0 111.35 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.61 -23.06 66.13 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 117.768 -1.111 . . . . 0.0 112.793 -174.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -44.42 -44.08 8.15 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.831 1.196 . . . . 0.0 110.493 167.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.58 10.09 4.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.651 -175.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.9 t -69.45 -1.03 7.42 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 120.107 1.321 . . . . 0.0 114.43 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.96 -15.19 56.7 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.384 0.992 . . . . 0.0 111.81 169.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -81.28 114.41 48.97 Favored Pre-proline 0 N--CA 1.452 -0.346 0 C-N-CA 124.414 1.086 . . . . 0.0 109.671 -172.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -62.05 118.38 5.26 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 N-CA-C 107.114 -1.918 . . . . 0.0 107.114 165.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.7 tpt85 124.96 -37.62 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 129.204 3.002 . . . . 0.0 108.776 -168.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -64.83 148.3 51.59 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 168.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.7 tm0? -154.83 131.89 10.93 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -62.04 125.01 22.38 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 126.694 1.998 . . . . 0.0 112.532 -168.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.68 -25.18 23.61 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-O 118.822 -0.988 . . . . 0.0 111.345 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -60.08 119.5 7.93 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.096 1.448 . . . . 0.0 108.28 173.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 mp -131.41 153.26 49.88 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 127.048 2.139 . . . . 0.0 107.044 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 55.6 m -48.5 -49.45 35.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.619 0.768 . . . . 0.0 111.269 173.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.252 4.6 tt0 -76.92 31.35 0.13 Allowed 'General case' 0 CA--C 1.547 0.832 0 O-C-N 119.881 -1.762 . . . . 0.0 113.615 175.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -143.11 30.31 1.43 Allowed 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.573 -1.329 . . . . 0.0 110.629 155.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' A' ' 69' ' ' TYR . 47.9 t -102.69 138.41 39.63 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.056 1.742 . . . . 0.0 110.48 -175.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.59 -19.02 64.44 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 120.929 -1.107 . . . . 0.0 112.256 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -85.09 -0.21 53.74 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.853 0.861 . . . . 0.0 111.672 172.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 33.5 t-105 -66.05 148.72 51.38 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 119.384 0.993 . . . . 0.0 110.897 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.01 -99.25 1.45 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 107.42 -2.272 . . . . 0.0 107.42 165.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -148.36 159.91 43.53 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.788 1.635 . . . . 0.0 107.061 175.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.91 146.61 41.61 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.266 0.555 . . . . 0.0 110.694 166.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.6 t -118.83 -52.75 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 125.575 1.55 . . . . 0.0 108.568 -177.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.993 ' OE1' ' CB ' ' A' ' 1' ' ' ALA . 13.9 pt20 -147.67 -152.85 0.46 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.672 0.789 . . . . 0.0 111.21 -175.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -56.54 68.45 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 130.031 3.332 . . . . 0.0 114.353 -163.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.05 30.71 67.37 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.648 1.118 . . . . 0.0 110.569 -174.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -129.19 146.35 51.13 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.359 1.464 . . . . 0.0 108.902 174.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -155.95 173.52 33.93 Favored Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.8 mtp-105 -78.13 130.22 36.11 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.097 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 39.8 t -88.25 161.61 17.09 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 150.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.1 p -123.97 166.4 15.77 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.709 0.686 . . . . 0.0 110.926 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 61.1 m80 96.41 117.59 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 129.811 3.244 . . . . 0.0 108.68 174.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -44.57 129.79 9.13 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.881 3.054 . . . . 0.0 113.319 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.326 0.6 OUTLIER 100.08 -20.33 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 130.135 3.374 . . . . 0.0 110.639 -166.363 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.452 ' CE2' ' CD2' ' A' ' 12' ' ' HIS . 0.2 OUTLIER -131.08 13.85 5.18 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.278 2.231 . . . . 0.0 112.162 175.407 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.58 -35.33 6.05 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.305 0.957 . . . . 0.0 110.956 -175.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.527 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 2.2 mp0 -48.64 -46.63 40.12 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 127.16 2.184 . . . . 0.0 113.102 -176.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.1 m -111.71 153.68 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.88 1.272 . . . . 0.0 109.781 -169.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.2 tp -84.53 127.97 34.33 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.2 t -98.62 141.84 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -170.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -68.07 133.85 49.65 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.56 -35.17 71.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 119.264 -0.398 . . . . 0.0 111.856 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.53 3.86 34.62 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 173.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.65 -176.48 16.1 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 119.499 1.045 . . . . 0.0 111.257 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 72.9 t90 -158.7 156.59 30.19 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 171.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 10.3 p -142.24 171.38 14.13 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.779 0.831 . . . . 0.0 110.718 169.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.0 p -71.41 -29.66 65.18 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -174.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.5 m -67.74 -70.35 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . 0.455 ' HA ' ' SG ' ' A' ' 36' ' ' CYS . 58.2 t80 58.72 -85.34 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.203 1.801 . . . . 0.0 112.241 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 62.68 124.95 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.258 1.823 . . . . 0.0 111.299 -162.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -71.26 146.75 51.86 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.096 1.864 . . . . 0.0 111.196 -177.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -91.93 48.66 1.46 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.733 0.778 . . . . 0.0 109.423 175.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.5 p . . . . . 0 C--O 1.247 0.972 0 C-N-CA 125.563 1.545 . . . . 0.0 107.188 -174.469 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.626 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . . . . . . . . 0 C--O 1.236 0.374 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 p -94.13 38.11 1.09 Allowed 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 124.714 1.259 . . . . 0.0 109.626 169.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.626 ' OE1' ' HB3' ' A' ' 1' ' ' ALA . 3.1 mp0 -60.06 129.29 88.22 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -70.52 128.75 15.76 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.419 2.08 . . . . 0.0 110.821 -169.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 34.9 mtt-85 -61.78 129.58 41.66 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.683 1.193 . . . . 0.0 111.137 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.97 143.35 56.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.241 1.417 . . . . 0.0 112.442 -172.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -78.03 144.7 36.42 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.48 1.112 . . . . 0.0 108.595 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -63.46 122.08 15.4 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 165.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.66 22.98 73.98 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.174 -1.348 . . . . 0.0 113.085 -172.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -39.96 -56.77 1.76 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 119.431 1.615 . . . . 0.0 111.253 167.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -168.32 175.85 6.2 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.612 1.565 . . . . 0.0 107.275 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 37.11 50.07 0.9 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.053 1.741 . . . . 0.0 112.865 175.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 57.37 23.53 9.04 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.57 0.748 . . . . 0.0 112.054 172.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -63.4 136.97 57.98 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 118.111 0.414 . . . . 0.0 110.911 -174.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.7 m -124.04 141.61 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 173.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 -69.32 -23.91 63.85 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 123.851 0.86 . . . . 0.0 111.764 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -115.55 115.13 25.93 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.675 1.19 . . . . 0.0 107.931 171.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -43.39 -48.33 7.02 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.807 1.243 . . . . 0.0 110.983 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.5 -35.18 52.44 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.45 -0.786 . . . . 0.0 112.962 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -51.42 -40.52 59.5 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.617 1.098 . . . . 0.0 110.809 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.72 6.6 5.75 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.343 -0.837 . . . . 0.0 112.785 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.9 t -52.2 -32.66 37.46 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.917 1.235 . . . . 0.0 112.507 173.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.37 -21.67 76.04 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 114.659 -1.155 . . . . 0.0 113.8 176.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -80.32 114.93 51.22 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 119.079 1.44 . . . . 0.0 111.355 -168.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.29 107.65 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 N-CA-C 107.229 -1.873 . . . . 0.0 107.229 165.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 143.16 -35.81 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 1 C-N-CA 132.074 4.15 . . . . 0.0 108.652 -174.934 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -77.12 151.27 35.45 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.284 1.034 . . . . 0.0 110.946 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -137.6 146.49 44.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.675 2.39 . . . . 0.0 105.638 166.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -63.28 158.97 18.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.077 0.951 . . . . 0.0 111.155 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.38 -26.71 4.95 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.28 0.943 . . . . 0.0 111.792 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -67.18 112.25 4.37 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.2 mp -124.61 148.26 48.0 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 177.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.8 m -42.18 -45.66 4.14 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.482 1.113 . . . . 0.0 111.919 172.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -56.08 -26.43 49.42 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.729 -1.232 . . . . 0.0 113.972 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -108.91 27.24 9.69 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.131 1.372 . . . . 0.0 112.055 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 50.1 t -94.95 139.9 30.7 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.108 1.363 . . . . 0.0 109.331 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.73 -24.82 67.05 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.333 -0.855 . . . . 0.0 112.569 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -82.19 -2.8 53.45 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.37 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -61.98 140.51 58.33 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 119.256 0.935 . . . . 0.0 111.726 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.64 -71.78 1.25 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.277 1.418 . . . . 0.0 109.78 173.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -174.7 157.38 2.51 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.197 1.399 . . . . 0.0 107.39 -167.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.73 133.47 34.37 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 169.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.98 -49.08 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 124.568 1.147 . . . . 0.0 109.887 -174.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -146.41 -161.25 1.28 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.26 1.024 . . . . 0.0 110.108 -172.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -56.4 71.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 129.361 3.064 . . . . 0.0 114.293 -161.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.74 34.35 77.78 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -172.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -129.58 146.15 51.41 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 125.259 1.424 . . . . 0.0 109.222 173.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.28 -172.6 28.84 Favored Glycine 0 N--CA 1.432 -1.621 0 CA-C-O 121.99 0.772 . . . . 0.0 112.097 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -93.11 139.68 30.31 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -171.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.1 t -118.44 98.9 6.5 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 173.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.4 p -76.8 71.69 3.37 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.646 0.778 . . . . 0.0 109.91 -171.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -161.67 123.45 1.67 Allowed Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 123.495 0.718 . . . . 0.0 110.092 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.13 132.88 25.32 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.945 1.763 . . . . 0.0 108.405 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 122.01 -40.19 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 129.228 3.011 . . . . 0.0 105.637 -155.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -124.05 -44.16 2.06 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.231 1.412 . . . . 0.0 113.18 -174.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -55.86 -18.51 8.96 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -173.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -51.05 -35.06 32.63 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.996 0.816 . . . . 0.0 112.881 169.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.1 m -128.43 163.56 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 125.325 1.45 . . . . 0.0 109.736 -172.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.4 tp -86.93 129.57 34.82 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.4 t -98.58 135.34 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 124.069 0.948 . . . . 0.0 108.812 -168.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -65.25 131.12 45.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 176.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.02 -39.81 63.41 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.226 0.611 . . . . 0.0 111.626 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -83.87 2.33 38.95 Favored 'General case' 0 C--N 1.342 0.242 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.78 -177.06 23.24 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 119.412 1.005 . . . . 0.0 111.314 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 60.8 t90 -160.77 149.98 16.97 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 171.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.559 ' SG ' HG13 ' A' ' 68' ' ' VAL . 7.5 p -134.77 162.51 32.14 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.194 1.398 . . . . 0.0 109.838 174.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.8 p -71.93 -14.33 61.89 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 120.655 -1.278 . . . . 0.0 112.79 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.559 HG13 ' SG ' ' A' ' 66' ' ' CYS 0.348 1.7 p -85.44 10.0 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 125.562 1.545 . . . . 0.0 111.723 166.194 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -52.84 126.16 19.28 Favored 'General case' 0 C--N 1.342 0.27 0 O-C-N 120.54 -1.35 . . . . 0.0 110.232 163.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.83 134.06 24.81 Favored Pre-proline 0 N--CA 1.454 -0.254 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 169.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.51 148.42 66.62 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 121.675 1.583 . . . . 0.0 110.821 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.96 35.43 1.88 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.882 0.873 . . . . 0.0 110.213 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.9 m . . . . . 0 C--O 1.254 1.306 0 C-N-CA 128.706 2.803 . . . . 0.0 105.257 179.458 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.668 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . . . . . . . . 0 N--CA 1.454 -0.237 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.1 m -81.83 64.91 6.73 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 167.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.668 ' OE1' ' HB3' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -58.58 153.37 40.66 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 122.294 0.237 . . . . 0.0 111.198 -174.162 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -59.44 145.09 98.98 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.532 2.155 . . . . 0.0 110.353 177.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.434 ' HB3' ' CH2' ' A' ' 47' ' ' TRP . 14.2 mtp180 -71.59 125.61 27.52 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -174.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -54.39 145.25 18.57 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.513 1.525 . . . . 0.0 113.1 -166.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.442 ' CD ' ' HD1' ' A' ' 10' ' ' HIS . 1.8 mp0 -76.2 142.66 41.43 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.227 1.011 . . . . 0.0 108.459 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -63.36 116.33 5.42 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 164.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.74 25.23 60.82 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.327 -1.263 . . . . 0.0 113.222 -172.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.442 ' HD1' ' CD ' ' A' ' 7' ' ' GLU . 84.7 t60 -41.74 -53.69 3.56 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 119.399 1.599 . . . . 0.0 110.743 166.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.06 178.57 6.29 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.298 1.439 . . . . 0.0 107.415 169.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.403 ' ND1' ' OD2' ' A' ' 54' ' ' ASP . 18.1 m170 39.97 48.13 2.05 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 125.977 1.711 . . . . 0.0 112.414 165.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.41 20.86 7.79 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.046 1.338 . . . . 0.0 112.545 170.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -63.12 133.97 55.28 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 118.397 0.544 . . . . 0.0 110.036 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.56 144.15 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 168.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -60.38 -38.1 82.83 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.346 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.12 136.11 44.35 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 168.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.62 -28.29 69.26 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.583 0.753 . . . . 0.0 110.884 171.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.68 -52.71 29.1 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.383 0.538 . . . . 0.0 111.792 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -55.71 -30.95 62.01 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.961 1.305 . . . . 0.0 111.729 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.4 -8.77 49.55 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.941 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.7 t -51.53 -31.6 24.67 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 119.672 1.124 . . . . 0.0 113.253 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.01 -24.55 67.06 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-N 115.02 -0.991 . . . . 0.0 113.158 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -88.51 107.56 17.58 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 124.779 1.232 . . . . 0.0 110.841 -171.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -58.67 120.57 8.53 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 N-CA-C 107.006 -1.959 . . . . 0.0 107.006 161.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 52.6 tpt85 127.58 -38.6 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 129.103 2.961 . . . . 0.0 108.876 -167.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -70.39 160.07 33.01 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.765 0.793 . . . . 0.0 109.715 169.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -155.18 131.36 10.25 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 113.87 -1.513 . . . . 0.0 109.242 169.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.0 mp0 -56.1 113.0 1.35 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 127.198 2.199 . . . . 0.0 109.998 -175.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 126.43 -33.79 3.36 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -67.42 118.79 11.24 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.377 1.088 . . . . 0.0 108.335 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.7 mp -131.94 152.85 50.83 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.452 1.901 . . . . 0.0 106.875 176.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.3 m -49.29 -47.58 46.74 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.661 0.784 . . . . 0.0 111.148 175.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.257 6.3 tt0 -75.1 23.96 0.1 Allowed 'General case' 0 CA--C 1.55 0.961 0 O-C-N 120.261 -1.524 . . . . 0.0 113.838 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -139.04 28.19 2.33 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.54 -1.35 . . . . 0.0 110.998 157.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 50.4 t -96.34 135.78 37.72 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.857 1.663 . . . . 0.0 108.291 175.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.42 -22.27 64.86 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.322 -0.861 . . . . 0.0 112.232 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -88.74 2.99 52.46 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 118.821 -0.609 . . . . 0.0 112.481 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 60.7 t-105 -59.51 139.39 57.17 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 119.065 0.848 . . . . 0.0 110.9 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.38 -105.87 0.6 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.163 -1.975 . . . . 0.0 108.163 167.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -146.26 156.31 43.29 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.959 1.304 . . . . 0.0 107.876 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.12 146.16 54.68 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 123.867 0.729 . . . . 0.0 110.577 171.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.5 t -118.99 -54.99 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.897 1.279 . . . . 0.0 109.214 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -154.1 155.63 35.76 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 124.515 1.126 . . . . 0.0 109.454 -176.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.9 t0 48.91 31.8 3.43 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 148.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.17 33.4 44.92 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 120.908 -1.12 . . . . 0.0 112.921 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.434 ' CH2' ' HB3' ' A' ' 5' ' ' ARG . 64.7 m95 -134.55 160.39 38.2 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 127.376 2.27 . . . . 0.0 108.739 175.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.56 175.69 38.95 Favored Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.3 mtp-105 -78.97 142.03 37.0 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.154 -0.523 . . . . 0.0 110.437 174.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.6 t -107.22 106.16 16.5 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 168.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -76.45 70.95 3.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.715 -0.616 . . . . 0.0 109.949 -174.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -154.83 113.8 2.37 Favored Pre-proline 0 N--CA 1.451 -0.397 0 C-N-CA 123.757 0.823 . . . . 0.0 109.625 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -53.19 124.66 16.17 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.521 2.147 . . . . 0.0 110.206 170.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.403 ' OD2' ' ND1' ' A' ' 12' ' ' HIS . 5.1 p-10 120.8 -29.2 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 130.455 3.502 . . . . 0.0 108.877 -167.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -124.03 -42.12 2.17 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.529 1.532 . . . . 0.0 112.375 177.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -44.49 -38.03 3.86 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.737 1.615 . . . . 0.0 113.192 -175.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -42.9 -42.21 3.6 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.4 1.08 . . . . 0.0 112.89 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.7 m -117.04 156.75 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 124.727 1.211 . . . . 0.0 109.569 -173.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.8 tp -81.66 132.4 35.3 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 69.0 t -104.58 131.14 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 123.763 0.825 . . . . 0.0 109.166 -167.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -62.02 132.1 51.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.02 -34.98 78.73 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.068 -177.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -81.34 -1.19 44.42 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 118.077 -0.963 . . . . 0.0 113.568 172.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.62 -174.55 16.63 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 119.751 1.16 . . . . 0.0 111.159 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 17.8 t90 -165.53 153.09 10.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.426 ' SG ' HG22 ' A' ' 68' ' ' VAL . 7.7 p -135.62 161.72 34.73 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.575 1.15 . . . . 0.0 109.259 174.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.2 p -71.64 -14.63 62.11 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.091 -1.006 . . . . 0.0 112.713 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.426 HG22 ' SG ' ' A' ' 66' ' ' CYS 0.35 0.9 OUTLIER -75.32 -6.85 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 119.327 0.967 . . . . 0.0 112.478 170.007 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -40.39 125.45 2.12 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 124.642 1.177 . . . . 0.0 112.441 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.18 134.44 23.37 Favored Pre-proline 0 C--N 1.331 -0.197 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 168.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.19 149.27 63.91 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 121.607 1.538 . . . . 0.0 110.917 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.33 33.59 2.4 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.801 0.841 . . . . 0.0 110.508 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.3 m . . . . . 0 C--O 1.249 1.046 0 C-N-CA 128.633 2.773 . . . . 0.0 105.598 177.929 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 1.024 ' HB1' ' OE2' ' A' ' 3' ' ' GLU . . . . . . . . 0 CA--C 1.534 0.348 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.3 m -153.75 47.49 0.64 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.434 1.015 . . . . 0.0 109.445 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 1.024 ' OE2' ' HB1' ' A' ' 1' ' ' ALA . 5.8 mp0 -79.87 151.55 73.69 Favored Pre-proline 0 N--CA 1.448 -0.542 0 C-N-CA 124.017 0.927 . . . . 0.0 108.503 -176.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -60.68 145.77 98.31 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.051 1.834 . . . . 0.0 110.687 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.44 ' HB3' ' CH2' ' A' ' 47' ' ' TRP . 26.0 mtp180 -81.71 126.93 32.38 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -170.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -53.84 140.14 31.25 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.339 1.456 . . . . 0.0 113.544 -165.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.7 145.31 48.92 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.348 1.459 . . . . 0.0 108.348 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -50.29 122.15 6.54 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 157.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 65.79 27.75 73.01 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.027 -1.43 . . . . 0.0 114.188 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -42.94 -56.37 3.32 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 119.839 1.819 . . . . 0.0 111.816 171.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.88 165.56 35.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 173.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.407 ' NE2' ' OD2' ' A' ' 54' ' ' ASP . 51.9 m-70 44.57 48.52 8.54 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.815 1.246 . . . . 0.0 113.22 170.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.24 20.23 10.82 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.995 0.518 . . . . 0.0 111.882 170.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -62.19 144.33 55.61 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.605 0.639 . . . . 0.0 112.676 -171.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.1 m -127.86 144.39 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 124.764 1.226 . . . . 0.0 108.594 173.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -70.49 -26.51 63.64 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.395 0.678 . . . . 0.0 112.372 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -117.69 116.31 26.8 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 173.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -46.5 -44.75 17.93 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.245 1.018 . . . . 0.0 111.065 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.47 -37.89 58.13 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.464 -0.779 . . . . 0.0 112.619 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -48.07 -43.08 30.23 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-O 122.237 1.018 . . . . 0.0 110.83 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.35 3.21 11.48 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 118.05 -0.976 . . . . 0.0 112.762 -174.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.4 t -58.73 -24.37 61.44 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 120.615 1.552 . . . . 0.0 112.463 173.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.59 -25.8 70.48 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.134 0.873 . . . . 0.0 113.117 171.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -81.5 111.06 22.23 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 124.477 1.111 . . . . 0.0 110.954 -172.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 58.3 Cg_endo -61.39 111.44 1.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 N-CA-C 107.172 -1.895 . . . . 0.0 107.172 163.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER 141.1 -44.19 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.785 1 C-N-CA 131.991 4.116 . . . . 0.0 105.762 -170.093 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -64.28 153.75 37.25 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.991 0.901 . . . . 0.0 110.89 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -144.57 138.51 27.52 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 128.168 2.587 . . . . 0.0 106.526 170.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -58.48 149.49 25.05 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 127.223 2.209 . . . . 0.0 110.19 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.24 -16.96 35.76 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.657 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -75.32 96.96 3.47 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.046 1.423 . . . . 0.0 109.242 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.7 mp -101.56 147.44 26.4 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.905 1.682 . . . . 0.0 107.408 165.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 m -44.64 -43.19 8.06 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.396 1.479 . . . . 0.0 111.425 175.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -61.97 -16.85 54.42 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.436 -1.415 . . . . 0.0 113.933 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -94.84 2.8 55.49 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.128 1.371 . . . . 0.0 111.84 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 38.3 t -81.28 131.92 35.31 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.537 1.135 . . . . 0.0 109.129 -173.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.73 -19.11 47.93 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.198 -0.939 . . . . 0.0 112.165 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.6 m-30 -87.39 -9.65 54.18 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.171 0.988 . . . . 0.0 112.328 177.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.415 ' CH2' ' HA3' ' A' ' 48' ' ' GLY . 77.1 t-105 -55.38 142.41 32.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.189 0.596 . . . . 0.0 111.154 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.62 -97.79 1.4 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 171.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -141.89 158.83 43.31 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.254 1.422 . . . . 0.0 107.834 178.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.04 151.08 43.4 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 123.822 0.701 . . . . 0.0 109.972 172.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.1 t -123.82 -50.72 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.208 1.403 . . . . 0.0 109.99 -172.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -140.73 -138.64 0.12 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.538 0.735 . . . . 0.0 112.206 -176.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -68.51 64.18 0.11 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 127.943 2.497 . . . . 0.0 113.583 -167.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.04 56.14 25.66 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 108.206 -1.957 . . . . 0.0 108.206 -168.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.44 ' CH2' ' HB3' ' A' ' 5' ' ' ARG . 66.7 m95 -133.75 154.51 50.92 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 165.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.415 ' HA3' ' CH2' ' A' ' 39' ' ' TRP . . . -164.97 174.82 40.94 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-O 122.489 1.05 . . . . 0.0 112.468 175.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -73.68 145.43 45.26 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 126.473 1.909 . . . . 0.0 111.452 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 29.0 t -116.55 -9.67 11.35 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.986 2.515 . . . . 0.0 110.148 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.3 p 71.44 -29.44 0.19 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.279 2.232 . . . . 0.0 114.758 169.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -85.68 134.11 40.43 Favored Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 123.791 0.837 . . . . 0.0 109.522 -170.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -57.06 -51.03 9.66 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.355 2.703 . . . . 0.0 111.903 -166.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.407 ' OD2' ' NE2' ' A' ' 12' ' ' HIS . 12.9 p-10 -72.72 51.17 0.27 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.56 1.944 . . . . 0.0 110.736 173.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -179.46 -42.29 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.084 0.953 . . . . 0.0 112.955 -177.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -92.19 5.64 49.64 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.818 0.847 . . . . 0.0 112.668 -164.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.94 -55.5 10.76 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 171.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.3 m -78.01 165.94 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 169.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 22.5 tp -102.87 131.3 49.86 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.624 1.17 . . . . 0.0 108.508 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.0 m -97.21 143.29 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 119.393 0.997 . . . . 0.0 110.368 -175.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.439 ' HE2' ' NE1' ' A' ' 47' ' ' TRP . 0.0 OUTLIER -58.12 137.02 57.3 Favored 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 172.587 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.08 -42.13 72.43 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.909 0.884 . . . . 0.0 110.214 171.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -80.95 7.1 11.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.91 -175.38 32.0 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 76.8 t90 -159.37 154.16 24.62 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 169.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 6.8 p -138.21 165.97 25.35 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 124.0 0.812 . . . . 0.0 110.755 170.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.0 p -64.48 -31.99 73.43 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.698 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.284 1.3 m -72.97 -3.23 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 118.353 -0.832 . . . . 0.0 113.095 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -44.84 127.15 6.21 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.35 0.977 . . . . 0.0 110.859 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.2 132.81 24.27 Favored Pre-proline 0 N--CA 1.454 -0.259 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 168.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.44 151.2 65.03 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.823 1.682 . . . . 0.0 110.971 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.73 33.07 1.92 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.808 0.843 . . . . 0.0 110.429 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.7 m . . . . . 0 C--O 1.254 1.3 0 C-N-CA 128.326 2.65 . . . . 0.0 105.748 177.418 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 1.303 ' HB3' ' OE2' ' A' ' 3' ' ' GLU . . . . . . . . 0 CA--C 1.53 0.175 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.5 m -162.09 55.92 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.147 1.779 . . . . 0.0 107.288 172.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 1.303 ' OE2' ' HB3' ' A' ' 1' ' ' ALA . 2.1 mp0 -59.63 150.95 64.32 Favored Pre-proline 0 N--CA 1.446 -0.629 0 C-N-CA 125.621 1.568 . . . . 0.0 108.463 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.74 131.28 28.76 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.557 1.504 . . . . 0.0 110.009 -174.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 34.0 mtt-85 -58.59 126.25 26.83 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.849 1.26 . . . . 0.0 110.476 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.33 143.58 39.23 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.474 1.51 . . . . 0.0 111.253 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.64 149.38 22.83 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.496 0.665 . . . . 0.0 111.113 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.85 121.02 11.86 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.94 15.78 69.21 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 117.913 -1.493 . . . . 0.0 113.124 -173.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.444 ' HE2' ' CD ' ' A' ' 57' ' ' GLU . 83.9 t60 -38.84 -58.44 1.08 Allowed 'General case' 0 C--N 1.346 0.448 0 CA-C-N 119.603 1.701 . . . . 0.0 111.994 172.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -169.03 172.01 7.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.548 1.539 . . . . 0.0 107.221 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 39.02 50.52 1.78 Allowed 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.709 1.604 . . . . 0.0 112.476 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 55.41 25.71 7.98 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.272 1.029 . . . . 0.0 112.553 174.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -63.65 137.58 58.15 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.386 0.539 . . . . 0.0 111.125 -175.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.4 m -124.22 144.29 34.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 172.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -71.89 -27.43 62.84 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.25 1.02 . . . . 0.0 111.852 176.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -113.98 114.21 25.85 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 171.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -40.63 -49.33 3.0 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.352 1.461 . . . . 0.0 111.054 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.54 -34.69 59.13 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.589 0.756 . . . . 0.0 112.982 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -50.04 -41.2 47.09 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.532 1.06 . . . . 0.0 110.935 174.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.74 9.78 2.61 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 118.428 -0.796 . . . . 0.0 112.805 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.3 t -52.66 -31.76 38.76 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 120.115 1.325 . . . . 0.0 112.691 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.82 -21.77 78.11 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.696 1.141 . . . . 0.0 113.823 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -79.72 115.45 53.78 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 118.752 1.276 . . . . 0.0 111.362 -168.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.02 72.87 3.22 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.961 2.441 . . . . 0.0 111.21 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 52.8 mmt-85 -178.06 -36.27 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 131.623 3.969 . . . . 0.0 107.953 173.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -58.91 151.63 21.31 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.58 0.705 . . . . 0.0 110.399 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -136.75 146.04 45.31 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 166.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -59.38 148.43 32.58 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.462 0.649 . . . . 0.0 110.167 176.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.43 -23.16 16.7 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.348 0.975 . . . . 0.0 112.569 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -72.63 105.09 4.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 118.342 1.071 . . . . 0.0 108.765 177.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.7 mp -117.29 149.0 41.18 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 14.8 m -42.19 -46.19 4.32 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.248 1.419 . . . . 0.0 111.33 172.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -56.91 -26.82 59.98 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.789 -1.194 . . . . 0.0 114.152 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -107.16 19.15 20.79 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.11 0.964 . . . . 0.0 112.562 176.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.5 t -82.88 134.56 35.08 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.612 1.165 . . . . 0.0 108.525 173.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.87 -19.26 59.88 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.056 -1.027 . . . . 0.0 112.108 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -87.63 -5.21 58.83 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.451 -0.785 . . . . 0.0 111.425 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -53.86 142.71 23.32 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.543 1.065 . . . . 0.0 111.465 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.87 -85.95 1.17 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 173.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -166.31 158.95 14.43 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.08 137.01 38.68 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 123.603 0.564 . . . . 0.0 110.029 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.513 HG21 HD11 ' A' ' 59' ' ' LEU . 90.1 t -108.99 -49.93 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 125.417 1.487 . . . . 0.0 109.255 -175.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -151.71 -155.44 0.62 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.339 1.056 . . . . 0.0 110.886 -175.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -56.96 70.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 129.394 3.077 . . . . 0.0 114.416 -160.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.58 36.65 88.53 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -172.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -130.81 143.44 50.74 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 125.444 1.497 . . . . 0.0 109.065 173.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.419 ' HA2' HG23 ' A' ' 43' ' ' VAL . . . -156.77 -176.56 28.99 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-O 121.755 0.642 . . . . 0.0 112.189 177.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.481 ' HD2' HD12 ' A' ' 59' ' ' LEU . 48.4 mmm-85 -90.87 154.89 19.16 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.34 1.056 . . . . 0.0 109.963 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 t -139.04 130.12 26.59 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.0 p -96.64 -179.37 4.57 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.593 1.157 . . . . 0.0 110.432 -169.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 10.3 m80 82.52 163.26 0.12 Allowed Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 126.288 1.835 . . . . 0.0 108.4 -176.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.61 148.05 12.3 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.651 2.234 . . . . 0.0 113.435 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 63.43 -171.5 0.17 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.179 1.792 . . . . 0.0 109.865 -172.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 73.84 -62.66 0.46 Allowed 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.309 1.444 . . . . 0.0 113.794 166.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -54.68 -24.68 22.9 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.442 0.697 . . . . 0.0 112.283 -176.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.444 ' CD ' ' HE2' ' A' ' 10' ' ' HIS . 31.2 mt-10 -24.34 -53.74 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.469 2.308 . . . . 0.0 112.897 160.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.6 m -126.7 159.05 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.853 1.661 . . . . 0.0 108.064 -170.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.513 HD11 HG21 ' A' ' 43' ' ' VAL . 10.3 tp -79.16 123.41 27.36 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.2 t -92.32 129.24 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -171.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -63.38 131.28 47.74 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.14 -41.99 49.85 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.484 0.714 . . . . 0.0 111.512 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -84.84 5.45 28.7 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.35 -176.01 27.43 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 119.414 1.006 . . . . 0.0 111.148 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 83.1 t90 -159.19 153.72 24.25 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 170.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.411 ' SG ' HG22 ' A' ' 68' ' ' VAL . 2.0 p -142.06 163.63 32.35 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.861 1.264 . . . . 0.0 110.578 175.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.1 p -78.14 -5.95 53.22 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.411 HG22 ' SG ' ' A' ' 66' ' ' CYS 0.284 1.5 m -83.61 0.3 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 119.598 1.09 . . . . 0.0 112.169 164.574 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -47.14 137.98 7.33 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 119.073 0.852 . . . . 0.0 111.708 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -134.57 138.7 30.59 Favored Pre-proline 0 N--CA 1.454 -0.259 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 167.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.11 149.85 52.97 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.033 1.822 . . . . 0.0 111.147 -176.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.22 37.82 1.3 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.932 0.893 . . . . 0.0 110.071 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 45.7 m . . . . . 0 C--O 1.253 1.284 0 C-N-CA 128.365 2.666 . . . . 0.0 105.527 178.832 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.263 0 CA-C-O 117.455 -1.26 . . . . 0.0 108.45 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m 50.91 35.08 11.59 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.821 1.248 . . . . 0.0 113.078 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 51.3 mp0 -61.59 150.77 80.26 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 123.316 0.646 . . . . 0.0 109.433 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.21 145.73 79.23 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.308 2.005 . . . . 0.0 110.813 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -57.89 125.69 24.16 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.065 1.346 . . . . 0.0 110.604 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.15 150.14 30.69 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.189 1.396 . . . . 0.0 112.75 -173.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.426 ' CD ' ' HD1' ' A' ' 10' ' ' HIS . 1.8 mp0 -83.34 144.57 29.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.913 1.285 . . . . 0.0 108.623 -179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.1 121.98 14.4 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 166.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.79 22.91 76.28 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.175 -1.347 . . . . 0.0 113.271 -173.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.426 ' HD1' ' CD ' ' A' ' 7' ' ' GLU . 80.6 t60 -42.04 -55.09 3.31 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 119.557 1.678 . . . . 0.0 111.182 168.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -165.94 173.89 10.03 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.066 1.347 . . . . 0.0 108.06 173.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 38.33 50.69 1.5 Allowed 'General case' 0 C--N 1.341 0.23 0 C-N-CA 126.025 1.73 . . . . 0.0 112.986 172.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.2 20.5 8.56 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.384 0.674 . . . . 0.0 111.905 171.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -63.22 136.02 57.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.862 0.755 . . . . 0.0 110.543 -175.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.9 m -122.62 142.19 40.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -62.74 -36.66 83.74 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.921 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -109.01 123.3 48.93 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 123.401 0.68 . . . . 0.0 109.362 170.65 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.56 -36.44 10.56 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.25 1.42 . . . . 0.0 110.919 171.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.24 -40.99 64.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -56.38 -37.63 70.34 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 122.024 0.916 . . . . 0.0 110.604 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.51 0.69 13.96 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 117.831 -1.081 . . . . 0.0 112.245 -175.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.2 t -52.29 -30.39 27.88 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 120.36 1.436 . . . . 0.0 112.861 172.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.25 -27.2 72.13 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.49 1.043 . . . . 0.0 113.679 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -81.49 114.86 52.91 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 118.375 1.087 . . . . 0.0 111.494 -169.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.403 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 59.0 Cg_endo -63.05 108.7 0.8 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 N-CA-C 107.614 -1.726 . . . . 0.0 107.614 165.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 25' ' ' PRO . 2.0 mmm180 139.34 -35.41 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 131.487 3.915 . . . . 0.0 108.748 -173.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -71.9 156.55 39.15 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.492 0.663 . . . . 0.0 109.765 175.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -155.16 138.94 16.17 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.384 165.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -54.71 115.61 2.25 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 128.114 2.565 . . . . 0.0 109.53 -175.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.37 -21.19 11.96 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -72.92 109.27 6.35 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 167.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.2 mp -122.89 148.64 45.2 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.355 2.262 . . . . 0.0 106.137 172.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 6.5 m -45.07 -44.49 10.35 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.498 1.519 . . . . 0.0 111.711 175.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -59.12 -18.81 39.0 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 120.657 -1.277 . . . . 0.0 113.903 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -96.8 3.98 51.99 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.217 1.407 . . . . 0.0 112.043 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.2 t -90.79 139.99 30.21 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.849 1.26 . . . . 0.0 110.396 -169.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.84 -11.3 58.31 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.007 -1.058 . . . . 0.0 112.857 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -88.96 -3.92 58.59 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.604 171.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -59.52 132.28 53.52 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.07 0.85 . . . . 0.0 110.321 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.88 -81.03 1.13 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 171.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.6 165.68 12.18 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.612 0.765 . . . . 0.0 110.165 163.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.406 ' HA ' ' HA3' ' A' ' 48' ' ' GLY . . . -58.74 146.64 36.03 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.313 1.045 . . . . 0.0 111.034 170.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.2 t -125.23 -48.47 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 124.925 1.29 . . . . 0.0 109.211 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -149.17 -159.15 0.99 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.016 0.926 . . . . 0.0 110.192 -174.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -59.32 70.3 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 129.648 3.179 . . . . 0.0 113.799 -162.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.0 30.08 57.96 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -131.55 143.02 50.06 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 124.949 1.299 . . . . 0.0 108.845 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 42' ' ' ALA . . . -152.89 172.91 31.91 Favored Glycine 0 N--CA 1.433 -1.508 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -72.03 127.76 33.56 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.105 170.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 52.0 t -84.64 167.74 15.95 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 104.778 -2.305 . . . . 0.0 104.778 141.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.4 p -127.45 165.8 19.13 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.933 0.893 . . . . 0.0 109.686 175.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 45.0 m80 93.95 120.09 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 129.276 3.03 . . . . 0.0 108.9 173.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -53.46 129.8 35.52 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.637 2.224 . . . . 0.0 111.295 -174.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 118.69 -46.14 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 130.984 3.714 . . . . 0.0 105.757 -160.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -133.51 52.44 2.07 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.386 1.474 . . . . 0.0 110.132 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -132.42 -40.68 0.99 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.792 0.837 . . . . 0.0 110.39 172.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -52.13 -41.43 62.5 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.456 1.903 . . . . 0.0 112.37 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.6 m -114.94 153.66 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 125.476 1.51 . . . . 0.0 109.424 -173.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.6 tp -85.28 136.27 33.57 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.6 t -104.97 134.8 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 123.608 0.763 . . . . 0.0 109.089 -167.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -64.01 129.64 40.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.17 -40.11 67.2 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.167 0.587 . . . . 0.0 111.632 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -82.7 1.26 39.5 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 175.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.57 -174.0 19.23 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 120.055 1.298 . . . . 0.0 111.832 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 75.2 t90 -163.87 150.64 11.81 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 174.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.6 p -135.76 162.99 31.21 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.142 1.377 . . . . 0.0 110.462 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.4 p -68.08 -21.76 64.96 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 118.454 -0.784 . . . . 0.0 112.521 -176.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.292 1.1 m -76.29 -4.64 6.39 Favored 'Isoleucine or valine' 0 C--N 1.344 0.36 0 CA-C-N 119.249 0.931 . . . . 0.0 112.705 175.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -42.69 126.47 3.67 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 118.777 0.717 . . . . 0.0 111.784 178.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.92 134.39 26.05 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 165.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.9 150.15 66.95 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 121.586 1.524 . . . . 0.0 111.027 -175.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.42 41.18 1.11 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.574 0.702 . . . . 0.0 109.807 172.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.6 m . . . . . 0 C--O 1.249 1.046 0 C-N-CA 127.977 2.511 . . . . 0.0 106.045 178.089 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 118.823 -0.608 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.4 m 61.92 51.86 3.6 Favored 'General case' 0 C--N 1.337 0.048 0 C-N-CA 124.846 1.258 . . . . 0.0 109.15 174.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -104.21 117.93 58.16 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.849 -148.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -65.3 154.8 71.91 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.546 2.164 . . . . 0.0 110.752 170.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.3 mtt180 -55.1 125.68 21.52 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.476 1.111 . . . . 0.0 110.868 172.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.58 152.5 34.8 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.64 1.176 . . . . 0.0 113.542 -172.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -84.8 143.4 29.13 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.452 1.501 . . . . 0.0 108.774 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -63.59 118.78 8.69 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 167.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.0 20.81 72.4 Favored Glycine 0 CA--C 1.531 1.094 0 CA-C-O 118.377 -1.235 . . . . 0.0 113.112 -173.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -43.89 -56.87 3.61 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 119.453 1.627 . . . . 0.0 111.477 169.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.09 172.96 10.79 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.146 1.378 . . . . 0.0 108.015 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 36.84 48.45 0.67 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.37 1.868 . . . . 0.0 113.246 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 55.77 23.85 6.75 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.853 0.861 . . . . 0.0 112.127 173.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -63.14 135.09 56.97 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.172 0.442 . . . . 0.0 110.096 -175.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.7 m -123.23 141.46 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 170.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.3 m-20 -62.61 -36.13 81.76 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 118.949 -0.548 . . . . 0.0 111.1 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.87 130.34 55.01 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 123.516 0.727 . . . . 0.0 109.334 168.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.49 -34.55 36.33 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.358 1.063 . . . . 0.0 110.654 170.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.05 -45.25 64.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.238 0.215 . . . . 0.0 111.434 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.52 -20.72 65.85 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.577 0.751 . . . . 0.0 111.933 -176.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.27 -6.53 55.26 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.544 -0.723 . . . . 0.0 111.968 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.2 m -62.73 91.88 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 119.162 0.892 . . . . 0.0 111.22 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.37 -36.0 1.03 Allowed Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.263 1.411 . . . . 0.0 110.764 -172.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -62.12 116.8 24.25 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.278 -0.868 . . . . 0.0 109.28 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.91 116.52 3.61 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 N-CA-C 107.455 -1.786 . . . . 0.0 107.455 170.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.5 tpt85 123.2 -35.54 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 129.438 3.095 . . . . 0.0 109.278 -170.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -62.7 149.73 42.96 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.52 0.676 . . . . 0.0 109.454 168.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -157.19 137.07 12.45 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.128 1.771 . . . . 0.0 106.368 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -58.33 123.47 16.21 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.522 2.329 . . . . 0.0 110.998 -172.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.94 -20.68 37.93 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-O 119.181 -0.788 . . . . 0.0 111.607 176.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -67.66 111.41 4.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 118.829 1.314 . . . . 0.0 107.909 173.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.6 mp -124.96 149.64 47.45 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 172.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.4 m -42.91 -45.54 5.01 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.042 1.337 . . . . 0.0 111.89 173.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -56.86 -26.08 57.83 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -109.26 25.72 11.47 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.178 0.991 . . . . 0.0 112.357 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 45.1 t -86.42 138.8 31.49 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.584 1.153 . . . . 0.0 108.838 172.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.09 -26.27 64.52 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.443 -0.785 . . . . 0.0 112.079 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -78.14 -10.92 59.85 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 117.719 -1.134 . . . . 0.0 112.559 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -49.56 127.77 16.22 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.988 1.267 . . . . 0.0 111.898 -172.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.18 -84.65 0.59 Allowed Glycine 0 C--N 1.335 0.485 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.81 171.17 11.64 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 155.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.28 145.76 46.3 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.55 1.14 . . . . 0.0 110.996 169.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.3 t -123.62 -47.45 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 125.746 1.619 . . . . 0.0 109.24 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -148.46 -162.73 1.62 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.987 0.915 . . . . 0.0 110.186 -174.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -58.05 71.23 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 129.675 3.19 . . . . 0.0 113.934 -163.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.95 26.82 57.61 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.985 1.278 . . . . 0.0 110.913 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -129.67 144.47 51.3 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 124.978 1.311 . . . . 0.0 109.644 176.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -154.04 -178.36 28.39 Favored Glycine 0 N--CA 1.437 -1.247 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.0 mtp85 -94.66 154.6 17.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 118.926 -0.559 . . . . 0.0 109.909 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.3 p -131.09 143.01 50.34 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.49 0.716 . . . . 0.0 109.093 159.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 34.4 p -82.26 61.14 5.33 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.62 1.168 . . . . 0.0 111.108 -160.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -153.81 114.58 2.59 Favored Pre-proline 0 N--CA 1.451 -0.397 0 CA-C-O 117.833 -1.08 . . . . 0.0 108.944 175.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -48.23 128.22 16.79 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 N-CA-C 107.917 -1.609 . . . . 0.0 107.917 159.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 124.03 -44.39 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 128.403 2.681 . . . . 0.0 105.953 -154.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -143.85 33.51 1.26 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.471 2.308 . . . . 0.0 110.024 -169.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -127.51 -41.89 1.68 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 122.253 1.025 . . . . 0.0 109.666 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.3 pm0 -51.92 -34.08 40.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.085 1.354 . . . . 0.0 111.549 166.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 m -127.39 149.62 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 125.285 1.434 . . . . 0.0 108.598 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.4 tp -91.55 142.66 27.41 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.371 1.468 . . . . 0.0 108.963 -171.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.2 t -102.06 124.7 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 124.927 1.291 . . . . 0.0 108.457 -162.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.3 tttm -61.6 126.81 28.69 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 171.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.65 -38.0 30.62 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.069 0.948 . . . . 0.0 111.676 175.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -83.54 -4.34 58.46 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.41 -173.32 29.73 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 119.034 0.834 . . . . 0.0 111.991 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 86.0 t90 -161.75 148.88 14.31 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.614 ' SG ' HG13 ' A' ' 68' ' ' VAL . 5.6 p -135.11 163.83 29.02 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.186 1.394 . . . . 0.0 109.341 172.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.7 p -73.07 -18.1 61.35 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.969 -1.082 . . . . 0.0 112.672 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.614 HG13 ' SG ' ' A' ' 66' ' ' CYS 0.373 1.5 p -77.87 7.13 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 124.866 1.266 . . . . 0.0 111.785 164.867 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -52.5 130.36 31.48 Favored 'General case' 0 C--N 1.345 0.394 0 O-C-N 120.206 -1.559 . . . . 0.0 110.28 162.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.95 134.63 26.53 Favored Pre-proline 0 N--CA 1.453 -0.291 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 171.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -73.28 148.37 43.62 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 121.788 1.659 . . . . 0.0 110.658 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.26 46.27 1.2 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.746 0.784 . . . . 0.0 109.523 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.2 p . . . . . 0 C--O 1.249 1.076 0 C-N-CA 125.84 1.656 . . . . 0.0 106.79 -172.284 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.795 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . . . . . . . . 0 CA--C 1.513 -0.476 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.82 29.34 0.06 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -174.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.795 ' OE1' ' HB3' ' A' ' 1' ' ' ALA . 2.2 mp0 -81.6 128.7 68.49 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -65.96 131.39 27.01 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.848 1.698 . . . . 0.0 109.881 -176.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.433 ' HB3' ' CH2' ' A' ' 47' ' ' TRP . 18.2 mtp180 -80.32 122.61 27.12 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -172.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.53 135.54 33.86 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.974 1.31 . . . . 0.0 112.804 -166.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.465 ' CD ' ' HD1' ' A' ' 10' ' ' HIS . 1.9 mp0 -68.41 147.93 51.37 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.681 1.192 . . . . 0.0 109.464 177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.27 87.75 0.12 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.744 0.818 . . . . 0.0 109.55 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.16 37.55 5.63 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.917 -173.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.465 ' HD1' ' CD ' ' A' ' 7' ' ' GLU . 79.9 t60 -39.65 -54.19 2.06 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 123.91 0.884 . . . . 0.0 109.943 164.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.416 ' HB3' ' CD2' ' A' ' 12' ' ' HIS . . . -165.76 175.21 8.94 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.494 1.518 . . . . 0.0 106.986 170.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.51 ' CD2' ' CE2' ' A' ' 55' ' ' PHE . 3.4 m-70 55.21 30.02 13.81 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.966 1.307 . . . . 0.0 113.603 169.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 57.08 34.58 25.1 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.603 1.161 . . . . 0.0 111.938 175.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -54.12 -64.48 0.81 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -171.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.284 23.6 m 55.52 134.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 127.206 2.202 . . . . 0.0 114.077 -169.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -66.69 -28.9 68.81 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 120.77 -1.206 . . . . 0.0 112.405 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -113.11 118.95 36.16 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 171.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.91 -43.59 29.01 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.48 1.112 . . . . 0.0 109.818 175.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.97 -40.24 13.99 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.75 0.82 . . . . 0.0 112.889 175.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -52.44 -34.85 50.61 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.507 1.049 . . . . 0.0 111.445 178.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.29 5.11 3.07 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 116.895 -1.526 . . . . 0.0 113.811 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.8 m -13.68 99.99 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 128.13 2.572 . . . . 0.0 113.942 170.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.15 21.66 64.19 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.312 0.958 . . . . 0.0 115.052 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -48.09 127.47 11.99 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 119.31 1.555 . . . . 0.0 107.783 162.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -61.01 110.26 0.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.708 0 CA-C-N 121.252 1.483 . . . . 0.0 108.299 175.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.5 tpt85 123.66 -40.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 129.578 3.151 . . . . 0.0 110.161 -171.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -70.82 143.39 51.14 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.795 0.725 . . . . 0.0 110.557 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.512 ' H ' ' NE2' ' A' ' 31' ' ' GLN . 23.0 mp0 -132.95 123.2 25.49 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 162.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.0 mp0 -54.15 119.05 4.58 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 128.407 2.683 . . . . 0.0 109.181 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.99 -34.55 3.38 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -174.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.512 ' NE2' ' H ' ' A' ' 28' ' ' GLN . 25.7 mt-30 -63.94 118.4 8.38 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 171.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.87 147.27 50.8 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 126.086 1.754 . . . . 0.0 107.154 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.5 m -44.04 -48.8 8.88 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.15 0.98 . . . . 0.0 111.444 174.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -61.34 -20.45 62.99 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 120.431 -1.418 . . . . 0.0 113.983 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -107.21 24.12 13.34 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.811 1.244 . . . . 0.0 111.845 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.4 t -95.3 134.52 37.98 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.391 1.476 . . . . 0.0 109.595 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.0 -20.21 56.55 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.433 -0.792 . . . . 0.0 112.726 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -97.52 6.64 47.83 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.138 0.575 . . . . 0.0 112.192 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 -59.66 145.74 43.67 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.594 0.633 . . . . 0.0 110.392 171.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.18 -69.78 1.28 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 172.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -176.46 160.4 2.06 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 -169.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.37 140.38 31.61 Favored 'General case' 0 N--CA 1.457 -0.083 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 169.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.727 HG23 ' HA2' ' A' ' 48' ' ' GLY . 55.5 t -107.53 -51.37 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.401 1.48 . . . . 0.0 109.279 -173.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.604 ' OE1' ' N ' ' A' ' 1' ' ' ALA . 16.6 pt20 -149.55 -136.88 0.08 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.421 0.689 . . . . 0.0 111.728 -170.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -71.43 65.71 0.45 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.054 2.142 . . . . 0.0 112.988 -163.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.0 42.38 77.82 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -173.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.433 ' CH2' ' HB3' ' A' ' 5' ' ' ARG . 80.7 m95 -133.45 156.12 48.29 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 125.514 1.526 . . . . 0.0 108.232 170.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.727 ' HA2' HG23 ' A' ' 43' ' ' VAL . . . -157.47 -174.08 26.71 Favored Glycine 0 N--CA 1.434 -1.476 0 O-C-N 124.496 1.122 . . . . 0.0 110.507 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -98.23 153.64 18.35 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.402 1.081 . . . . 0.0 108.882 -176.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.519 ' HB2' HG21 ' A' ' 60' ' ' VAL . 9.2 t -134.25 134.66 42.21 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 125.463 1.505 . . . . 0.0 107.867 177.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 64.3 p -105.98 52.62 0.72 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.909 0.883 . . . . 0.0 111.271 -162.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.01 154.65 72.73 Favored Pre-proline 0 CA--C 1.53 0.207 0 C-N-CA 123.916 0.886 . . . . 0.0 109.012 177.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.54 144.32 72.43 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.757 2.304 . . . . 0.0 110.855 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.9 t0 60.55 46.66 9.28 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.579 1.152 . . . . 0.0 107.935 -173.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.51 ' CE2' ' CD2' ' A' ' 12' ' ' HIS . 1.1 m-85 -166.4 -53.37 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.861 1.664 . . . . 0.0 107.759 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.4 p-10 -23.49 -50.89 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.595 1.958 . . . . 0.0 113.327 153.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -44.91 -42.56 8.19 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.939 1.296 . . . . 0.0 114.311 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.3 m -130.4 156.4 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.07 0.948 . . . . 0.0 111.951 -160.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.725 HD11 HG21 ' A' ' 43' ' ' VAL . 9.1 tp -78.81 126.76 31.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 173.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.519 HG21 ' HB2' ' A' ' 50' ' ' CYS . 11.0 m -98.13 134.93 34.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 118.815 0.734 . . . . 0.0 109.546 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -61.16 134.91 57.52 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.1 -40.56 73.87 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.66 0.384 . . . . 0.0 111.223 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -76.8 -2.34 32.72 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 175.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.11 -178.52 8.62 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 70.5 t90 -148.71 -179.48 7.02 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 170.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.432 ' SG ' HG22 ' A' ' 68' ' ' VAL . 5.7 p -162.66 164.85 26.37 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 119.038 0.835 . . . . 0.0 110.357 159.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.5 p -63.0 -30.99 72.03 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 118.939 -0.553 . . . . 0.0 111.781 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.432 HG22 ' SG ' ' A' ' 66' ' ' CYS 0.301 1.1 m -72.42 -5.34 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 118.885 0.766 . . . . 0.0 112.478 177.432 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -46.03 137.0 6.19 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.884 0.874 . . . . 0.0 112.031 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.43 140.59 39.12 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 165.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.04 147.76 38.96 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.282 1.988 . . . . 0.0 111.248 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.3 46.75 1.27 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.611 0.72 . . . . 0.0 109.424 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.5 p . . . . . 0 C--O 1.248 1.018 0 C-N-CA 125.66 1.584 . . . . 0.0 107.122 -172.937 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 1.348 ' CB ' ' OE1' ' A' ' 3' ' ' GLU . . . . . . . . 0 CA--C 1.513 -0.453 0 CA-C-O 117.276 -1.345 . . . . 0.0 107.834 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 m -50.74 -32.45 19.7 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-O 122.621 1.201 . . . . 0.0 112.931 161.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 1.348 ' OE1' ' CB ' ' A' ' 1' ' ' ALA . 2.7 mp0 -77.29 127.51 82.94 Favored Pre-proline 0 C--N 1.318 -0.795 0 C-N-CA 126.78 2.032 . . . . 0.0 108.252 171.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.92 153.76 58.25 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.495 2.797 . . . . 0.0 110.795 174.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.437 ' HB3' ' CH2' ' A' ' 47' ' ' TRP . 16.1 mtp180 -79.23 123.13 27.12 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -54.61 142.7 27.12 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.82 1.248 . . . . 0.0 112.68 -170.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.459 ' CD ' ' HD1' ' A' ' 10' ' ' HIS . 1.6 mp0 -76.58 145.61 38.85 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.006 1.322 . . . . 0.0 108.417 -178.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -64.86 121.57 14.92 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 167.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.97 25.73 74.12 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 118.275 -1.292 . . . . 0.0 112.855 -170.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.459 ' HD1' ' CD ' ' A' ' 7' ' ' GLU . 78.9 t60 -41.95 -57.87 2.26 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 119.388 1.594 . . . . 0.0 110.7 168.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.19 174.06 4.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.746 1.619 . . . . 0.0 107.351 173.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' HIS . . . . . 0.455 ' CD2' ' CE2' ' A' ' 55' ' ' PHE . 10.4 m-70 54.46 31.97 15.78 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.802 1.241 . . . . 0.0 113.137 172.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 55.1 29.99 13.54 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.256 1.023 . . . . 0.0 111.596 -176.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -64.35 134.68 55.11 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.972 -0.455 . . . . 0.0 110.043 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.0 m -122.9 142.04 40.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 170.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -63.27 -34.92 78.73 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 118.993 -0.527 . . . . 0.0 111.534 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.69 127.27 54.47 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 123.634 0.774 . . . . 0.0 109.733 169.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.16 -38.47 11.86 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.732 1.213 . . . . 0.0 110.58 168.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.15 -41.76 60.33 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -59.7 -30.61 68.91 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.131 0.491 . . . . 0.0 111.373 -176.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.01 -0.31 30.67 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 118.85 -0.595 . . . . 0.0 112.448 -176.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.3 m -61.79 91.56 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 119.248 0.931 . . . . 0.0 111.377 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.06 -32.43 1.41 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.087 1.327 . . . . 0.0 111.431 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -60.26 125.12 80.79 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 118.067 0.933 . . . . 0.0 109.567 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 59.5 Cg_endo -65.21 102.3 0.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 N-CA-C 107.258 -1.862 . . . . 0.0 107.258 169.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER 139.9 -29.44 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 130.9 3.68 . . . . 0.0 110.235 -173.585 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -75.71 79.86 2.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.432 0.635 . . . . 0.0 109.769 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -64.75 137.62 57.9 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 161.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -59.46 118.55 6.16 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 128.085 2.554 . . . . 0.0 112.193 -172.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.67 -1.18 63.57 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-O 119.381 -0.677 . . . . 0.0 111.909 174.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -60.87 121.87 13.42 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.388 1.094 . . . . 0.0 108.372 166.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.7 mp -128.94 145.1 51.32 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.661 1.984 . . . . 0.0 107.723 173.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 6.8 m -45.54 -45.17 13.28 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 124.829 1.252 . . . . 0.0 112.75 177.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -64.84 -13.97 57.82 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 119.863 -1.773 . . . . 0.0 114.01 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -93.09 -1.16 56.76 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.318 1.047 . . . . 0.0 111.416 173.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.6 t -80.12 131.41 35.73 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.417 1.087 . . . . 0.0 109.138 -175.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.67 -6.29 19.89 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.969 -1.082 . . . . 0.0 112.472 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -93.57 -2.28 54.41 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.936 0.789 . . . . 0.0 111.755 171.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -59.56 149.37 30.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 118.518 0.599 . . . . 0.0 111.194 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.86 -74.82 1.27 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.287 1.422 . . . . 0.0 109.593 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -173.21 154.11 2.63 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.284 1.433 . . . . 0.0 107.152 -168.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.61 137.24 37.05 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 171.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.615 HG23 ' HA2' ' A' ' 48' ' ' GLY . 75.9 t -107.69 -48.62 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 125.244 1.418 . . . . 0.0 108.972 -173.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -149.37 -140.8 0.1 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.728 0.411 . . . . 0.0 111.866 -168.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -72.12 65.05 0.56 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.257 2.223 . . . . 0.0 112.561 -167.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.42 31.08 47.38 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.437 ' CH2' ' HB3' ' A' ' 5' ' ' ARG . 74.7 m95 -132.2 152.39 51.33 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 125.301 1.441 . . . . 0.0 109.224 173.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.615 ' HA2' HG23 ' A' ' 43' ' ' VAL . . . -154.84 -179.93 30.42 Favored Glycine 0 N--CA 1.431 -1.64 0 O-C-N 124.669 1.231 . . . . 0.0 110.832 178.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -86.05 145.77 26.92 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.62 133.2 34.08 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 126.589 1.956 . . . . 0.0 105.751 174.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.9 p -91.42 171.08 9.45 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 122.754 0.421 . . . . 0.0 111.321 -168.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 18.5 m80 100.23 141.19 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 130.231 3.412 . . . . 0.0 107.91 174.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -57.6 147.63 78.13 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.25 1.967 . . . . 0.0 111.554 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.2 t0 58.83 40.01 23.36 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.742 1.217 . . . . 0.0 109.94 -165.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.455 ' CE2' ' CD2' ' A' ' 12' ' ' HIS . 1.2 m-85 -163.22 -55.56 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.152 1.781 . . . . 0.0 109.483 172.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -37.37 -46.66 0.79 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.423 1.489 . . . . 0.0 111.98 173.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -65.86 -17.24 64.51 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.701 1.6 . . . . 0.0 115.28 -174.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.27 149.02 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 120.192 1.36 . . . . 0.0 111.239 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.598 HD11 HG21 ' A' ' 43' ' ' VAL . 7.3 tp -77.78 130.41 36.67 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 174.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.4 t -106.04 129.67 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -174.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.419 ' HD2' ' CZ2' ' A' ' 47' ' ' TRP . 32.5 tttm -61.87 129.79 42.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 174.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.9 -36.69 67.94 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.565 0.746 . . . . 0.0 111.483 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -80.83 -7.03 59.32 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.57 -0.729 . . . . 0.0 112.455 178.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.38 -173.07 20.8 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 118.906 0.775 . . . . 0.0 111.915 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -161.19 150.68 16.8 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.41 ' SG ' HG22 ' A' ' 68' ' ' VAL . 1.8 p -139.82 172.44 12.78 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.235 1.014 . . . . 0.0 111.223 170.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 81.0 p -72.06 -35.53 69.31 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.41 HG22 ' SG ' ' A' ' 66' ' ' CYS . 2.4 m -64.84 -23.85 34.31 Favored 'Isoleucine or valine' 0 C--N 1.347 0.467 0 CA-C-N 118.568 0.622 . . . . 0.0 111.632 -175.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -20.45 105.39 0.02 OUTLIER 'General case' 0 C--O 1.237 0.403 0 C-N-CA 128.033 2.533 . . . . 0.0 113.486 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.57 120.57 57.26 Favored Pre-proline 0 N--CA 1.454 -0.234 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 165.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -66.1 134.41 36.67 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.253 1.302 . . . . 0.0 112.81 -173.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.56 -13.71 33.98 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 142.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.9 m . . . . . 0 C--O 1.25 1.108 1 C-N-CA 134.156 4.982 . . . . 0.0 103.518 174.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.432 ' O ' ' OE2' ' A' ' 3' ' ' GLU . . . . . . . . 0 CA--C 1.52 -0.194 0 CA-C-O 116.592 -1.67 . . . . 0.0 109.874 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.4 p -105.64 58.42 0.67 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 173.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.432 ' OE2' ' O ' ' A' ' 1' ' ' ALA . 1.8 pm0 -73.93 140.55 77.54 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -173.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.49 147.91 65.64 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.527 2.151 . . . . 0.0 111.312 -176.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.1 mtt180 -62.46 127.37 31.01 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.783 1.233 . . . . 0.0 109.987 171.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.41 145.53 43.31 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.584 1.553 . . . . 0.0 111.514 -175.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.3 146.15 24.91 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.375 0.607 . . . . 0.0 110.94 175.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.92 120.33 9.43 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 172.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.75 18.7 65.12 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 117.997 -1.446 . . . . 0.0 113.742 -174.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -36.01 -55.3 0.76 Allowed 'General case' 0 C--N 1.347 0.467 0 CA-C-N 119.637 1.718 . . . . 0.0 111.602 168.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -164.77 -179.47 5.87 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 164.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.4 m170 46.22 45.95 13.1 Favored 'General case' 0 CA--C 1.527 0.071 0 O-C-N 124.213 0.945 . . . . 0.0 111.865 160.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 56.23 24.59 8.28 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.955 1.302 . . . . 0.0 112.219 172.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -62.49 136.69 58.02 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 118.152 0.433 . . . . 0.0 111.415 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.1 m -125.46 142.26 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 174.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -70.65 -24.87 62.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.2 1.0 . . . . 0.0 112.053 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -115.31 120.57 40.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.12 1.368 . . . . 0.0 107.919 168.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.04 -49.62 40.38 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.189 0.996 . . . . 0.0 111.665 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.7 -20.03 64.4 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 118.201 -0.904 . . . . 0.0 112.785 -173.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -44.57 -43.84 8.37 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.805 1.184 . . . . 0.0 110.466 165.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.03 7.9 12.07 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -175.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.6 p -33.14 -59.16 0.37 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 127.344 2.257 . . . . 0.0 113.19 174.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.93 -29.82 35.64 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 112.239 -2.255 . . . . 0.0 113.805 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -70.04 117.51 54.73 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 118.687 1.243 . . . . 0.0 110.908 -171.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -60.68 105.74 0.33 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 N-CA-C 107.439 -1.793 . . . . 0.0 107.439 163.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 141.41 -40.0 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 130.983 3.713 . . . . 0.0 108.662 -172.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -68.78 150.4 47.89 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 173.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -150.3 132.14 15.09 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.272 1.1 pm0 -56.94 107.26 0.38 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.31 1.444 . . . . 0.0 112.076 -173.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.39 -1.87 27.98 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 119.139 -0.811 . . . . 0.0 111.983 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -73.07 110.81 7.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.74 1.77 . . . . 0.0 107.044 164.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.5 mp -121.57 150.27 41.9 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.925 2.09 . . . . 0.0 106.346 170.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.8 m -47.7 -45.72 28.79 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.326 1.05 . . . . 0.0 111.946 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -62.89 -13.65 36.79 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 120.209 -1.557 . . . . 0.0 113.588 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -95.68 2.52 54.07 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 120.82 -1.175 . . . . 0.0 111.874 175.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 24.6 t -86.83 137.06 32.72 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.754 1.222 . . . . 0.0 109.448 -171.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.02 -20.66 65.52 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.188 -0.945 . . . . 0.0 111.867 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -87.29 2.07 51.31 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.566 -0.731 . . . . 0.0 112.528 173.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 48.2 t-105 -59.09 142.93 50.14 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.749 1.158 . . . . 0.0 111.071 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.43 -109.47 0.93 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 165.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -139.43 157.26 46.16 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.274 1.43 . . . . 0.0 107.782 175.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.27 141.44 58.02 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 123.929 0.768 . . . . 0.0 109.444 165.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.7 t -113.5 -54.05 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 124.5 1.12 . . . . 0.0 109.257 -174.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -157.87 153.97 27.19 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.364 1.066 . . . . 0.0 109.46 -177.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.4 t0 50.09 35.99 11.18 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 155.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.3 31.89 80.38 Favored Glycine 0 CA--C 1.535 1.331 0 O-C-N 120.615 -1.303 . . . . 0.0 112.992 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -123.37 152.73 41.22 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 127.935 2.494 . . . . 0.0 108.394 170.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -159.29 176.85 36.03 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-O 122.002 0.779 . . . . 0.0 111.363 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.62 145.06 30.79 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 114.647 -0.776 . . . . 0.0 111.814 176.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 21.7 t -107.07 144.05 34.31 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 160.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.8 p -97.36 -15.72 20.59 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.479 0.711 . . . . 0.0 111.391 -174.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -63.22 118.74 46.29 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-O 117.805 -1.093 . . . . 0.0 110.391 -176.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.3 119.37 5.36 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 123.223 2.615 . . . . 0.0 111.497 172.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.372 0.8 OUTLIER 110.07 -16.06 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 130.755 3.622 . . . . 0.0 112.203 -170.935 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -128.23 14.22 6.69 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.982 1.713 . . . . 0.0 110.928 165.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -80.72 -31.22 36.17 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.292 1.437 . . . . 0.0 111.212 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -70.46 0.32 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -175.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -69.84 165.98 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.712 0.805 . . . . 0.0 111.755 -171.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.3 tp -91.62 118.5 30.68 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 170.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.2 m -91.88 148.45 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -66.59 138.78 57.71 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.96 -36.93 80.68 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.178 0.445 . . . . 0.0 111.09 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -82.26 3.2 28.47 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 171.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.08 -176.91 28.24 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 73.5 t90 -163.64 153.93 15.5 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.408 ' SG ' HG22 ' A' ' 68' ' ' VAL . 3.1 p -135.69 160.26 39.06 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.774 1.23 . . . . 0.0 110.329 172.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.8 p -71.35 -15.9 62.41 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.325 -0.859 . . . . 0.0 112.654 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.408 HG22 ' SG ' ' A' ' 66' ' ' CYS 0.322 0.9 OUTLIER -76.48 -4.44 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 119.342 0.974 . . . . 0.0 112.323 172.132 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -42.91 130.92 4.26 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 124.183 0.993 . . . . 0.0 112.261 177.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.58 135.21 26.31 Favored Pre-proline 0 N--CA 1.455 -0.217 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 165.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -69.5 149.84 69.05 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 121.735 1.623 . . . . 0.0 110.798 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.7 39.54 1.16 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.667 0.746 . . . . 0.0 110.007 174.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 C--O 1.248 0.981 0 C-N-CA 128.388 2.675 . . . . 0.0 105.699 178.127 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.349 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.6 m 48.92 37.05 9.34 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.079 1.352 . . . . 0.0 114.412 174.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -80.75 148.87 66.37 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 122.684 0.394 . . . . 0.0 110.053 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.6 140.6 26.85 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.659 2.239 . . . . 0.0 111.73 -173.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 31.9 mtt-85 -61.25 131.43 50.37 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.482 1.513 . . . . 0.0 111.158 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.32 142.96 54.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.012 1.325 . . . . 0.0 112.057 -178.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -84.95 155.23 21.72 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 122.042 0.925 . . . . 0.0 112.197 174.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -67.34 96.23 0.48 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.616 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.48 24.99 10.42 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.56 1.076 . . . . 0.0 111.667 -176.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -34.21 -55.52 0.51 Allowed 'General case' 0 C--N 1.345 0.372 0 C-N-CA 125.238 1.415 . . . . 0.0 111.896 170.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.37 169.66 22.64 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 169.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 43.77 46.45 6.46 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.933 1.293 . . . . 0.0 113.419 170.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 58.83 27.0 15.5 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.184 0.594 . . . . 0.0 112.298 169.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -46.99 -60.3 2.54 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -165.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.254 34.7 m 56.85 132.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 126.757 2.023 . . . . 0.0 113.893 -171.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -68.78 -27.68 66.1 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 120.574 -1.329 . . . . 0.0 112.746 -177.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -110.43 115.29 29.4 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 170.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -42.36 -46.64 4.7 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.07 1.348 . . . . 0.0 110.656 173.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.99 -37.31 44.16 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.915 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -51.63 -35.45 42.0 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.411 1.005 . . . . 0.0 111.643 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.88 2.83 13.5 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -177.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 64.8 m -61.62 93.0 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 119.598 1.09 . . . . 0.0 111.306 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.5 -34.51 1.06 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.52 1.533 . . . . 0.0 110.49 -174.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -62.74 115.71 18.86 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 117.871 -1.062 . . . . 0.0 109.335 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -62.73 120.34 7.82 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 N-CA-C 107.587 -1.736 . . . . 0.0 107.587 171.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 118.91 -39.22 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 129.185 2.994 . . . . 0.0 108.902 -168.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -64.05 142.11 58.53 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 166.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -144.84 147.82 33.28 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 174.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.1 mp0 -55.73 117.46 3.66 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.434 1.493 . . . . 0.0 110.776 -170.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.13 7.41 70.18 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 119.705 -0.497 . . . . 0.0 112.373 175.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -72.63 91.14 1.41 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 119.037 1.419 . . . . 0.0 108.509 167.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.5 mp -95.48 150.0 20.79 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.949 1.3 . . . . 0.0 109.003 169.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 2.1 m -46.21 -44.98 16.64 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.936 1.295 . . . . 0.0 110.653 172.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -63.06 -12.68 28.31 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 120.714 -1.241 . . . . 0.0 114.123 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -97.99 2.63 49.15 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.867 1.267 . . . . 0.0 111.938 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 35.2 t -84.04 135.59 34.37 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.784 1.234 . . . . 0.0 109.779 -171.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.17 -16.17 59.23 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.601 -0.687 . . . . 0.0 112.446 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -94.65 0.03 54.77 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.387 174.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -55.58 140.11 42.03 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.525 1.057 . . . . 0.0 110.807 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.41 -100.14 1.05 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 172.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -145.65 155.55 43.08 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.743 1.617 . . . . 0.0 107.388 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.38 145.75 49.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 123.749 0.655 . . . . 0.0 109.562 170.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.0 t -123.1 -45.21 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 125.316 1.446 . . . . 0.0 109.504 -174.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -147.78 -165.06 2.16 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.151 0.98 . . . . 0.0 109.821 -175.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -51.74 71.36 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 129.815 3.246 . . . . 0.0 114.847 -164.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.2 42.47 94.26 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -173.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -133.39 142.83 48.56 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.43 1.492 . . . . 0.0 108.9 172.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -156.46 173.34 34.27 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-O 122.25 0.917 . . . . 0.0 112.965 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -74.76 153.55 38.75 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 125.982 1.713 . . . . 0.0 112.317 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.8 t -141.52 117.76 10.72 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.109 1.364 . . . . 0.0 108.188 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 62.8 p -77.57 64.3 2.86 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.448 1.099 . . . . 0.0 111.862 -164.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.64 127.31 9.13 Favored Pre-proline 0 C--O 1.223 -0.326 0 C-N-CA 125.128 1.371 . . . . 0.0 108.138 176.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -58.15 -41.77 63.9 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.102 1.868 . . . . 0.0 110.794 -177.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -69.03 38.59 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.773 2.429 . . . . 0.0 112.463 172.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -176.58 -36.74 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.839 0.856 . . . . 0.0 112.555 -172.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -90.41 20.94 4.15 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.193 0.997 . . . . 0.0 112.377 -169.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.51 -55.56 4.23 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 167.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.3 m -76.3 176.73 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.497 169.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 22.3 tp -109.92 130.82 55.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.76 1.624 . . . . 0.0 107.763 171.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.6 m -93.85 140.66 16.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 118.703 0.683 . . . . 0.0 109.912 -174.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 tttm -62.96 135.45 57.31 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.02 -41.72 64.97 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 123.168 0.587 . . . . 0.0 111.018 173.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -83.42 6.3 20.6 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 175.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.66 -169.48 14.04 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 171.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 60.7 t90 -158.29 -179.7 8.35 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 174.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.838 ' SG ' HG22 ' A' ' 68' ' ' VAL . 5.2 p -163.03 161.15 25.29 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.531 1.06 . . . . 0.0 110.217 161.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.9 p -72.28 -9.84 59.01 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.227 -0.92 . . . . 0.0 113.084 -174.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.838 HG22 ' SG ' ' A' ' 66' ' ' CYS . 3.1 m -74.94 -17.56 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 119.427 1.012 . . . . 0.0 111.423 168.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -38.57 132.79 1.11 Allowed 'General case' 0 C--N 1.348 0.502 0 C-N-CA 125.31 1.444 . . . . 0.0 113.117 -174.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.84 135.02 26.85 Favored Pre-proline 0 N--CA 1.452 -0.343 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 165.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -72.4 147.29 46.52 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.998 1.799 . . . . 0.0 111.169 -175.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.63 51.94 2.21 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.765 0.793 . . . . 0.0 109.306 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.4 p . . . . . 0 C--O 1.254 1.322 0 CA-C-O 115.282 -2.294 . . . . 0.0 107.886 -177.214 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.072 0 CA-C-O 118.366 -0.826 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.2 m 50.4 38.05 17.08 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.258 1.023 . . . . 0.0 113.288 -174.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -64.8 153.1 88.9 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 168.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.92 143.34 54.58 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.071 1.847 . . . . 0.0 111.274 -174.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 36.6 mtt-85 -55.14 127.83 30.99 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.467 1.507 . . . . 0.0 111.956 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.11 147.51 52.05 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.441 1.096 . . . . 0.0 112.491 -175.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.4 pm0 -92.26 152.67 19.7 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 125.815 1.646 . . . . 0.0 112.324 -177.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.28 96.4 0.65 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.604 -175.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.01 28.71 14.48 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.426 -175.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -36.87 -53.11 0.94 Allowed 'General case' 0 C--N 1.344 0.344 0 C-N-CA 124.608 1.163 . . . . 0.0 111.001 166.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.55 -178.63 5.94 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 169.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 31.86 50.7 0.16 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.88 2.472 . . . . 0.0 113.269 173.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 55.49 30.34 14.95 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.676 0.79 . . . . 0.0 112.228 169.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -50.91 -64.95 0.65 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -168.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.288 19.1 m 54.18 130.12 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 126.897 2.079 . . . . 0.0 114.212 -171.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -66.1 -25.52 67.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 120.646 -1.284 . . . . 0.0 112.881 -172.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -110.32 117.12 32.78 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 171.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -45.47 -43.62 11.69 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.686 1.194 . . . . 0.0 110.793 172.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.3 -38.13 57.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.461 -0.78 . . . . 0.0 112.913 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -52.49 -39.64 61.46 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.199 0.909 . . . . 0.0 110.61 175.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.59 2.18 8.54 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 118.91 -0.567 . . . . 0.0 112.501 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.5 t -66.86 -2.95 5.77 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 120.055 1.298 . . . . 0.0 114.411 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.62 -9.87 71.19 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.27 0.938 . . . . 0.0 112.337 169.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -95.04 112.11 57.14 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 124.917 1.287 . . . . 0.0 110.449 -169.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -59.31 120.86 8.95 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 N-CA-C 107.424 -1.798 . . . . 0.0 107.424 163.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.5 tpt85 122.76 -40.33 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 129.175 2.99 . . . . 0.0 108.452 -168.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -65.39 146.32 55.04 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 166.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? -143.04 135.35 27.29 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -50.33 111.45 0.53 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.716 2.007 . . . . 0.0 111.736 -174.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.6 -10.31 45.59 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-O 118.98 -0.9 . . . . 0.0 111.623 174.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -64.75 118.58 9.16 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 119.109 1.455 . . . . 0.0 107.534 171.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 mp -130.04 149.06 51.92 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 125.989 1.716 . . . . 0.0 106.486 176.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.4 m -45.73 -46.91 15.31 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.065 0.946 . . . . 0.0 111.943 174.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -62.45 -15.84 51.85 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.428 -1.42 . . . . 0.0 114.167 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -110.74 23.38 14.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.625 1.17 . . . . 0.0 112.21 172.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.8 t -90.82 135.63 33.6 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.372 1.469 . . . . 0.0 108.236 172.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.79 -23.49 63.34 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 121.268 -0.895 . . . . 0.0 112.645 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -74.98 -13.49 60.52 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 118.337 -0.84 . . . . 0.0 112.53 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -52.33 136.33 31.22 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.52 1.055 . . . . 0.0 112.821 -171.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.83 -66.38 1.28 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 125.831 1.681 . . . . 0.0 110.352 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -178.24 154.02 0.81 Allowed 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -161.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.47 134.82 34.09 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 166.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.1 t -113.7 -39.73 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.891 1.676 . . . . 0.0 110.153 -172.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -147.27 -172.67 4.06 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.303 1.041 . . . . 0.0 110.192 -169.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -52.81 72.08 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 130.196 3.398 . . . . 0.0 113.69 -172.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.77 37.24 83.99 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -172.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -129.76 148.39 51.63 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 125.663 1.585 . . . . 0.0 108.852 172.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -165.07 -176.12 36.42 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.5 mtp-105 -96.65 152.69 18.41 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 119.008 -0.52 . . . . 0.0 110.313 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 p -123.86 136.1 54.16 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 156.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.4 p -80.84 56.33 2.69 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.985 1.314 . . . . 0.0 110.66 -161.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -155.14 99.1 2.35 Favored Pre-proline 0 N--CA 1.448 -0.567 0 O-C-N 121.754 -0.591 . . . . 0.0 110.784 -170.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -45.97 131.32 13.75 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.827 3.018 . . . . 0.0 111.482 170.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 118.27 -47.53 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 129.894 3.278 . . . . 0.0 104.884 -153.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -137.61 31.69 2.54 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.313 1.845 . . . . 0.0 110.757 -172.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -113.44 -41.84 3.58 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.669 0.788 . . . . 0.0 109.737 175.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.437 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 1.2 mp0 -49.4 -44.96 45.58 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.738 1.615 . . . . 0.0 111.568 177.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.2 m -111.91 149.88 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.697 1.599 . . . . 0.0 108.653 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.6 tp -77.95 132.43 37.87 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.0 t -90.31 122.47 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 125.912 1.685 . . . . 0.0 107.856 -169.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -60.78 130.55 47.03 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 121.023 -1.048 . . . . 0.0 108.455 171.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.02 -40.17 66.8 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.071 0.548 . . . . 0.0 111.657 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -83.51 3.04 34.04 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 175.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.24 -172.52 8.59 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 172.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -154.91 178.0 10.67 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 172.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.46 ' SG ' HG22 ' A' ' 68' ' ' VAL . 3.6 p -161.08 159.15 28.84 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.489 1.041 . . . . 0.0 109.013 163.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.7 p -73.77 -1.79 20.72 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.021 -1.049 . . . . 0.0 112.99 -175.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.46 HG22 ' SG ' ' A' ' 66' ' ' CYS 0.329 0.9 OUTLIER -83.31 -8.77 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 119.35 0.977 . . . . 0.0 112.286 164.957 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -38.86 123.7 1.31 Allowed 'General case' 0 C--N 1.344 0.368 0 C-N-CA 125.3 1.44 . . . . 0.0 112.914 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.33 134.84 23.06 Favored Pre-proline 0 N--CA 1.455 -0.213 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 169.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -70.82 150.32 61.57 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.08 1.853 . . . . 0.0 110.957 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.7 37.21 1.64 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.979 0.911 . . . . 0.0 110.227 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--O 1.25 1.106 0 C-N-CA 128.966 2.906 . . . . 0.0 105.242 177.764 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.75 ' HB3' ' CD ' ' A' ' 3' ' ' GLU . . . . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 m -107.97 55.29 0.65 Allowed 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 158.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.75 ' CD ' ' HB3' ' A' ' 1' ' ' ALA . 29.5 mp0 -60.5 140.05 92.3 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 123.031 0.532 . . . . 0.0 110.239 -175.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.64 151.88 83.34 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.634 2.223 . . . . 0.0 110.673 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.441 ' HB3' ' CH2' ' A' ' 47' ' ' TRP . 14.4 mtp180 -72.33 125.87 28.43 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -174.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -54.85 141.85 31.6 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.716 1.606 . . . . 0.0 112.817 -168.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -77.29 144.38 38.16 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.293 1.037 . . . . 0.0 108.592 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.09 120.16 10.91 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 165.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.86 25.19 72.37 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.219 -1.323 . . . . 0.0 112.93 -172.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -40.42 -54.84 2.38 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 119.595 1.698 . . . . 0.0 110.771 166.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -167.67 177.78 5.66 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.388 1.475 . . . . 0.0 107.579 172.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 33.38 52.04 0.35 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 127.057 2.143 . . . . 0.0 113.099 172.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 60.06 18.85 8.05 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.071 0.948 . . . . 0.0 112.675 169.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -62.69 137.42 58.26 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 118.554 0.615 . . . . 0.0 110.029 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.2 m -126.84 143.68 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 168.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -59.97 -34.59 73.49 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 119.12 -0.467 . . . . 0.0 111.284 -174.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.96 128.67 54.53 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 123.433 0.693 . . . . 0.0 110.285 169.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.11 -31.86 20.68 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.52 1.128 . . . . 0.0 110.63 165.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.18 -45.45 75.78 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.425 0.557 . . . . 0.0 111.406 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -29.75 70.09 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.216 0.532 . . . . 0.0 110.606 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.23 -6.05 36.71 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 118.324 -0.846 . . . . 0.0 112.599 -177.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 67.0 m -50.0 -32.41 15.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.22 -24.57 73.45 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.664 1.126 . . . . 0.0 113.164 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -79.03 117.72 68.42 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 118.404 1.102 . . . . 0.0 111.082 -169.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -63.94 108.45 0.93 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 N-CA-C 107.266 -1.859 . . . . 0.0 107.266 164.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 135.69 -31.79 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 131.166 3.787 . . . . 0.0 109.881 -173.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -68.5 149.12 49.63 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 171.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? -143.46 136.7 27.97 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -50.58 110.48 0.42 Allowed 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.954 2.101 . . . . 0.0 111.753 -174.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.14 -9.82 43.11 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-O 119.093 -0.837 . . . . 0.0 111.561 174.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -64.82 120.03 11.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.06 1.43 . . . . 0.0 107.824 172.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 mp -131.77 153.06 50.49 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.218 1.807 . . . . 0.0 107.206 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 33.6 m -48.96 -47.12 44.19 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.873 0.76 . . . . 0.0 110.993 174.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.257 6.2 tt0 -75.72 26.13 0.11 Allowed 'General case' 0 CA--C 1.549 0.915 0 O-C-N 120.32 -1.488 . . . . 0.0 113.671 176.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -142.25 29.77 1.61 Allowed 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.596 -1.315 . . . . 0.0 110.793 156.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 50.6 t -96.72 139.24 33.07 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.886 1.674 . . . . 0.0 109.208 177.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.89 -21.12 64.45 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.569 -0.707 . . . . 0.0 112.572 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -96.4 15.28 21.75 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 119.001 -0.523 . . . . 0.0 111.951 175.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -66.85 149.74 50.16 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.424 1.011 . . . . 0.0 110.997 175.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.53 -101.23 1.97 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.372 -1.891 . . . . 0.0 108.372 169.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -149.95 153.92 37.41 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.76 1.624 . . . . 0.0 107.648 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.13 141.54 58.72 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 123.69 0.619 . . . . 0.0 110.612 168.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.5 t -114.13 -49.19 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 126.28 1.832 . . . . 0.0 109.23 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -148.02 -150.58 0.35 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.408 0.683 . . . . 0.0 111.214 -171.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -67.55 68.16 0.09 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 128.338 2.655 . . . . 0.0 113.21 -161.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.01 29.33 46.92 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.548 1.07 . . . . 0.0 110.501 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TRP . . . . . 0.441 ' CH2' ' HB3' ' A' ' 5' ' ' ARG . 84.6 m95 -132.19 148.21 52.45 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.192 1.397 . . . . 0.0 109.462 177.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.64 178.8 36.49 Favored Glycine 0 N--CA 1.433 -1.564 0 O-C-N 124.395 1.059 . . . . 0.0 110.691 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -82.0 132.69 35.26 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.852 -0.674 . . . . 0.0 110.67 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 43.2 t -89.12 153.31 21.07 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 155.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.8 p -119.84 28.8 7.9 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.49 0.716 . . . . 0.0 111.468 -175.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -113.07 112.68 49.78 Favored Pre-proline 0 N--CA 1.455 -0.203 0 CA-C-O 117.721 -1.133 . . . . 0.0 108.19 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -46.59 124.11 7.78 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.852 1.701 . . . . 0.0 107.89 160.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 129.82 -43.52 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 128.887 2.875 . . . . 0.0 106.472 -157.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -131.48 -38.4 1.18 Allowed 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.361 2.264 . . . . 0.0 111.87 -171.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -42.12 -39.39 1.98 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.7 1.6 . . . . 0.0 112.921 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.431 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 2.5 mp0 -45.71 -39.73 8.41 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.119 0.968 . . . . 0.0 113.257 176.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.5 m -117.04 160.39 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 125.071 1.348 . . . . 0.0 109.872 -172.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 22.5 tp -83.64 131.18 34.97 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.8 t -104.63 133.71 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 123.674 0.79 . . . . 0.0 108.909 -167.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.413 ' HD2' ' CZ2' ' A' ' 47' ' ' TRP . 30.1 tttm -62.98 126.72 28.28 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 175.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.56 -31.78 68.3 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.343 0.657 . . . . 0.0 110.841 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -81.21 -8.19 59.71 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.796 1.238 . . . . 0.0 112.443 176.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.76 -172.42 35.87 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 72.3 t90 -165.84 150.58 8.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.7 p -134.22 162.36 32.36 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.965 1.306 . . . . 0.0 110.001 175.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.4 p -69.91 -20.42 63.36 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.0 -1.062 . . . . 0.0 112.672 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.364 0.8 OUTLIER -71.94 -3.75 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 119.553 1.069 . . . . 0.0 112.595 170.596 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -45.14 128.83 7.63 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.809 0.732 . . . . 0.0 111.012 171.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.73 137.67 31.45 Favored Pre-proline 0 N--CA 1.452 -0.334 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 165.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.8 148.95 59.47 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.028 1.819 . . . . 0.0 110.794 -177.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.13 42.83 1.09 Allowed 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.492 0.717 . . . . 0.0 109.953 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.1 p . . . . . 0 C--O 1.253 1.272 0 CA-C-O 114.889 -2.481 . . . . 0.0 106.759 -172.345 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo . . . . . 0 N--CA 1.454 -0.84 0 N-CA-C 110.515 -0.61 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 43.9 mtt-85 -58.19 126.33 27.02 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.814 1.245 . . . . 0.0 110.243 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.36 142.95 46.7 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.117 1.367 . . . . 0.0 112.489 -172.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -76.61 143.27 40.31 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.422 1.089 . . . . 0.0 108.294 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -62.03 117.01 5.41 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 165.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.8 16.59 67.59 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 118.263 -1.298 . . . . 0.0 113.652 -174.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -45.58 -58.29 3.52 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 119.818 1.809 . . . . 0.0 112.051 173.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.97 162.18 40.39 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 24.7 m-70 45.33 47.36 10.51 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.15 1.38 . . . . 0.0 113.199 172.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.85 25.81 10.84 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.69 0.796 . . . . 0.0 111.845 173.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -62.07 142.67 57.42 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 117.928 0.331 . . . . 0.0 111.194 -175.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.9 146.1 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 172.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -73.17 -26.99 61.39 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 124.402 1.081 . . . . 0.0 112.235 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -115.99 116.59 28.19 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 171.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -42.62 -48.97 5.54 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.343 1.057 . . . . 0.0 110.99 175.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.63 -38.16 31.01 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.839 0.856 . . . . 0.0 113.018 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -49.11 -39.53 28.71 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 119.181 0.9 . . . . 0.0 111.477 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.66 9.04 1.2 Allowed 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 118.301 -0.857 . . . . 0.0 113.119 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 62.6 m -49.77 -31.02 10.59 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 120.47 1.486 . . . . 0.0 114.226 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.44 -24.45 76.86 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.64 1.114 . . . . 0.0 112.927 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -79.99 120.13 78.84 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.562 1.145 . . . . 0.0 110.426 -171.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -46.48 -49.28 12.11 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.145 2.563 . . . . 0.0 113.924 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -15.76 60.79 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 117.563 -1.208 . . . . 0.0 113.418 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -73.91 145.82 44.48 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 120.878 1.672 . . . . 0.0 111.529 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -133.38 150.04 51.83 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 127.973 2.509 . . . . 0.0 104.377 165.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -66.69 165.02 15.72 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 124.064 0.852 . . . . 0.0 111.512 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.72 -26.26 3.21 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.077 1.322 . . . . 0.0 112.009 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -69.96 112.1 6.13 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 117.534 0.667 . . . . 0.0 109.333 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.1 mp -123.36 148.96 45.51 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.5 m -42.03 -46.71 4.28 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.437 1.095 . . . . 0.0 110.939 172.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -56.34 -26.8 53.82 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -109.2 23.61 14.27 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.711 1.204 . . . . 0.0 112.001 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 45.7 t -86.48 139.0 31.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.711 1.204 . . . . 0.0 108.942 174.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.52 -25.3 66.0 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 121.319 -0.863 . . . . 0.0 111.813 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -91.29 8.35 36.43 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.479 -0.772 . . . . 0.0 112.047 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 66.3 t-105 -56.73 138.18 53.31 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 120.188 1.358 . . . . 0.0 109.99 174.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.78 -85.18 1.03 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 171.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -163.91 159.1 20.57 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.27 136.41 39.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.581 HG23 ' HA2' ' A' ' 48' ' ' GLY . 90.2 t -106.74 -48.53 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.652 1.181 . . . . 0.0 108.383 -172.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -151.43 -138.98 0.09 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.93 0.492 . . . . 0.0 112.24 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -69.19 66.83 0.17 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.919 2.488 . . . . 0.0 113.013 -163.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.52 33.34 61.13 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 -175.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -131.65 143.5 50.35 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 125.893 1.677 . . . . 0.0 108.684 173.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.581 ' HA2' HG23 ' A' ' 43' ' ' VAL . . . -153.14 178.01 30.44 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 124.183 0.897 . . . . 0.0 111.489 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.417 ' HG3' ' CG2' ' A' ' 43' ' ' VAL . 32.4 mtp85 -88.31 159.13 18.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.308 0.643 . . . . 0.0 111.998 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.5 t . . . . . 0 CA--C 1.531 0.226 0 C-N-CA 125.837 1.655 . . . . 0.0 108.038 179.259 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.7 t70 . . . . . 0 CA--C 1.536 0.409 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -35.87 -45.44 0.4 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.98 1.312 . . . . 0.0 112.075 166.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 m -116.5 150.63 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 123.831 0.852 . . . . 0.0 108.987 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.517 HD11 HG21 ' A' ' 43' ' ' VAL . 12.4 tp -82.64 121.39 26.77 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.3 m -88.44 144.25 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 118.923 0.783 . . . . 0.0 109.161 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.3 tttm -67.01 136.97 56.11 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 174.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.62 -40.9 66.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 119.313 -0.375 . . . . 0.0 111.488 174.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -85.05 7.95 19.62 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 174.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.73 -177.27 23.46 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -160.07 155.58 25.48 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 172.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.0 p -143.27 167.17 22.78 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.097 0.959 . . . . 0.0 110.766 173.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.3 p -73.5 -21.7 60.34 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.33 1.0 OUTLIER -71.13 -5.37 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 119.433 1.015 . . . . 0.0 112.448 171.022 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -45.72 132.16 8.77 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 119.058 0.844 . . . . 0.0 111.652 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.32 139.47 35.74 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 166.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.25 151.14 54.28 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.058 1.838 . . . . 0.0 110.657 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.351 0 C-N-CA 123.894 0.878 . . . . 0.0 110.289 178.206 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo . . . . . 0 N--CA 1.455 -0.791 0 N-CA-C 111.079 -0.393 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 42.5 mtt-85 -63.95 125.31 24.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.557 1.143 . . . . 0.0 110.212 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.22 142.75 54.02 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.796 1.238 . . . . 0.0 112.171 -173.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -76.17 145.7 39.7 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.497 1.119 . . . . 0.0 108.731 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -62.37 121.21 12.65 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 164.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.87 20.85 75.53 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 118.267 -1.296 . . . . 0.0 113.448 -172.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -40.97 -56.8 2.17 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 119.488 1.644 . . . . 0.0 111.46 169.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.2 172.74 10.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.658 1.583 . . . . 0.0 106.96 174.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 44.28 47.56 7.84 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 124.412 1.085 . . . . 0.0 112.76 171.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 57.53 21.29 6.92 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 122.799 0.44 . . . . 0.0 111.498 172.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -62.53 140.7 58.63 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.521 0.601 . . . . 0.0 111.259 -172.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.2 m -126.88 143.56 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 173.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -71.33 -26.89 63.02 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.882 0.873 . . . . 0.0 111.684 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -112.08 111.42 22.31 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 169.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -45.13 -44.32 10.52 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.909 1.284 . . . . 0.0 110.957 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.55 -35.54 63.36 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.125 -0.94 . . . . 0.0 112.627 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -48.18 -43.75 32.02 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-O 122.278 1.037 . . . . 0.0 110.84 174.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.35 6.23 5.92 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.458 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -55.08 -28.54 53.19 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 120.258 1.39 . . . . 0.0 112.368 171.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.44 -14.15 59.47 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.518 1.056 . . . . 0.0 113.769 174.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -99.89 108.19 50.33 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 125.891 1.677 . . . . 0.0 111.502 -171.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -54.51 117.55 4.08 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 N-CA-C 108.258 -1.478 . . . . 0.0 108.258 162.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.7 tpt85 127.18 -41.32 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 129.023 2.929 . . . . 0.0 108.517 -169.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -66.81 153.79 42.49 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 169.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -152.75 136.26 15.97 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.198 168.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.5 mp0 -60.3 115.35 3.46 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.521 1.928 . . . . 0.0 110.112 -169.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.4 -30.76 5.29 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -176.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -66.93 115.66 6.91 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 mp -131.04 149.85 52.42 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 127.004 2.122 . . . . 0.0 105.405 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.2 m -43.58 -47.37 7.42 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.953 1.301 . . . . 0.0 111.43 173.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.44 -22.02 52.99 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -109.77 26.13 11.0 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.307 1.043 . . . . 0.0 112.344 175.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.7 t -97.06 136.78 37.12 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.568 1.547 . . . . 0.0 109.263 175.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.46 -20.86 65.93 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 120.929 -1.107 . . . . 0.0 113.002 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -80.4 -8.58 59.58 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.437 0.562 . . . . 0.0 112.113 175.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.402 ' CH2' ' HA3' ' A' ' 48' ' ' GLY . 74.9 t-105 -58.29 141.12 51.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.705 0.684 . . . . 0.0 111.501 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.61 -69.0 1.27 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 173.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -174.5 157.35 2.62 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -168.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.32 130.97 35.22 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 166.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.4 t -97.05 -49.31 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -175.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -152.07 -128.59 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -171.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -74.77 63.93 1.21 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.379 1.872 . . . . 0.0 112.623 -162.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.6 28.19 67.9 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.258 0.933 . . . . 0.0 110.944 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -126.79 145.17 50.73 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.823 1.649 . . . . 0.0 109.168 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.402 ' HA3' ' CH2' ' A' ' 39' ' ' TRP . . . -153.77 178.7 30.56 Favored Glycine 0 N--CA 1.436 -1.352 0 CA-C-O 122.208 0.893 . . . . 0.0 112.302 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -89.58 145.87 24.97 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.22 -0.99 . . . . 0.0 108.437 -172.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 175.241 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.471 0.578 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.0 pm0 -61.75 -16.82 52.68 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -175.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.2 m -132.01 158.36 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 119.556 1.071 . . . . 0.0 110.499 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.1 tp -91.85 123.2 35.04 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 175.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.0 m -94.85 148.97 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -67.65 137.22 55.42 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.14 -42.23 65.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.936 173.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -81.32 6.1 15.3 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 175.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.62 -177.32 34.76 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 119.539 1.063 . . . . 0.0 110.654 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 43.8 t90 -163.15 154.72 17.49 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 170.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.486 ' SG ' ' HB ' ' A' ' 68' ' ' VAL . 7.9 p -139.92 161.54 37.35 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.748 1.619 . . . . 0.0 110.034 173.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 89.9 p -70.65 -10.05 58.46 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.327 -0.858 . . . . 0.0 112.921 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.486 ' HB ' ' SG ' ' A' ' 66' ' ' CYS . 4.7 t -64.76 -35.26 74.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.268 1.027 . . . . 0.0 109.256 168.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -27.06 113.01 0.06 Allowed 'General case' 0 C--N 1.347 0.46 0 C-N-CA 126.43 1.892 . . . . 0.0 114.285 -170.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -113.24 133.18 22.14 Favored Pre-proline 0 N--CA 1.455 -0.22 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 167.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.11 150.55 66.26 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.704 1.602 . . . . 0.0 110.929 -177.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.331 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.342 177.003 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo . . . . . 0 N--CA 1.458 -0.603 0 N-CA-C 111.239 -0.331 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.9 mtt-85 -62.41 133.25 54.78 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.491 1.116 . . . . 0.0 110.895 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.98 145.49 55.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.986 1.315 . . . . 0.0 112.25 -174.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -75.45 142.89 42.88 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 124.82 1.248 . . . . 0.0 108.183 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -62.38 120.33 10.83 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 164.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.94 26.41 66.88 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 118.116 -1.38 . . . . 0.0 113.37 -172.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -42.73 -55.8 3.46 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 119.765 1.782 . . . . 0.0 110.767 167.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -165.48 169.99 14.93 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.715 1.206 . . . . 0.0 108.315 174.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 35.0 m-70 46.71 40.73 9.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.561 1.544 . . . . 0.0 113.335 172.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 57.16 30.65 18.68 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.621 1.168 . . . . 0.0 111.771 177.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -62.92 139.74 58.77 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 122.159 -0.338 . . . . 0.0 111.048 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 m -124.74 141.35 45.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 125.028 1.331 . . . . 0.0 107.841 172.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -68.54 -24.43 64.63 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 123.899 0.88 . . . . 0.0 112.196 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -117.7 122.8 44.46 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.138 1.375 . . . . 0.0 108.031 170.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.6 -49.05 62.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.667 0.787 . . . . 0.0 111.35 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.61 -23.06 66.13 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 117.768 -1.111 . . . . 0.0 112.793 -174.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -44.42 -44.08 8.15 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.831 1.196 . . . . 0.0 110.493 167.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.58 10.09 4.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.651 -175.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.9 t -69.45 -1.03 7.42 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 120.107 1.321 . . . . 0.0 114.43 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.96 -15.19 56.7 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.384 0.992 . . . . 0.0 111.81 169.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -81.28 114.41 48.97 Favored Pre-proline 0 N--CA 1.452 -0.346 0 C-N-CA 124.414 1.086 . . . . 0.0 109.671 -172.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -62.05 118.38 5.26 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 N-CA-C 107.114 -1.918 . . . . 0.0 107.114 165.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.7 tpt85 124.96 -37.62 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 129.204 3.002 . . . . 0.0 108.776 -168.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -64.83 148.3 51.59 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 168.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.7 tm0? -154.83 131.89 10.93 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -62.04 125.01 22.38 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 126.694 1.998 . . . . 0.0 112.532 -168.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.68 -25.18 23.61 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-O 118.822 -0.988 . . . . 0.0 111.345 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -60.08 119.5 7.93 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.096 1.448 . . . . 0.0 108.28 173.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 mp -131.41 153.26 49.88 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 127.048 2.139 . . . . 0.0 107.044 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 55.6 m -48.5 -49.45 35.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.619 0.768 . . . . 0.0 111.269 173.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.252 4.6 tt0 -76.92 31.35 0.13 Allowed 'General case' 0 CA--C 1.547 0.832 0 O-C-N 119.881 -1.762 . . . . 0.0 113.615 175.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -143.11 30.31 1.43 Allowed 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.573 -1.329 . . . . 0.0 110.629 155.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' A' ' 69' ' ' TYR . 47.9 t -102.69 138.41 39.63 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.056 1.742 . . . . 0.0 110.48 -175.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.59 -19.02 64.44 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 120.929 -1.107 . . . . 0.0 112.256 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -85.09 -0.21 53.74 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.853 0.861 . . . . 0.0 111.672 172.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 33.5 t-105 -66.05 148.72 51.38 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 119.384 0.993 . . . . 0.0 110.897 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.01 -99.25 1.45 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 107.42 -2.272 . . . . 0.0 107.42 165.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -148.36 159.91 43.53 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.788 1.635 . . . . 0.0 107.061 175.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.91 146.61 41.61 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.266 0.555 . . . . 0.0 110.694 166.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.6 t -118.83 -52.75 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 125.575 1.55 . . . . 0.0 108.568 -177.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -147.67 -152.85 0.46 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.672 0.789 . . . . 0.0 111.21 -175.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -56.54 68.45 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 130.031 3.332 . . . . 0.0 114.353 -163.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.05 30.71 67.37 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.648 1.118 . . . . 0.0 110.569 -174.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -129.19 146.35 51.13 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.359 1.464 . . . . 0.0 108.902 174.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -155.95 173.52 33.93 Favored Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.8 mtp-105 -78.13 130.22 36.11 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.097 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 39.8 t . . . . . 0 CA--C 1.536 0.422 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 150.574 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 121.178 0.513 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.527 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 2.2 mp0 -48.64 -46.63 40.12 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 127.16 2.184 . . . . 0.0 113.102 -176.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.1 m -111.71 153.68 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.88 1.272 . . . . 0.0 109.781 -169.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.2 tp -84.53 127.97 34.33 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.2 t -98.62 141.84 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -170.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -68.07 133.85 49.65 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.56 -35.17 71.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 119.264 -0.398 . . . . 0.0 111.856 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.53 3.86 34.62 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 173.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.65 -176.48 16.1 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 119.499 1.045 . . . . 0.0 111.257 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 72.9 t90 -158.7 156.59 30.19 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 171.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 10.3 p -142.24 171.38 14.13 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.779 0.831 . . . . 0.0 110.718 169.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.0 p -71.41 -29.66 65.18 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -174.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.5 m -67.74 -70.35 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . 0.455 ' HA ' ' SG ' ' A' ' 36' ' ' CYS . 58.2 t80 58.72 -85.34 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.203 1.801 . . . . 0.0 112.241 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 62.68 124.95 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.258 1.823 . . . . 0.0 111.299 -162.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -71.26 146.75 51.86 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.096 1.864 . . . . 0.0 111.196 -177.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.404 0 CA-C-O 121.733 0.778 . . . . 0.0 109.423 175.626 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo . . . . . 0 N--CA 1.454 -0.819 0 N-CA-C 110.821 -0.492 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 34.9 mtt-85 -61.78 129.58 41.66 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.683 1.193 . . . . 0.0 111.137 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.97 143.35 56.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.241 1.417 . . . . 0.0 112.442 -172.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -78.03 144.7 36.42 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.48 1.112 . . . . 0.0 108.595 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -63.46 122.08 15.4 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 165.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.66 22.98 73.98 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.174 -1.348 . . . . 0.0 113.085 -172.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -39.96 -56.77 1.76 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 119.431 1.615 . . . . 0.0 111.253 167.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -168.32 175.85 6.2 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.612 1.565 . . . . 0.0 107.275 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 37.11 50.07 0.9 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.053 1.741 . . . . 0.0 112.865 175.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 57.37 23.53 9.04 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.57 0.748 . . . . 0.0 112.054 172.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -63.4 136.97 57.98 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 118.111 0.414 . . . . 0.0 110.911 -174.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.7 m -124.04 141.61 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 173.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 -69.32 -23.91 63.85 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 123.851 0.86 . . . . 0.0 111.764 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -115.55 115.13 25.93 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.675 1.19 . . . . 0.0 107.931 171.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -43.39 -48.33 7.02 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.807 1.243 . . . . 0.0 110.983 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.5 -35.18 52.44 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.45 -0.786 . . . . 0.0 112.962 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -51.42 -40.52 59.5 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.617 1.098 . . . . 0.0 110.809 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.72 6.6 5.75 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.343 -0.837 . . . . 0.0 112.785 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.9 t -52.2 -32.66 37.46 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.917 1.235 . . . . 0.0 112.507 173.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.37 -21.67 76.04 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 114.659 -1.155 . . . . 0.0 113.8 176.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -80.32 114.93 51.22 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 119.079 1.44 . . . . 0.0 111.355 -168.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.29 107.65 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 N-CA-C 107.229 -1.873 . . . . 0.0 107.229 165.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 143.16 -35.81 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 1 C-N-CA 132.074 4.15 . . . . 0.0 108.652 -174.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -77.12 151.27 35.45 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.284 1.034 . . . . 0.0 110.946 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -137.6 146.49 44.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.675 2.39 . . . . 0.0 105.638 166.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -63.28 158.97 18.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.077 0.951 . . . . 0.0 111.155 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.38 -26.71 4.95 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.28 0.943 . . . . 0.0 111.792 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -67.18 112.25 4.37 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.2 mp -124.61 148.26 48.0 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 177.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.8 m -42.18 -45.66 4.14 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.482 1.113 . . . . 0.0 111.919 172.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -56.08 -26.43 49.42 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.729 -1.232 . . . . 0.0 113.972 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -108.91 27.24 9.69 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.131 1.372 . . . . 0.0 112.055 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 50.1 t -94.95 139.9 30.7 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.108 1.363 . . . . 0.0 109.331 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.73 -24.82 67.05 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.333 -0.855 . . . . 0.0 112.569 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -82.19 -2.8 53.45 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.37 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -61.98 140.51 58.33 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 119.256 0.935 . . . . 0.0 111.726 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.64 -71.78 1.25 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.277 1.418 . . . . 0.0 109.78 173.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -174.7 157.38 2.51 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.197 1.399 . . . . 0.0 107.39 -167.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.73 133.47 34.37 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 169.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.98 -49.08 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 124.568 1.147 . . . . 0.0 109.887 -174.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -146.41 -161.25 1.28 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.26 1.024 . . . . 0.0 110.108 -172.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -56.4 71.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 129.361 3.064 . . . . 0.0 114.293 -161.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.74 34.35 77.78 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -172.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -129.58 146.15 51.41 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 125.259 1.424 . . . . 0.0 109.222 173.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.28 -172.6 28.84 Favored Glycine 0 N--CA 1.432 -1.621 0 CA-C-O 121.99 0.772 . . . . 0.0 112.097 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -93.11 139.68 30.31 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -171.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.1 t . . . . . 0 C--N 1.33 -0.26 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 173.202 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 p30 . . . . . 0 CA--C 1.536 0.424 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -51.05 -35.06 32.63 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.996 0.816 . . . . 0.0 112.881 169.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.1 m -128.43 163.56 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 125.325 1.45 . . . . 0.0 109.736 -172.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.4 tp -86.93 129.57 34.82 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.4 t -98.58 135.34 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 124.069 0.948 . . . . 0.0 108.812 -168.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -65.25 131.12 45.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 176.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.02 -39.81 63.41 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.226 0.611 . . . . 0.0 111.626 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -83.87 2.33 38.95 Favored 'General case' 0 C--N 1.342 0.242 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.78 -177.06 23.24 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 119.412 1.005 . . . . 0.0 111.314 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 60.8 t90 -160.77 149.98 16.97 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 171.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.559 ' SG ' HG13 ' A' ' 68' ' ' VAL . 7.5 p -134.77 162.51 32.14 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.194 1.398 . . . . 0.0 109.838 174.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.8 p -71.93 -14.33 61.89 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 120.655 -1.278 . . . . 0.0 112.79 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.559 HG13 ' SG ' ' A' ' 66' ' ' CYS 0.348 1.7 p -85.44 10.0 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 125.562 1.545 . . . . 0.0 111.723 166.194 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -52.84 126.16 19.28 Favored 'General case' 0 C--N 1.342 0.27 0 O-C-N 120.54 -1.35 . . . . 0.0 110.232 163.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.83 134.06 24.81 Favored Pre-proline 0 N--CA 1.454 -0.254 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 169.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.51 148.42 66.62 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 121.675 1.583 . . . . 0.0 110.821 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.356 0 C-N-CA 123.882 0.873 . . . . 0.0 110.213 177.913 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo . . . . . 0 N--CA 1.452 -0.952 0 N-CA-C 110.353 -0.672 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.434 ' HB3' ' CH2' ' A' ' 47' ' ' TRP . 14.2 mtp180 -71.59 125.61 27.52 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -174.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -54.39 145.25 18.57 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.513 1.525 . . . . 0.0 113.1 -166.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -76.2 142.66 41.43 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.227 1.011 . . . . 0.0 108.459 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -63.36 116.33 5.42 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 164.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.74 25.23 60.82 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.327 -1.263 . . . . 0.0 113.222 -172.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -41.74 -53.69 3.56 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 119.399 1.599 . . . . 0.0 110.743 166.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.06 178.57 6.29 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.298 1.439 . . . . 0.0 107.415 169.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.1 m170 39.97 48.13 2.05 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 125.977 1.711 . . . . 0.0 112.414 165.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.41 20.86 7.79 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.046 1.338 . . . . 0.0 112.545 170.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -63.12 133.97 55.28 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 118.397 0.544 . . . . 0.0 110.036 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.56 144.15 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 168.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -60.38 -38.1 82.83 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.346 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.12 136.11 44.35 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 168.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.62 -28.29 69.26 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.583 0.753 . . . . 0.0 110.884 171.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.68 -52.71 29.1 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.383 0.538 . . . . 0.0 111.792 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -55.71 -30.95 62.01 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.961 1.305 . . . . 0.0 111.729 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.4 -8.77 49.55 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.941 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.7 t -51.53 -31.6 24.67 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 119.672 1.124 . . . . 0.0 113.253 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.01 -24.55 67.06 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-N 115.02 -0.991 . . . . 0.0 113.158 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -88.51 107.56 17.58 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 124.779 1.232 . . . . 0.0 110.841 -171.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -58.67 120.57 8.53 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 N-CA-C 107.006 -1.959 . . . . 0.0 107.006 161.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 52.6 tpt85 127.58 -38.6 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 129.103 2.961 . . . . 0.0 108.876 -167.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -70.39 160.07 33.01 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.765 0.793 . . . . 0.0 109.715 169.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -155.18 131.36 10.25 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 113.87 -1.513 . . . . 0.0 109.242 169.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.0 mp0 -56.1 113.0 1.35 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 127.198 2.199 . . . . 0.0 109.998 -175.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 126.43 -33.79 3.36 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -67.42 118.79 11.24 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.377 1.088 . . . . 0.0 108.335 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.7 mp -131.94 152.85 50.83 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.452 1.901 . . . . 0.0 106.875 176.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.3 m -49.29 -47.58 46.74 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.661 0.784 . . . . 0.0 111.148 175.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.257 6.3 tt0 -75.1 23.96 0.1 Allowed 'General case' 0 CA--C 1.55 0.961 0 O-C-N 120.261 -1.524 . . . . 0.0 113.838 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -139.04 28.19 2.33 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.54 -1.35 . . . . 0.0 110.998 157.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 50.4 t -96.34 135.78 37.72 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.857 1.663 . . . . 0.0 108.291 175.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.42 -22.27 64.86 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.322 -0.861 . . . . 0.0 112.232 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -88.74 2.99 52.46 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 118.821 -0.609 . . . . 0.0 112.481 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 60.7 t-105 -59.51 139.39 57.17 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 119.065 0.848 . . . . 0.0 110.9 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.38 -105.87 0.6 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.163 -1.975 . . . . 0.0 108.163 167.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -146.26 156.31 43.29 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.959 1.304 . . . . 0.0 107.876 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.12 146.16 54.68 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 123.867 0.729 . . . . 0.0 110.577 171.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.5 t -118.99 -54.99 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.897 1.279 . . . . 0.0 109.214 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -154.1 155.63 35.76 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 124.515 1.126 . . . . 0.0 109.454 -176.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.9 t0 48.91 31.8 3.43 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 148.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.17 33.4 44.92 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 120.908 -1.12 . . . . 0.0 112.921 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.434 ' CH2' ' HB3' ' A' ' 5' ' ' ARG . 64.7 m95 -134.55 160.39 38.2 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 127.376 2.27 . . . . 0.0 108.739 175.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.56 175.69 38.95 Favored Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.3 mtp-105 -78.97 142.03 37.0 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.154 -0.523 . . . . 0.0 110.437 174.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.6 t . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 168.15 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.4 t70 . . . . . 0 N--CA 1.466 0.356 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -42.9 -42.21 3.6 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.4 1.08 . . . . 0.0 112.89 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.7 m -117.04 156.75 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 124.727 1.211 . . . . 0.0 109.569 -173.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.8 tp -81.66 132.4 35.3 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 69.0 t -104.58 131.14 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 123.763 0.825 . . . . 0.0 109.166 -167.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -62.02 132.1 51.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.02 -34.98 78.73 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.068 -177.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -81.34 -1.19 44.42 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 118.077 -0.963 . . . . 0.0 113.568 172.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.62 -174.55 16.63 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 119.751 1.16 . . . . 0.0 111.159 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 17.8 t90 -165.53 153.09 10.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.426 ' SG ' HG22 ' A' ' 68' ' ' VAL . 7.7 p -135.62 161.72 34.73 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.575 1.15 . . . . 0.0 109.259 174.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.2 p -71.64 -14.63 62.11 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.091 -1.006 . . . . 0.0 112.713 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.426 HG22 ' SG ' ' A' ' 66' ' ' CYS 0.35 0.9 OUTLIER -75.32 -6.85 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 119.327 0.967 . . . . 0.0 112.478 170.007 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -40.39 125.45 2.12 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 124.642 1.177 . . . . 0.0 112.441 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.18 134.44 23.37 Favored Pre-proline 0 C--N 1.331 -0.197 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 168.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.19 149.27 63.91 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 121.607 1.538 . . . . 0.0 110.917 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.336 0 C-N-CA 123.801 0.841 . . . . 0.0 110.508 178.417 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 N--CA 1.452 -0.945 0 N-CA-C 110.687 -0.543 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.44 ' HB3' ' CH2' ' A' ' 47' ' ' TRP . 26.0 mtp180 -81.71 126.93 32.38 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -170.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -53.84 140.14 31.25 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.339 1.456 . . . . 0.0 113.544 -165.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.7 145.31 48.92 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.348 1.459 . . . . 0.0 108.348 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -50.29 122.15 6.54 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 157.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 65.79 27.75 73.01 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.027 -1.43 . . . . 0.0 114.188 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -42.94 -56.37 3.32 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 119.839 1.819 . . . . 0.0 111.816 171.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.88 165.56 35.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 173.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 44.57 48.52 8.54 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.815 1.246 . . . . 0.0 113.22 170.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.24 20.23 10.82 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.995 0.518 . . . . 0.0 111.882 170.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -62.19 144.33 55.61 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.605 0.639 . . . . 0.0 112.676 -171.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.1 m -127.86 144.39 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 124.764 1.226 . . . . 0.0 108.594 173.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -70.49 -26.51 63.64 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.395 0.678 . . . . 0.0 112.372 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -117.69 116.31 26.8 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 173.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -46.5 -44.75 17.93 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.245 1.018 . . . . 0.0 111.065 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.47 -37.89 58.13 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.464 -0.779 . . . . 0.0 112.619 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -48.07 -43.08 30.23 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-O 122.237 1.018 . . . . 0.0 110.83 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.35 3.21 11.48 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 118.05 -0.976 . . . . 0.0 112.762 -174.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.4 t -58.73 -24.37 61.44 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 120.615 1.552 . . . . 0.0 112.463 173.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.59 -25.8 70.48 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.134 0.873 . . . . 0.0 113.117 171.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -81.5 111.06 22.23 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 124.477 1.111 . . . . 0.0 110.954 -172.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 58.3 Cg_endo -61.39 111.44 1.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 N-CA-C 107.172 -1.895 . . . . 0.0 107.172 163.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER 141.1 -44.19 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.785 1 C-N-CA 131.991 4.116 . . . . 0.0 105.762 -170.093 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -64.28 153.75 37.25 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.991 0.901 . . . . 0.0 110.89 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -144.57 138.51 27.52 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 128.168 2.587 . . . . 0.0 106.526 170.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -58.48 149.49 25.05 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 127.223 2.209 . . . . 0.0 110.19 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.24 -16.96 35.76 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.657 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -75.32 96.96 3.47 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.046 1.423 . . . . 0.0 109.242 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.7 mp -101.56 147.44 26.4 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.905 1.682 . . . . 0.0 107.408 165.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 m -44.64 -43.19 8.06 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.396 1.479 . . . . 0.0 111.425 175.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -61.97 -16.85 54.42 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.436 -1.415 . . . . 0.0 113.933 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -94.84 2.8 55.49 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.128 1.371 . . . . 0.0 111.84 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 38.3 t -81.28 131.92 35.31 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.537 1.135 . . . . 0.0 109.129 -173.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.73 -19.11 47.93 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.198 -0.939 . . . . 0.0 112.165 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.6 m-30 -87.39 -9.65 54.18 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.171 0.988 . . . . 0.0 112.328 177.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.415 ' CH2' ' HA3' ' A' ' 48' ' ' GLY . 77.1 t-105 -55.38 142.41 32.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.189 0.596 . . . . 0.0 111.154 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.62 -97.79 1.4 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 171.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -141.89 158.83 43.31 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.254 1.422 . . . . 0.0 107.834 178.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.04 151.08 43.4 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 123.822 0.701 . . . . 0.0 109.972 172.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.1 t -123.82 -50.72 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.208 1.403 . . . . 0.0 109.99 -172.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -140.73 -138.64 0.12 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.538 0.735 . . . . 0.0 112.206 -176.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -68.51 64.18 0.11 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 127.943 2.497 . . . . 0.0 113.583 -167.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.04 56.14 25.66 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 108.206 -1.957 . . . . 0.0 108.206 -168.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.44 ' CH2' ' HB3' ' A' ' 5' ' ' ARG . 66.7 m95 -133.75 154.51 50.92 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 165.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.415 ' HA3' ' CH2' ' A' ' 39' ' ' TRP . . . -164.97 174.82 40.94 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-O 122.489 1.05 . . . . 0.0 112.468 175.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -73.68 145.43 45.26 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 126.473 1.909 . . . . 0.0 111.452 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 29.0 t . . . . . 0 CA--C 1.549 0.924 0 C-N-CA 127.986 2.515 . . . . 0.0 110.148 -176.0 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.6 t70 . . . . . 0 CA--C 1.535 0.374 0 N-CA-C 112.668 0.618 . . . . 0.0 112.668 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.94 -55.5 10.76 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 171.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.3 m -78.01 165.94 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 169.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 22.5 tp -102.87 131.3 49.86 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.624 1.17 . . . . 0.0 108.508 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.0 m -97.21 143.29 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 119.393 0.997 . . . . 0.0 110.368 -175.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.439 ' HE2' ' NE1' ' A' ' 47' ' ' TRP . 0.0 OUTLIER -58.12 137.02 57.3 Favored 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 172.587 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.08 -42.13 72.43 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.909 0.884 . . . . 0.0 110.214 171.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -80.95 7.1 11.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.91 -175.38 32.0 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 76.8 t90 -159.37 154.16 24.62 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 169.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 6.8 p -138.21 165.97 25.35 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 124.0 0.812 . . . . 0.0 110.755 170.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.0 p -64.48 -31.99 73.43 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.698 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.284 1.3 m -72.97 -3.23 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 118.353 -0.832 . . . . 0.0 113.095 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -44.84 127.15 6.21 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.35 0.977 . . . . 0.0 110.859 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.2 132.81 24.27 Favored Pre-proline 0 N--CA 1.454 -0.259 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 168.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.44 151.2 65.03 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.823 1.682 . . . . 0.0 110.971 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.348 0 C-N-CA 123.808 0.843 . . . . 0.0 110.429 176.388 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo . . . . . 0 N--CA 1.451 -1.018 0 N-CA-C 110.009 -0.804 . . . . 0.0 110.009 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 34.0 mtt-85 -58.59 126.25 26.83 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.849 1.26 . . . . 0.0 110.476 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.33 143.58 39.23 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.474 1.51 . . . . 0.0 111.253 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.64 149.38 22.83 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.496 0.665 . . . . 0.0 111.113 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.85 121.02 11.86 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.94 15.78 69.21 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 117.913 -1.493 . . . . 0.0 113.124 -173.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -38.84 -58.44 1.08 Allowed 'General case' 0 C--N 1.346 0.448 0 CA-C-N 119.603 1.701 . . . . 0.0 111.994 172.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -169.03 172.01 7.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.548 1.539 . . . . 0.0 107.221 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 39.02 50.52 1.78 Allowed 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.709 1.604 . . . . 0.0 112.476 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 55.41 25.71 7.98 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.272 1.029 . . . . 0.0 112.553 174.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -63.65 137.58 58.15 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.386 0.539 . . . . 0.0 111.125 -175.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.4 m -124.22 144.29 34.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 172.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -71.89 -27.43 62.84 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.25 1.02 . . . . 0.0 111.852 176.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -113.98 114.21 25.85 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 171.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -40.63 -49.33 3.0 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.352 1.461 . . . . 0.0 111.054 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.54 -34.69 59.13 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.589 0.756 . . . . 0.0 112.982 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -50.04 -41.2 47.09 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.532 1.06 . . . . 0.0 110.935 174.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.74 9.78 2.61 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 118.428 -0.796 . . . . 0.0 112.805 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.3 t -52.66 -31.76 38.76 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 120.115 1.325 . . . . 0.0 112.691 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.82 -21.77 78.11 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.696 1.141 . . . . 0.0 113.823 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -79.72 115.45 53.78 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 118.752 1.276 . . . . 0.0 111.362 -168.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.02 72.87 3.22 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.961 2.441 . . . . 0.0 111.21 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 52.8 mmt-85 -178.06 -36.27 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 131.623 3.969 . . . . 0.0 107.953 173.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -58.91 151.63 21.31 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.58 0.705 . . . . 0.0 110.399 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -136.75 146.04 45.31 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 166.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -59.38 148.43 32.58 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.462 0.649 . . . . 0.0 110.167 176.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.43 -23.16 16.7 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.348 0.975 . . . . 0.0 112.569 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -72.63 105.09 4.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 118.342 1.071 . . . . 0.0 108.765 177.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.7 mp -117.29 149.0 41.18 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 14.8 m -42.19 -46.19 4.32 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.248 1.419 . . . . 0.0 111.33 172.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -56.91 -26.82 59.98 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.789 -1.194 . . . . 0.0 114.152 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -107.16 19.15 20.79 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.11 0.964 . . . . 0.0 112.562 176.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.5 t -82.88 134.56 35.08 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.612 1.165 . . . . 0.0 108.525 173.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.87 -19.26 59.88 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.056 -1.027 . . . . 0.0 112.108 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -87.63 -5.21 58.83 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.451 -0.785 . . . . 0.0 111.425 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -53.86 142.71 23.32 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.543 1.065 . . . . 0.0 111.465 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.87 -85.95 1.17 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 173.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -166.31 158.95 14.43 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.08 137.01 38.68 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 123.603 0.564 . . . . 0.0 110.029 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.513 HG21 HD11 ' A' ' 59' ' ' LEU . 90.1 t -108.99 -49.93 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 125.417 1.487 . . . . 0.0 109.255 -175.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -151.71 -155.44 0.62 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.339 1.056 . . . . 0.0 110.886 -175.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -56.96 70.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 129.394 3.077 . . . . 0.0 114.416 -160.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.58 36.65 88.53 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -172.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -130.81 143.44 50.74 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 125.444 1.497 . . . . 0.0 109.065 173.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.419 ' HA2' HG23 ' A' ' 43' ' ' VAL . . . -156.77 -176.56 28.99 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-O 121.755 0.642 . . . . 0.0 112.189 177.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.481 ' HD2' HD12 ' A' ' 59' ' ' LEU . 48.4 mmm-85 -90.87 154.89 19.16 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.34 1.056 . . . . 0.0 109.963 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.455 -0.183 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -179.097 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.2 t70 . . . . . 0 CA--C 1.536 0.433 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -24.34 -53.74 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.469 2.308 . . . . 0.0 112.897 160.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.6 m -126.7 159.05 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.853 1.661 . . . . 0.0 108.064 -170.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.513 HD11 HG21 ' A' ' 43' ' ' VAL . 10.3 tp -79.16 123.41 27.36 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.2 t -92.32 129.24 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -171.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -63.38 131.28 47.74 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.14 -41.99 49.85 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.484 0.714 . . . . 0.0 111.512 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -84.84 5.45 28.7 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.35 -176.01 27.43 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 119.414 1.006 . . . . 0.0 111.148 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 83.1 t90 -159.19 153.72 24.25 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 170.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.411 ' SG ' HG22 ' A' ' 68' ' ' VAL . 2.0 p -142.06 163.63 32.35 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.861 1.264 . . . . 0.0 110.578 175.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.1 p -78.14 -5.95 53.22 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.411 HG22 ' SG ' ' A' ' 66' ' ' CYS 0.284 1.5 m -83.61 0.3 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 119.598 1.09 . . . . 0.0 112.169 164.574 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -47.14 137.98 7.33 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 119.073 0.852 . . . . 0.0 111.708 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -134.57 138.7 30.59 Favored Pre-proline 0 N--CA 1.454 -0.259 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 167.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.11 149.85 52.97 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.033 1.822 . . . . 0.0 111.147 -176.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.321 0 C-N-CA 123.932 0.893 . . . . 0.0 110.071 176.463 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo . . . . . 0 N--CA 1.455 -0.743 0 N-CA-C 110.813 -0.495 . . . . 0.0 110.813 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -57.89 125.69 24.16 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.065 1.346 . . . . 0.0 110.604 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.15 150.14 30.69 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.189 1.396 . . . . 0.0 112.75 -173.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -83.34 144.57 29.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.913 1.285 . . . . 0.0 108.623 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.1 121.98 14.4 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 166.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.79 22.91 76.28 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.175 -1.347 . . . . 0.0 113.271 -173.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -42.04 -55.09 3.31 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 119.557 1.678 . . . . 0.0 111.182 168.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -165.94 173.89 10.03 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.066 1.347 . . . . 0.0 108.06 173.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 38.33 50.69 1.5 Allowed 'General case' 0 C--N 1.341 0.23 0 C-N-CA 126.025 1.73 . . . . 0.0 112.986 172.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.2 20.5 8.56 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.384 0.674 . . . . 0.0 111.905 171.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -63.22 136.02 57.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.862 0.755 . . . . 0.0 110.543 -175.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.9 m -122.62 142.19 40.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -62.74 -36.66 83.74 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.921 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -109.01 123.3 48.93 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 123.401 0.68 . . . . 0.0 109.362 170.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.56 -36.44 10.56 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.25 1.42 . . . . 0.0 110.919 171.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.24 -40.99 64.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -56.38 -37.63 70.34 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 122.024 0.916 . . . . 0.0 110.604 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.51 0.69 13.96 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 117.831 -1.081 . . . . 0.0 112.245 -175.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.2 t -52.29 -30.39 27.88 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 120.36 1.436 . . . . 0.0 112.861 172.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.25 -27.2 72.13 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.49 1.043 . . . . 0.0 113.679 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -81.49 114.86 52.91 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 118.375 1.087 . . . . 0.0 111.494 -169.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.403 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 59.0 Cg_endo -63.05 108.7 0.8 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 N-CA-C 107.614 -1.726 . . . . 0.0 107.614 165.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 25' ' ' PRO . 2.0 mmm180 139.34 -35.41 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 131.487 3.915 . . . . 0.0 108.748 -173.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -71.9 156.55 39.15 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.492 0.663 . . . . 0.0 109.765 175.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -155.16 138.94 16.17 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.384 165.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -54.71 115.61 2.25 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 128.114 2.565 . . . . 0.0 109.53 -175.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.37 -21.19 11.96 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -72.92 109.27 6.35 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 167.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.2 mp -122.89 148.64 45.2 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.355 2.262 . . . . 0.0 106.137 172.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 6.5 m -45.07 -44.49 10.35 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.498 1.519 . . . . 0.0 111.711 175.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -59.12 -18.81 39.0 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 120.657 -1.277 . . . . 0.0 113.903 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -96.8 3.98 51.99 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.217 1.407 . . . . 0.0 112.043 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.2 t -90.79 139.99 30.21 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.849 1.26 . . . . 0.0 110.396 -169.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.84 -11.3 58.31 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.007 -1.058 . . . . 0.0 112.857 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -88.96 -3.92 58.59 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.604 171.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -59.52 132.28 53.52 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.07 0.85 . . . . 0.0 110.321 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.88 -81.03 1.13 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 171.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.6 165.68 12.18 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.612 0.765 . . . . 0.0 110.165 163.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.406 ' HA ' ' HA3' ' A' ' 48' ' ' GLY . . . -58.74 146.64 36.03 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.313 1.045 . . . . 0.0 111.034 170.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.2 t -125.23 -48.47 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 124.925 1.29 . . . . 0.0 109.211 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -149.17 -159.15 0.99 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.016 0.926 . . . . 0.0 110.192 -174.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -59.32 70.3 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 129.648 3.179 . . . . 0.0 113.799 -162.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.0 30.08 57.96 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -131.55 143.02 50.06 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 124.949 1.299 . . . . 0.0 108.845 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 42' ' ' ALA . . . -152.89 172.91 31.91 Favored Glycine 0 N--CA 1.433 -1.508 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -72.03 127.76 33.56 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.105 170.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 52.0 t . . . . . 0 C--O 1.242 0.7 0 N-CA-C 104.778 -2.305 . . . . 0.0 104.778 141.062 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 t0 . . . . . 0 CA--C 1.532 0.279 0 CA-C-O 120.974 0.416 . . . . 0.0 110.39 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -52.13 -41.43 62.5 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.456 1.903 . . . . 0.0 112.37 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.6 m -114.94 153.66 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 125.476 1.51 . . . . 0.0 109.424 -173.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.6 tp -85.28 136.27 33.57 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.6 t -104.97 134.8 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 123.608 0.763 . . . . 0.0 109.089 -167.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -64.01 129.64 40.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.17 -40.11 67.2 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.167 0.587 . . . . 0.0 111.632 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -82.7 1.26 39.5 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 175.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.57 -174.0 19.23 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 120.055 1.298 . . . . 0.0 111.832 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 75.2 t90 -163.87 150.64 11.81 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 174.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.6 p -135.76 162.99 31.21 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.142 1.377 . . . . 0.0 110.462 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.4 p -68.08 -21.76 64.96 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 118.454 -0.784 . . . . 0.0 112.521 -176.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.292 1.1 m -76.29 -4.64 6.39 Favored 'Isoleucine or valine' 0 C--N 1.344 0.36 0 CA-C-N 119.249 0.931 . . . . 0.0 112.705 175.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -42.69 126.47 3.67 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 118.777 0.717 . . . . 0.0 111.784 178.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.92 134.39 26.05 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 165.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.9 150.15 66.95 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 121.586 1.524 . . . . 0.0 111.027 -175.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.367 0 CA-C-O 121.574 0.702 . . . . 0.0 109.807 172.568 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo . . . . . 0 N--CA 1.458 -0.6 0 N-CA-C 110.752 -0.519 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.3 mtt180 -55.1 125.68 21.52 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.476 1.111 . . . . 0.0 110.868 172.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.58 152.5 34.8 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.64 1.176 . . . . 0.0 113.542 -172.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -84.8 143.4 29.13 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.452 1.501 . . . . 0.0 108.774 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -63.59 118.78 8.69 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 167.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.0 20.81 72.4 Favored Glycine 0 CA--C 1.531 1.094 0 CA-C-O 118.377 -1.235 . . . . 0.0 113.112 -173.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -43.89 -56.87 3.61 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 119.453 1.627 . . . . 0.0 111.477 169.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.09 172.96 10.79 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.146 1.378 . . . . 0.0 108.015 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 36.84 48.45 0.67 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.37 1.868 . . . . 0.0 113.246 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 55.77 23.85 6.75 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.853 0.861 . . . . 0.0 112.127 173.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -63.14 135.09 56.97 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.172 0.442 . . . . 0.0 110.096 -175.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.7 m -123.23 141.46 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 170.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.3 m-20 -62.61 -36.13 81.76 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 118.949 -0.548 . . . . 0.0 111.1 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.87 130.34 55.01 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 123.516 0.727 . . . . 0.0 109.334 168.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.49 -34.55 36.33 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.358 1.063 . . . . 0.0 110.654 170.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.05 -45.25 64.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.238 0.215 . . . . 0.0 111.434 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.52 -20.72 65.85 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.577 0.751 . . . . 0.0 111.933 -176.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.27 -6.53 55.26 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.544 -0.723 . . . . 0.0 111.968 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.2 m -62.73 91.88 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 119.162 0.892 . . . . 0.0 111.22 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.37 -36.0 1.03 Allowed Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.263 1.411 . . . . 0.0 110.764 -172.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -62.12 116.8 24.25 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.278 -0.868 . . . . 0.0 109.28 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.91 116.52 3.61 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 N-CA-C 107.455 -1.786 . . . . 0.0 107.455 170.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.5 tpt85 123.2 -35.54 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 129.438 3.095 . . . . 0.0 109.278 -170.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -62.7 149.73 42.96 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.52 0.676 . . . . 0.0 109.454 168.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -157.19 137.07 12.45 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.128 1.771 . . . . 0.0 106.368 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -58.33 123.47 16.21 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.522 2.329 . . . . 0.0 110.998 -172.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.94 -20.68 37.93 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-O 119.181 -0.788 . . . . 0.0 111.607 176.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -67.66 111.41 4.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 118.829 1.314 . . . . 0.0 107.909 173.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.6 mp -124.96 149.64 47.45 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 172.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.4 m -42.91 -45.54 5.01 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.042 1.337 . . . . 0.0 111.89 173.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -56.86 -26.08 57.83 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -109.26 25.72 11.47 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.178 0.991 . . . . 0.0 112.357 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 45.1 t -86.42 138.8 31.49 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.584 1.153 . . . . 0.0 108.838 172.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.09 -26.27 64.52 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.443 -0.785 . . . . 0.0 112.079 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -78.14 -10.92 59.85 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 117.719 -1.134 . . . . 0.0 112.559 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -49.56 127.77 16.22 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.988 1.267 . . . . 0.0 111.898 -172.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.18 -84.65 0.59 Allowed Glycine 0 C--N 1.335 0.485 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.81 171.17 11.64 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 155.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.28 145.76 46.3 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.55 1.14 . . . . 0.0 110.996 169.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.3 t -123.62 -47.45 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 125.746 1.619 . . . . 0.0 109.24 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -148.46 -162.73 1.62 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.987 0.915 . . . . 0.0 110.186 -174.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -58.05 71.23 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 129.675 3.19 . . . . 0.0 113.934 -163.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.95 26.82 57.61 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.985 1.278 . . . . 0.0 110.913 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -129.67 144.47 51.3 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 124.978 1.311 . . . . 0.0 109.644 176.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -154.04 -178.36 28.39 Favored Glycine 0 N--CA 1.437 -1.247 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.0 mtp85 -94.66 154.6 17.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 118.926 -0.559 . . . . 0.0 109.909 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.454 -0.239 0 C-N-CA 123.49 0.716 . . . . 0.0 109.093 159.972 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 . . . . . 0 N--CA 1.466 0.35 0 CA-C-O 122.253 1.025 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.3 pm0 -51.92 -34.08 40.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.085 1.354 . . . . 0.0 111.549 166.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 m -127.39 149.62 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 125.285 1.434 . . . . 0.0 108.598 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.4 tp -91.55 142.66 27.41 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.371 1.468 . . . . 0.0 108.963 -171.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.2 t -102.06 124.7 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 124.927 1.291 . . . . 0.0 108.457 -162.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.3 tttm -61.6 126.81 28.69 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 171.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.65 -38.0 30.62 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.069 0.948 . . . . 0.0 111.676 175.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -83.54 -4.34 58.46 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.41 -173.32 29.73 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 119.034 0.834 . . . . 0.0 111.991 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 86.0 t90 -161.75 148.88 14.31 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.614 ' SG ' HG13 ' A' ' 68' ' ' VAL . 5.6 p -135.11 163.83 29.02 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.186 1.394 . . . . 0.0 109.341 172.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.7 p -73.07 -18.1 61.35 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.969 -1.082 . . . . 0.0 112.672 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.614 HG13 ' SG ' ' A' ' 66' ' ' CYS 0.373 1.5 p -77.87 7.13 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 124.866 1.266 . . . . 0.0 111.785 164.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -52.5 130.36 31.48 Favored 'General case' 0 C--N 1.345 0.394 0 O-C-N 120.206 -1.559 . . . . 0.0 110.28 162.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.95 134.63 26.53 Favored Pre-proline 0 N--CA 1.453 -0.291 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 171.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -73.28 148.37 43.62 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 121.788 1.659 . . . . 0.0 110.658 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.389 0 CA-C-O 121.746 0.784 . . . . 0.0 109.523 178.843 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo . . . . . 0 N--CA 1.454 -0.804 0 N-CA-C 109.881 -0.853 . . . . 0.0 109.881 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.433 ' HB3' ' CH2' ' A' ' 47' ' ' TRP . 18.2 mtp180 -80.32 122.61 27.12 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -172.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.53 135.54 33.86 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.974 1.31 . . . . 0.0 112.804 -166.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -68.41 147.93 51.37 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.681 1.192 . . . . 0.0 109.464 177.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.27 87.75 0.12 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.744 0.818 . . . . 0.0 109.55 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.16 37.55 5.63 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.917 -173.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -39.65 -54.19 2.06 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 123.91 0.884 . . . . 0.0 109.943 164.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.416 ' HB3' ' CD2' ' A' ' 12' ' ' HIS . . . -165.76 175.21 8.94 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.494 1.518 . . . . 0.0 106.986 170.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . 0.416 ' CD2' ' HB3' ' A' ' 11' ' ' ALA . 3.4 m-70 55.21 30.02 13.81 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.966 1.307 . . . . 0.0 113.603 169.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 57.08 34.58 25.1 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.603 1.161 . . . . 0.0 111.938 175.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -54.12 -64.48 0.81 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -171.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.284 23.6 m 55.52 134.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 127.206 2.202 . . . . 0.0 114.077 -169.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -66.69 -28.9 68.81 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 120.77 -1.206 . . . . 0.0 112.405 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -113.11 118.95 36.16 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 171.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.91 -43.59 29.01 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.48 1.112 . . . . 0.0 109.818 175.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.97 -40.24 13.99 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.75 0.82 . . . . 0.0 112.889 175.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -52.44 -34.85 50.61 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.507 1.049 . . . . 0.0 111.445 178.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.29 5.11 3.07 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 116.895 -1.526 . . . . 0.0 113.811 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.8 m -13.68 99.99 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 128.13 2.572 . . . . 0.0 113.942 170.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.15 21.66 64.19 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.312 0.958 . . . . 0.0 115.052 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -48.09 127.47 11.99 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 119.31 1.555 . . . . 0.0 107.783 162.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -61.01 110.26 0.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.708 0 CA-C-N 121.252 1.483 . . . . 0.0 108.299 175.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.5 tpt85 123.66 -40.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 129.578 3.151 . . . . 0.0 110.161 -171.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -70.82 143.39 51.14 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.795 0.725 . . . . 0.0 110.557 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . 0.512 ' H ' ' NE2' ' A' ' 31' ' ' GLN . 23.0 mp0 -132.95 123.2 25.49 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 162.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.0 mp0 -54.15 119.05 4.58 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 128.407 2.683 . . . . 0.0 109.181 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.99 -34.55 3.38 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -174.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.512 ' NE2' ' H ' ' A' ' 28' ' ' GLN . 25.7 mt-30 -63.94 118.4 8.38 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 171.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.87 147.27 50.8 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 126.086 1.754 . . . . 0.0 107.154 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.5 m -44.04 -48.8 8.88 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.15 0.98 . . . . 0.0 111.444 174.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -61.34 -20.45 62.99 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 120.431 -1.418 . . . . 0.0 113.983 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -107.21 24.12 13.34 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.811 1.244 . . . . 0.0 111.845 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.4 t -95.3 134.52 37.98 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.391 1.476 . . . . 0.0 109.595 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.0 -20.21 56.55 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.433 -0.792 . . . . 0.0 112.726 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -97.52 6.64 47.83 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.138 0.575 . . . . 0.0 112.192 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 -59.66 145.74 43.67 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.594 0.633 . . . . 0.0 110.392 171.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.18 -69.78 1.28 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 172.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -176.46 160.4 2.06 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 -169.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.37 140.38 31.61 Favored 'General case' 0 N--CA 1.457 -0.083 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 169.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.727 HG23 ' HA2' ' A' ' 48' ' ' GLY . 55.5 t -107.53 -51.37 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.401 1.48 . . . . 0.0 109.279 -173.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -149.55 -136.88 0.08 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.421 0.689 . . . . 0.0 111.728 -170.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -71.43 65.71 0.45 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.054 2.142 . . . . 0.0 112.988 -163.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.0 42.38 77.82 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -173.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.433 ' CH2' ' HB3' ' A' ' 5' ' ' ARG . 80.7 m95 -133.45 156.12 48.29 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 125.514 1.526 . . . . 0.0 108.232 170.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.727 ' HA2' HG23 ' A' ' 43' ' ' VAL . . . -157.47 -174.08 26.71 Favored Glycine 0 N--CA 1.434 -1.476 0 O-C-N 124.496 1.122 . . . . 0.0 110.507 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -98.23 153.64 18.35 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.402 1.081 . . . . 0.0 108.882 -176.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.519 ' HB2' HG21 ' A' ' 60' ' ' VAL . 9.2 t . . . . . 0 CA--C 1.528 0.132 0 C-N-CA 125.463 1.505 . . . . 0.0 107.867 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.4 p-10 . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -44.91 -42.56 8.19 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.939 1.296 . . . . 0.0 114.311 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.3 m -130.4 156.4 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.07 0.948 . . . . 0.0 111.951 -160.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.725 HD11 HG21 ' A' ' 43' ' ' VAL . 9.1 tp -78.81 126.76 31.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 173.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.519 HG21 ' HB2' ' A' ' 50' ' ' CYS . 11.0 m -98.13 134.93 34.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 118.815 0.734 . . . . 0.0 109.546 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -61.16 134.91 57.52 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.1 -40.56 73.87 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.66 0.384 . . . . 0.0 111.223 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -76.8 -2.34 32.72 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 175.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.11 -178.52 8.62 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 70.5 t90 -148.71 -179.48 7.02 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 170.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.432 ' SG ' HG22 ' A' ' 68' ' ' VAL . 5.7 p -162.66 164.85 26.37 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 119.038 0.835 . . . . 0.0 110.357 159.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.5 p -63.0 -30.99 72.03 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 118.939 -0.553 . . . . 0.0 111.781 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.432 HG22 ' SG ' ' A' ' 66' ' ' CYS 0.301 1.1 m -72.42 -5.34 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 118.885 0.766 . . . . 0.0 112.478 177.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -46.03 137.0 6.19 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.884 0.874 . . . . 0.0 112.031 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.43 140.59 39.12 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 165.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.04 147.76 38.96 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.282 1.988 . . . . 0.0 111.248 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 121.611 0.72 . . . . 0.0 109.424 177.016 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo . . . . . 0 N--CA 1.458 -0.577 0 N-CA-C 110.795 -0.502 . . . . 0.0 110.795 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.437 ' HB3' ' CH2' ' A' ' 47' ' ' TRP . 16.1 mtp180 -79.23 123.13 27.12 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -54.61 142.7 27.12 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.82 1.248 . . . . 0.0 112.68 -170.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.459 ' CD ' ' HD1' ' A' ' 10' ' ' HIS . 1.6 mp0 -76.58 145.61 38.85 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.006 1.322 . . . . 0.0 108.417 -178.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -64.86 121.57 14.92 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 167.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.97 25.73 74.12 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 118.275 -1.292 . . . . 0.0 112.855 -170.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.459 ' HD1' ' CD ' ' A' ' 7' ' ' GLU . 78.9 t60 -41.95 -57.87 2.26 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 119.388 1.594 . . . . 0.0 110.7 168.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.19 174.06 4.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.746 1.619 . . . . 0.0 107.351 173.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 54.46 31.97 15.78 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.802 1.241 . . . . 0.0 113.137 172.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 55.1 29.99 13.54 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.256 1.023 . . . . 0.0 111.596 -176.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -64.35 134.68 55.11 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.972 -0.455 . . . . 0.0 110.043 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.0 m -122.9 142.04 40.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 170.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -63.27 -34.92 78.73 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 118.993 -0.527 . . . . 0.0 111.534 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.69 127.27 54.47 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 123.634 0.774 . . . . 0.0 109.733 169.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.16 -38.47 11.86 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.732 1.213 . . . . 0.0 110.58 168.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.15 -41.76 60.33 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -59.7 -30.61 68.91 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.131 0.491 . . . . 0.0 111.373 -176.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.01 -0.31 30.67 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 118.85 -0.595 . . . . 0.0 112.448 -176.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.3 m -61.79 91.56 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 119.248 0.931 . . . . 0.0 111.377 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.06 -32.43 1.41 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.087 1.327 . . . . 0.0 111.431 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -60.26 125.12 80.79 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 118.067 0.933 . . . . 0.0 109.567 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 59.5 Cg_endo -65.21 102.3 0.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 N-CA-C 107.258 -1.862 . . . . 0.0 107.258 169.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER 139.9 -29.44 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 130.9 3.68 . . . . 0.0 110.235 -173.585 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -75.71 79.86 2.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.432 0.635 . . . . 0.0 109.769 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -64.75 137.62 57.9 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 161.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -59.46 118.55 6.16 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 128.085 2.554 . . . . 0.0 112.193 -172.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.67 -1.18 63.57 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-O 119.381 -0.677 . . . . 0.0 111.909 174.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -60.87 121.87 13.42 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.388 1.094 . . . . 0.0 108.372 166.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.7 mp -128.94 145.1 51.32 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.661 1.984 . . . . 0.0 107.723 173.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 6.8 m -45.54 -45.17 13.28 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 124.829 1.252 . . . . 0.0 112.75 177.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -64.84 -13.97 57.82 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 119.863 -1.773 . . . . 0.0 114.01 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -93.09 -1.16 56.76 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.318 1.047 . . . . 0.0 111.416 173.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.6 t -80.12 131.41 35.73 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.417 1.087 . . . . 0.0 109.138 -175.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.67 -6.29 19.89 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.969 -1.082 . . . . 0.0 112.472 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -93.57 -2.28 54.41 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.936 0.789 . . . . 0.0 111.755 171.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -59.56 149.37 30.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 118.518 0.599 . . . . 0.0 111.194 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.86 -74.82 1.27 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.287 1.422 . . . . 0.0 109.593 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -173.21 154.11 2.63 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.284 1.433 . . . . 0.0 107.152 -168.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.61 137.24 37.05 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 171.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.615 HG23 ' HA2' ' A' ' 48' ' ' GLY . 75.9 t -107.69 -48.62 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 125.244 1.418 . . . . 0.0 108.972 -173.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -149.37 -140.8 0.1 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.728 0.411 . . . . 0.0 111.866 -168.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -72.12 65.05 0.56 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.257 2.223 . . . . 0.0 112.561 -167.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.42 31.08 47.38 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.437 ' CH2' ' HB3' ' A' ' 5' ' ' ARG . 74.7 m95 -132.2 152.39 51.33 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 125.301 1.441 . . . . 0.0 109.224 173.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.615 ' HA2' HG23 ' A' ' 43' ' ' VAL . . . -154.84 -179.93 30.42 Favored Glycine 0 N--CA 1.431 -1.64 0 O-C-N 124.669 1.231 . . . . 0.0 110.832 178.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -86.05 145.77 26.92 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.142 0 C-N-CA 126.589 1.956 . . . . 0.0 105.751 174.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 . . . . . 0 N--CA 1.471 0.578 0 CA-C-O 121.482 0.658 . . . . 0.0 111.98 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -65.86 -17.24 64.51 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.701 1.6 . . . . 0.0 115.28 -174.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.27 149.02 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 120.192 1.36 . . . . 0.0 111.239 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.598 HD11 HG21 ' A' ' 43' ' ' VAL . 7.3 tp -77.78 130.41 36.67 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 174.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.4 t -106.04 129.67 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -174.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.419 ' HD2' ' CZ2' ' A' ' 47' ' ' TRP . 32.5 tttm -61.87 129.79 42.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 174.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.9 -36.69 67.94 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.565 0.746 . . . . 0.0 111.483 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -80.83 -7.03 59.32 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.57 -0.729 . . . . 0.0 112.455 178.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.38 -173.07 20.8 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 118.906 0.775 . . . . 0.0 111.915 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -161.19 150.68 16.8 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.41 ' SG ' HG22 ' A' ' 68' ' ' VAL . 1.8 p -139.82 172.44 12.78 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.235 1.014 . . . . 0.0 111.223 170.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 81.0 p -72.06 -35.53 69.31 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.41 HG22 ' SG ' ' A' ' 66' ' ' CYS . 2.4 m -64.84 -23.85 34.31 Favored 'Isoleucine or valine' 0 C--N 1.347 0.467 0 CA-C-N 118.568 0.622 . . . . 0.0 111.632 -175.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -20.45 105.39 0.02 OUTLIER 'General case' 0 C--O 1.237 0.403 0 C-N-CA 128.033 2.533 . . . . 0.0 113.486 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.57 120.57 57.26 Favored Pre-proline 0 N--CA 1.454 -0.234 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 165.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -66.1 134.41 36.67 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.253 1.302 . . . . 0.0 112.81 -173.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.235 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 142.48 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.453 -0.876 0 N-CA-C 111.312 -0.303 . . . . 0.0 111.312 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.1 mtt180 -62.46 127.37 31.01 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.783 1.233 . . . . 0.0 109.987 171.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.41 145.53 43.31 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.584 1.553 . . . . 0.0 111.514 -175.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.3 146.15 24.91 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.375 0.607 . . . . 0.0 110.94 175.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.92 120.33 9.43 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 172.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.75 18.7 65.12 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 117.997 -1.446 . . . . 0.0 113.742 -174.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -36.01 -55.3 0.76 Allowed 'General case' 0 C--N 1.347 0.467 0 CA-C-N 119.637 1.718 . . . . 0.0 111.602 168.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -164.77 -179.47 5.87 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 164.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.4 m170 46.22 45.95 13.1 Favored 'General case' 0 CA--C 1.527 0.071 0 O-C-N 124.213 0.945 . . . . 0.0 111.865 160.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 56.23 24.59 8.28 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.955 1.302 . . . . 0.0 112.219 172.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -62.49 136.69 58.02 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 118.152 0.433 . . . . 0.0 111.415 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.1 m -125.46 142.26 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 174.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -70.65 -24.87 62.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.2 1.0 . . . . 0.0 112.053 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -115.31 120.57 40.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.12 1.368 . . . . 0.0 107.919 168.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.04 -49.62 40.38 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.189 0.996 . . . . 0.0 111.665 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.7 -20.03 64.4 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 118.201 -0.904 . . . . 0.0 112.785 -173.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -44.57 -43.84 8.37 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.805 1.184 . . . . 0.0 110.466 165.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.03 7.9 12.07 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -175.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.6 p -33.14 -59.16 0.37 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 127.344 2.257 . . . . 0.0 113.19 174.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.93 -29.82 35.64 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 112.239 -2.255 . . . . 0.0 113.805 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -70.04 117.51 54.73 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 118.687 1.243 . . . . 0.0 110.908 -171.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -60.68 105.74 0.33 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 N-CA-C 107.439 -1.793 . . . . 0.0 107.439 163.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 141.41 -40.0 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 130.983 3.713 . . . . 0.0 108.662 -172.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -68.78 150.4 47.89 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 173.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -150.3 132.14 15.09 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.272 1.1 pm0 -56.94 107.26 0.38 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.31 1.444 . . . . 0.0 112.076 -173.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.39 -1.87 27.98 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 119.139 -0.811 . . . . 0.0 111.983 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -73.07 110.81 7.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.74 1.77 . . . . 0.0 107.044 164.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.5 mp -121.57 150.27 41.9 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.925 2.09 . . . . 0.0 106.346 170.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.8 m -47.7 -45.72 28.79 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.326 1.05 . . . . 0.0 111.946 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -62.89 -13.65 36.79 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 120.209 -1.557 . . . . 0.0 113.588 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -95.68 2.52 54.07 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 120.82 -1.175 . . . . 0.0 111.874 175.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 24.6 t -86.83 137.06 32.72 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.754 1.222 . . . . 0.0 109.448 -171.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.02 -20.66 65.52 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.188 -0.945 . . . . 0.0 111.867 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -87.29 2.07 51.31 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.566 -0.731 . . . . 0.0 112.528 173.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 48.2 t-105 -59.09 142.93 50.14 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.749 1.158 . . . . 0.0 111.071 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.43 -109.47 0.93 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 165.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -139.43 157.26 46.16 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.274 1.43 . . . . 0.0 107.782 175.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.27 141.44 58.02 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 123.929 0.768 . . . . 0.0 109.444 165.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.7 t -113.5 -54.05 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 124.5 1.12 . . . . 0.0 109.257 -174.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -157.87 153.97 27.19 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.364 1.066 . . . . 0.0 109.46 -177.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.4 t0 50.09 35.99 11.18 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 155.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.3 31.89 80.38 Favored Glycine 0 CA--C 1.535 1.331 0 O-C-N 120.615 -1.303 . . . . 0.0 112.992 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -123.37 152.73 41.22 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 127.935 2.494 . . . . 0.0 108.394 170.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -159.29 176.85 36.03 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-O 122.002 0.779 . . . . 0.0 111.363 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.62 145.06 30.79 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 114.647 -0.776 . . . . 0.0 111.814 176.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 21.7 t . . . . . 0 N--CA 1.445 -0.723 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 160.429 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 . . . . . 0 N--CA 1.452 -0.354 0 N-CA-C 111.212 0.078 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -70.46 0.32 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -175.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -69.84 165.98 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.712 0.805 . . . . 0.0 111.755 -171.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.3 tp -91.62 118.5 30.68 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 170.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.2 m -91.88 148.45 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -66.59 138.78 57.71 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.96 -36.93 80.68 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.178 0.445 . . . . 0.0 111.09 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -82.26 3.2 28.47 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 171.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.08 -176.91 28.24 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 73.5 t90 -163.64 153.93 15.5 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.408 ' SG ' HG22 ' A' ' 68' ' ' VAL . 3.1 p -135.69 160.26 39.06 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.774 1.23 . . . . 0.0 110.329 172.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.8 p -71.35 -15.9 62.41 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.325 -0.859 . . . . 0.0 112.654 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.408 HG22 ' SG ' ' A' ' 66' ' ' CYS 0.322 0.9 OUTLIER -76.48 -4.44 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 119.342 0.974 . . . . 0.0 112.323 172.132 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -42.91 130.92 4.26 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 124.183 0.993 . . . . 0.0 112.261 177.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.58 135.21 26.31 Favored Pre-proline 0 N--CA 1.455 -0.217 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 165.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -69.5 149.84 69.05 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 121.735 1.623 . . . . 0.0 110.798 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.418 0 CA-C-O 121.667 0.746 . . . . 0.0 110.007 174.01 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 N--CA 1.458 -0.574 0 CA-C-O 121.025 0.344 . . . . 0.0 111.73 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 31.9 mtt-85 -61.25 131.43 50.37 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.482 1.513 . . . . 0.0 111.158 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.32 142.96 54.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.012 1.325 . . . . 0.0 112.057 -178.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -84.95 155.23 21.72 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 122.042 0.925 . . . . 0.0 112.197 174.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -67.34 96.23 0.48 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.616 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.48 24.99 10.42 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.56 1.076 . . . . 0.0 111.667 -176.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -34.21 -55.52 0.51 Allowed 'General case' 0 C--N 1.345 0.372 0 C-N-CA 125.238 1.415 . . . . 0.0 111.896 170.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.37 169.66 22.64 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 169.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 43.77 46.45 6.46 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.933 1.293 . . . . 0.0 113.419 170.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 58.83 27.0 15.5 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.184 0.594 . . . . 0.0 112.298 169.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -46.99 -60.3 2.54 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -165.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.254 34.7 m 56.85 132.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 126.757 2.023 . . . . 0.0 113.893 -171.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -68.78 -27.68 66.1 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 120.574 -1.329 . . . . 0.0 112.746 -177.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -110.43 115.29 29.4 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 170.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -42.36 -46.64 4.7 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.07 1.348 . . . . 0.0 110.656 173.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.99 -37.31 44.16 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.915 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -51.63 -35.45 42.0 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.411 1.005 . . . . 0.0 111.643 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.88 2.83 13.5 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -177.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 64.8 m -61.62 93.0 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 119.598 1.09 . . . . 0.0 111.306 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.5 -34.51 1.06 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.52 1.533 . . . . 0.0 110.49 -174.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -62.74 115.71 18.86 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 117.871 -1.062 . . . . 0.0 109.335 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -62.73 120.34 7.82 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 N-CA-C 107.587 -1.736 . . . . 0.0 107.587 171.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 118.91 -39.22 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 129.185 2.994 . . . . 0.0 108.902 -168.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -64.05 142.11 58.53 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 166.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -144.84 147.82 33.28 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 174.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.1 mp0 -55.73 117.46 3.66 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.434 1.493 . . . . 0.0 110.776 -170.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.13 7.41 70.18 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 119.705 -0.497 . . . . 0.0 112.373 175.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -72.63 91.14 1.41 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 119.037 1.419 . . . . 0.0 108.509 167.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.5 mp -95.48 150.0 20.79 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.949 1.3 . . . . 0.0 109.003 169.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 2.1 m -46.21 -44.98 16.64 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.936 1.295 . . . . 0.0 110.653 172.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -63.06 -12.68 28.31 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 120.714 -1.241 . . . . 0.0 114.123 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -97.99 2.63 49.15 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.867 1.267 . . . . 0.0 111.938 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 35.2 t -84.04 135.59 34.37 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.784 1.234 . . . . 0.0 109.779 -171.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.17 -16.17 59.23 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.601 -0.687 . . . . 0.0 112.446 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -94.65 0.03 54.77 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.387 174.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -55.58 140.11 42.03 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.525 1.057 . . . . 0.0 110.807 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.41 -100.14 1.05 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 172.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -145.65 155.55 43.08 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.743 1.617 . . . . 0.0 107.388 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.38 145.75 49.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 123.749 0.655 . . . . 0.0 109.562 170.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.0 t -123.1 -45.21 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 125.316 1.446 . . . . 0.0 109.504 -174.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -147.78 -165.06 2.16 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.151 0.98 . . . . 0.0 109.821 -175.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -51.74 71.36 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 129.815 3.246 . . . . 0.0 114.847 -164.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.2 42.47 94.26 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -173.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -133.39 142.83 48.56 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.43 1.492 . . . . 0.0 108.9 172.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -156.46 173.34 34.27 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-O 122.25 0.917 . . . . 0.0 112.965 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -74.76 153.55 38.75 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 125.982 1.713 . . . . 0.0 112.317 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 CA--C 1.53 0.208 0 C-N-CA 125.109 1.364 . . . . 0.0 108.188 179.937 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.8 t0 . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.51 -55.56 4.23 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 167.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.3 m -76.3 176.73 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.497 169.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 22.3 tp -109.92 130.82 55.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.76 1.624 . . . . 0.0 107.763 171.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.6 m -93.85 140.66 16.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 118.703 0.683 . . . . 0.0 109.912 -174.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 tttm -62.96 135.45 57.31 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.02 -41.72 64.97 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 123.168 0.587 . . . . 0.0 111.018 173.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -83.42 6.3 20.6 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 175.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.66 -169.48 14.04 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 171.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 60.7 t90 -158.29 -179.7 8.35 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 174.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.838 ' SG ' HG22 ' A' ' 68' ' ' VAL . 5.2 p -163.03 161.15 25.29 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.531 1.06 . . . . 0.0 110.217 161.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.9 p -72.28 -9.84 59.01 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.227 -0.92 . . . . 0.0 113.084 -174.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.838 HG22 ' SG ' ' A' ' 66' ' ' CYS . 3.1 m -74.94 -17.56 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 119.427 1.012 . . . . 0.0 111.423 168.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -38.57 132.79 1.11 Allowed 'General case' 0 C--N 1.348 0.502 0 C-N-CA 125.31 1.444 . . . . 0.0 113.117 -174.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.84 135.02 26.85 Favored Pre-proline 0 N--CA 1.452 -0.343 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 165.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -72.4 147.29 46.52 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.998 1.799 . . . . 0.0 111.169 -175.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.462 0 CA-C-O 121.765 0.793 . . . . 0.0 109.306 176.011 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 N--CA 1.456 -0.687 0 N-CA-C 111.274 -0.318 . . . . 0.0 111.274 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 36.6 mtt-85 -55.14 127.83 30.99 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.467 1.507 . . . . 0.0 111.956 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.11 147.51 52.05 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.441 1.096 . . . . 0.0 112.491 -175.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.4 pm0 -92.26 152.67 19.7 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 125.815 1.646 . . . . 0.0 112.324 -177.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.28 96.4 0.65 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.604 -175.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.01 28.71 14.48 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.426 -175.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -36.87 -53.11 0.94 Allowed 'General case' 0 C--N 1.344 0.344 0 C-N-CA 124.608 1.163 . . . . 0.0 111.001 166.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.55 -178.63 5.94 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 169.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 31.86 50.7 0.16 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.88 2.472 . . . . 0.0 113.269 173.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 55.49 30.34 14.95 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.676 0.79 . . . . 0.0 112.228 169.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -50.91 -64.95 0.65 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -168.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.288 19.1 m 54.18 130.12 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 126.897 2.079 . . . . 0.0 114.212 -171.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -66.1 -25.52 67.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 120.646 -1.284 . . . . 0.0 112.881 -172.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -110.32 117.12 32.78 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 171.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -45.47 -43.62 11.69 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.686 1.194 . . . . 0.0 110.793 172.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.3 -38.13 57.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.461 -0.78 . . . . 0.0 112.913 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -52.49 -39.64 61.46 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.199 0.909 . . . . 0.0 110.61 175.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.59 2.18 8.54 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 118.91 -0.567 . . . . 0.0 112.501 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.5 t -66.86 -2.95 5.77 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 120.055 1.298 . . . . 0.0 114.411 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.62 -9.87 71.19 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.27 0.938 . . . . 0.0 112.337 169.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -95.04 112.11 57.14 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 124.917 1.287 . . . . 0.0 110.449 -169.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -59.31 120.86 8.95 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 N-CA-C 107.424 -1.798 . . . . 0.0 107.424 163.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.5 tpt85 122.76 -40.33 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 129.175 2.99 . . . . 0.0 108.452 -168.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -65.39 146.32 55.04 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 166.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? -143.04 135.35 27.29 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -50.33 111.45 0.53 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.716 2.007 . . . . 0.0 111.736 -174.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.6 -10.31 45.59 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-O 118.98 -0.9 . . . . 0.0 111.623 174.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -64.75 118.58 9.16 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 119.109 1.455 . . . . 0.0 107.534 171.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 mp -130.04 149.06 51.92 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 125.989 1.716 . . . . 0.0 106.486 176.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.4 m -45.73 -46.91 15.31 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.065 0.946 . . . . 0.0 111.943 174.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -62.45 -15.84 51.85 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.428 -1.42 . . . . 0.0 114.167 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -110.74 23.38 14.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.625 1.17 . . . . 0.0 112.21 172.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.8 t -90.82 135.63 33.6 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.372 1.469 . . . . 0.0 108.236 172.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.79 -23.49 63.34 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 121.268 -0.895 . . . . 0.0 112.645 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -74.98 -13.49 60.52 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 118.337 -0.84 . . . . 0.0 112.53 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -52.33 136.33 31.22 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.52 1.055 . . . . 0.0 112.821 -171.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.83 -66.38 1.28 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 125.831 1.681 . . . . 0.0 110.352 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -178.24 154.02 0.81 Allowed 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -161.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.47 134.82 34.09 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 166.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.1 t -113.7 -39.73 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.891 1.676 . . . . 0.0 110.153 -172.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -147.27 -172.67 4.06 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.303 1.041 . . . . 0.0 110.192 -169.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -52.81 72.08 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 130.196 3.398 . . . . 0.0 113.69 -172.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.77 37.24 83.99 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -172.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -129.76 148.39 51.63 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 125.663 1.585 . . . . 0.0 108.852 172.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -165.07 -176.12 36.42 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.5 mtp-105 -96.65 152.69 18.41 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 119.008 -0.52 . . . . 0.0 110.313 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.453 -0.286 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 156.593 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 t70 . . . . . 0 CA--C 1.532 0.268 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.437 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 1.2 mp0 -49.4 -44.96 45.58 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.738 1.615 . . . . 0.0 111.568 177.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.2 m -111.91 149.88 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.697 1.599 . . . . 0.0 108.653 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.6 tp -77.95 132.43 37.87 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.0 t -90.31 122.47 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 125.912 1.685 . . . . 0.0 107.856 -169.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -60.78 130.55 47.03 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 121.023 -1.048 . . . . 0.0 108.455 171.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.02 -40.17 66.8 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.071 0.548 . . . . 0.0 111.657 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -83.51 3.04 34.04 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 175.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.24 -172.52 8.59 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 172.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -154.91 178.0 10.67 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 172.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.46 ' SG ' HG22 ' A' ' 68' ' ' VAL . 3.6 p -161.08 159.15 28.84 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.489 1.041 . . . . 0.0 109.013 163.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.7 p -73.77 -1.79 20.72 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.021 -1.049 . . . . 0.0 112.99 -175.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.46 HG22 ' SG ' ' A' ' 66' ' ' CYS 0.329 0.9 OUTLIER -83.31 -8.77 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 119.35 0.977 . . . . 0.0 112.286 164.957 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -38.86 123.7 1.31 Allowed 'General case' 0 C--N 1.344 0.368 0 C-N-CA 125.3 1.44 . . . . 0.0 112.914 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.33 134.84 23.06 Favored Pre-proline 0 N--CA 1.455 -0.213 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 169.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -70.82 150.32 61.57 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.08 1.853 . . . . 0.0 110.957 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.341 0 C-N-CA 123.979 0.911 . . . . 0.0 110.227 176.759 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo . . . . . 0 N--CA 1.456 -0.726 0 N-CA-C 110.673 -0.549 . . . . 0.0 110.673 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.441 ' HB3' ' CH2' ' A' ' 47' ' ' TRP . 14.4 mtp180 -72.33 125.87 28.43 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -174.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -54.85 141.85 31.6 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.716 1.606 . . . . 0.0 112.817 -168.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -77.29 144.38 38.16 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.293 1.037 . . . . 0.0 108.592 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.09 120.16 10.91 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 165.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.86 25.19 72.37 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.219 -1.323 . . . . 0.0 112.93 -172.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -40.42 -54.84 2.38 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 119.595 1.698 . . . . 0.0 110.771 166.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -167.67 177.78 5.66 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.388 1.475 . . . . 0.0 107.579 172.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 33.38 52.04 0.35 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 127.057 2.143 . . . . 0.0 113.099 172.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 60.06 18.85 8.05 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.071 0.948 . . . . 0.0 112.675 169.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -62.69 137.42 58.26 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 118.554 0.615 . . . . 0.0 110.029 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.2 m -126.84 143.68 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 168.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -59.97 -34.59 73.49 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 119.12 -0.467 . . . . 0.0 111.284 -174.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.96 128.67 54.53 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 123.433 0.693 . . . . 0.0 110.285 169.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.11 -31.86 20.68 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.52 1.128 . . . . 0.0 110.63 165.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.18 -45.45 75.78 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.425 0.557 . . . . 0.0 111.406 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -29.75 70.09 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.216 0.532 . . . . 0.0 110.606 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.23 -6.05 36.71 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 118.324 -0.846 . . . . 0.0 112.599 -177.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 67.0 m -50.0 -32.41 15.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.22 -24.57 73.45 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.664 1.126 . . . . 0.0 113.164 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -79.03 117.72 68.42 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 118.404 1.102 . . . . 0.0 111.082 -169.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -63.94 108.45 0.93 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 N-CA-C 107.266 -1.859 . . . . 0.0 107.266 164.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 135.69 -31.79 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 131.166 3.787 . . . . 0.0 109.881 -173.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -68.5 149.12 49.63 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 171.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? -143.46 136.7 27.97 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -50.58 110.48 0.42 Allowed 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.954 2.101 . . . . 0.0 111.753 -174.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.14 -9.82 43.11 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-O 119.093 -0.837 . . . . 0.0 111.561 174.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -64.82 120.03 11.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.06 1.43 . . . . 0.0 107.824 172.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 mp -131.77 153.06 50.49 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.218 1.807 . . . . 0.0 107.206 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 33.6 m -48.96 -47.12 44.19 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.873 0.76 . . . . 0.0 110.993 174.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.257 6.2 tt0 -75.72 26.13 0.11 Allowed 'General case' 0 CA--C 1.549 0.915 0 O-C-N 120.32 -1.488 . . . . 0.0 113.671 176.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -142.25 29.77 1.61 Allowed 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.596 -1.315 . . . . 0.0 110.793 156.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 50.6 t -96.72 139.24 33.07 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.886 1.674 . . . . 0.0 109.208 177.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.89 -21.12 64.45 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.569 -0.707 . . . . 0.0 112.572 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -96.4 15.28 21.75 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 119.001 -0.523 . . . . 0.0 111.951 175.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -66.85 149.74 50.16 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.424 1.011 . . . . 0.0 110.997 175.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.53 -101.23 1.97 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.372 -1.891 . . . . 0.0 108.372 169.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -149.95 153.92 37.41 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.76 1.624 . . . . 0.0 107.648 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.13 141.54 58.72 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 123.69 0.619 . . . . 0.0 110.612 168.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.5 t -114.13 -49.19 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 126.28 1.832 . . . . 0.0 109.23 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -148.02 -150.58 0.35 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.408 0.683 . . . . 0.0 111.214 -171.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -67.55 68.16 0.09 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 128.338 2.655 . . . . 0.0 113.21 -161.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.01 29.33 46.92 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.548 1.07 . . . . 0.0 110.501 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TRP . . . . . 0.441 ' CH2' ' HB3' ' A' ' 5' ' ' ARG . 84.6 m95 -132.19 148.21 52.45 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.192 1.397 . . . . 0.0 109.462 177.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.64 178.8 36.49 Favored Glycine 0 N--CA 1.433 -1.564 0 O-C-N 124.395 1.059 . . . . 0.0 110.691 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -82.0 132.69 35.26 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.852 -0.674 . . . . 0.0 110.67 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 43.2 t . . . . . 0 CA--C 1.535 0.378 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 155.036 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.9 t0 . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.431 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 2.5 mp0 -45.71 -39.73 8.41 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.119 0.968 . . . . 0.0 113.257 176.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.5 m -117.04 160.39 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 125.071 1.348 . . . . 0.0 109.872 -172.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 22.5 tp -83.64 131.18 34.97 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.8 t -104.63 133.71 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 123.674 0.79 . . . . 0.0 108.909 -167.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.413 ' HD2' ' CZ2' ' A' ' 47' ' ' TRP . 30.1 tttm -62.98 126.72 28.28 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 175.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.56 -31.78 68.3 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.343 0.657 . . . . 0.0 110.841 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -81.21 -8.19 59.71 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.796 1.238 . . . . 0.0 112.443 176.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.76 -172.42 35.87 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 72.3 t90 -165.84 150.58 8.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.7 p -134.22 162.36 32.36 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.965 1.306 . . . . 0.0 110.001 175.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.4 p -69.91 -20.42 63.36 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.0 -1.062 . . . . 0.0 112.672 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.364 0.8 OUTLIER -71.94 -3.75 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 119.553 1.069 . . . . 0.0 112.595 170.596 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -45.14 128.83 7.63 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.809 0.732 . . . . 0.0 111.012 171.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.73 137.67 31.45 Favored Pre-proline 0 N--CA 1.452 -0.334 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 165.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.8 148.95 59.47 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.028 1.819 . . . . 0.0 110.794 -177.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.308 0 C-N-CA 123.492 0.717 . . . . 0.0 109.953 179.536 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.384 0 CA-C-O 117.674 -1.155 . . . . 0.0 108.859 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.73 71.47 1.45 Allowed 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 162.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -52.0 151.57 6.48 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 123.17 0.588 . . . . 0.0 110.465 177.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -62.6 142.06 88.38 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 122.468 2.112 . . . . 0.0 110.515 -177.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 43.9 mtt-85 -58.19 126.33 27.02 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.814 1.245 . . . . 0.0 110.243 176.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.36 142.95 46.7 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 125.117 1.367 . . . . 0.0 112.489 -172.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -76.61 143.27 40.31 Favored 'General case' 0 N--CA 1.443 -0.779 0 C-N-CA 124.422 1.089 . . . . 0.0 108.294 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -62.03 117.01 5.41 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 165.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.8 16.59 67.59 Favored Glycine 0 CA--C 1.531 1.082 0 CA-C-O 118.263 -1.298 . . . . 0.0 113.652 -174.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -45.58 -58.29 3.52 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 119.818 1.809 . . . . 0.0 112.051 173.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -155.97 162.18 40.39 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.422 ' NE2' ' OD2' ' A' ' 54' ' ' ASP . 24.7 m-70 45.33 47.36 10.51 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.15 1.38 . . . . 0.0 113.199 172.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 56.85 25.81 10.84 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.69 0.796 . . . . 0.0 111.845 173.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -62.07 142.67 57.42 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 117.928 0.331 . . . . 0.0 111.194 -175.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.2 m -127.9 146.1 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 172.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.1 m-20 -73.17 -26.99 61.39 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 124.402 1.081 . . . . 0.0 112.235 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -115.99 116.59 28.19 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 171.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -42.62 -48.97 5.54 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.343 1.057 . . . . 0.0 110.99 175.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.63 -38.16 31.01 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.839 0.856 . . . . 0.0 113.018 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -49.11 -39.53 28.71 Favored 'General case' 0 C--N 1.344 0.36 0 CA-C-N 119.181 0.9 . . . . 0.0 111.477 177.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.66 9.04 1.2 Allowed 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 118.301 -0.857 . . . . 0.0 113.119 -175.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 62.6 m -49.77 -31.02 10.59 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 120.47 1.486 . . . . 0.0 114.226 171.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -71.44 -24.45 76.86 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.64 1.114 . . . . 0.0 112.927 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -79.99 120.13 78.84 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 124.562 1.145 . . . . 0.0 110.426 -171.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -46.48 -49.28 12.11 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 123.145 2.563 . . . . 0.0 113.924 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -15.76 60.79 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 117.563 -1.208 . . . . 0.0 113.418 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -73.91 145.82 44.48 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 120.878 1.672 . . . . 0.0 111.529 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -133.38 150.04 51.83 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 127.973 2.509 . . . . 0.0 104.377 165.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -66.69 165.02 15.72 Favored 'General case' 0 N--CA 1.447 -0.623 0 O-C-N 124.064 0.852 . . . . 0.0 111.512 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.72 -26.26 3.21 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 125.077 1.322 . . . . 0.0 112.009 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -69.96 112.1 6.13 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 117.534 0.667 . . . . 0.0 109.333 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.1 mp -123.36 148.96 45.51 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 175.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.5 m -42.03 -46.71 4.28 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.437 1.095 . . . . 0.0 110.939 172.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -56.34 -26.8 53.82 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.2 p30 -109.2 23.61 14.27 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.711 1.204 . . . . 0.0 112.001 177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 45.7 t -86.48 139.0 31.3 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.711 1.204 . . . . 0.0 108.942 174.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.52 -25.3 66.0 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 121.319 -0.863 . . . . 0.0 111.813 177.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -91.29 8.35 36.43 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 118.479 -0.772 . . . . 0.0 112.047 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 66.3 t-105 -56.73 138.18 53.31 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 120.188 1.358 . . . . 0.0 109.99 174.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.78 -85.18 1.03 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 171.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -163.91 159.1 20.57 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 178.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -76.27 136.41 39.65 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 175.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.581 HG23 ' HA2' ' A' ' 48' ' ' GLY . 90.2 t -106.74 -48.53 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.652 1.181 . . . . 0.0 108.383 -172.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -151.43 -138.98 0.09 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.93 0.492 . . . . 0.0 112.24 -176.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -69.19 66.83 0.17 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 127.919 2.488 . . . . 0.0 113.013 -163.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.52 33.34 61.13 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 -175.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 86.3 m95 -131.65 143.5 50.35 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 125.893 1.677 . . . . 0.0 108.684 173.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.581 ' HA2' HG23 ' A' ' 43' ' ' VAL . . . -153.14 178.01 30.44 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 124.183 0.897 . . . . 0.0 111.489 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.417 ' HG3' ' CG2' ' A' ' 43' ' ' VAL . 32.4 mtp85 -88.31 159.13 18.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 123.308 0.643 . . . . 0.0 111.998 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.5 t -133.39 120.86 21.49 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.837 1.655 . . . . 0.0 108.038 179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.1 p -74.89 68.62 1.79 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.926 1.291 . . . . 0.0 110.921 -173.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -146.43 131.77 9.16 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 167.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -59.2 -43.97 37.58 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 121.839 1.693 . . . . 0.0 109.519 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.422 ' OD2' ' NE2' ' A' ' 12' ' ' HIS . 11.2 p-10 -70.1 47.14 0.08 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.701 2.401 . . . . 0.0 111.603 169.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -172.71 -55.4 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.097 1.359 . . . . 0.0 110.468 177.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -55.47 -27.93 51.32 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.74 1.216 . . . . 0.0 113.513 -172.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -35.87 -45.44 0.4 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 124.98 1.312 . . . . 0.0 112.075 166.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 m -116.5 150.63 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 123.831 0.852 . . . . 0.0 108.987 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.517 HD11 HG21 ' A' ' 43' ' ' VAL . 12.4 tp -82.64 121.39 26.77 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.3 m -88.44 144.25 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 118.923 0.783 . . . . 0.0 109.161 -177.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.3 tttm -67.01 136.97 56.11 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 174.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.62 -40.9 66.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 119.313 -0.375 . . . . 0.0 111.488 174.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -85.05 7.95 19.62 Favored 'General case' 0 C--N 1.341 0.229 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 174.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.73 -177.27 23.46 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 175.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 74.6 t90 -160.07 155.58 25.48 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 172.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.0 p -143.27 167.17 22.78 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.097 0.959 . . . . 0.0 110.766 173.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 51.3 p -73.5 -21.7 60.34 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.33 1.0 OUTLIER -71.13 -5.37 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 119.433 1.015 . . . . 0.0 112.448 171.022 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -45.72 132.16 8.77 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 119.058 0.844 . . . . 0.0 111.652 175.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.32 139.47 35.74 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 166.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.25 151.14 54.28 Favored 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 122.058 1.838 . . . . 0.0 110.657 -177.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.4 34.84 1.72 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.894 0.878 . . . . 0.0 110.289 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.3 m . . . . . 0 C--O 1.255 1.346 0 C-N-CA 128.674 2.79 . . . . 0.0 105.367 178.852 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 1.112 ' CB ' ' OE1' ' A' ' 3' ' ' GLU . . . . . . . . 0 CA--C 1.513 -0.445 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.2 m -134.3 31.83 3.45 Favored 'General case' 0 C--N 1.332 -0.157 0 O-C-N 123.598 0.561 . . . . 0.0 110.846 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 1.112 ' OE1' ' CB ' ' A' ' 1' ' ' ALA . 3.4 mp0 -64.72 132.39 95.42 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 174.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -69.13 130.04 19.38 Favored 'Trans proline' 0 N--CA 1.455 -0.791 0 C-N-CA 122.39 2.06 . . . . 0.0 111.079 -171.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 42.5 mtt-85 -63.95 125.31 24.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.557 1.143 . . . . 0.0 110.212 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.22 142.75 54.02 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.796 1.238 . . . . 0.0 112.171 -173.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -76.17 145.7 39.7 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.497 1.119 . . . . 0.0 108.731 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -62.37 121.21 12.65 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 164.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.87 20.85 75.53 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 118.267 -1.296 . . . . 0.0 113.448 -172.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -40.97 -56.8 2.17 Favored 'General case' 0 C--N 1.348 0.511 0 CA-C-N 119.488 1.644 . . . . 0.0 111.46 169.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.2 172.74 10.88 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.658 1.583 . . . . 0.0 106.96 174.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 44.28 47.56 7.84 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 124.412 1.085 . . . . 0.0 112.76 171.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 57.53 21.29 6.92 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 122.799 0.44 . . . . 0.0 111.498 172.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -62.53 140.7 58.63 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 118.521 0.601 . . . . 0.0 111.259 -172.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.2 m -126.88 143.56 39.94 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 173.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.0 m-20 -71.33 -26.89 63.02 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 123.882 0.873 . . . . 0.0 111.684 176.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -112.08 111.42 22.31 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 169.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -45.13 -44.32 10.52 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.909 1.284 . . . . 0.0 110.957 176.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.55 -35.54 63.36 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-O 118.125 -0.94 . . . . 0.0 112.627 179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -48.18 -43.75 32.02 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-O 122.278 1.037 . . . . 0.0 110.84 174.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.35 6.23 5.92 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 118.347 -0.835 . . . . 0.0 112.458 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -55.08 -28.54 53.19 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 120.258 1.39 . . . . 0.0 112.368 171.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.44 -14.15 59.47 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.518 1.056 . . . . 0.0 113.769 174.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -99.89 108.19 50.33 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 125.891 1.677 . . . . 0.0 111.502 -171.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -54.51 117.55 4.08 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 N-CA-C 108.258 -1.478 . . . . 0.0 108.258 162.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 27.7 tpt85 127.18 -41.32 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 129.023 2.929 . . . . 0.0 108.517 -169.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -66.81 153.79 42.49 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 169.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -152.75 136.26 15.97 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.198 168.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 22.5 mp0 -60.3 115.35 3.46 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 126.521 1.928 . . . . 0.0 110.112 -169.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.4 -30.76 5.29 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -176.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -66.93 115.66 6.91 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 175.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 mp -131.04 149.85 52.42 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 127.004 2.122 . . . . 0.0 105.405 176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.2 m -43.58 -47.37 7.42 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.953 1.301 . . . . 0.0 111.43 173.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.44 -22.02 52.99 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.1 p30 -109.77 26.13 11.0 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.307 1.043 . . . . 0.0 112.344 175.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.7 t -97.06 136.78 37.12 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.568 1.547 . . . . 0.0 109.263 175.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.46 -20.86 65.93 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 120.929 -1.107 . . . . 0.0 113.002 -177.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -80.4 -8.58 59.58 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 118.437 0.562 . . . . 0.0 112.113 175.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.402 ' CH2' ' HA3' ' A' ' 48' ' ' GLY . 74.9 t-105 -58.29 141.12 51.95 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.705 0.684 . . . . 0.0 111.501 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.61 -69.0 1.27 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 173.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -174.5 157.35 2.62 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 -168.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -82.32 130.97 35.22 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 166.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.4 t -97.05 -49.31 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -175.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -152.07 -128.59 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -171.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -74.77 63.93 1.21 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.379 1.872 . . . . 0.0 112.623 -162.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.6 28.19 67.9 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.258 0.933 . . . . 0.0 110.944 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 87.0 m95 -126.79 145.17 50.73 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.823 1.649 . . . . 0.0 109.168 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.402 ' HA3' ' CH2' ' A' ' 39' ' ' TRP . . . -153.77 178.7 30.56 Favored Glycine 0 N--CA 1.436 -1.352 0 CA-C-O 122.208 0.893 . . . . 0.0 112.302 177.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -89.58 145.87 24.97 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 114.22 -0.99 . . . . 0.0 108.437 -172.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 2.3 t -134.85 128.64 33.08 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 175.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 73.7 p -91.71 158.02 16.61 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.108 0.563 . . . . 0.0 111.331 -167.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 95.72 136.8 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 130.617 3.567 . . . . 0.0 110.227 178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -59.51 139.74 90.75 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.715 2.277 . . . . 0.0 110.045 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.393 0.2 OUTLIER 98.28 -13.49 0.06 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 128.022 2.529 . . . . 0.0 111.133 -168.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -127.24 -41.11 1.78 Allowed 'General case' 0 C--N 1.346 0.443 0 CA-C-O 117.975 -1.012 . . . . 0.0 113.342 158.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -36.98 -45.69 0.59 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.435 1.494 . . . . 0.0 112.807 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 17.0 pm0 -61.75 -16.82 52.68 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -175.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.2 m -132.01 158.36 43.28 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 119.556 1.071 . . . . 0.0 110.499 -177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.1 tp -91.85 123.2 35.04 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 175.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.0 m -94.85 148.97 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.8 tttm -67.65 137.22 55.42 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.14 -42.23 65.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 119.311 -0.376 . . . . 0.0 110.936 173.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -81.32 6.1 15.3 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 175.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.62 -177.32 34.76 Favored Glycine 0 CA--C 1.524 0.654 0 CA-C-N 119.539 1.063 . . . . 0.0 110.654 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 43.8 t90 -163.15 154.72 17.49 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 170.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.486 ' SG ' ' HB ' ' A' ' 68' ' ' VAL . 7.9 p -139.92 161.54 37.35 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.748 1.619 . . . . 0.0 110.034 173.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 89.9 p -70.65 -10.05 58.46 Favored 'General case' 0 CA--C 1.534 0.345 0 O-C-N 121.327 -0.858 . . . . 0.0 112.921 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.486 ' HB ' ' SG ' ' A' ' 66' ' ' CYS . 4.7 t -64.76 -35.26 74.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 C-N-CA 124.268 1.027 . . . . 0.0 109.256 168.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -27.06 113.01 0.06 Allowed 'General case' 0 C--N 1.347 0.46 0 C-N-CA 126.43 1.892 . . . . 0.0 114.285 -170.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -113.24 133.18 22.14 Favored Pre-proline 0 N--CA 1.455 -0.22 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 167.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.11 150.55 66.26 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 121.704 1.602 . . . . 0.0 110.929 -177.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.76 35.41 1.85 Allowed 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.342 177.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.5 m . . . . . 0 C--O 1.253 1.253 0 C-N-CA 128.624 2.77 . . . . 0.0 105.462 177.615 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.993 ' CB ' ' OE1' ' A' ' 44' ' ' GLN . . . . . . . . 0 CA--C 1.516 -0.352 0 N-CA-C 107.022 -1.474 . . . . 0.0 107.022 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.31 -158.48 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.127 164.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -45.53 154.34 0.53 Allowed Pre-proline 0 CA--C 1.544 0.728 0 C-N-CA 129.247 3.019 . . . . 0.0 114.773 -166.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -64.78 147.98 89.89 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.006 2.47 . . . . 0.0 111.239 178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.9 mtt-85 -62.41 133.25 54.78 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 124.491 1.116 . . . . 0.0 110.895 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.98 145.49 55.77 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.986 1.315 . . . . 0.0 112.25 -174.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -75.45 142.89 42.88 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 124.82 1.248 . . . . 0.0 108.183 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -62.38 120.33 10.83 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 164.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.94 26.41 66.88 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-O 118.116 -1.38 . . . . 0.0 113.37 -172.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -42.73 -55.8 3.46 Favored 'General case' 0 C--N 1.346 0.449 0 CA-C-N 119.765 1.782 . . . . 0.0 110.767 167.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -165.48 169.99 14.93 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.715 1.206 . . . . 0.0 108.315 174.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.452 ' CD2' ' CE2' ' A' ' 55' ' ' PHE . 35.0 m-70 46.71 40.73 9.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.561 1.544 . . . . 0.0 113.335 172.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 57.16 30.65 18.68 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.621 1.168 . . . . 0.0 111.771 177.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -62.92 139.74 58.77 Favored 'General case' 0 N--CA 1.453 -0.324 0 O-C-N 122.159 -0.338 . . . . 0.0 111.048 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.4 m -124.74 141.35 45.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 C-N-CA 125.028 1.331 . . . . 0.0 107.841 172.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -68.54 -24.43 64.63 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 123.899 0.88 . . . . 0.0 112.196 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -117.7 122.8 44.46 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.138 1.375 . . . . 0.0 108.031 170.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.6 -49.05 62.93 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.667 0.787 . . . . 0.0 111.35 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.61 -23.06 66.13 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 117.768 -1.111 . . . . 0.0 112.793 -174.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -44.42 -44.08 8.15 Favored 'General case' 0 C--N 1.344 0.361 0 CA-C-N 119.831 1.196 . . . . 0.0 110.493 167.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.58 10.09 4.29 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.346 -0.843 . . . . 0.0 112.651 -175.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 15.9 t -69.45 -1.03 7.42 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 120.107 1.321 . . . . 0.0 114.43 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -90.96 -15.19 56.7 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.384 0.992 . . . . 0.0 111.81 169.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -81.28 114.41 48.97 Favored Pre-proline 0 N--CA 1.452 -0.346 0 C-N-CA 124.414 1.086 . . . . 0.0 109.671 -172.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -62.05 118.38 5.26 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 N-CA-C 107.114 -1.918 . . . . 0.0 107.114 165.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 30.7 tpt85 124.96 -37.62 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 129.204 3.002 . . . . 0.0 108.776 -168.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -64.83 148.3 51.59 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 168.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.7 tm0? -154.83 131.89 10.93 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 -176.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -62.04 125.01 22.38 Favored 'General case' 0 N--CA 1.445 -0.687 0 C-N-CA 126.694 1.998 . . . . 0.0 112.532 -168.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.68 -25.18 23.61 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-O 118.822 -0.988 . . . . 0.0 111.345 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -60.08 119.5 7.93 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.096 1.448 . . . . 0.0 108.28 173.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 mp -131.41 153.26 49.88 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 127.048 2.139 . . . . 0.0 107.044 174.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 55.6 m -48.5 -49.45 35.78 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.619 0.768 . . . . 0.0 111.269 173.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.252 4.6 tt0 -76.92 31.35 0.13 Allowed 'General case' 0 CA--C 1.547 0.832 0 O-C-N 119.881 -1.762 . . . . 0.0 113.615 175.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -143.11 30.31 1.43 Allowed 'General case' 0 CA--C 1.538 0.505 0 O-C-N 120.573 -1.329 . . . . 0.0 110.629 155.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' A' ' 69' ' ' TYR . 47.9 t -102.69 138.41 39.63 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 126.056 1.742 . . . . 0.0 110.48 -175.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.59 -19.02 64.44 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 120.929 -1.107 . . . . 0.0 112.256 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -85.09 -0.21 53.74 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.853 0.861 . . . . 0.0 111.672 172.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 33.5 t-105 -66.05 148.72 51.38 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 119.384 0.993 . . . . 0.0 110.897 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.01 -99.25 1.45 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 107.42 -2.272 . . . . 0.0 107.42 165.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -148.36 159.91 43.53 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.788 1.635 . . . . 0.0 107.061 175.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.91 146.61 41.61 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.266 0.555 . . . . 0.0 110.694 166.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 74.6 t -118.83 -52.75 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 C-N-CA 125.575 1.55 . . . . 0.0 108.568 -177.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.993 ' OE1' ' CB ' ' A' ' 1' ' ' ALA . 13.9 pt20 -147.67 -152.85 0.46 Allowed 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.672 0.789 . . . . 0.0 111.21 -175.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -56.54 68.45 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 130.031 3.332 . . . . 0.0 114.353 -163.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.05 30.71 67.37 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 124.648 1.118 . . . . 0.0 110.569 -174.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -129.19 146.35 51.13 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.359 1.464 . . . . 0.0 108.902 174.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -155.95 173.52 33.93 Favored Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.8 mtp-105 -78.13 130.22 36.11 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.097 176.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 39.8 t -88.25 161.61 17.09 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 150.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.1 p -123.97 166.4 15.77 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.709 0.686 . . . . 0.0 110.926 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 61.1 m80 96.41 117.59 0.02 OUTLIER Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 129.811 3.244 . . . . 0.0 108.68 174.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -44.57 129.79 9.13 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.881 3.054 . . . . 0.0 113.319 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.326 0.6 OUTLIER 100.08 -20.33 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 130.135 3.374 . . . . 0.0 110.639 -166.363 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.452 ' CE2' ' CD2' ' A' ' 12' ' ' HIS . 0.2 OUTLIER -131.08 13.85 5.18 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.278 2.231 . . . . 0.0 112.162 175.407 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -110.58 -35.33 6.05 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.305 0.957 . . . . 0.0 110.956 -175.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.527 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 2.2 mp0 -48.64 -46.63 40.12 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 127.16 2.184 . . . . 0.0 113.102 -176.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.1 m -111.71 153.68 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 C-N-CA 124.88 1.272 . . . . 0.0 109.781 -169.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.2 tp -84.53 127.97 34.33 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.2 t -98.62 141.84 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -170.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -68.07 133.85 49.65 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.56 -35.17 71.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 119.264 -0.398 . . . . 0.0 111.856 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.53 3.86 34.62 Favored 'General case' 0 C--N 1.342 0.249 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 173.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.65 -176.48 16.1 Favored Glycine 0 CA--C 1.524 0.646 0 CA-C-N 119.499 1.045 . . . . 0.0 111.257 177.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 72.9 t90 -158.7 156.59 30.19 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 171.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 10.3 p -142.24 171.38 14.13 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 123.779 0.831 . . . . 0.0 110.718 169.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.0 p -71.41 -29.66 65.18 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -174.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.5 m -67.74 -70.35 0.21 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . 0.455 ' HA ' ' SG ' ' A' ' 36' ' ' CYS . 58.2 t80 58.72 -85.34 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.203 1.801 . . . . 0.0 112.241 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . 62.68 124.95 0.02 OUTLIER Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 126.258 1.823 . . . . 0.0 111.299 -162.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -71.26 146.75 51.86 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.096 1.864 . . . . 0.0 111.196 -177.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -91.93 48.66 1.46 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.733 0.778 . . . . 0.0 109.423 175.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.5 p . . . . . 0 C--O 1.247 0.972 0 C-N-CA 125.563 1.545 . . . . 0.0 107.188 -174.469 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.626 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . . . . . . . . 0 C--O 1.236 0.374 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.6 p -94.13 38.11 1.09 Allowed 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 124.714 1.259 . . . . 0.0 109.626 169.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.626 ' OE1' ' HB3' ' A' ' 1' ' ' ALA . 3.1 mp0 -60.06 129.29 88.22 Favored Pre-proline 0 CA--C 1.542 0.669 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -70.52 128.75 15.76 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.419 2.08 . . . . 0.0 110.821 -169.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 34.9 mtt-85 -61.78 129.58 41.66 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.683 1.193 . . . . 0.0 111.137 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.97 143.35 56.63 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.241 1.417 . . . . 0.0 112.442 -172.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -78.03 144.7 36.42 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.48 1.112 . . . . 0.0 108.595 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -63.46 122.08 15.4 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 165.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.66 22.98 73.98 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.174 -1.348 . . . . 0.0 113.085 -172.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -39.96 -56.77 1.76 Allowed 'General case' 0 C--N 1.346 0.439 0 CA-C-N 119.431 1.615 . . . . 0.0 111.253 167.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -168.32 175.85 6.2 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.612 1.565 . . . . 0.0 107.275 174.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 26.5 m-70 37.11 50.07 0.9 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 126.053 1.741 . . . . 0.0 112.865 175.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 57.37 23.53 9.04 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.57 0.748 . . . . 0.0 112.054 172.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -63.4 136.97 57.98 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 118.111 0.414 . . . . 0.0 110.911 -174.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.7 m -124.04 141.61 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 173.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 -69.32 -23.91 63.85 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 123.851 0.86 . . . . 0.0 111.764 177.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -115.55 115.13 25.93 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.675 1.19 . . . . 0.0 107.931 171.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -43.39 -48.33 7.02 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 124.807 1.243 . . . . 0.0 110.983 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.5 -35.18 52.44 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 118.45 -0.786 . . . . 0.0 112.962 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -51.42 -40.52 59.5 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 119.617 1.098 . . . . 0.0 110.809 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.72 6.6 5.75 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 118.343 -0.837 . . . . 0.0 112.785 -177.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 11.9 t -52.2 -32.66 37.46 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.917 1.235 . . . . 0.0 112.507 173.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -69.37 -21.67 76.04 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 114.659 -1.155 . . . . 0.0 113.8 176.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -80.32 114.93 51.22 Favored Pre-proline 0 CA--C 1.533 0.311 0 CA-C-N 119.079 1.44 . . . . 0.0 111.355 -168.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.29 107.65 0.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 N-CA-C 107.229 -1.873 . . . . 0.0 107.229 165.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 143.16 -35.81 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 1 C-N-CA 132.074 4.15 . . . . 0.0 108.652 -174.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -77.12 151.27 35.45 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.284 1.034 . . . . 0.0 110.946 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.1 mp0 -137.6 146.49 44.06 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 127.675 2.39 . . . . 0.0 105.638 166.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -63.28 158.97 18.92 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.077 0.951 . . . . 0.0 111.155 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.38 -26.71 4.95 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.28 0.943 . . . . 0.0 111.792 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -67.18 112.25 4.37 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.2 mp -124.61 148.26 48.0 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 106.063 -1.829 . . . . 0.0 106.063 177.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.8 m -42.18 -45.66 4.14 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.482 1.113 . . . . 0.0 111.919 172.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -56.08 -26.43 49.42 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 120.729 -1.232 . . . . 0.0 113.972 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 19.3 p30 -108.91 27.24 9.69 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.131 1.372 . . . . 0.0 112.055 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 50.1 t -94.95 139.9 30.7 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.108 1.363 . . . . 0.0 109.331 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.73 -24.82 67.05 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 121.333 -0.855 . . . . 0.0 112.569 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -82.19 -2.8 53.45 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 118.712 -0.661 . . . . 0.0 112.37 176.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 73.0 t-105 -61.98 140.51 58.33 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 119.256 0.935 . . . . 0.0 111.726 -177.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.64 -71.78 1.25 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 125.277 1.418 . . . . 0.0 109.78 173.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -174.7 157.38 2.51 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 125.197 1.399 . . . . 0.0 107.39 -167.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.73 133.47 34.37 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 169.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.1 t -107.98 -49.08 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 C-N-CA 124.568 1.147 . . . . 0.0 109.887 -174.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -146.41 -161.25 1.28 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.26 1.024 . . . . 0.0 110.108 -172.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -56.4 71.12 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 129.361 3.064 . . . . 0.0 114.293 -161.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.74 34.35 77.78 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -172.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -129.58 146.15 51.41 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 125.259 1.424 . . . . 0.0 109.222 173.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.28 -172.6 28.84 Favored Glycine 0 N--CA 1.432 -1.621 0 CA-C-O 121.99 0.772 . . . . 0.0 112.097 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -93.11 139.68 30.31 Favored 'General case' 0 N--CA 1.446 -0.675 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -171.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.1 t -118.44 98.9 6.5 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 173.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.4 p -76.8 71.69 3.37 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.646 0.778 . . . . 0.0 109.91 -171.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -161.67 123.45 1.67 Allowed Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 123.495 0.718 . . . . 0.0 110.092 177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -69.13 132.88 25.32 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.945 1.763 . . . . 0.0 108.405 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 122.01 -40.19 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 129.228 3.011 . . . . 0.0 105.637 -155.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -124.05 -44.16 2.06 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 125.231 1.412 . . . . 0.0 113.18 -174.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -55.86 -18.51 8.96 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 114.426 1.269 . . . . 0.0 114.426 -173.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -51.05 -35.06 32.63 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.996 0.816 . . . . 0.0 112.881 169.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 15.1 m -128.43 163.56 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 125.325 1.45 . . . . 0.0 109.736 -172.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 14.4 tp -86.93 129.57 34.82 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 175.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 42.4 t -98.58 135.34 33.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 C-N-CA 124.069 0.948 . . . . 0.0 108.812 -168.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -65.25 131.12 45.67 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 176.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.02 -39.81 63.41 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.226 0.611 . . . . 0.0 111.626 176.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -83.87 2.33 38.95 Favored 'General case' 0 C--N 1.342 0.242 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 176.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.78 -177.06 23.24 Favored Glycine 0 CA--C 1.526 0.778 0 CA-C-N 119.412 1.005 . . . . 0.0 111.314 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 60.8 t90 -160.77 149.98 16.97 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 171.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.559 ' SG ' HG13 ' A' ' 68' ' ' VAL . 7.5 p -134.77 162.51 32.14 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.194 1.398 . . . . 0.0 109.838 174.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.8 p -71.93 -14.33 61.89 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 120.655 -1.278 . . . . 0.0 112.79 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.559 HG13 ' SG ' ' A' ' 66' ' ' CYS 0.348 1.7 p -85.44 10.0 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 125.562 1.545 . . . . 0.0 111.723 166.194 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -52.84 126.16 19.28 Favored 'General case' 0 C--N 1.342 0.27 0 O-C-N 120.54 -1.35 . . . . 0.0 110.232 163.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -122.83 134.06 24.81 Favored Pre-proline 0 N--CA 1.454 -0.254 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 169.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -69.51 148.42 66.62 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 121.675 1.583 . . . . 0.0 110.821 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -98.96 35.43 1.88 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.882 0.873 . . . . 0.0 110.213 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.9 m . . . . . 0 C--O 1.254 1.306 0 C-N-CA 128.706 2.803 . . . . 0.0 105.257 179.458 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.668 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . . . . . . . . 0 N--CA 1.454 -0.237 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.1 m -81.83 64.91 6.73 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 167.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.668 ' OE1' ' HB3' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -58.58 153.37 40.66 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 122.294 0.237 . . . . 0.0 111.198 -174.162 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -59.44 145.09 98.98 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.532 2.155 . . . . 0.0 110.353 177.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.434 ' HB3' ' CH2' ' A' ' 47' ' ' TRP . 14.2 mtp180 -71.59 125.61 27.52 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -174.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -54.39 145.25 18.57 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.513 1.525 . . . . 0.0 113.1 -166.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -76.2 142.66 41.43 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.227 1.011 . . . . 0.0 108.459 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -63.36 116.33 5.42 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 164.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.74 25.23 60.82 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 118.327 -1.263 . . . . 0.0 113.222 -172.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -41.74 -53.69 3.56 Favored 'General case' 0 C--N 1.347 0.466 0 CA-C-N 119.399 1.599 . . . . 0.0 110.743 166.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.06 178.57 6.29 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.298 1.439 . . . . 0.0 107.415 169.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.403 ' ND1' ' OD2' ' A' ' 54' ' ' ASP . 18.1 m170 39.97 48.13 2.05 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 125.977 1.711 . . . . 0.0 112.414 165.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.41 20.86 7.79 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.046 1.338 . . . . 0.0 112.545 170.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -63.12 133.97 55.28 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 118.397 0.544 . . . . 0.0 110.036 -179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -121.56 144.15 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 168.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -60.38 -38.1 82.83 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.346 -175.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -104.12 136.11 44.35 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 168.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.62 -28.29 69.26 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 123.583 0.753 . . . . 0.0 110.884 171.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.68 -52.71 29.1 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.383 0.538 . . . . 0.0 111.792 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -55.71 -30.95 62.01 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.961 1.305 . . . . 0.0 111.729 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.4 -8.77 49.55 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 118.367 -0.825 . . . . 0.0 111.941 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.7 t -51.53 -31.6 24.67 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 119.672 1.124 . . . . 0.0 113.253 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -63.01 -24.55 67.06 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-N 115.02 -0.991 . . . . 0.0 113.158 175.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 2.5 t-80 -88.51 107.56 17.58 Favored Pre-proline 0 CA--C 1.535 0.379 0 C-N-CA 124.779 1.232 . . . . 0.0 110.841 -171.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -58.67 120.57 8.53 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 N-CA-C 107.006 -1.959 . . . . 0.0 107.006 161.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 52.6 tpt85 127.58 -38.6 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 129.103 2.961 . . . . 0.0 108.876 -167.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -70.39 160.07 33.01 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.765 0.793 . . . . 0.0 109.715 169.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -155.18 131.36 10.25 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 113.87 -1.513 . . . . 0.0 109.242 169.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.0 mp0 -56.1 113.0 1.35 Allowed 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 127.198 2.199 . . . . 0.0 109.998 -175.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 126.43 -33.79 3.36 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -67.42 118.79 11.24 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.377 1.088 . . . . 0.0 108.335 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.7 mp -131.94 152.85 50.83 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 126.452 1.901 . . . . 0.0 106.875 176.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 26.3 m -49.29 -47.58 46.74 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.661 0.784 . . . . 0.0 111.148 175.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.257 6.3 tt0 -75.1 23.96 0.1 Allowed 'General case' 0 CA--C 1.55 0.961 0 O-C-N 120.261 -1.524 . . . . 0.0 113.838 176.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -139.04 28.19 2.33 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 120.54 -1.35 . . . . 0.0 110.998 157.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 50.4 t -96.34 135.78 37.72 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.857 1.663 . . . . 0.0 108.291 175.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.42 -22.27 64.86 Favored 'General case' 0 CA--C 1.53 0.21 0 O-C-N 121.322 -0.861 . . . . 0.0 112.232 -178.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -88.74 2.99 52.46 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 118.821 -0.609 . . . . 0.0 112.481 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 60.7 t-105 -59.51 139.39 57.17 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 119.065 0.848 . . . . 0.0 110.9 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.38 -105.87 0.6 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.163 -1.975 . . . . 0.0 108.163 167.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -146.26 156.31 43.29 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.959 1.304 . . . . 0.0 107.876 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.12 146.16 54.68 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 123.867 0.729 . . . . 0.0 110.577 171.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 95.5 t -118.99 -54.99 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.897 1.279 . . . . 0.0 109.214 -175.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -154.1 155.63 35.76 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 124.515 1.126 . . . . 0.0 109.454 -176.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.9 t0 48.91 31.8 3.43 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 148.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.17 33.4 44.92 Favored Glycine 0 CA--C 1.536 1.366 0 O-C-N 120.908 -1.12 . . . . 0.0 112.921 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.434 ' CH2' ' HB3' ' A' ' 5' ' ' ARG . 64.7 m95 -134.55 160.39 38.2 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 127.376 2.27 . . . . 0.0 108.739 175.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.56 175.69 38.95 Favored Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 176.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 4.3 mtp-105 -78.97 142.03 37.0 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.154 -0.523 . . . . 0.0 110.437 174.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 5.6 t -107.22 106.16 16.5 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 105.33 -2.1 . . . . 0.0 105.33 168.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.2 p -76.45 70.95 3.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.715 -0.616 . . . . 0.0 109.949 -174.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -154.83 113.8 2.37 Favored Pre-proline 0 N--CA 1.451 -0.397 0 C-N-CA 123.757 0.823 . . . . 0.0 109.625 177.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -53.19 124.66 16.17 Favored 'Trans proline' 0 N--CA 1.456 -0.713 0 C-N-CA 122.521 2.147 . . . . 0.0 110.206 170.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.403 ' OD2' ' ND1' ' A' ' 12' ' ' HIS . 5.1 p-10 120.8 -29.2 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 130.455 3.502 . . . . 0.0 108.877 -167.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -124.03 -42.12 2.17 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 125.529 1.532 . . . . 0.0 112.375 177.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -44.49 -38.03 3.86 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.737 1.615 . . . . 0.0 113.192 -175.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -42.9 -42.21 3.6 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.4 1.08 . . . . 0.0 112.89 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.7 m -117.04 156.75 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 C-N-CA 124.727 1.211 . . . . 0.0 109.569 -173.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.8 tp -81.66 132.4 35.3 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 69.0 t -104.58 131.14 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 123.763 0.825 . . . . 0.0 109.166 -167.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.1 tttm -62.02 132.1 51.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.02 -34.98 78.73 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 119.273 -0.394 . . . . 0.0 111.068 -177.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -81.34 -1.19 44.42 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 118.077 -0.963 . . . . 0.0 113.568 172.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -70.62 -174.55 16.63 Favored Glycine 0 C--N 1.334 0.456 0 CA-C-N 119.751 1.16 . . . . 0.0 111.159 176.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 17.8 t90 -165.53 153.09 10.73 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 175.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.426 ' SG ' HG22 ' A' ' 68' ' ' VAL . 7.7 p -135.62 161.72 34.73 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.575 1.15 . . . . 0.0 109.259 174.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.2 p -71.64 -14.63 62.11 Favored 'General case' 0 C--O 1.236 0.357 0 O-C-N 121.091 -1.006 . . . . 0.0 112.713 -179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.426 HG22 ' SG ' ' A' ' 66' ' ' CYS 0.35 0.9 OUTLIER -75.32 -6.85 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 119.327 0.967 . . . . 0.0 112.478 170.007 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -40.39 125.45 2.12 Favored 'General case' 0 C--N 1.348 0.502 0 C-N-CA 124.642 1.177 . . . . 0.0 112.441 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -118.18 134.44 23.37 Favored Pre-proline 0 C--N 1.331 -0.197 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 168.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -70.19 149.27 63.91 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 121.607 1.538 . . . . 0.0 110.917 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.33 33.59 2.4 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.801 0.841 . . . . 0.0 110.508 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.3 m . . . . . 0 C--O 1.249 1.046 0 C-N-CA 128.633 2.773 . . . . 0.0 105.598 177.929 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 1.024 ' HB1' ' OE2' ' A' ' 3' ' ' GLU . . . . . . . . 0 CA--C 1.534 0.348 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.3 m -153.75 47.49 0.64 Allowed 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 119.434 1.015 . . . . 0.0 109.445 -175.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 1.024 ' OE2' ' HB1' ' A' ' 1' ' ' ALA . 5.8 mp0 -79.87 151.55 73.69 Favored Pre-proline 0 N--CA 1.448 -0.542 0 C-N-CA 124.017 0.927 . . . . 0.0 108.503 -176.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -60.68 145.77 98.31 Favored 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 122.051 1.834 . . . . 0.0 110.687 -177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.44 ' HB3' ' CH2' ' A' ' 47' ' ' TRP . 26.0 mtp180 -81.71 126.93 32.38 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -170.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -53.84 140.14 31.25 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 125.339 1.456 . . . . 0.0 113.544 -165.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.7 145.31 48.92 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.348 1.459 . . . . 0.0 108.348 175.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -50.29 122.15 6.54 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 157.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 65.79 27.75 73.01 Favored Glycine 0 CA--C 1.53 0.997 0 CA-C-O 118.027 -1.43 . . . . 0.0 114.188 -177.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 80.0 t60 -42.94 -56.37 3.32 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 119.839 1.819 . . . . 0.0 111.816 171.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -156.88 165.56 35.86 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 173.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.407 ' NE2' ' OD2' ' A' ' 54' ' ' ASP . 51.9 m-70 44.57 48.52 8.54 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.815 1.246 . . . . 0.0 113.22 170.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.24 20.23 10.82 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.995 0.518 . . . . 0.0 111.882 170.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -62.19 144.33 55.61 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.605 0.639 . . . . 0.0 112.676 -171.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.1 m -127.86 144.39 37.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 C-N-CA 124.764 1.226 . . . . 0.0 108.594 173.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -70.49 -26.51 63.64 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 123.395 0.678 . . . . 0.0 112.372 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -117.69 116.31 26.8 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 173.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -46.5 -44.75 17.93 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.245 1.018 . . . . 0.0 111.065 177.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.47 -37.89 58.13 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.464 -0.779 . . . . 0.0 112.619 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -48.07 -43.08 30.23 Favored 'General case' 0 C--N 1.344 0.337 0 CA-C-O 122.237 1.018 . . . . 0.0 110.83 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.35 3.21 11.48 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 118.05 -0.976 . . . . 0.0 112.762 -174.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 9.4 t -58.73 -24.37 61.44 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 120.615 1.552 . . . . 0.0 112.463 173.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -64.59 -25.8 70.48 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.134 0.873 . . . . 0.0 113.117 171.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -81.5 111.06 22.23 Favored Pre-proline 0 CA--C 1.535 0.403 0 C-N-CA 124.477 1.111 . . . . 0.0 110.954 -172.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.411 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 58.3 Cg_endo -61.39 111.44 1.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.698 0 N-CA-C 107.172 -1.895 . . . . 0.0 107.172 163.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER 141.1 -44.19 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.785 1 C-N-CA 131.991 4.116 . . . . 0.0 105.762 -170.093 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -64.28 153.75 37.25 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.991 0.901 . . . . 0.0 110.89 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -144.57 138.51 27.52 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 128.168 2.587 . . . . 0.0 106.526 170.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -58.48 149.49 25.05 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 127.223 2.209 . . . . 0.0 110.19 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.24 -16.96 35.76 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.657 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -75.32 96.96 3.47 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.046 1.423 . . . . 0.0 109.242 174.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.7 mp -101.56 147.44 26.4 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 125.905 1.682 . . . . 0.0 107.408 165.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 m -44.64 -43.19 8.06 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.396 1.479 . . . . 0.0 111.425 175.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -61.97 -16.85 54.42 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 120.436 -1.415 . . . . 0.0 113.933 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 42.1 m-20 -94.84 2.8 55.49 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.128 1.371 . . . . 0.0 111.84 175.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 38.3 t -81.28 131.92 35.31 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.537 1.135 . . . . 0.0 109.129 -173.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.73 -19.11 47.93 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.198 -0.939 . . . . 0.0 112.165 177.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 17.6 m-30 -87.39 -9.65 54.18 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.171 0.988 . . . . 0.0 112.328 177.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.415 ' CH2' ' HA3' ' A' ' 48' ' ' GLY . 77.1 t-105 -55.38 142.41 32.43 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.189 0.596 . . . . 0.0 111.154 179.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.62 -97.79 1.4 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 171.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -141.89 158.83 43.31 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.254 1.422 . . . . 0.0 107.834 178.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -72.04 151.08 43.4 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 123.822 0.701 . . . . 0.0 109.972 172.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 99.1 t -123.82 -50.72 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.208 1.403 . . . . 0.0 109.99 -172.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -140.73 -138.64 0.12 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.538 0.735 . . . . 0.0 112.206 -176.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -68.51 64.18 0.11 Allowed 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 127.943 2.497 . . . . 0.0 113.583 -167.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.04 56.14 25.66 Favored Glycine 0 N--CA 1.446 -0.674 0 N-CA-C 108.206 -1.957 . . . . 0.0 108.206 -168.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.44 ' CH2' ' HB3' ' A' ' 5' ' ' ARG . 66.7 m95 -133.75 154.51 50.92 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 106.427 -1.694 . . . . 0.0 106.427 165.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.415 ' HA3' ' CH2' ' A' ' 39' ' ' TRP . . . -164.97 174.82 40.94 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-O 122.489 1.05 . . . . 0.0 112.468 175.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -73.68 145.43 45.26 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 126.473 1.909 . . . . 0.0 111.452 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 29.0 t -116.55 -9.67 11.35 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 127.986 2.515 . . . . 0.0 110.148 -176.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.3 p 71.44 -29.44 0.19 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 127.279 2.232 . . . . 0.0 114.758 169.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 2.8 m80 -85.68 134.11 40.43 Favored Pre-proline 0 CA--C 1.531 0.226 0 C-N-CA 123.791 0.837 . . . . 0.0 109.522 -170.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -57.06 -51.03 9.66 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.355 2.703 . . . . 0.0 111.903 -166.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.407 ' OD2' ' NE2' ' A' ' 12' ' ' HIS . 12.9 p-10 -72.72 51.17 0.27 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 126.56 1.944 . . . . 0.0 110.736 173.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -179.46 -42.29 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.084 0.953 . . . . 0.0 112.955 -177.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -92.19 5.64 49.64 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.818 0.847 . . . . 0.0 112.668 -164.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.94 -55.5 10.76 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 171.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.3 m -78.01 165.94 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.157 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 169.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 22.5 tp -102.87 131.3 49.86 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.624 1.17 . . . . 0.0 108.508 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.0 m -97.21 143.29 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-N 119.393 0.997 . . . . 0.0 110.368 -175.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.439 ' HE2' ' NE1' ' A' ' 47' ' ' TRP . 0.0 OUTLIER -58.12 137.02 57.3 Favored 'General case' 0 C--O 1.223 -0.325 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 172.587 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.08 -42.13 72.43 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 123.909 0.884 . . . . 0.0 110.214 171.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -80.95 7.1 11.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 174.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -73.91 -175.38 32.0 Favored Glycine 0 CA--C 1.522 0.521 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 179.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 76.8 t90 -159.37 154.16 24.62 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 169.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 6.8 p -138.21 165.97 25.35 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 124.0 0.812 . . . . 0.0 110.755 170.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.0 p -64.48 -31.99 73.43 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.698 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.284 1.3 m -72.97 -3.23 3.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-O 118.353 -0.832 . . . . 0.0 113.095 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 22.3 t80 -44.84 127.15 6.21 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.35 0.977 . . . . 0.0 110.859 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -123.2 132.81 24.27 Favored Pre-proline 0 N--CA 1.454 -0.259 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 168.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.44 151.2 65.03 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.823 1.682 . . . . 0.0 110.971 -177.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.73 33.07 1.92 Allowed 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.808 0.843 . . . . 0.0 110.429 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.7 m . . . . . 0 C--O 1.254 1.3 0 C-N-CA 128.326 2.65 . . . . 0.0 105.748 177.418 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 1.303 ' HB3' ' OE2' ' A' ' 3' ' ' GLU . . . . . . . . 0 CA--C 1.53 0.175 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.5 m -162.09 55.92 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 126.147 1.779 . . . . 0.0 107.288 172.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 1.303 ' OE2' ' HB3' ' A' ' 1' ' ' ALA . 2.1 mp0 -59.63 150.95 64.32 Favored Pre-proline 0 N--CA 1.446 -0.629 0 C-N-CA 125.621 1.568 . . . . 0.0 108.463 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.74 131.28 28.76 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 121.557 1.504 . . . . 0.0 110.009 -174.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 34.0 mtt-85 -58.59 126.25 26.83 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.849 1.26 . . . . 0.0 110.476 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -57.33 143.58 39.23 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.474 1.51 . . . . 0.0 111.253 -177.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.64 149.38 22.83 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.496 0.665 . . . . 0.0 111.113 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -61.85 121.02 11.86 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 173.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 83.94 15.78 69.21 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 117.913 -1.493 . . . . 0.0 113.124 -173.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -38.84 -58.44 1.08 Allowed 'General case' 0 C--N 1.346 0.448 0 CA-C-N 119.603 1.701 . . . . 0.0 111.994 172.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -169.03 172.01 7.82 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.548 1.539 . . . . 0.0 107.221 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 39.02 50.52 1.78 Allowed 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 125.709 1.604 . . . . 0.0 112.476 177.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 55.41 25.71 7.98 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.272 1.029 . . . . 0.0 112.553 174.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -63.65 137.58 58.15 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 118.386 0.539 . . . . 0.0 111.125 -175.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.4 m -124.22 144.29 34.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 172.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 23.4 m-20 -71.89 -27.43 62.84 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 124.25 1.02 . . . . 0.0 111.852 176.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -113.98 114.21 25.85 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 171.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -40.63 -49.33 3.0 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 125.352 1.461 . . . . 0.0 111.054 174.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.54 -34.69 59.13 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.589 0.756 . . . . 0.0 112.982 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -50.04 -41.2 47.09 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.532 1.06 . . . . 0.0 110.935 174.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.74 9.78 2.61 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 118.428 -0.796 . . . . 0.0 112.805 -177.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 10.3 t -52.66 -31.76 38.76 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 120.115 1.325 . . . . 0.0 112.691 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -70.82 -21.77 78.11 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.696 1.141 . . . . 0.0 113.823 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 23.8 t-80 -79.72 115.45 53.78 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 118.752 1.276 . . . . 0.0 111.362 -168.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -73.02 72.87 3.22 Favored 'Trans proline' 0 CA--C 1.538 0.706 0 C-N-CA 122.961 2.441 . . . . 0.0 111.21 179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 52.8 mmt-85 -178.06 -36.27 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 131.623 3.969 . . . . 0.0 107.953 173.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -58.91 151.63 21.31 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.58 0.705 . . . . 0.0 110.399 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -136.75 146.04 45.31 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 166.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -59.38 148.43 32.58 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.462 0.649 . . . . 0.0 110.167 176.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.43 -23.16 16.7 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 124.348 0.975 . . . . 0.0 112.569 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -72.63 105.09 4.11 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 118.342 1.071 . . . . 0.0 108.765 177.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.7 mp -117.29 149.0 41.18 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 14.8 m -42.19 -46.19 4.32 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.248 1.419 . . . . 0.0 111.33 172.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -56.91 -26.82 59.98 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.789 -1.194 . . . . 0.0 114.152 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -107.16 19.15 20.79 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 124.11 0.964 . . . . 0.0 112.562 176.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.5 t -82.88 134.56 35.08 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.612 1.165 . . . . 0.0 108.525 173.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.87 -19.26 59.88 Favored 'General case' 0 CA--C 1.53 0.199 0 O-C-N 121.056 -1.027 . . . . 0.0 112.108 177.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.7 m-30 -87.63 -5.21 58.83 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 118.451 -0.785 . . . . 0.0 111.425 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 62.8 t-105 -53.86 142.71 23.32 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.543 1.065 . . . . 0.0 111.465 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.87 -85.95 1.17 Allowed Glycine 0 CA--C 1.525 0.674 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 173.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -166.31 158.95 14.43 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.08 137.01 38.68 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 123.603 0.564 . . . . 0.0 110.029 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.513 HG21 HD11 ' A' ' 59' ' ' LEU . 90.1 t -108.99 -49.93 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 125.417 1.487 . . . . 0.0 109.255 -175.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -151.71 -155.44 0.62 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.339 1.056 . . . . 0.0 110.886 -175.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -56.96 70.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 129.394 3.077 . . . . 0.0 114.416 -160.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 67.58 36.65 88.53 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -172.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 91.5 m95 -130.81 143.44 50.74 Favored 'General case' 0 N--CA 1.443 -0.814 0 C-N-CA 125.444 1.497 . . . . 0.0 109.065 173.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.419 ' HA2' HG23 ' A' ' 43' ' ' VAL . . . -156.77 -176.56 28.99 Favored Glycine 0 N--CA 1.438 -1.204 0 CA-C-O 121.755 0.642 . . . . 0.0 112.189 177.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.481 ' HD2' HD12 ' A' ' 59' ' ' LEU . 48.4 mmm-85 -90.87 154.89 19.16 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 124.34 1.056 . . . . 0.0 109.963 -178.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 t -139.04 130.12 26.59 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 37.0 p -96.64 -179.37 4.57 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.593 1.157 . . . . 0.0 110.432 -169.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 10.3 m80 82.52 163.26 0.12 Allowed Pre-proline 0 CA--C 1.536 0.421 0 C-N-CA 126.288 1.835 . . . . 0.0 108.4 -176.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -49.61 148.05 12.3 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.651 2.234 . . . . 0.0 113.435 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 63.43 -171.5 0.17 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.179 1.792 . . . . 0.0 109.865 -172.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 73.84 -62.66 0.46 Allowed 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 125.309 1.444 . . . . 0.0 113.794 166.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -54.68 -24.68 22.9 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.442 0.697 . . . . 0.0 112.283 -176.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -24.34 -53.74 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 127.469 2.308 . . . . 0.0 112.897 160.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.6 m -126.7 159.05 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.853 1.661 . . . . 0.0 108.064 -170.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.513 HD11 HG21 ' A' ' 43' ' ' VAL . 10.3 tp -79.16 123.41 27.36 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 54.2 t -92.32 129.24 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -171.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.5 tttm -63.38 131.28 47.74 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 176.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.14 -41.99 49.85 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.484 0.714 . . . . 0.0 111.512 173.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -84.84 5.45 28.7 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.35 -176.01 27.43 Favored Glycine 0 CA--C 1.526 0.741 0 CA-C-N 119.414 1.006 . . . . 0.0 111.148 176.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 83.1 t90 -159.19 153.72 24.25 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 170.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.411 ' SG ' HG22 ' A' ' 68' ' ' VAL . 2.0 p -142.06 163.63 32.35 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.861 1.264 . . . . 0.0 110.578 175.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.1 p -78.14 -5.95 53.22 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -176.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.411 HG22 ' SG ' ' A' ' 66' ' ' CYS 0.284 1.5 m -83.61 0.3 4.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 119.598 1.09 . . . . 0.0 112.169 164.574 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 41.2 t80 -47.14 137.98 7.33 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 119.073 0.852 . . . . 0.0 111.708 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -134.57 138.7 30.59 Favored Pre-proline 0 N--CA 1.454 -0.259 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 167.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.11 149.85 52.97 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.033 1.822 . . . . 0.0 111.147 -176.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -97.22 37.82 1.3 Allowed 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.932 0.893 . . . . 0.0 110.071 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 45.7 m . . . . . 0 C--O 1.253 1.284 0 C-N-CA 128.365 2.666 . . . . 0.0 105.527 178.832 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.263 0 CA-C-O 117.455 -1.26 . . . . 0.0 108.45 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m 50.91 35.08 11.59 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.821 1.248 . . . . 0.0 113.078 178.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 51.3 mp0 -61.59 150.77 80.26 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 123.316 0.646 . . . . 0.0 109.433 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -66.21 145.73 79.23 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.308 2.005 . . . . 0.0 110.813 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 35.5 mtt180 -57.89 125.69 24.16 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.065 1.346 . . . . 0.0 110.604 177.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.15 150.14 30.69 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 125.189 1.396 . . . . 0.0 112.75 -173.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -83.34 144.57 29.58 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.913 1.285 . . . . 0.0 108.623 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -62.1 121.98 14.4 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 166.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 74.79 22.91 76.28 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-O 118.175 -1.347 . . . . 0.0 113.271 -173.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -42.04 -55.09 3.31 Favored 'General case' 0 C--N 1.346 0.44 0 CA-C-N 119.557 1.678 . . . . 0.0 111.182 168.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -165.94 173.89 10.03 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 125.066 1.347 . . . . 0.0 108.06 173.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 38.33 50.69 1.5 Allowed 'General case' 0 C--N 1.341 0.23 0 C-N-CA 126.025 1.73 . . . . 0.0 112.986 172.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.2 20.5 8.56 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.384 0.674 . . . . 0.0 111.905 171.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -63.22 136.02 57.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.862 0.755 . . . . 0.0 110.543 -175.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.9 m -122.62 142.19 40.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -62.74 -36.66 83.74 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.921 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -109.01 123.3 48.93 Favored 'General case' 0 N--CA 1.433 -1.294 0 C-N-CA 123.401 0.68 . . . . 0.0 109.362 170.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.56 -36.44 10.56 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.25 1.42 . . . . 0.0 110.919 171.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.24 -40.99 64.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 111.695 0.257 . . . . 0.0 111.695 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -56.38 -37.63 70.34 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 122.024 0.916 . . . . 0.0 110.604 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.51 0.69 13.96 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 117.831 -1.081 . . . . 0.0 112.245 -175.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 17.2 t -52.29 -30.39 27.88 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 120.36 1.436 . . . . 0.0 112.861 172.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -65.25 -27.2 72.13 Favored Glycine 0 CA--C 1.536 1.398 0 C-N-CA 124.49 1.043 . . . . 0.0 113.679 175.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -81.49 114.86 52.91 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 118.375 1.087 . . . . 0.0 111.494 -169.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.403 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 59.0 Cg_endo -63.05 108.7 0.8 Allowed 'Trans proline' 0 N--CA 1.456 -0.68 0 N-CA-C 107.614 -1.726 . . . . 0.0 107.614 165.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 25' ' ' PRO . 2.0 mmm180 139.34 -35.41 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 131.487 3.915 . . . . 0.0 108.748 -173.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -71.9 156.55 39.15 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 121.492 0.663 . . . . 0.0 109.765 175.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 12.3 tp60 -155.16 138.94 16.17 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.384 165.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -54.71 115.61 2.25 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 128.114 2.565 . . . . 0.0 109.53 -175.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.37 -21.19 11.96 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -72.92 109.27 6.35 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 167.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.2 mp -122.89 148.64 45.2 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.355 2.262 . . . . 0.0 106.137 172.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 6.5 m -45.07 -44.49 10.35 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 125.498 1.519 . . . . 0.0 111.711 175.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -59.12 -18.81 39.0 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 120.657 -1.277 . . . . 0.0 113.903 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 40.5 m-20 -96.8 3.98 51.99 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.217 1.407 . . . . 0.0 112.043 178.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.2 t -90.79 139.99 30.21 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.849 1.26 . . . . 0.0 110.396 -169.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.84 -11.3 58.31 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.007 -1.058 . . . . 0.0 112.857 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.5 m-30 -88.96 -3.92 58.59 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 118.617 -0.706 . . . . 0.0 111.604 171.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 61.2 t-105 -59.52 132.28 53.52 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 119.07 0.85 . . . . 0.0 110.321 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.88 -81.03 1.13 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 108.102 -1.999 . . . . 0.0 108.102 171.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.6 165.68 12.18 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.612 0.765 . . . . 0.0 110.165 163.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.406 ' HA ' ' HA3' ' A' ' 48' ' ' GLY . . . -58.74 146.64 36.03 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.313 1.045 . . . . 0.0 111.034 170.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 92.2 t -125.23 -48.47 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 124.925 1.29 . . . . 0.0 109.211 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -149.17 -159.15 0.99 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.016 0.926 . . . . 0.0 110.192 -174.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -59.32 70.3 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 129.648 3.179 . . . . 0.0 113.799 -162.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.0 30.08 57.96 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 82.5 m95 -131.55 143.02 50.06 Favored 'General case' 0 N--CA 1.438 -1.056 0 C-N-CA 124.949 1.299 . . . . 0.0 108.845 174.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 42' ' ' ALA . . . -152.89 172.91 31.91 Favored Glycine 0 N--CA 1.433 -1.508 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 176.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -72.03 127.76 33.56 Favored 'General case' 0 N--CA 1.429 -1.498 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.105 170.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 52.0 t -84.64 167.74 15.95 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 104.778 -2.305 . . . . 0.0 104.778 141.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 71.4 p -127.45 165.8 19.13 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.933 0.893 . . . . 0.0 109.686 175.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 45.0 m80 93.95 120.09 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 129.276 3.03 . . . . 0.0 108.9 173.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -53.46 129.8 35.52 Favored 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.637 2.224 . . . . 0.0 111.295 -174.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 118.69 -46.14 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 130.984 3.714 . . . . 0.0 105.757 -160.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -133.51 52.44 2.07 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.386 1.474 . . . . 0.0 110.132 177.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -132.42 -40.68 0.99 Allowed 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.792 0.837 . . . . 0.0 110.39 172.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -52.13 -41.43 62.5 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.456 1.903 . . . . 0.0 112.37 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.6 m -114.94 153.66 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 125.476 1.51 . . . . 0.0 109.424 -173.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 18.6 tp -85.28 136.27 33.57 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 25.6 t -104.97 134.8 45.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 123.608 0.763 . . . . 0.0 109.089 -167.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 36.6 tttm -64.01 129.64 40.82 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 176.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.17 -40.11 67.2 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.167 0.587 . . . . 0.0 111.632 177.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -82.7 1.26 39.5 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 175.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -71.57 -174.0 19.23 Favored Glycine 0 C--N 1.334 0.435 0 CA-C-N 120.055 1.298 . . . . 0.0 111.832 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 75.2 t90 -163.87 150.64 11.81 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 174.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.6 p -135.76 162.99 31.21 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 125.142 1.377 . . . . 0.0 110.462 174.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 80.4 p -68.08 -21.76 64.96 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 118.454 -0.784 . . . . 0.0 112.521 -176.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.292 1.1 m -76.29 -4.64 6.39 Favored 'Isoleucine or valine' 0 C--N 1.344 0.36 0 CA-C-N 119.249 0.931 . . . . 0.0 112.705 175.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -42.69 126.47 3.67 Favored 'General case' 0 C--N 1.345 0.378 0 CA-C-N 118.777 0.717 . . . . 0.0 111.784 178.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -126.92 134.39 26.05 Favored Pre-proline 0 N--CA 1.454 -0.265 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 165.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -69.9 150.15 66.95 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 121.586 1.524 . . . . 0.0 111.027 -175.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.42 41.18 1.11 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 121.574 0.702 . . . . 0.0 109.807 172.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.6 m . . . . . 0 C--O 1.249 1.046 0 C-N-CA 127.977 2.511 . . . . 0.0 106.045 178.089 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.35 0 CA-C-O 118.823 -0.608 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.4 m 61.92 51.86 3.6 Favored 'General case' 0 C--N 1.337 0.048 0 C-N-CA 124.846 1.258 . . . . 0.0 109.15 174.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -104.21 117.93 58.16 Favored Pre-proline 0 CA--C 1.543 0.687 0 CA-C-N 115.207 -0.906 . . . . 0.0 112.849 -148.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -65.3 154.8 71.91 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.546 2.164 . . . . 0.0 110.752 170.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 33.3 mtt180 -55.1 125.68 21.52 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.476 1.111 . . . . 0.0 110.868 172.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.58 152.5 34.8 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.64 1.176 . . . . 0.0 113.542 -172.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -84.8 143.4 29.13 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 125.452 1.501 . . . . 0.0 108.774 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -63.59 118.78 8.69 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 167.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.0 20.81 72.4 Favored Glycine 0 CA--C 1.531 1.094 0 CA-C-O 118.377 -1.235 . . . . 0.0 113.112 -173.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -43.89 -56.87 3.61 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 119.453 1.627 . . . . 0.0 111.477 169.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.09 172.96 10.79 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.146 1.378 . . . . 0.0 108.015 177.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 36.84 48.45 0.67 Allowed 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 126.37 1.868 . . . . 0.0 113.246 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 55.77 23.85 6.75 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.853 0.861 . . . . 0.0 112.127 173.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -63.14 135.09 56.97 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 118.172 0.442 . . . . 0.0 110.096 -175.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.7 m -123.23 141.46 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 170.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 13.3 m-20 -62.61 -36.13 81.76 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 118.949 -0.548 . . . . 0.0 111.1 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.87 130.34 55.01 Favored 'General case' 0 N--CA 1.437 -1.1 0 C-N-CA 123.516 0.727 . . . . 0.0 109.334 168.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.49 -34.55 36.33 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.358 1.063 . . . . 0.0 110.654 170.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.05 -45.25 64.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.238 0.215 . . . . 0.0 111.434 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.52 -20.72 65.85 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 123.577 0.751 . . . . 0.0 111.933 -176.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.27 -6.53 55.26 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.544 -0.723 . . . . 0.0 111.968 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.2 m -62.73 91.88 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 119.162 0.892 . . . . 0.0 111.22 178.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.37 -36.0 1.03 Allowed Glycine 0 CA--C 1.527 0.8 0 C-N-CA 125.263 1.411 . . . . 0.0 110.764 -172.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -62.12 116.8 24.25 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 118.278 -0.868 . . . . 0.0 109.28 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.91 116.52 3.61 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 N-CA-C 107.455 -1.786 . . . . 0.0 107.455 170.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.5 tpt85 123.2 -35.54 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 129.438 3.095 . . . . 0.0 109.278 -170.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -62.7 149.73 42.96 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.52 0.676 . . . . 0.0 109.454 168.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -157.19 137.07 12.45 Favored 'General case' 0 N--CA 1.446 -0.659 0 C-N-CA 126.128 1.771 . . . . 0.0 106.368 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -58.33 123.47 16.21 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 127.522 2.329 . . . . 0.0 110.998 -172.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.94 -20.68 37.93 Favored Glycine 0 CA--C 1.523 0.583 0 CA-C-O 119.181 -0.788 . . . . 0.0 111.607 176.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -67.66 111.41 4.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 118.829 1.314 . . . . 0.0 107.909 173.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.6 mp -124.96 149.64 47.45 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 172.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 24.4 m -42.91 -45.54 5.01 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 125.042 1.337 . . . . 0.0 111.89 173.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -56.86 -26.08 57.83 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -109.26 25.72 11.47 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.178 0.991 . . . . 0.0 112.357 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 45.1 t -86.42 138.8 31.49 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.584 1.153 . . . . 0.0 108.838 172.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.09 -26.27 64.52 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.443 -0.785 . . . . 0.0 112.079 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -78.14 -10.92 59.85 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 117.719 -1.134 . . . . 0.0 112.559 176.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -49.56 127.77 16.22 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 119.988 1.267 . . . . 0.0 111.898 -172.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.18 -84.65 0.59 Allowed Glycine 0 C--N 1.335 0.485 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -166.81 171.17 11.64 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 155.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.28 145.76 46.3 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.55 1.14 . . . . 0.0 110.996 169.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.3 t -123.62 -47.45 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 125.746 1.619 . . . . 0.0 109.24 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -148.46 -162.73 1.62 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.987 0.915 . . . . 0.0 110.186 -174.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -58.05 71.23 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 129.675 3.19 . . . . 0.0 113.934 -163.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.95 26.82 57.61 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 124.985 1.278 . . . . 0.0 110.913 -177.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 78.9 m95 -129.67 144.47 51.3 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 124.978 1.311 . . . . 0.0 109.644 176.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -154.04 -178.36 28.39 Favored Glycine 0 N--CA 1.437 -1.247 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 22.0 mtp85 -94.66 154.6 17.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 118.926 -0.559 . . . . 0.0 109.909 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.3 p -131.09 143.01 50.34 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 123.49 0.716 . . . . 0.0 109.093 159.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 34.4 p -82.26 61.14 5.33 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.62 1.168 . . . . 0.0 111.108 -160.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -153.81 114.58 2.59 Favored Pre-proline 0 N--CA 1.451 -0.397 0 CA-C-O 117.833 -1.08 . . . . 0.0 108.944 175.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -48.23 128.22 16.79 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 N-CA-C 107.917 -1.609 . . . . 0.0 107.917 159.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 124.03 -44.39 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 128.403 2.681 . . . . 0.0 105.953 -154.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -143.85 33.51 1.26 Allowed 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 127.471 2.308 . . . . 0.0 110.024 -169.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -127.51 -41.89 1.68 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 122.253 1.025 . . . . 0.0 109.666 178.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.3 pm0 -51.92 -34.08 40.08 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 125.085 1.354 . . . . 0.0 111.549 166.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 21.8 m -127.39 149.62 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 C-N-CA 125.285 1.434 . . . . 0.0 108.598 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 19.4 tp -91.55 142.66 27.41 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 125.371 1.468 . . . . 0.0 108.963 -171.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.2 t -102.06 124.7 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 C-N-CA 124.927 1.291 . . . . 0.0 108.457 -162.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.3 tttm -61.6 126.81 28.69 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 171.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.65 -38.0 30.62 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 124.069 0.948 . . . . 0.0 111.676 175.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -83.54 -4.34 58.46 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 113.268 0.84 . . . . 0.0 113.268 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -74.41 -173.32 29.73 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 119.034 0.834 . . . . 0.0 111.991 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 86.0 t90 -161.75 148.88 14.31 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 176.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.614 ' SG ' HG13 ' A' ' 68' ' ' VAL . 5.6 p -135.11 163.83 29.02 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 125.186 1.394 . . . . 0.0 109.341 172.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.7 p -73.07 -18.1 61.35 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.969 -1.082 . . . . 0.0 112.672 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.614 HG13 ' SG ' ' A' ' 66' ' ' CYS 0.373 1.5 p -77.87 7.13 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.946 0 C-N-CA 124.866 1.266 . . . . 0.0 111.785 164.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -52.5 130.36 31.48 Favored 'General case' 0 C--N 1.345 0.394 0 O-C-N 120.206 -1.559 . . . . 0.0 110.28 162.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.95 134.63 26.53 Favored Pre-proline 0 N--CA 1.453 -0.291 0 N-CA-C 106.453 -1.684 . . . . 0.0 106.453 171.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_endo -73.28 148.37 43.62 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 121.788 1.659 . . . . 0.0 110.658 -177.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -93.26 46.27 1.2 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.746 0.784 . . . . 0.0 109.523 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 51.2 p . . . . . 0 C--O 1.249 1.076 0 C-N-CA 125.84 1.656 . . . . 0.0 106.79 -172.284 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.795 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . . . . . . . . 0 CA--C 1.513 -0.476 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.82 29.34 0.06 Allowed 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 -174.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.795 ' OE1' ' HB3' ' A' ' 1' ' ' ALA . 2.2 mp0 -81.6 128.7 68.49 Favored Pre-proline 0 N--CA 1.45 -0.429 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 176.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -65.96 131.39 27.01 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.848 1.698 . . . . 0.0 109.881 -176.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.433 ' HB3' ' CH2' ' A' ' 47' ' ' TRP . 18.2 mtp180 -80.32 122.61 27.12 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -172.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -52.53 135.54 33.86 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.974 1.31 . . . . 0.0 112.804 -166.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -68.41 147.93 51.37 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.681 1.192 . . . . 0.0 109.464 177.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.27 87.75 0.12 Allowed 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 123.744 0.818 . . . . 0.0 109.55 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.16 37.55 5.63 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.917 -173.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -39.65 -54.19 2.06 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 123.91 0.884 . . . . 0.0 109.943 164.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.416 ' HB3' ' CD2' ' A' ' 12' ' ' HIS . . . -165.76 175.21 8.94 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 125.494 1.518 . . . . 0.0 106.986 170.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.51 ' CD2' ' CE2' ' A' ' 55' ' ' PHE . 3.4 m-70 55.21 30.02 13.81 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.966 1.307 . . . . 0.0 113.603 169.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 57.08 34.58 25.1 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.603 1.161 . . . . 0.0 111.938 175.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -54.12 -64.48 0.81 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.41 1.263 . . . . 0.0 114.41 -171.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.284 23.6 m 55.52 134.8 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 C-N-CA 127.206 2.202 . . . . 0.0 114.077 -169.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.2 m-20 -66.69 -28.9 68.81 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 120.77 -1.206 . . . . 0.0 112.405 -174.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -113.11 118.95 36.16 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 171.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.91 -43.59 29.01 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.48 1.112 . . . . 0.0 109.818 175.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.97 -40.24 13.99 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 123.75 0.82 . . . . 0.0 112.889 175.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -52.44 -34.85 50.61 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 119.507 1.049 . . . . 0.0 111.445 178.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -72.29 5.11 3.07 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 116.895 -1.526 . . . . 0.0 113.811 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.8 m -13.68 99.99 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 128.13 2.572 . . . . 0.0 113.942 170.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.15 21.66 64.19 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.312 0.958 . . . . 0.0 115.052 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -48.09 127.47 11.99 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 119.31 1.555 . . . . 0.0 107.783 162.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -61.01 110.26 0.82 Allowed 'Trans proline' 0 N--CA 1.456 -0.708 0 CA-C-N 121.252 1.483 . . . . 0.0 108.299 175.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.5 tpt85 123.66 -40.72 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 129.578 3.151 . . . . 0.0 110.161 -171.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -70.82 143.39 51.14 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.795 0.725 . . . . 0.0 110.557 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.512 ' H ' ' NE2' ' A' ' 31' ' ' GLN . 23.0 mp0 -132.95 123.2 25.49 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 162.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.0 mp0 -54.15 119.05 4.58 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 128.407 2.683 . . . . 0.0 109.181 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 124.99 -34.55 3.38 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -174.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.512 ' NE2' ' H ' ' A' ' 28' ' ' GLN . 25.7 mt-30 -63.94 118.4 8.38 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 171.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -128.87 147.27 50.8 Favored 'General case' 0 C--N 1.334 -0.106 0 C-N-CA 126.086 1.754 . . . . 0.0 107.154 -178.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.5 m -44.04 -48.8 8.88 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.15 0.98 . . . . 0.0 111.444 174.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -61.34 -20.45 62.99 Favored 'General case' 0 CA--C 1.54 0.562 0 O-C-N 120.431 -1.418 . . . . 0.0 113.983 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -107.21 24.12 13.34 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.811 1.244 . . . . 0.0 111.845 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.4 t -95.3 134.52 37.98 Favored 'General case' 0 C--O 1.232 0.153 0 C-N-CA 125.391 1.476 . . . . 0.0 109.595 176.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.0 -20.21 56.55 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.433 -0.792 . . . . 0.0 112.726 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -97.52 6.64 47.83 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.138 0.575 . . . . 0.0 112.192 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 77.0 t-105 -59.66 145.74 43.67 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.594 0.633 . . . . 0.0 110.392 171.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.18 -69.78 1.28 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 172.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -176.46 160.4 2.06 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 -169.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.37 140.38 31.61 Favored 'General case' 0 N--CA 1.457 -0.083 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 169.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.727 HG23 ' HA2' ' A' ' 48' ' ' GLY . 55.5 t -107.53 -51.37 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.401 1.48 . . . . 0.0 109.279 -173.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.604 ' OE1' ' N ' ' A' ' 1' ' ' ALA . 16.6 pt20 -149.55 -136.88 0.08 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.421 0.689 . . . . 0.0 111.728 -170.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -71.43 65.71 0.45 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 127.054 2.142 . . . . 0.0 112.988 -163.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.0 42.38 77.82 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 -173.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.433 ' CH2' ' HB3' ' A' ' 5' ' ' ARG . 80.7 m95 -133.45 156.12 48.29 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 125.514 1.526 . . . . 0.0 108.232 170.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.727 ' HA2' HG23 ' A' ' 43' ' ' VAL . . . -157.47 -174.08 26.71 Favored Glycine 0 N--CA 1.434 -1.476 0 O-C-N 124.496 1.122 . . . . 0.0 110.507 177.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -98.23 153.64 18.35 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.402 1.081 . . . . 0.0 108.882 -176.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.519 ' HB2' HG21 ' A' ' 60' ' ' VAL . 9.2 t -134.25 134.66 42.21 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 125.463 1.505 . . . . 0.0 107.867 177.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 64.3 p -105.98 52.62 0.72 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.909 0.883 . . . . 0.0 111.271 -162.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.01 154.65 72.73 Favored Pre-proline 0 CA--C 1.53 0.207 0 C-N-CA 123.916 0.886 . . . . 0.0 109.012 177.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.54 144.32 72.43 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 122.757 2.304 . . . . 0.0 110.855 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.9 t0 60.55 46.66 9.28 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.579 1.152 . . . . 0.0 107.935 -173.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.51 ' CE2' ' CD2' ' A' ' 12' ' ' HIS . 1.1 m-85 -166.4 -53.37 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.861 1.664 . . . . 0.0 107.759 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.4 p-10 -23.49 -50.89 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 126.595 1.958 . . . . 0.0 113.327 153.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -44.91 -42.56 8.19 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.939 1.296 . . . . 0.0 114.311 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 24.3 m -130.4 156.4 42.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 C-N-CA 124.07 0.948 . . . . 0.0 111.951 -160.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.725 HD11 HG21 ' A' ' 43' ' ' VAL . 9.1 tp -78.81 126.76 31.15 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 173.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.519 HG21 ' HB2' ' A' ' 50' ' ' CYS . 11.0 m -98.13 134.93 34.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 118.815 0.734 . . . . 0.0 109.546 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -61.16 134.91 57.52 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 172.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.1 -40.56 73.87 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.66 0.384 . . . . 0.0 111.223 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -76.8 -2.34 32.72 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 175.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -66.11 -178.52 8.62 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 174.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 70.5 t90 -148.71 -179.48 7.02 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 170.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.432 ' SG ' HG22 ' A' ' 68' ' ' VAL . 5.7 p -162.66 164.85 26.37 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 119.038 0.835 . . . . 0.0 110.357 159.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 79.5 p -63.0 -30.99 72.03 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 118.939 -0.553 . . . . 0.0 111.781 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.432 HG22 ' SG ' ' A' ' 66' ' ' CYS 0.301 1.1 m -72.42 -5.34 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.47 0 CA-C-N 118.885 0.766 . . . . 0.0 112.478 177.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -46.03 137.0 6.19 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 123.884 0.874 . . . . 0.0 112.031 177.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -130.43 140.59 39.12 Favored Pre-proline 0 CA--C 1.531 0.214 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 165.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -74.04 147.76 38.96 Favored 'Trans proline' 0 N--CA 1.45 -1.07 0 C-N-CA 122.282 1.988 . . . . 0.0 111.248 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -92.3 46.75 1.27 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.611 0.72 . . . . 0.0 109.424 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 57.5 p . . . . . 0 C--O 1.248 1.018 0 C-N-CA 125.66 1.584 . . . . 0.0 107.122 -172.937 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 1.348 ' CB ' ' OE1' ' A' ' 3' ' ' GLU . . . . . . . . 0 CA--C 1.513 -0.453 0 CA-C-O 117.276 -1.345 . . . . 0.0 107.834 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 m -50.74 -32.45 19.7 Favored 'General case' 0 C--O 1.226 -0.136 0 CA-C-O 122.621 1.201 . . . . 0.0 112.931 161.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 1.348 ' OE1' ' CB ' ' A' ' 1' ' ' ALA . 2.7 mp0 -77.29 127.51 82.94 Favored Pre-proline 0 C--N 1.318 -0.795 0 C-N-CA 126.78 2.032 . . . . 0.0 108.252 171.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.92 153.76 58.25 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 123.495 2.797 . . . . 0.0 110.795 174.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.437 ' HB3' ' CH2' ' A' ' 47' ' ' TRP . 16.1 mtp180 -79.23 123.13 27.12 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -54.61 142.7 27.12 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.82 1.248 . . . . 0.0 112.68 -170.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -76.58 145.61 38.85 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 125.006 1.322 . . . . 0.0 108.417 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -64.86 121.57 14.92 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 167.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 71.97 25.73 74.12 Favored Glycine 0 CA--C 1.532 1.109 0 CA-C-O 118.275 -1.292 . . . . 0.0 112.855 -170.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -41.95 -57.87 2.26 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 119.388 1.594 . . . . 0.0 110.7 168.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -171.19 174.06 4.74 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.746 1.619 . . . . 0.0 107.351 173.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . 0.455 ' CD2' ' CE2' ' A' ' 55' ' ' PHE . 10.4 m-70 54.46 31.97 15.78 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.802 1.241 . . . . 0.0 113.137 172.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 55.1 29.99 13.54 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.256 1.023 . . . . 0.0 111.596 -176.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 63.2 t80 -64.35 134.68 55.11 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.972 -0.455 . . . . 0.0 110.043 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 8.0 m -122.9 142.04 40.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 170.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.3 m-20 -63.27 -34.92 78.73 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 118.993 -0.527 . . . . 0.0 111.534 -178.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -109.69 127.27 54.47 Favored 'General case' 0 N--CA 1.436 -1.125 0 C-N-CA 123.634 0.774 . . . . 0.0 109.733 169.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -47.16 -38.47 11.86 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.732 1.213 . . . . 0.0 110.58 168.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.15 -41.76 60.33 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -59.7 -30.61 68.91 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.131 0.491 . . . . 0.0 111.373 -176.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.01 -0.31 30.67 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 118.85 -0.595 . . . . 0.0 112.448 -176.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.3 m -61.79 91.56 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 119.248 0.931 . . . . 0.0 111.377 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.06 -32.43 1.41 Allowed Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.087 1.327 . . . . 0.0 111.431 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -60.26 125.12 80.79 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 118.067 0.933 . . . . 0.0 109.567 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 26' ' ' ARG . 59.5 Cg_endo -65.21 102.3 0.45 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 N-CA-C 107.258 -1.862 . . . . 0.0 107.258 169.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 25' ' ' PRO . 0.1 OUTLIER 139.9 -29.44 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 130.9 3.68 . . . . 0.0 110.235 -173.585 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 59.2 t80 -75.71 79.86 2.67 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.432 0.635 . . . . 0.0 109.769 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.8 tm0? -64.75 137.62 57.9 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 161.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -59.46 118.55 6.16 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 128.085 2.554 . . . . 0.0 112.193 -172.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.67 -1.18 63.57 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-O 119.381 -0.677 . . . . 0.0 111.909 174.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -60.87 121.87 13.42 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 118.388 1.094 . . . . 0.0 108.372 166.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.7 mp -128.94 145.1 51.32 Favored 'General case' 0 N--CA 1.465 0.298 0 C-N-CA 126.661 1.984 . . . . 0.0 107.723 173.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 6.8 m -45.54 -45.17 13.28 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 124.829 1.252 . . . . 0.0 112.75 177.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -64.84 -13.97 57.82 Favored 'General case' 0 CA--C 1.54 0.593 0 O-C-N 119.863 -1.773 . . . . 0.0 114.01 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -93.09 -1.16 56.76 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.318 1.047 . . . . 0.0 111.416 173.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.6 t -80.12 131.41 35.73 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.417 1.087 . . . . 0.0 109.138 -175.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.67 -6.29 19.89 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 120.969 -1.082 . . . . 0.0 112.472 179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -93.57 -2.28 54.41 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.936 0.789 . . . . 0.0 111.755 171.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 75.1 t-105 -59.56 149.37 30.23 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 118.518 0.599 . . . . 0.0 111.194 178.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.86 -74.82 1.27 Allowed Glycine 0 CA--C 1.525 0.672 0 C-N-CA 125.287 1.422 . . . . 0.0 109.593 173.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -173.21 154.11 2.63 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 125.284 1.433 . . . . 0.0 107.152 -168.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.61 137.24 37.05 Favored 'General case' 0 C--N 1.34 0.165 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 171.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.615 HG23 ' HA2' ' A' ' 48' ' ' GLY . 75.9 t -107.69 -48.62 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 C-N-CA 125.244 1.418 . . . . 0.0 108.972 -173.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -149.37 -140.8 0.1 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.728 0.411 . . . . 0.0 111.866 -168.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -72.12 65.05 0.56 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 127.257 2.223 . . . . 0.0 112.561 -167.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.42 31.08 47.38 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -178.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.437 ' CH2' ' HB3' ' A' ' 5' ' ' ARG . 74.7 m95 -132.2 152.39 51.33 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 125.301 1.441 . . . . 0.0 109.224 173.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.615 ' HA2' HG23 ' A' ' 43' ' ' VAL . . . -154.84 -179.93 30.42 Favored Glycine 0 N--CA 1.431 -1.64 0 O-C-N 124.669 1.231 . . . . 0.0 110.832 178.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -86.05 145.77 26.92 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 177.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -137.62 133.2 34.08 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 126.589 1.956 . . . . 0.0 105.751 174.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.9 p -91.42 171.08 9.45 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 122.754 0.421 . . . . 0.0 111.321 -168.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 18.5 m80 100.23 141.19 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 130.231 3.412 . . . . 0.0 107.91 174.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -57.6 147.63 78.13 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.25 1.967 . . . . 0.0 111.554 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 41.2 t0 58.83 40.01 23.36 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.742 1.217 . . . . 0.0 109.94 -165.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.455 ' CE2' ' CD2' ' A' ' 12' ' ' HIS . 1.2 m-85 -163.22 -55.56 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.152 1.781 . . . . 0.0 109.483 172.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -37.37 -46.66 0.79 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.423 1.489 . . . . 0.0 111.98 173.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -65.86 -17.24 64.51 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.701 1.6 . . . . 0.0 115.28 -174.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.27 149.02 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 120.192 1.36 . . . . 0.0 111.239 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.598 HD11 HG21 ' A' ' 43' ' ' VAL . 7.3 tp -77.78 130.41 36.67 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 174.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 38.4 t -106.04 129.67 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -174.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.419 ' HD2' ' CZ2' ' A' ' 47' ' ' TRP . 32.5 tttm -61.87 129.79 42.61 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 174.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.9 -36.69 67.94 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.565 0.746 . . . . 0.0 111.483 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -80.83 -7.03 59.32 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 118.57 -0.729 . . . . 0.0 112.455 178.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.38 -173.07 20.8 Favored Glycine 0 C--N 1.334 0.45 0 CA-C-N 118.906 0.775 . . . . 0.0 111.915 -177.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -161.19 150.68 16.8 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.41 ' SG ' HG22 ' A' ' 68' ' ' VAL . 1.8 p -139.82 172.44 12.78 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.235 1.014 . . . . 0.0 111.223 170.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 81.0 p -72.06 -35.53 69.31 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.41 HG22 ' SG ' ' A' ' 66' ' ' CYS . 2.4 m -64.84 -23.85 34.31 Favored 'Isoleucine or valine' 0 C--N 1.347 0.467 0 CA-C-N 118.568 0.622 . . . . 0.0 111.632 -175.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -20.45 105.39 0.02 OUTLIER 'General case' 0 C--O 1.237 0.403 0 C-N-CA 128.033 2.533 . . . . 0.0 113.486 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -99.57 120.57 57.26 Favored Pre-proline 0 N--CA 1.454 -0.234 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 165.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -66.1 134.41 36.67 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.253 1.302 . . . . 0.0 112.81 -173.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -90.56 -13.71 33.98 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 142.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.9 m . . . . . 0 C--O 1.25 1.108 1 C-N-CA 134.156 4.982 . . . . 0.0 103.518 174.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.432 ' O ' ' OE2' ' A' ' 3' ' ' GLU . . . . . . . . 0 CA--C 1.52 -0.194 0 CA-C-O 116.592 -1.67 . . . . 0.0 109.874 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.4 p -105.64 58.42 0.67 Allowed 'General case' 0 CA--C 1.53 0.186 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 173.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.432 ' OE2' ' O ' ' A' ' 1' ' ' ALA . 1.8 pm0 -73.93 140.55 77.54 Favored Pre-proline 0 CA--C 1.539 0.533 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -173.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.49 147.91 65.64 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.527 2.151 . . . . 0.0 111.312 -176.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 39.1 mtt180 -62.46 127.37 31.01 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.783 1.233 . . . . 0.0 109.987 171.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -59.41 145.53 43.31 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 125.584 1.553 . . . . 0.0 111.514 -175.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.3 146.15 24.91 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.375 0.607 . . . . 0.0 110.94 175.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.92 120.33 9.43 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 172.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 82.75 18.7 65.12 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-O 117.997 -1.446 . . . . 0.0 113.742 -174.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -36.01 -55.3 0.76 Allowed 'General case' 0 C--N 1.347 0.467 0 CA-C-N 119.637 1.718 . . . . 0.0 111.602 168.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -164.77 -179.47 5.87 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 164.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 52.4 m170 46.22 45.95 13.1 Favored 'General case' 0 CA--C 1.527 0.071 0 O-C-N 124.213 0.945 . . . . 0.0 111.865 160.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 56.23 24.59 8.28 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.955 1.302 . . . . 0.0 112.219 172.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -62.49 136.69 58.02 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 118.152 0.433 . . . . 0.0 111.415 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.1 m -125.46 142.26 42.8 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 174.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -70.65 -24.87 62.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.2 1.0 . . . . 0.0 112.053 177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -115.31 120.57 40.08 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 125.12 1.368 . . . . 0.0 107.919 168.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -49.04 -49.62 40.38 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 124.189 0.996 . . . . 0.0 111.665 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.7 -20.03 64.4 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 118.201 -0.904 . . . . 0.0 112.785 -173.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -44.57 -43.84 8.37 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 119.805 1.184 . . . . 0.0 110.466 165.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.03 7.9 12.07 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 113.229 0.825 . . . . 0.0 113.229 -175.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 5.6 p -33.14 -59.16 0.37 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 127.344 2.257 . . . . 0.0 113.19 174.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -52.93 -29.82 35.64 Favored Glycine 0 CA--C 1.535 1.315 0 CA-C-N 112.239 -2.255 . . . . 0.0 113.805 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -70.04 117.51 54.73 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-N 118.687 1.243 . . . . 0.0 110.908 -171.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -60.68 105.74 0.33 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 N-CA-C 107.439 -1.793 . . . . 0.0 107.439 163.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 141.41 -40.0 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 130.983 3.713 . . . . 0.0 108.662 -172.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -68.78 150.4 47.89 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 173.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -150.3 132.14 15.09 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 106.08 -1.822 . . . . 0.0 106.08 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . 0.272 1.1 pm0 -56.94 107.26 0.38 Allowed 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.31 1.444 . . . . 0.0 112.076 -173.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.39 -1.87 27.98 Favored Glycine 0 CA--C 1.526 0.74 0 CA-C-O 119.139 -0.811 . . . . 0.0 111.983 178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -73.07 110.81 7.64 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 119.74 1.77 . . . . 0.0 107.044 164.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.5 mp -121.57 150.27 41.9 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.925 2.09 . . . . 0.0 106.346 170.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.8 m -47.7 -45.72 28.79 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.326 1.05 . . . . 0.0 111.946 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -62.89 -13.65 36.79 Favored 'General case' 0 CA--C 1.549 0.931 0 O-C-N 120.209 -1.557 . . . . 0.0 113.588 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -95.68 2.52 54.07 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 120.82 -1.175 . . . . 0.0 111.874 175.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 24.6 t -86.83 137.06 32.72 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 124.754 1.222 . . . . 0.0 109.448 -171.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.02 -20.66 65.52 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 121.188 -0.945 . . . . 0.0 111.867 177.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -87.29 2.07 51.31 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 118.566 -0.731 . . . . 0.0 112.528 173.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 48.2 t-105 -59.09 142.93 50.14 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.749 1.158 . . . . 0.0 111.071 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.43 -109.47 0.93 Allowed Glycine 0 CA--C 1.523 0.533 0 N-CA-C 107.482 -2.247 . . . . 0.0 107.482 165.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -139.43 157.26 46.16 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 125.274 1.43 . . . . 0.0 107.782 175.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.27 141.44 58.02 Favored 'General case' 0 N--CA 1.451 -0.403 0 O-C-N 123.929 0.768 . . . . 0.0 109.444 165.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.7 t -113.5 -54.05 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 124.5 1.12 . . . . 0.0 109.257 -174.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -157.87 153.97 27.19 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.364 1.066 . . . . 0.0 109.46 -177.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.4 t0 50.09 35.99 11.18 Favored 'General case' 0 CA--C 1.547 0.828 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 155.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.3 31.89 80.38 Favored Glycine 0 CA--C 1.535 1.331 0 O-C-N 120.615 -1.303 . . . . 0.0 112.992 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 83.2 m95 -123.37 152.73 41.22 Favored 'General case' 0 N--CA 1.442 -0.858 0 C-N-CA 127.935 2.494 . . . . 0.0 108.394 170.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -159.29 176.85 36.03 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-O 122.002 0.779 . . . . 0.0 111.363 174.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.62 145.06 30.79 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 114.647 -0.776 . . . . 0.0 111.814 176.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 21.7 t -107.07 144.05 34.31 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 160.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 68.8 p -97.36 -15.72 20.59 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 123.479 0.711 . . . . 0.0 111.391 -174.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -63.22 118.74 46.29 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-O 117.805 -1.093 . . . . 0.0 110.391 -176.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -51.3 119.37 5.36 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 123.223 2.615 . . . . 0.0 111.497 172.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . 0.372 0.8 OUTLIER 110.07 -16.06 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 130.755 3.622 . . . . 0.0 112.203 -170.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -128.23 14.22 6.69 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.982 1.713 . . . . 0.0 110.928 165.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -80.72 -31.22 36.17 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 125.292 1.437 . . . . 0.0 111.212 -176.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -70.46 0.32 Allowed 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -175.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.9 m -69.84 165.98 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.712 0.805 . . . . 0.0 111.755 -171.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.3 tp -91.62 118.5 30.68 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 170.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.2 m -91.88 148.45 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.2 tttm -66.59 138.78 57.71 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 177.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.96 -36.93 80.68 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 118.178 0.445 . . . . 0.0 111.09 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -82.26 3.2 28.47 Favored 'General case' 0 C--N 1.343 0.309 0 N-CA-C 113.857 1.058 . . . . 0.0 113.857 171.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.08 -176.91 28.24 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 109.996 -1.241 . . . . 0.0 109.996 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 73.5 t90 -163.64 153.93 15.5 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 174.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.408 ' SG ' HG22 ' A' ' 68' ' ' VAL . 3.1 p -135.69 160.26 39.06 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.774 1.23 . . . . 0.0 110.329 172.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 46.8 p -71.35 -15.9 62.41 Favored 'General case' 0 N--CA 1.452 -0.339 0 O-C-N 121.325 -0.859 . . . . 0.0 112.654 -177.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.408 HG22 ' SG ' ' A' ' 66' ' ' CYS 0.322 0.9 OUTLIER -76.48 -4.44 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-N 119.342 0.974 . . . . 0.0 112.323 172.132 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 37.3 t80 -42.91 130.92 4.26 Favored 'General case' 0 C--N 1.346 0.452 0 C-N-CA 124.183 0.993 . . . . 0.0 112.261 177.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.58 135.21 26.31 Favored Pre-proline 0 N--CA 1.455 -0.217 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 165.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -69.5 149.84 69.05 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 121.735 1.623 . . . . 0.0 110.798 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -96.7 39.54 1.16 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.667 0.746 . . . . 0.0 110.007 174.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.4 m . . . . . 0 C--O 1.248 0.981 0 C-N-CA 128.388 2.675 . . . . 0.0 105.699 178.127 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.349 0 N-CA-C 114.811 1.412 . . . . 0.0 114.811 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.6 m 48.92 37.05 9.34 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.079 1.352 . . . . 0.0 114.412 174.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -80.75 148.87 66.37 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 122.684 0.394 . . . . 0.0 110.053 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.6 140.6 26.85 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.659 2.239 . . . . 0.0 111.73 -173.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 31.9 mtt-85 -61.25 131.43 50.37 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.482 1.513 . . . . 0.0 111.158 174.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.32 142.96 54.0 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.012 1.325 . . . . 0.0 112.057 -178.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -84.95 155.23 21.72 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 122.042 0.925 . . . . 0.0 112.197 174.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -67.34 96.23 0.48 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.616 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 98.48 24.99 10.42 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.56 1.076 . . . . 0.0 111.667 -176.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -34.21 -55.52 0.51 Allowed 'General case' 0 C--N 1.345 0.372 0 C-N-CA 125.238 1.415 . . . . 0.0 111.896 170.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -160.37 169.66 22.64 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.813 -1.921 . . . . 0.0 105.813 169.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 43.77 46.45 6.46 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.933 1.293 . . . . 0.0 113.419 170.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 58.83 27.0 15.5 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.184 0.594 . . . . 0.0 112.298 169.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -46.99 -60.3 2.54 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -165.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.254 34.7 m 56.85 132.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 126.757 2.023 . . . . 0.0 113.893 -171.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -68.78 -27.68 66.1 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 120.574 -1.329 . . . . 0.0 112.746 -177.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 52.6 tt0 -110.43 115.29 29.4 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 170.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -42.36 -46.64 4.7 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 125.07 1.348 . . . . 0.0 110.656 173.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.99 -37.31 44.16 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 118.154 -0.927 . . . . 0.0 112.915 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -51.63 -35.45 42.0 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.411 1.005 . . . . 0.0 111.643 178.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.88 2.83 13.5 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 113.317 0.858 . . . . 0.0 113.317 -177.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 64.8 m -61.62 93.0 0.04 OUTLIER 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 119.598 1.09 . . . . 0.0 111.306 176.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.5 -34.51 1.06 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 125.52 1.533 . . . . 0.0 110.49 -174.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.2 t-80 -62.74 115.71 18.86 Favored Pre-proline 0 CA--C 1.535 0.379 0 CA-C-O 117.871 -1.062 . . . . 0.0 109.335 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -62.73 120.34 7.82 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 N-CA-C 107.587 -1.736 . . . . 0.0 107.587 171.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 118.91 -39.22 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 129.185 2.994 . . . . 0.0 108.902 -168.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -64.05 142.11 58.53 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 166.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -144.84 147.82 33.28 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 174.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.1 mp0 -55.73 117.46 3.66 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.434 1.493 . . . . 0.0 110.776 -170.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.13 7.41 70.18 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 119.705 -0.497 . . . . 0.0 112.373 175.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -72.63 91.14 1.41 Allowed 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 119.037 1.419 . . . . 0.0 108.509 167.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.5 mp -95.48 150.0 20.79 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 124.949 1.3 . . . . 0.0 109.003 169.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 2.1 m -46.21 -44.98 16.64 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.936 1.295 . . . . 0.0 110.653 172.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -63.06 -12.68 28.31 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 120.714 -1.241 . . . . 0.0 114.123 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.7 m-20 -97.99 2.63 49.15 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.867 1.267 . . . . 0.0 111.938 174.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 35.2 t -84.04 135.59 34.37 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.784 1.234 . . . . 0.0 109.779 -171.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.17 -16.17 59.23 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.601 -0.687 . . . . 0.0 112.446 178.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -94.65 0.03 54.77 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.387 174.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 77.2 t-105 -55.58 140.11 42.03 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.525 1.057 . . . . 0.0 110.807 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.41 -100.14 1.05 Allowed Glycine 0 CA--C 1.526 0.737 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 172.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -145.65 155.55 43.08 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.743 1.617 . . . . 0.0 107.388 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.38 145.75 49.18 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 123.749 0.655 . . . . 0.0 109.562 170.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 51.0 t -123.1 -45.21 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 125.316 1.446 . . . . 0.0 109.504 -174.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -147.78 -165.06 2.16 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.151 0.98 . . . . 0.0 109.821 -175.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -51.74 71.36 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 129.815 3.246 . . . . 0.0 114.847 -164.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 66.2 42.47 94.26 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -173.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -133.39 142.83 48.56 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 125.43 1.492 . . . . 0.0 108.9 172.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -156.46 173.34 34.27 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-O 122.25 0.917 . . . . 0.0 112.965 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -74.76 153.55 38.75 Favored 'General case' 0 N--CA 1.438 -1.05 0 C-N-CA 125.982 1.713 . . . . 0.0 112.317 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.8 t -141.52 117.76 10.72 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.109 1.364 . . . . 0.0 108.188 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 62.8 p -77.57 64.3 2.86 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.448 1.099 . . . . 0.0 111.862 -164.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -143.64 127.31 9.13 Favored Pre-proline 0 C--O 1.223 -0.326 0 C-N-CA 125.128 1.371 . . . . 0.0 108.138 176.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -58.15 -41.77 63.9 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.102 1.868 . . . . 0.0 110.794 -177.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -69.03 38.59 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.773 2.429 . . . . 0.0 112.463 172.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -176.58 -36.74 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.839 0.856 . . . . 0.0 112.555 -172.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -90.41 20.94 4.15 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.193 0.997 . . . . 0.0 112.377 -169.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.51 -55.56 4.23 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 167.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 34.3 m -76.3 176.73 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.497 169.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 22.3 tp -109.92 130.82 55.48 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.76 1.624 . . . . 0.0 107.763 171.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 17.6 m -93.85 140.66 16.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 118.703 0.683 . . . . 0.0 109.912 -174.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.5 tttm -62.96 135.45 57.31 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -53.02 -41.72 64.97 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 123.168 0.587 . . . . 0.0 111.018 173.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -83.42 6.3 20.6 Favored 'General case' 0 C--N 1.343 0.285 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 175.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -72.66 -169.48 14.04 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 171.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 60.7 t90 -158.29 -179.7 8.35 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 174.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.838 ' SG ' HG22 ' A' ' 68' ' ' VAL . 5.2 p -163.03 161.15 25.29 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 119.531 1.06 . . . . 0.0 110.217 161.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.9 p -72.28 -9.84 59.01 Favored 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.227 -0.92 . . . . 0.0 113.084 -174.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.838 HG22 ' SG ' ' A' ' 66' ' ' CYS . 3.1 m -74.94 -17.56 16.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 119.427 1.012 . . . . 0.0 111.423 168.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -38.57 132.79 1.11 Allowed 'General case' 0 C--N 1.348 0.502 0 C-N-CA 125.31 1.444 . . . . 0.0 113.117 -174.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -129.84 135.02 26.85 Favored Pre-proline 0 N--CA 1.452 -0.343 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 165.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -72.4 147.29 46.52 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.998 1.799 . . . . 0.0 111.169 -175.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -89.63 51.94 2.21 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.765 0.793 . . . . 0.0 109.306 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 75.4 p . . . . . 0 C--O 1.254 1.322 0 CA-C-O 115.282 -2.294 . . . . 0.0 107.886 -177.214 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.072 0 CA-C-O 118.366 -0.826 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.2 m 50.4 38.05 17.08 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.258 1.023 . . . . 0.0 113.288 -174.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -64.8 153.1 88.9 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 168.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -68.92 143.34 54.58 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.071 1.847 . . . . 0.0 111.274 -174.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 36.6 mtt-85 -55.14 127.83 30.99 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.467 1.507 . . . . 0.0 111.956 178.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.11 147.51 52.05 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.441 1.096 . . . . 0.0 112.491 -175.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.4 pm0 -92.26 152.67 19.7 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 125.815 1.646 . . . . 0.0 112.324 -177.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -68.28 96.4 0.65 Allowed 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.604 -175.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.01 28.71 14.48 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.426 -175.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 85.3 t60 -36.87 -53.11 0.94 Allowed 'General case' 0 C--N 1.344 0.344 0 C-N-CA 124.608 1.163 . . . . 0.0 111.001 166.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.55 -178.63 5.94 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 169.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 31.86 50.7 0.16 Allowed 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 127.88 2.472 . . . . 0.0 113.269 173.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 55.49 30.34 14.95 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.676 0.79 . . . . 0.0 112.228 169.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -50.91 -64.95 0.65 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.648 1.351 . . . . 0.0 114.648 -168.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.288 19.1 m 54.18 130.12 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 C-N-CA 126.897 2.079 . . . . 0.0 114.212 -171.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -66.1 -25.52 67.04 Favored 'General case' 0 N--CA 1.448 -0.543 0 O-C-N 120.646 -1.284 . . . . 0.0 112.881 -172.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -110.32 117.12 32.78 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 171.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -45.47 -43.62 11.69 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 124.686 1.194 . . . . 0.0 110.793 172.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.3 -38.13 57.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 118.461 -0.78 . . . . 0.0 112.913 177.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -52.49 -39.64 61.46 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 119.199 0.909 . . . . 0.0 110.61 175.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.59 2.18 8.54 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 118.91 -0.567 . . . . 0.0 112.501 -177.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 14.5 t -66.86 -2.95 5.77 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 120.055 1.298 . . . . 0.0 114.411 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -87.62 -9.87 71.19 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 124.27 0.938 . . . . 0.0 112.337 169.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -95.04 112.11 57.14 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 124.917 1.287 . . . . 0.0 110.449 -169.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -59.31 120.86 8.95 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 N-CA-C 107.424 -1.798 . . . . 0.0 107.424 163.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.5 tpt85 122.76 -40.33 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 129.175 2.99 . . . . 0.0 108.452 -168.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -65.39 146.32 55.04 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 166.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? -143.04 135.35 27.29 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 177.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -50.33 111.45 0.53 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.716 2.007 . . . . 0.0 111.736 -174.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.6 -10.31 45.59 Favored Glycine 0 CA--C 1.522 0.527 0 CA-C-O 118.98 -0.9 . . . . 0.0 111.623 174.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -64.75 118.58 9.16 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 119.109 1.455 . . . . 0.0 107.534 171.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.7 mp -130.04 149.06 51.92 Favored 'General case' 0 N--CA 1.457 -0.112 0 C-N-CA 125.989 1.716 . . . . 0.0 106.486 176.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 16.4 m -45.73 -46.91 15.31 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 124.065 0.946 . . . . 0.0 111.943 174.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -62.45 -15.84 51.85 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 120.428 -1.42 . . . . 0.0 114.167 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.0 p30 -110.74 23.38 14.26 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.625 1.17 . . . . 0.0 112.21 172.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.8 t -90.82 135.63 33.6 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 125.372 1.469 . . . . 0.0 108.236 172.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.79 -23.49 63.34 Favored 'General case' 0 C--N 1.331 -0.235 0 O-C-N 121.268 -0.895 . . . . 0.0 112.645 -178.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -74.98 -13.49 60.52 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 118.337 -0.84 . . . . 0.0 112.53 175.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -52.33 136.33 31.22 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 119.52 1.055 . . . . 0.0 112.821 -171.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.83 -66.38 1.28 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 125.831 1.681 . . . . 0.0 110.352 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -178.24 154.02 0.81 Allowed 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -161.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.47 134.82 34.09 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 166.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 88.1 t -113.7 -39.73 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.891 1.676 . . . . 0.0 110.153 -172.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -147.27 -172.67 4.06 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.303 1.041 . . . . 0.0 110.192 -169.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -52.81 72.08 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 130.196 3.398 . . . . 0.0 113.69 -172.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.77 37.24 83.99 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -172.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -129.76 148.39 51.63 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 125.663 1.585 . . . . 0.0 108.852 172.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -165.07 -176.12 36.42 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 177.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.5 mtp-105 -96.65 152.69 18.41 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 119.008 -0.52 . . . . 0.0 110.313 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.7 p -123.86 136.1 54.16 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 156.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 40.4 p -80.84 56.33 2.69 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.985 1.314 . . . . 0.0 110.66 -161.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -155.14 99.1 2.35 Favored Pre-proline 0 N--CA 1.448 -0.567 0 O-C-N 121.754 -0.591 . . . . 0.0 110.784 -170.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -45.97 131.32 13.75 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.827 3.018 . . . . 0.0 111.482 170.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 118.27 -47.53 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 129.894 3.278 . . . . 0.0 104.884 -153.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -137.61 31.69 2.54 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 126.313 1.845 . . . . 0.0 110.757 -172.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -113.44 -41.84 3.58 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.669 0.788 . . . . 0.0 109.737 175.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.437 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 1.2 mp0 -49.4 -44.96 45.58 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.738 1.615 . . . . 0.0 111.568 177.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.2 m -111.91 149.88 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 125.697 1.599 . . . . 0.0 108.653 -178.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 15.6 tp -77.95 132.43 37.87 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 62.0 t -90.31 122.47 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 125.912 1.685 . . . . 0.0 107.856 -169.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -60.78 130.55 47.03 Favored 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 121.023 -1.048 . . . . 0.0 108.455 171.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.02 -40.17 66.8 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 123.071 0.548 . . . . 0.0 111.657 177.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -83.51 3.04 34.04 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 175.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -69.24 -172.52 8.59 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 172.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 85.9 t90 -154.91 178.0 10.67 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 172.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.46 ' SG ' HG22 ' A' ' 68' ' ' VAL . 3.6 p -161.08 159.15 28.84 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 119.489 1.041 . . . . 0.0 109.013 163.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.7 p -73.77 -1.79 20.72 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 121.021 -1.049 . . . . 0.0 112.99 -175.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.46 HG22 ' SG ' ' A' ' 66' ' ' CYS 0.329 0.9 OUTLIER -83.31 -8.77 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 119.35 0.977 . . . . 0.0 112.286 164.957 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -38.86 123.7 1.31 Allowed 'General case' 0 C--N 1.344 0.368 0 C-N-CA 125.3 1.44 . . . . 0.0 112.914 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -117.33 134.84 23.06 Favored Pre-proline 0 N--CA 1.455 -0.213 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 169.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -70.82 150.32 61.57 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 122.08 1.853 . . . . 0.0 110.957 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -99.7 37.21 1.64 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.979 0.911 . . . . 0.0 110.227 176.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 C--O 1.25 1.106 0 C-N-CA 128.966 2.906 . . . . 0.0 105.242 177.764 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.75 ' HB3' ' CD ' ' A' ' 3' ' ' GLU . . . . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 m -107.97 55.29 0.65 Allowed 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 158.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.75 ' CD ' ' HB3' ' A' ' 1' ' ' ALA . 29.5 mp0 -60.5 140.05 92.3 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 123.031 0.532 . . . . 0.0 110.239 -175.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -65.64 151.88 83.34 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.634 2.223 . . . . 0.0 110.673 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.441 ' HB3' ' CH2' ' A' ' 47' ' ' TRP . 14.4 mtp180 -72.33 125.87 28.43 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -174.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -54.85 141.85 31.6 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.716 1.606 . . . . 0.0 112.817 -168.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -77.29 144.38 38.16 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.293 1.037 . . . . 0.0 108.592 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -63.09 120.16 10.91 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 165.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.86 25.19 72.37 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 118.219 -1.323 . . . . 0.0 112.93 -172.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -40.42 -54.84 2.38 Favored 'General case' 0 C--N 1.347 0.458 0 CA-C-N 119.595 1.698 . . . . 0.0 110.771 166.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -167.67 177.78 5.66 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.388 1.475 . . . . 0.0 107.579 172.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 33.38 52.04 0.35 Allowed 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 127.057 2.143 . . . . 0.0 113.099 172.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 60.06 18.85 8.05 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.071 0.948 . . . . 0.0 112.675 169.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -62.69 137.42 58.26 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 118.554 0.615 . . . . 0.0 110.029 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.2 m -126.84 143.68 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 168.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -59.97 -34.59 73.49 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 119.12 -0.467 . . . . 0.0 111.284 -174.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.96 128.67 54.53 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 123.433 0.693 . . . . 0.0 110.285 169.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.11 -31.86 20.68 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 124.52 1.128 . . . . 0.0 110.63 165.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.18 -45.45 75.78 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.425 0.557 . . . . 0.0 111.406 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.34 -29.75 70.09 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.216 0.532 . . . . 0.0 110.606 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.23 -6.05 36.71 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 118.324 -0.846 . . . . 0.0 112.599 -177.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 67.0 m -50.0 -32.41 15.13 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -67.22 -24.57 73.45 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 124.664 1.126 . . . . 0.0 113.164 178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -79.03 117.72 68.42 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 118.404 1.102 . . . . 0.0 111.082 -169.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -63.94 108.45 0.93 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 N-CA-C 107.266 -1.859 . . . . 0.0 107.266 164.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 mmm-85 135.69 -31.79 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 131.166 3.787 . . . . 0.0 109.881 -173.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 70.3 t80 -68.5 149.12 49.63 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 171.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 4.2 tm0? -143.46 136.7 27.97 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 175.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.7 mp0 -50.58 110.48 0.42 Allowed 'General case' 0 N--CA 1.444 -0.734 0 C-N-CA 126.954 2.101 . . . . 0.0 111.753 -174.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.14 -9.82 43.11 Favored Glycine 0 C--N 1.334 0.463 0 CA-C-O 119.093 -0.837 . . . . 0.0 111.561 174.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -64.82 120.03 11.75 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 119.06 1.43 . . . . 0.0 107.824 172.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.4 mp -131.77 153.06 50.49 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.218 1.807 . . . . 0.0 107.206 177.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 33.6 m -48.96 -47.12 44.19 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.873 0.76 . . . . 0.0 110.993 174.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.257 6.2 tt0 -75.72 26.13 0.11 Allowed 'General case' 0 CA--C 1.549 0.915 0 O-C-N 120.32 -1.488 . . . . 0.0 113.671 176.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -142.25 29.77 1.61 Allowed 'General case' 0 CA--C 1.537 0.453 0 O-C-N 120.596 -1.315 . . . . 0.0 110.793 156.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 50.6 t -96.72 139.24 33.07 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.886 1.674 . . . . 0.0 109.208 177.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.89 -21.12 64.45 Favored 'General case' 0 CA--C 1.531 0.232 0 O-C-N 121.569 -0.707 . . . . 0.0 112.572 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -96.4 15.28 21.75 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 119.001 -0.523 . . . . 0.0 111.951 175.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 48.6 t-105 -66.85 149.74 50.16 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 119.424 1.011 . . . . 0.0 110.997 175.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.53 -101.23 1.97 Allowed Glycine 0 CA--C 1.525 0.673 0 N-CA-C 108.372 -1.891 . . . . 0.0 108.372 169.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -149.95 153.92 37.41 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.76 1.624 . . . . 0.0 107.648 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.13 141.54 58.72 Favored 'General case' 0 N--CA 1.451 -0.396 0 O-C-N 123.69 0.619 . . . . 0.0 110.612 168.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.5 t -114.13 -49.19 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 126.28 1.832 . . . . 0.0 109.23 -178.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -148.02 -150.58 0.35 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.408 0.683 . . . . 0.0 111.214 -171.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -67.55 68.16 0.09 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 128.338 2.655 . . . . 0.0 113.21 -161.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.01 29.33 46.92 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 124.548 1.07 . . . . 0.0 110.501 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TRP . . . . . 0.441 ' CH2' ' HB3' ' A' ' 5' ' ' ARG . 84.6 m95 -132.19 148.21 52.45 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.192 1.397 . . . . 0.0 109.462 177.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -160.64 178.8 36.49 Favored Glycine 0 N--CA 1.433 -1.564 0 O-C-N 124.395 1.059 . . . . 0.0 110.691 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -82.0 132.69 35.26 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 114.852 -0.674 . . . . 0.0 110.67 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 43.2 t -89.12 153.31 21.07 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 155.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 66.8 p -119.84 28.8 7.9 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.49 0.716 . . . . 0.0 111.468 -175.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -113.07 112.68 49.78 Favored Pre-proline 0 N--CA 1.455 -0.203 0 CA-C-O 117.721 -1.133 . . . . 0.0 108.19 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -46.59 124.11 7.78 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 121.852 1.701 . . . . 0.0 107.89 160.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 129.82 -43.52 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 128.887 2.875 . . . . 0.0 106.472 -157.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -131.48 -38.4 1.18 Allowed 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.361 2.264 . . . . 0.0 111.87 -171.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -42.12 -39.39 1.98 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.7 1.6 . . . . 0.0 112.921 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.431 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 2.5 mp0 -45.71 -39.73 8.41 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.119 0.968 . . . . 0.0 113.257 176.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.5 m -117.04 160.39 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 C-N-CA 125.071 1.348 . . . . 0.0 109.872 -172.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 22.5 tp -83.64 131.18 34.97 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 173.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 51.8 t -104.63 133.71 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 C-N-CA 123.674 0.79 . . . . 0.0 108.909 -167.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.413 ' HD2' ' CZ2' ' A' ' 47' ' ' TRP . 30.1 tttm -62.98 126.72 28.28 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 175.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.56 -31.78 68.3 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.343 0.657 . . . . 0.0 110.841 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -81.21 -8.19 59.71 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 124.796 1.238 . . . . 0.0 112.443 176.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -76.76 -172.42 35.87 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TRP . . . . . . . . . . . . . 72.3 t90 -165.84 150.58 8.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 3.7 p -134.22 162.36 32.36 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 124.965 1.306 . . . . 0.0 110.001 175.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.4 p -69.91 -20.42 63.36 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.0 -1.062 . . . . 0.0 112.672 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.364 0.8 OUTLIER -71.94 -3.75 4.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 119.553 1.069 . . . . 0.0 112.595 170.596 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -45.14 128.83 7.63 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 118.809 0.732 . . . . 0.0 111.012 171.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -128.73 137.67 31.45 Favored Pre-proline 0 N--CA 1.452 -0.334 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 165.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.8 148.95 59.47 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.028 1.819 . . . . 0.0 110.794 -177.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -95.13 42.83 1.09 Allowed 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.492 0.717 . . . . 0.0 109.953 179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.1 p . . . . . 0 C--O 1.253 1.272 0 CA-C-O 114.889 -2.481 . . . . 0.0 106.759 -172.345 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SF4 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_